<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="review-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Nutrients</journal-id><journal-id journal-id-type="iso-abbrev">Nutrients</journal-id><journal-id journal-id-type="pmc-domain-id">1692</journal-id><journal-id journal-id-type="pmc-domain">nutrients</journal-id><journal-id journal-id-type="publisher-id">nutrients</journal-id><journal-title-group><journal-title>Nutrients</journal-title></journal-title-group><issn pub-type="epub">2072-6643</issn><publisher><publisher-name>Multidisciplinary Digital Publishing Institute  (MDPI)</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12430471</article-id><article-id pub-id-type="pmcid-ver">PMC12430471.1</article-id><article-id pub-id-type="pmcaid">12430471</article-id><article-id pub-id-type="pmcaiid">12430471</article-id><article-id pub-id-type="doi">10.3390/nu17172884</article-id><article-id pub-id-type="publisher-id">nutrients-17-02884</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>The Neuroprotective Role of Curcumin: From Molecular Pathways to Clinical Translation&#8212;A Narrative Review</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-4285-7518</contrib-id><name name-style="western"><surname>Lehoczki</surname><given-names initials="A">Andrea</given-names></name><xref rid="af1-nutrients-17-02884" ref-type="aff">1</xref><xref rid="af2-nutrients-17-02884" ref-type="aff">2</xref><xref rid="af3-nutrients-17-02884" ref-type="aff">3</xref><xref rid="fn1-nutrients-17-02884" ref-type="author-notes">&#8224;</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-8632-2120</contrib-id><name name-style="western"><surname>Fekete</surname><given-names initials="M">M&#243;nika</given-names></name><xref rid="af1-nutrients-17-02884" ref-type="aff">1</xref><xref rid="af2-nutrients-17-02884" ref-type="aff">2</xref><xref rid="fn1-nutrients-17-02884" ref-type="author-notes">&#8224;</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-8419-5292</contrib-id><name name-style="western"><surname>Jarecsny</surname><given-names initials="T">Tam&#225;s</given-names></name><xref rid="af4-nutrients-17-02884" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Z&#225;b&#243;</surname><given-names initials="V">Vir&#225;g</given-names></name><xref rid="af2-nutrients-17-02884" ref-type="aff">2</xref><xref rid="af5-nutrients-17-02884" ref-type="aff">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Szappanos</surname><given-names initials="&#xC1;">&#193;gnes</given-names></name><xref rid="af5-nutrients-17-02884" ref-type="aff">5</xref><xref rid="af6-nutrients-17-02884" ref-type="aff">6</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Cs&#237;p&#337;</surname><given-names initials="T">Tam&#225;s</given-names></name><xref rid="af1-nutrients-17-02884" ref-type="aff">1</xref><xref rid="af2-nutrients-17-02884" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0009-0003-7608-3041</contrib-id><name name-style="western"><surname>Lip&#233;cz</surname><given-names initials="&#xC1;">&#193;gnes</given-names></name><xref rid="af1-nutrients-17-02884" ref-type="aff">1</xref><xref rid="af2-nutrients-17-02884" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-6108-9745</contrib-id><name name-style="western"><surname>Major</surname><given-names initials="D">D&#225;vid</given-names></name><xref rid="af1-nutrients-17-02884" ref-type="aff">1</xref><xref rid="af2-nutrients-17-02884" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-6405-4003</contrib-id><name name-style="western"><surname>Fazekas-Pongor</surname><given-names initials="V">Vince</given-names></name><xref rid="af1-nutrients-17-02884" ref-type="aff">1</xref><xref rid="af2-nutrients-17-02884" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Varga</surname><given-names initials="P">P&#233;ter</given-names></name><xref rid="af1-nutrients-17-02884" ref-type="aff">1</xref><xref rid="af2-nutrients-17-02884" ref-type="aff">2</xref><xref rid="af3-nutrients-17-02884" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-8552-1336</contrib-id><name name-style="western"><surname>Varga</surname><given-names initials="JT">J&#225;nos Tam&#225;s</given-names></name><xref rid="af7-nutrients-17-02884" ref-type="aff">7</xref><xref rid="c1-nutrients-17-02884" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name name-style="western"><surname>Lin</surname><given-names initials="CL">Chih-Li</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-nutrients-17-02884"><label>1</label>Institute of Preventive Medicine and Public Health, Semmelweis University, 1085 Budapest, Hungary; <email>ceglediandi@freemail.hu</email> (A.L.); <email>fekete.monika@semmelweis.hu</email> (M.F.); <email>csipo.tamas@semmelweis.hu</email> (T.C.); <email>lipecz.agnes@semmelweis.hu</email> (&#193;.L.); <email>major.david@semmelweis.hu</email> (D.M.); <email>pongor.vince@semmelweis.hu</email> (V.F.-P.); <email>varga.peter@semmelweis.hu</email> (P.V.)</aff><aff id="af2-nutrients-17-02884"><label>2</label>Fodor Center for Prevention and Healthy Aging, Semmelweis University, 1085 Budapest, Hungary; <email>zabo.virag@semmelweis.hu</email></aff><aff id="af3-nutrients-17-02884"><label>3</label>Health Sciences Division, Doctoral College, Semmelweis University, 1085 Budapest, Hungary</aff><aff id="af4-nutrients-17-02884"><label>4</label>Department of Neurology and Stroke, Saint John&#8217;s Central Hospital of North Buda, 1125 Budapest, Hungary; <email>jarecsny.tamas@janoskorhaz.hu</email></aff><aff id="af5-nutrients-17-02884"><label>5</label>Heart and Vascular Center, Semmelweis University, 1122 Budapest, Hungary; <email>drszappanos@gmail.com</email></aff><aff id="af6-nutrients-17-02884"><label>6</label>Department of Rheumatology and Clinical Immunology, Semmelweis University, 1085 Budapest, Hungary</aff><aff id="af7-nutrients-17-02884"><label>7</label>Department of Pulmonology, Semmelweis University, 1083 Budapest, Hungary</aff><author-notes><corresp id="c1-nutrients-17-02884"><label>*</label>Correspondence: <email>varga.janos.tamas@semmelweis.hu</email></corresp><fn id="fn1-nutrients-17-02884"><label>&#8224;</label><p>These authors contributed equally to this work.</p></fn></author-notes><pub-date pub-type="epub"><day>06</day><month>9</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>9</month><year>2025</year></pub-date><volume>17</volume><issue>17</issue><issue-id pub-id-type="pmc-issue-id">495755</issue-id><elocation-id>2884</elocation-id><history><date date-type="received"><day>12</day><month>8</month><year>2025</year></date><date date-type="rev-recd"><day>31</day><month>8</month><year>2025</year></date><date date-type="accepted"><day>05</day><month>9</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>06</day><month>09</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>13</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-13 16:25:51.440"><day>13</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; 2025 by the authors.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nutrients-17-02884.pdf"/><abstract><p>Neurodegenerative disorders, including Alzheimer&#8217;s disease (AD), Parkinson&#8217;s disease (PD), and post-stroke cognitive impairment (PSCI), represent an escalating global health and economic challenge. In the quest for disease-modifying interventions, natural polyphenols&#8212;most notably curcumin, the principal bioactive compound of Curcuma longa&#8212;have attracted considerable interest due to their pleiotropic neuroprotective effects. This narrative review critically synthesizes findings from a selection of peer-reviewed articles published between 2000 and 2025, chosen for their relevance to curcumin&#8217;s molecular mechanisms and translational potential. Curcumin&#8217;s complex chemical structure confers antioxidant, anti-inflammatory, and epigenetic modulatory properties; however, its clinical application is limited by poor oral bioavailability. Mechanistically, curcumin attenuates oxidative stress and suppresses key inflammatory mediators, including nuclear factor kappa B (NF-&#954;B), cyclooxygenase-2 (COX-2), and inducible nitric oxide synthase (iNOS). Additionally, it modulates apoptosis, inhibits amyloid-beta aggregation, and enhances cellular quality control processes such as autophagy and mitophagy, while upregulating neurotrophic factors such as brain-derived neurotrophic factor (BDNF). Preclinical studies employing rodent models of AD, PD, and ischemic stroke have demonstrated curcumin&#8217;s dose-dependent neuroprotective efficacy, with improved outcomes observed using nanoparticle-based delivery systems. Early-phase clinical trials further support curcumin&#8217;s favorable safety profile and potential cognitive benefits, although challenges remain regarding pharmacokinetics, formulation standardization, and therapeutic reproducibility. Future directions include the development of advanced drug delivery platforms, combinatory therapeutic regimens, and personalized medicine approaches integrating curcumin within multifaceted neurotherapeutic strategies. Collectively, this narrative review highlights curcumin as a promising multi-targeted candidate for combating neurodegenerative diseases, while emphasizing the need for further translational and clinical validation.</p></abstract><kwd-group><kwd>curcumin</kwd><kwd>neurodegeneration</kwd><kwd>Alzheimer&#8217;s disease</kwd><kwd>Parkinson&#8217;s disease</kwd><kwd>polyphenols</kwd><kwd>neuroinflammation</kwd><kwd>oxidative stress</kwd><kwd>narrative review</kwd><kwd>clinical translation</kwd></kwd-group><funding-group><award-group><funding-source>Semmelweis University</funding-source></award-group><award-group><funding-source>National Research, Development and Innovation Fund under TKP2021-NKTA</funding-source><award-id>TKP2021-NKTA-47</award-id></award-group><award-group><funding-source>Ministry of Innovation and Technology under the National Cardiovascular Laboratory Program</funding-source><award-id>RRF-2.3.1-21-2022-00003</award-id></award-group><award-group><funding-source>European University for Well-Being (EUniWell) program</funding-source><award-id>101004093/EUniWell/EAC-A02-2019/EAC-A02-2019-1</award-id></award-group><award-group><funding-source>National Institute on Aging</funding-source><award-id>NIA R03AG070479</award-id><award-id>NIA K01AG073614</award-id></award-group><award-group><funding-source>American Heart Association</funding-source><award-id>AHA CDA941290</award-id></award-group><award-group><funding-source>NIA-supported Geroscience Training Program in Oklahoma</funding-source><award-id>T32AG052363</award-id></award-group><award-group><funding-source>New National Excellence Program of the Ministry for Culture and Innovation from the National Research, Development and Innovation Fund</funding-source><award-id>EK&#214;P-2024-9</award-id></award-group><funding-statement>Open access funding provided by Semmelweis University. Project: no. TKP2021-NKTA-47 was funded by the National Research, Development and Innovation Fund under TKP2021-NKTA, with support from the Ministry of Innovation and Technology of Hungary. The project was funded by the Ministry of Innovation and Technology under the National Cardiovascular Laboratory Program (RRF-2.3.1-21-2022-00003) from the National Research, Development and Innovation Fund. This work was also supported by the European University for Well-Being (EUniWell) program (grant agreement number: 101004093/EUniWell/EAC-A02-2019/EAC-A02-2019-1) and the National Institute on Aging (NIA R03AG070479, NIA K01AG073614), the American Heart Association AHA CDA941290, and the NIA-supported Geroscience Training Program in Oklahoma (T32AG052363). A.L. was supported by the EK&#214;P-2024-9 New National Excellence Program of the Ministry for Culture and Innovation from the National Research, Development and Innovation Fund. The funding sources had no role in the study design; in the collection, analysis and interpretation of data; in the writing of the report; or in the decision to submit the article for publication.</funding-statement></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="sec1-nutrients-17-02884"><title>1. Introduction</title><p>Neurodegenerative diseases such as Alzheimer&#8217;s disease (AD), Parkinson&#8217;s disease (PD), and post-stroke neurodegeneration pose a significant and growing global health challenge, with profound social and economic consequences [<xref rid="B1-nutrients-17-02884" ref-type="bibr">1</xref>]. These disorders are characterized by progressive neuronal loss and functional decline, and current therapeutic options largely focus on symptom management rather than disease modification [<xref rid="B2-nutrients-17-02884" ref-type="bibr">2</xref>]. Central to neurodegeneration are interrelated molecular mechanisms, including oxidative stress, chronic neuroinflammation, mitochondrial dysfunction, impaired proteostasis, and apoptosis, all contributing to irreversible neuronal damage [<xref rid="B3-nutrients-17-02884" ref-type="bibr">3</xref>].</p><p>Recently, naturally derived polyphenols with pleiotropic bioactivity have garnered considerable attention for their capacity to modulate these interconnected pathological pathways [<xref rid="B4-nutrients-17-02884" ref-type="bibr">4</xref>,<xref rid="B5-nutrients-17-02884" ref-type="bibr">5</xref>]. Among them, curcumin&#8212;the principal bioactive compound in Curcuma longa (turmeric)&#8212;has emerged as a promising neuroprotective agent due to its antioxidant, anti-inflammatory, anti-apoptotic, and metal-chelating properties [<xref rid="B6-nutrients-17-02884" ref-type="bibr">6</xref>]. Long utilized in traditional Asian medicine, curcumin has recently attracted biomedical interest for its ability to target key molecular drivers of neurodegeneration [<xref rid="B7-nutrients-17-02884" ref-type="bibr">7</xref>].</p><p>Curcumin exerts diverse neuroprotective effects, including modulation of intracellular signaling cascades, preservation of mitochondrial integrity, suppression of microglial activation, and enhancement of synaptic plasticity [<xref rid="B8-nutrients-17-02884" ref-type="bibr">8</xref>,<xref rid="B9-nutrients-17-02884" ref-type="bibr">9</xref>]. Notably, curcumin interacts with nicotinic acetylcholine receptors, particularly the &#945;7 subtype (&#945;7-nAChRs), which regulate dopaminergic neurotransmission, neuroinflammation, and cellular resilience [<xref rid="B10-nutrients-17-02884" ref-type="bibr">10</xref>]. Experimental models of PD suggest that &#945;7-nAChR modulation by curcumin may contribute to improved motor function and dopaminergic neuron survival [<xref rid="B11-nutrients-17-02884" ref-type="bibr">11</xref>,<xref rid="B12-nutrients-17-02884" ref-type="bibr">12</xref>].</p><p>Despite promising in vitro, in vivo, and in silico evidence, clinical translation is hindered by curcumin&#8217;s low oral bioavailability, rapid metabolism, and limited central nervous system penetration [<xref rid="B13-nutrients-17-02884" ref-type="bibr">13</xref>]. Nevertheless, preclinical and early clinical studies report beneficial effects on cognitive function, neuroinflammation, and neuronal survival across multiple neurodegenerative models [<xref rid="B14-nutrients-17-02884" ref-type="bibr">14</xref>,<xref rid="B15-nutrients-17-02884" ref-type="bibr">15</xref>].</p><p>This article presents a narrative review that synthesizes and critically evaluates current evidence on the neuroprotective properties of curcumin, with particular emphasis on its molecular mechanisms in neurodegenerative disorders such as Alzheimer&#8217;s disease, Parkinson&#8217;s disease, and post-stroke cognitive impairment. The literature was identified through a broad search of peer-reviewed publications in major biomedical databases (2000&#8211;2025), with selection based on thematic relevance and scientific quality rather than strict systematic criteria. By clarifying the mechanistic basis of curcumin&#8217;s neuroprotective effects and assessing its translational potential, this review aims to provide a balanced overview of both the opportunities and limitations of curcumin-based interventions in neurodegenerative diseases.</p></sec><sec sec-type="methods" id="sec2-nutrients-17-02884"><title>2. Methods</title><sec id="sec2dot1-nutrients-17-02884"><title>2.1. Literature Search Strategy</title><p>A comprehensive literature search was conducted between March and May 2025 across four major databases&#8212;PubMed/MEDLINE, Web of Science, Scopus, and Embase&#8212;supplemented by Google Scholar to capture grey literature and additional sources not indexed in traditional databases.</p><p>The search strategy combined Medical Subject Headings (MeSH) with free-text keywords to ensure broad coverage. The primary search strings included:<list list-type="bullet"><list-item><p>&#8220;curcumin&#8221; AND (&#8220;neurodegeneration&#8221; OR &#8220;neurodegenerative disease&#8221; OR &#8220;Parkinson&#8217;s disease&#8221; OR &#8220;Alzheimer&#8217;s disease&#8221; OR &#8220;stroke&#8221; OR &#8220;cognitive impairment&#8221;)</p></list-item><list-item><p>&#8220;curcumin&#8221; AND (&#8220;oxidative stress&#8221; OR &#8220;neuroinflammation&#8221; OR &#8220;BDNF&#8221; OR &#8220;NF-&#954;B&#8221; OR &#8220;mitophagy&#8221; OR &#8220;apoptosis&#8221;)</p></list-item><list-item><p>&#8220;curcumin&#8221; AND (&#8220;bioavailability&#8221; OR &#8220;nanoparticles&#8221; OR &#8220;clinical trial&#8221;)</p></list-item></list></p><p>Searches were limited to English-language publications between January 2000 and May 2025. The temporal restriction was chosen because research on the molecular mechanisms of curcumin in neurodegenerative disorders has significantly expanded since 2000, coinciding with advances in molecular biology techniques, biomarker discovery, and the initiation of early-phase clinical trials. Earlier literature prior to 2000 primarily addressed curcumin&#8217;s general pharmacological and anti-inflammatory effects, without a strong focus on neurodegeneration. Thus, this timeframe was selected to ensure both scientific relevance and methodological rigor. No restrictions were placed on study design, enabling the inclusion of in vitro, in vivo, clinical studies, and systematic or narrative reviews. Reference lists of key articles were also manually screened to identify additional eligible studies.</p></sec><sec id="sec2dot2-nutrients-17-02884"><title>2.2. Study Selection and Inclusion Criteria</title><p>Studies were included if they:<list list-type="simple"><list-item><label>(i)</label><p>investigated molecular or cellular mechanisms of curcumin relevant to neurodegenerative disorders;</p></list-item><list-item><label>(ii)</label><p>reported preclinical data from in vitro or in vivo models, or clinical evidence of neuroprotective effects;</p></list-item><list-item><label>(iii)</label><p>addressed pharmacokinetics, bioavailability, or delivery strategies within a neurological context.</p></list-item></list></p><p>Exclusion criteria were:<list list-type="simple"><list-item><label>(i)</label><p>non-peer-reviewed publications (unless of significant foundational value);</p></list-item><list-item><label>(ii)</label><p>studies focused solely on non-neurological conditions;</p></list-item><list-item><label>(iii)</label><p>duplicate or non-English publications.</p></list-item></list></p></sec><sec id="sec2dot3-nutrients-17-02884"><title>2.3. Guiding Research Question</title><p>To provide focus and clarity, the following guiding research question was formulated: &#8220;What are the key molecular mechanisms by which curcumin exerts neuroprotective effects, and how can these mechanisms be translated into clinical applications in neurodegenerative diseases?&#8221;</p></sec><sec id="sec2dot4-nutrients-17-02884"><title>2.4. Data Extraction and Synthesis</title><p>For each included study, the following data were extracted:<list list-type="simple"><list-item><label>(i)</label><p>molecular pathways modulated by curcumin (oxidative stress, neuroinflammation, autophagy, apoptosis, mitochondrial function);</p></list-item><list-item><label>(ii)</label><p>pharmacokinetic characteristics and bioavailability enhancement strategies;</p></list-item><list-item><label>(iii)</label><p>experimental models used, particularly animal models of Alzheimer&#8217;s disease, Parkinson&#8217;s disease, and ischemic stroke;</p></list-item><list-item><label>(iv)</label><p>clinical efficacy and safety outcomes.</p></list-item></list></p><p>The evidence was synthesized narratively, integrating mechanistic insights with preclinical and clinical findings. Special attention was given to identifying translational gaps, methodological limitations, and promising future directions for curcumin-based therapeutic interventions in neurodegenerative disorders.</p></sec></sec><sec id="sec3-nutrients-17-02884"><title>3. Biological Properties of Curcumin</title><sec id="sec3dot1-nutrients-17-02884"><title>3.1. Chemical Structure and Physical Characteristics</title><p>Curcumin (diferuloylmethane), the principal polyphenolic constituent of Curcuma longa, was first isolated in the early 19th century, and its chemical structure was elucidated in 1910 [<xref rid="B16-nutrients-17-02884" ref-type="bibr">16</xref>]. It is a symmetric molecule composed of two aromatic rings substituted with ortho-methoxy and phenolic groups, linked by a seven-carbon chain containing a conjugated &#946;-diketone moiety [<xref rid="B17-nutrients-17-02884" ref-type="bibr">17</xref>,<xref rid="B18-nutrients-17-02884" ref-type="bibr">18</xref>]. The molecule exists in tautomeric keto and enol forms, with the keto form predominating under acidic or neutral pH conditions, whereas the enol form is favored in alkaline environments [<xref rid="B19-nutrients-17-02884" ref-type="bibr">19</xref>].</p><p>The curcuminoid fraction of turmeric primarily comprises three naturally occurring analogs: curcumin (I), demethoxycurcumin (II), and bisdemethoxycurcumin (III), each contributing differently to its biological activity [<xref rid="B20-nutrients-17-02884" ref-type="bibr">20</xref>]. Curcumin is a highly lipophilic compound that is practically insoluble in water but soluble in organic solvents such as ethanol, dimethyl sulfoxide (DMSO), and acetone [<xref rid="B21-nutrients-17-02884" ref-type="bibr">21</xref>]. Its hydrophobic nature and chemical instability under physiological conditions pose significant challenges for its pharmacological application [<xref rid="B22-nutrients-17-02884" ref-type="bibr">22</xref>].</p></sec><sec id="sec3dot2-nutrients-17-02884"><title>3.2. Pharmacokinetics and Bioavailability</title><p>Following oral administration, curcumin demonstrates poor systemic bioavailability due to limited intestinal absorption, rapid hepatic metabolism, and swift systemic elimination [<xref rid="B23-nutrients-17-02884" ref-type="bibr">23</xref>]. Clinical pharmacokinetic studies have shown that even high oral doses (4&#8211;8 g/day) yield low plasma concentrations, typically ranging from 0.4 to 1.7 micromoles per liter (&#956;mol/L) [<xref rid="B24-nutrients-17-02884" ref-type="bibr">24</xref>]. These low levels are largely attributed to extensive first-pass hepatic metabolism, including reductive metabolism and subsequent conjugation with glucuronic acid and sulfate, producing curcumin glucuronides and sulfates (<xref rid="nutrients-17-02884-f001" ref-type="fig">Figure 1</xref>) [<xref rid="B25-nutrients-17-02884" ref-type="bibr">25</xref>].</p><p>To overcome these limitations, a wide range of formulation strategies has been developed to enhance curcumin&#8217;s oral bioavailability [<xref rid="B26-nutrients-17-02884" ref-type="bibr">26</xref>]. These include nanoemulsions, liposomal encapsulation, and polymer-based nanoparticle systems, such as poly(lactic-co-glycolic acid) (PLGA), alginate, and lactoferrin nanoparticles [<xref rid="B27-nutrients-17-02884" ref-type="bibr">27</xref>]. Cyclodextrin complexes have also been shown to improve curcumin&#8217;s aqueous solubility and chemical stability. In addition, co-administration with piperine (an alkaloid derived from Piper nigrum) significantly inhibits curcumin glucuronidation, thereby increasing its plasma concentration by up to 2000% and extending its elimination half-life [<xref rid="B28-nutrients-17-02884" ref-type="bibr">28</xref>]. These advanced delivery systems not only increase systemic exposure but also enhance blood&#8211;brain barrier (BBB) penetration, which is crucial for achieving therapeutic concentrations in the central nervous system, particularly in the context of neurodegenerative diseases such as Alzheimer&#8217;s and Parkinson&#8217;s disease [<xref rid="B29-nutrients-17-02884" ref-type="bibr">29</xref>,<xref rid="B30-nutrients-17-02884" ref-type="bibr">30</xref>].</p></sec><sec id="sec3dot3-nutrients-17-02884"><title>3.3. Antioxidant, Anti-Inflammatory, and Epigenetic Effects</title><p>Curcumin exhibits a broad spectrum of biological activities, with its antioxidant and anti-inflammatory properties underpinning its neuroprotective potential [<xref rid="B31-nutrients-17-02884" ref-type="bibr">31</xref>]. As an antioxidant, curcumin directly scavenges reactive oxygen and nitrogen species (ROS/RNS) and upregulates endogenous antioxidant enzymes, including superoxide dismutase, catalase, and glutathione peroxidase [<xref rid="B32-nutrients-17-02884" ref-type="bibr">32</xref>]. It further inhibits lipid peroxidation and preserves mitochondrial integrity under oxidative stress conditions [<xref rid="B33-nutrients-17-02884" ref-type="bibr">33</xref>].</p><p>The anti-inflammatory effects of curcumin are mediated via downregulation of pivotal inflammatory signaling pathways, notably nuclear factor-kappa B (NF-&#954;B), alongside suppression of pro-inflammatory enzymes such as cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) [<xref rid="B34-nutrients-17-02884" ref-type="bibr">34</xref>]. Additionally, curcumin attenuates microglial activation, thereby mitigating neuroinflammation in pathological contexts [<xref rid="B8-nutrients-17-02884" ref-type="bibr">8</xref>].</p><p>At the epigenetic level [<xref rid="B35-nutrients-17-02884" ref-type="bibr">35</xref>], curcumin modulates DNA methylation, histone acetylation, and microRNA expression, regulating gene networks associated with neuronal survival, apoptosis inhibition, and synaptic plasticity [<xref rid="B36-nutrients-17-02884" ref-type="bibr">36</xref>]. These epigenetic modifications contribute to the restoration of cellular homeostasis and enhanced resilience in neurodegenerative milieus [<xref rid="B37-nutrients-17-02884" ref-type="bibr">37</xref>]. Collectively, curcumin&#8217;s capacity to attenuate oxidative damage, suppress neuroinflammation, and promote neuronal survival underscores its therapeutic promise in central and peripheral neurodegenerative disorders [<xref rid="B38-nutrients-17-02884" ref-type="bibr">38</xref>,<xref rid="B39-nutrients-17-02884" ref-type="bibr">39</xref>]. Its multi-targeted mechanisms of action render curcumin a compelling natural candidate in the development of effective neuroprotective interventions [<xref rid="B11-nutrients-17-02884" ref-type="bibr">11</xref>].</p></sec></sec><sec id="sec4-nutrients-17-02884"><title>4. Molecular Mechanisms Underlying the Neuroprotective Effects of Curcumin</title><p>The neuroprotective potential of curcumin arises from its capacity to modulate multiple interconnected pathophysiological processes within the central nervous system (CNS) [<xref rid="B14-nutrients-17-02884" ref-type="bibr">14</xref>,<xref rid="B40-nutrients-17-02884" ref-type="bibr">40</xref>]. Curcumin is widely recognized for its potent, multifaceted anti-aging [<xref rid="B41-nutrients-17-02884" ref-type="bibr">41</xref>,<xref rid="B42-nutrients-17-02884" ref-type="bibr">42</xref>,<xref rid="B43-nutrients-17-02884" ref-type="bibr">43</xref>], pro-survival, and pro-longevity properties [<xref rid="B41-nutrients-17-02884" ref-type="bibr">41</xref>,<xref rid="B42-nutrients-17-02884" ref-type="bibr">42</xref>] exerted via synergistic modulation of diverse cellular and molecular mechanisms associated with aging and neurodegeneration [<xref rid="B44-nutrients-17-02884" ref-type="bibr">44</xref>]. Its key molecular targets encompass oxidative stress, inflammatory signaling pathways, apoptosis, amyloid protein aggregation, autophagy/mitophagy, and neurotrophic factor regulation.</p><p>Emerging evidence suggests that the gut&#8211;brain axis plays a critical role in the neuroprotective effects of curcumin, a pathway that has received limited attention in both preclinical and clinical analyses. Given curcumin&#8217;s minimal oral bioavailability, a substantial portion of the ingested compound remains in the gastrointestinal tract, where it can directly modulate gut microbiota composition and function. This alternative mechanism provides a plausible explanation for curcumin&#8217;s neuroprotective effects independent of systemic plasma levels.</p><p>Preclinical studies have demonstrated that curcumin favorably alters gut microbial communities, promoting the proliferation of beneficial taxa such as Lactobacillus and Bifidobacterium, while inhibiting pro-inflammatory bacteria [<xref rid="B45-nutrients-17-02884" ref-type="bibr">45</xref>,<xref rid="B46-nutrients-17-02884" ref-type="bibr">46</xref>,<xref rid="B47-nutrients-17-02884" ref-type="bibr">47</xref>,<xref rid="B48-nutrients-17-02884" ref-type="bibr">48</xref>]. Curcumin also enhances the production of microbial metabolites, particularly short-chain fatty acids (SCFAs) such as butyrate, which exert systemic anti-inflammatory and neuroprotective effects by modulating microglial activation and tight junction protein expression in the gut epithelium [<xref rid="B46-nutrients-17-02884" ref-type="bibr">46</xref>,<xref rid="B49-nutrients-17-02884" ref-type="bibr">49</xref>]. Furthermore, curcumin has been shown to improve intestinal barrier integrity, reducing the so-called &#8220;leaky gut&#8221; phenomenon that is increasingly implicated in systemic inflammation and neuroinflammation [<xref rid="B50-nutrients-17-02884" ref-type="bibr">50</xref>,<xref rid="B51-nutrients-17-02884" ref-type="bibr">51</xref>].</p><p>Mechanistically, SCFAs produced under curcumin-induced microbial modulation can influence central nervous system function through several pathways, including histone deacetylase inhibition, enhancement of regulatory T cell differentiation, and modulation of inflammatory signaling via NF-&#954;B and inflammasome pathways. This gut-mediated signaling may complement curcumin&#8217;s direct CNS actions, providing a comprehensive explanation for its observed neuroprotective efficacy despite low systemic bioavailability. Integrating these findings offers a more complete mechanistic framework, suggesting that curcumin&#8217;s neuroprotective potential is mediated not only by direct antioxidant and anti-inflammatory effects in the CNS but also through modulation of peripheral microbiota&#8211;gut&#8211;brain interactions [<xref rid="B49-nutrients-17-02884" ref-type="bibr">49</xref>,<xref rid="B52-nutrients-17-02884" ref-type="bibr">52</xref>].</p><sec id="sec4dot1-nutrients-17-02884"><title>4.1. Modulation of Oxidative Stress by Curcumin: Molecular Mechanisms and Neuroprotective Potential</title><p>Oxidative stress, characterized by the excessive intracellular accumulation of reactive oxygen species (ROS) and reactive nitrogen species (RNS), plays a central role in the etiology of numerous neurodegenerative disorders, including Alzheimer&#8217;s disease, Parkinson&#8217;s disease, and amyotrophic lateral sclerosis (ALS) [<xref rid="B53-nutrients-17-02884" ref-type="bibr">53</xref>,<xref rid="B54-nutrients-17-02884" ref-type="bibr">54</xref>]. The resulting oxidative damage contributes to aberrant protein aggregation, mitochondrial dysfunction, DNA strand breaks, and the activation of neuroinflammatory and apoptotic pathways [<xref rid="B55-nutrients-17-02884" ref-type="bibr">55</xref>]. Curcumin, a natural polyphenolic antioxidant, mitigates these deleterious effects through multiple mechanisms, including direct radical scavenging, upregulation of endogenous antioxidant defenses, and preservation of mitochondrial function.</p><sec id="sec4dot1dot1-nutrients-17-02884"><title>4.1.1. Direct Free Radical-Scavenging Activity</title><p>Curcumin&#8217;s chemical structure, featuring phenolic hydroxyl groups, enables it to function as an effective hydrogen or electron donor, thereby directly neutralizing reactive free radicals such as superoxide anion (O<sub>2</sub><sup>&#8722;</sup>), hydroxyl radical (&#8226;OH), peroxynitrite (ONOO<sup>&#8722;</sup>), and hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) [<xref rid="B56-nutrients-17-02884" ref-type="bibr">56</xref>]. This potent radical-scavenging capacity has been extensively validated in vitro, in animal models, and in clinical contexts [<xref rid="B57-nutrients-17-02884" ref-type="bibr">57</xref>,<xref rid="B58-nutrients-17-02884" ref-type="bibr">58</xref>]. For example, in benzo[a]pyrene-exposed murine models, oral administration of curcumin at 60 mg/kg significantly attenuated ROS production and lipid peroxidation in pulmonary tissue, concomitant with restoration of intracellular glutathione (GSH) levels [<xref rid="B59-nutrients-17-02884" ref-type="bibr">59</xref>]. Similarly, a human intervention study involving subjects with chronic exposure to arsenic-contaminated water demonstrated that supplementation with 500 mg curcumin twice daily markedly reduced systemic ROS, lipid peroxidation, and DNA damage in peripheral blood mononuclear cells [<xref rid="B60-nutrients-17-02884" ref-type="bibr">60</xref>].</p></sec><sec id="sec4dot1dot2-nutrients-17-02884"><title>4.1.2. Activation of Endogenous Antioxidant Enzymes</title><p>In addition to its direct radical-scavenging activity, curcumin enhances endogenous cellular antioxidant defenses by upregulating the activity and expression of critical antioxidant enzymes. Preclinical studies in rodent models have demonstrated that curcumin significantly increases the activity of superoxide dismutase (SOD), glutathione peroxidase (GPx), glutathione reductase (GR), catalase (CAT), and glutathione-S-transferase (GST) across multiple tissues, including liver, kidney, and nervous system [<xref rid="B61-nutrients-17-02884" ref-type="bibr">61</xref>,<xref rid="B62-nutrients-17-02884" ref-type="bibr">62</xref>]. These enzymes play vital roles in maintaining intracellular redox balance by detoxifying reactive oxygen species and preventing lipid peroxidation, thereby contributing to cellular protection against oxidative injury.</p></sec><sec id="sec4dot1dot3-nutrients-17-02884"><title>4.1.3. Activation of the Nrf2&#8211;ARE Pathway</title><p>Curcumin also exerts its antioxidant effects through activation of the nuclear factor erythroid 2&#8211;2-related factor 2 (Nrf2) signaling pathway, a master regulator of cellular defense against oxidative stress [<xref rid="B63-nutrients-17-02884" ref-type="bibr">63</xref>,<xref rid="B64-nutrients-17-02884" ref-type="bibr">64</xref>]. Upon activation, Nrf2 dissociates from its cytoplasmic inhibitor Keap1, translocates into the nucleus, and binds to antioxidant response elements (ARE) in the promoter regions of target genes. This induces the transcription of cytoprotective enzymes such as heme oxygenase-1 (HO-1), NAD(P)H quinone oxidoreductase-1 (NQO1), and glutathione synthetase, which collectively enhance cellular resilience to oxidative damage. Curcumin has been shown to promote Nrf2 nuclear translocation and increase HO-1 expression in neuronal, endothelial, and renal cell models [<xref rid="B65-nutrients-17-02884" ref-type="bibr">65</xref>,<xref rid="B66-nutrients-17-02884" ref-type="bibr">66</xref>]. This pathway is especially relevant in the central nervous system, where basal antioxidant capacity is often compromised in neurodegenerative conditions.</p></sec><sec id="sec4dot1dot4-nutrients-17-02884"><title>4.1.4. Mitochondrial Protection and Inhibition of Lipid Peroxidation</title><p>Mitochondria serve both as a primary source and a principal target of oxidative stress. Curcumin preserves mitochondrial membrane integrity, maintains mitochondrial membrane potential, and attenuates mitochondrial ROS generation [<xref rid="B67-nutrients-17-02884" ref-type="bibr">67</xref>]. Additionally, it stabilizes the electron transport chain complexes, particularly Complexes I and III, and inhibits cardiolipin oxidation, an early event triggering apoptotic cascades [<xref rid="B68-nutrients-17-02884" ref-type="bibr">68</xref>]. The anti&#8211;lipid peroxidation properties of curcumin have been corroborated in various in vivo models, as evidenced by significant reductions in malondialdehyde (MDA) and 4-hydroxynonenal (4-HNE) levels, both established biomarkers of oxidative membrane damage [<xref rid="B59-nutrients-17-02884" ref-type="bibr">59</xref>,<xref rid="B69-nutrients-17-02884" ref-type="bibr">69</xref>].</p></sec></sec><sec id="sec4dot2-nutrients-17-02884"><title>4.2. Anti-Inflammatory Mechanisms of Curcumin: Inhibition of NF-&#954;B, COX-2, and iNOS</title><p>Curcumin exerts broad-spectrum anti-inflammatory effects predominantly via modulation of the nuclear factor kappa B (NF-&#954;B) signaling pathway [<xref rid="B70-nutrients-17-02884" ref-type="bibr">70</xref>]. By inhibiting NF-&#954;B activation, curcumin suppresses the transcription of pivotal pro-inflammatory mediators, including cytokines such as interleukin-1&#946; (IL-1&#946;), tumor necrosis factor-alpha (TNF-&#945;), interleukin-6 (IL-6), COX-2, and iNOS. This downregulation reduces the biosynthesis of nitric oxide (NO) and prostaglandins, culminating in attenuation of both systemic and central nervous system inflammation. Consequently, curcumin is regarded as a promising adjunct therapeutic agent in inflammatory and neurodegenerative disorders (<xref rid="nutrients-17-02884-f002" ref-type="fig">Figure 2</xref>).</p><p>Chronic NF-&#954;B activation is a pathological hallmark of neurodegenerative diseases, driven mainly by sustained microglial activation, oxidative stress, apoptosis, and persistent release of inflammatory mediators. Curcumin&#8217;s inhibition of NF-&#954;B signaling mitigates these deleterious processes, thereby protecting neuronal integrity. Thus, NF-&#954;B inhibition represents a critical mechanism underlying curcumin&#8217;s neuroprotective efficacy.</p><sec id="sec4dot2dot1-nutrients-17-02884"><title>4.2.1. Inhibition of the NF-&#954;B Signaling Pathway</title><p>NF-&#954;B is a master transcription factor that orchestrates the expression of numerous pro-inflammatory genes, including IL-1&#946;, TNF-&#945;, IL-6, iNOS, and COX-2. Under basal conditions, NF-&#954;B is sequestered in the cytoplasm as an inactive complex with the inhibitor protein I&#954;B&#945;. Upon stimulation by agents such as lipopolysaccharide (LPS), I&#954;B kinase (IKK) phosphorylates I&#954;B&#945;, triggering its ubiquitination and proteasomal degradation. This degradation liberates NF-&#954;B, allowing its nuclear translocation and subsequent initiation of inflammatory gene transcription [<xref rid="B71-nutrients-17-02884" ref-type="bibr">71</xref>].</p><p>Curcumin modulates this signaling cascade at multiple checkpoints. It inhibits IKK&#946; activity, thereby preventing I&#954;B&#945; phosphorylation and degradation. Additionally, curcumin stabilizes I&#954;B&#945;, preserving the NF-&#954;B/I&#954;B&#945; complex in the cytoplasm and inhibiting NF-&#954;B nuclear translocation. Furthermore, curcumin attenuates the DNA-binding activity of NF-&#954;B, cumulatively resulting in suppressed transcription of pro-inflammatory target genes. These multi-level inhibitory effects effectively reduce inflammation in both peripheral tissues and the central nervous system.</p></sec><sec id="sec4dot2dot2-nutrients-17-02884"><title>4.2.2. Inhibition of COX-2 Expression</title><p>COX-2 is an inducible enzyme predominantly upregulated in response to inflammatory stimuli and is critical for the biosynthesis of pro-inflammatory prostaglandins, notably prostaglandin E<sub>2</sub> (PGE<sub>2</sub>). Curcumin exerts dose-dependent inhibition of COX-2 mRNA and protein expression across various experimental inflammation models, mainly through the suppression of transcription factors NF-&#954;B and activator protein 1 (AP-1). This suppression is particularly relevant in neuroinflammation, where elevated PGE<sub>2</sub> levels contribute to microglial activation and exacerbate neuronal damage [<xref rid="B72-nutrients-17-02884" ref-type="bibr">72</xref>,<xref rid="B73-nutrients-17-02884" ref-type="bibr">73</xref>]. For instance, in LPS-stimulated murine models, curcumin administration at 50&#8211;100 mg/kg significantly reduced COX-2 expression in brain tissue, correlating with attenuated neuroinflammatory responses.</p></sec><sec id="sec4dot2dot3-nutrients-17-02884"><title>4.2.3. Downregulation of iNOS Expression and Nitric Oxide Production</title><p>Inducible nitric oxide synthase (iNOS) is a key inflammatory enzyme responsible for high-output production of nitric oxide under pathological conditions. Excessive NO, particularly when reacting with superoxide anion (O<sub>2</sub><sup>&#8722;</sup>) to generate peroxynitrite (ONOO<sup>&#8722;</sup>), exerts cytotoxic effects through mechanisms such as DNA damage, lipid peroxidation, and protein nitration. Curcumin effectively suppresses iNOS gene transcription and protein expression, leading to a significant reduction in NO production. These inhibitory effects have been extensively validated in multiple in vitro models, including lipopolysaccharide (LPS)-stimulated BV2 microglial cultures, as well as in in vivo models of inflammation [<xref rid="B74-nutrients-17-02884" ref-type="bibr">74</xref>,<xref rid="B75-nutrients-17-02884" ref-type="bibr">75</xref>,<xref rid="B76-nutrients-17-02884" ref-type="bibr">76</xref>,<xref rid="B77-nutrients-17-02884" ref-type="bibr">77</xref>,<xref rid="B78-nutrients-17-02884" ref-type="bibr">78</xref>,<xref rid="B79-nutrients-17-02884" ref-type="bibr">79</xref>]. For example, curcumin at concentrations of 10&#8211;20 &#181;M markedly decreased iNOS expression and NO release in LPS-treated BV2 cells. Similarly, oral administration of curcumin at 100 mg/kg in murine models of colitis resulted in reduced intestinal iNOS expression, which correlated with improved histopathological outcomes [<xref rid="B80-nutrients-17-02884" ref-type="bibr">80</xref>].</p></sec></sec><sec id="sec4dot3-nutrients-17-02884"><title>4.3. Role of Curcumin in Apoptosis Regulation: Molecular Mechanisms and Neuroprotective Relevance</title><p>Programmed cell death (apoptosis) plays a central role in the pathophysiology of neurodegenerative diseases. Oxidative stress, inflammatory mediators, mitochondrial dysfunction, and DNA damage contribute to pathological neuronal loss, particularly in Alzheimer&#8217;s disease, Parkinson&#8217;s disease, and ischemic brain injury. Curcumin has been demonstrated to modulate major apoptotic signaling pathways, thereby promoting neuronal survival and preservation of neural tissue.</p><sec id="sec4dot3dot1-nutrients-17-02884"><title>4.3.1. Inhibition of Intrinsic (Mitochondrial) Apoptosis</title><p>The intrinsic apoptotic pathway is predominantly activated by oxidative stress or mitochondrial dysfunction, with the B-cell lymphoma 2 (Bcl-2) protein family serving as key regulators. Curcumin has been reported to downregulate the expression of pro-apoptotic Bax, while upregulating anti-apoptotic proteins such as Bcl-2 and myeloid cell leukemia 1 (Mcl-1). This shift in the Bcl-2/Bax ratio prevents mitochondrial outer membrane permeabilization (MOMP), thereby inhibiting the release of cytochrome c into the cytosol and subsequent activation of the apoptosome and caspase-9&#8212;caspase-3 cascade. This mechanism is especially relevant in neurons, where curcumin selectively targets pathologically altered or dysfunctional cells for apoptosis while exerting minimal cytotoxicity on healthy neuronal populations. Such selective modulation underscores curcumin&#8217;s therapeutic potential in neurodegenerative disorders [<xref rid="B81-nutrients-17-02884" ref-type="bibr">81</xref>,<xref rid="B82-nutrients-17-02884" ref-type="bibr">82</xref>,<xref rid="B83-nutrients-17-02884" ref-type="bibr">83</xref>,<xref rid="B84-nutrients-17-02884" ref-type="bibr">84</xref>,<xref rid="B85-nutrients-17-02884" ref-type="bibr">85</xref>,<xref rid="B86-nutrients-17-02884" ref-type="bibr">86</xref>].</p></sec><sec id="sec4dot3dot2-nutrients-17-02884"><title>4.3.2. Modulation of Extrinsic, Death Receptor-Mediated Apoptosis</title><p>Curcumin also modulates the extrinsic apoptotic pathway, which is triggered by activation of death receptors on the cell surface, such as Fas (CD95) and tumor necrosis factor-related apoptosis-inducing ligand receptor (TRAIL-R). Activation of these receptors leads to recruitment of adaptor proteins and activation of initiator caspase-8, which directly cleaves and activates executioner caspase-3. Alternatively, caspase-8 cleaves BH3-interacting domain death agonist (Bid), linking to the intrinsic mitochondrial apoptotic pathway.</p><p>Preclinical studies have shown that curcumin enhances the cleavage of caspase-8 and caspase-3, suggesting a dual mechanism promoting apoptosis. This may facilitate selective elimination of inflamed, damaged, or dysfunctional cells within the CNS, contributing to the restoration of tissue homeostasis in neurodegenerative conditions [<xref rid="B87-nutrients-17-02884" ref-type="bibr">87</xref>,<xref rid="B88-nutrients-17-02884" ref-type="bibr">88</xref>,<xref rid="B89-nutrients-17-02884" ref-type="bibr">89</xref>,<xref rid="B90-nutrients-17-02884" ref-type="bibr">90</xref>].</p></sec><sec id="sec4dot3dot3-nutrients-17-02884"><title>4.3.3. Modulation of Apoptosis-Related Signaling Pathways: NF-&#954;B, p53, and MAPK</title><p>Curcumin exerts complex regulatory effects on key apoptosis-related signaling pathways, including nuclear factor kappa B (NF-&#954;B), tumor protein p53, and mitogen-activated protein kinases (MAPKs) [<xref rid="B91-nutrients-17-02884" ref-type="bibr">91</xref>,<xref rid="B92-nutrients-17-02884" ref-type="bibr">92</xref>,<xref rid="B93-nutrients-17-02884" ref-type="bibr">93</xref>].</p><list list-type="bullet"><list-item><p>NF-&#954;B pathway: Curcumin inhibits NF-&#954;B activation by stabilizing its inhibitor I&#954;B&#945;, preventing NF-&#954;B nuclear translocation. This results in decreased transcription of anti-apoptotic genes such as Bcl-2, Mcl-1, and X-linked inhibitor of apoptosis protein (XIAP). In the context of chronic neuroinflammation, this may restore apoptosis susceptibility in damaged neurons.</p></list-item><list-item><p>p53 pathway: Curcumin upregulates p53, a key mediator of the cellular stress response. Activated p53 enhances transcription of pro-apoptotic genes such as Bax, promoting mitochondrial-mediated apoptosis in response to oxidative stress or DNA damage, thereby supporting neuronal quality control.</p></list-item><list-item><p>MAPK pathway: Curcumin modulates multiple MAPK signaling branches. It inhibits p38 MAPK, implicated in inflammation and apoptosis, and regulates c-Jun <italic toggle="yes">N</italic>-terminal kinase (JNK) and extracellular signal-regulated kinase (ERK) pathways, exerting context-dependent effects on neuronal survival and stress response.</p></list-item></list></sec><sec id="sec4dot3dot4-nutrients-17-02884"><title>4.3.4. Bax/Bcl-2 Ratio as a Molecular Marker</title><p>Curcumin&#8217;s modulation of the Bax/Bcl-2 ratio is well documented and serves as a reliable indicator of intrinsic apoptosis activation. An increased Bax/Bcl-2 ratio correlates with mitochondrial membrane permeabilization and progression toward apoptosis. Numerous in vitro and in vivo studies have confirmed the relevance of this parameter in assessing curcumin&#8217;s neuroprotective efficacy [<xref rid="B94-nutrients-17-02884" ref-type="bibr">94</xref>].</p></sec></sec><sec id="sec4dot4-nutrients-17-02884"><title>4.4. Modulation of Pathological Protein Aggregation</title><p>Curcumin exerts neuroprotective effects, in part, by modulating the aggregation of key pathological proteins implicated in neurodegenerative disorders, including amyloid-&#946; (A&#946;) in Alzheimer&#8217;s disease, &#945;-synuclein in Parkinson&#8217;s disease, and Tau in tauopathies.</p><sec id="sec4dot4dot1-nutrients-17-02884"><title>4.4.1. Amyloid-&#946; Aggregation</title><p>Among curcumin&#8217;s diverse neuroprotective properties, its capacity to inhibit A&#946; aggregation remains particularly significant in AD pathogenesis. The progression of AD is closely linked to misfolding and self-assembly of A&#946; peptides into soluble oligomers and insoluble fibrils, which contribute to synaptic dysfunction, neuronal toxicity, and extracellular plaque deposition.</p><p>Curcumin has been shown to bind directly to A&#946; oligomers and fibrils, stabilizing them in more soluble and less neurotoxic conformations, thereby inhibiting further fibrillogenesis [<xref rid="B95-nutrients-17-02884" ref-type="bibr">95</xref>,<xref rid="B96-nutrients-17-02884" ref-type="bibr">96</xref>]. This anti-aggregation activity is primarily attributed to curcumin&#8217;s molecular structure&#8212;especially its aromatic rings and &#946;-diketone moiety&#8212;which facilitate &#960;&#8211;&#960; stacking interactions, hydrophobic contacts, and hydrogen bonding with A&#946; residues. Structure&#8211;activity relationship studies revealed that curcumin derivatives bearing hydroxyl or trifluoromethoxy substituents enhance inhibition of A&#946; fibril formation [<xref rid="B97-nutrients-17-02884" ref-type="bibr">97</xref>,<xref rid="B98-nutrients-17-02884" ref-type="bibr">98</xref>]. Furthermore, curcumin chelates redox-active metal ions such as Cu<sup>2+</sup>, Zn<sup>2+</sup>, and Fe<sup>3+</sup>, which are known to accelerate A&#946; aggregation and promote ROS generation [<xref rid="B99-nutrients-17-02884" ref-type="bibr">99</xref>,<xref rid="B100-nutrients-17-02884" ref-type="bibr">100</xref>].</p></sec><sec id="sec4dot4dot2-nutrients-17-02884"><title>4.4.2. &#945;-Synuclein Aggregation</title><p>&#945;-Synuclein aggregation is a central pathological mechanism in PD, leading to the formation of Lewy bodies and neurodegeneration [<xref rid="B101-nutrients-17-02884" ref-type="bibr">101</xref>]. Curcumin has been reported to inhibit &#945;-synuclein fibrillation and stabilize non-toxic oligomeric species, reducing cytotoxicity in cellular and animal PD models [<xref rid="B102-nutrients-17-02884" ref-type="bibr">102</xref>,<xref rid="B103-nutrients-17-02884" ref-type="bibr">103</xref>]. This effect appears to involve direct binding to &#945;-synuclein monomers and oligomers, modulation of hydrophobic interactions, and interference with &#946;-sheet formation, positioning curcumin as a potential disease-modifying agent in synucleinopathies.</p></sec><sec id="sec4dot4dot3-nutrients-17-02884"><title>4.4.3. Tau Aggregation and Hyperphosphorylation</title><p>Hyperphosphorylation of the Tau protein contributes to neurofibrillary tangle formation in AD and other tauopathies [<xref rid="B104-nutrients-17-02884" ref-type="bibr">104</xref>]. Preclinical and clinical evidence suggest that curcumin can interfere with Tau hyperphosphorylation and aggregation [<xref rid="B105-nutrients-17-02884" ref-type="bibr">105</xref>,<xref rid="B106-nutrients-17-02884" ref-type="bibr">106</xref>,<xref rid="B107-nutrients-17-02884" ref-type="bibr">107</xref>]. Notably, a Longvida<sup>&#174;</sup> study demonstrated reductions in Tau dimer levels following curcumin supplementation [<xref rid="B106-nutrients-17-02884" ref-type="bibr">106</xref>,<xref rid="B108-nutrients-17-02884" ref-type="bibr">108</xref>,<xref rid="B109-nutrients-17-02884" ref-type="bibr">109</xref>]. Mechanistically, curcumin may modulate Tau kinases and phosphatases, reduce oxidative stress, and inhibit inflammatory pathways that promote Tau pathology [<xref rid="B107-nutrients-17-02884" ref-type="bibr">107</xref>]. Through these complementary mechanisms&#8212;including direct interactions with A&#946;, &#945;-synuclein, and Tau, inhibition of fibrillogenesis, and metal ion chelation&#8212;curcumin exhibits broad anti-protein aggregation activity. This multi-targeted mode of action supports its potential as an adjunctive or preventive therapeutic strategy across neurodegenerative disorders characterized by pathological protein aggregation.</p></sec></sec><sec id="sec4dot5-nutrients-17-02884"><title>4.5. Regulation of Autophagy and Mitophagy</title><p>Curcumin exerts neuroprotective effects partly through the modulation of autophagy and mitophagy&#8212;two fundamental cellular quality control mechanisms essential for maintaining neuronal homeostasis. Autophagy is a highly conserved lysosome-dependent catabolic process responsible for the degradation of damaged organelles, misfolded proteins, and cytoplasmic debris. In post-mitotic neurons, which lack proliferative capacity, efficient autophagic activity is crucial for proteostasis and the prevention of neurodegenerative pathology.</p><p>A substantial body of evidence indicates that curcumin enhances autophagic flux, as demonstrated by increased expression of key autophagy markers such as LC3-II (microtubule-associated protein 1A/1B-light chain 3, form II) and Beclin-1, which are involved in autophagosome formation and initiation, respectively. Curcumin promotes the conversion (lipidation) of LC3-I to LC3-II and upregulates Beclin-1 expression, reflecting the activation of the autophagic machinery [<xref rid="B110-nutrients-17-02884" ref-type="bibr">110</xref>,<xref rid="B111-nutrients-17-02884" ref-type="bibr">111</xref>].</p><p>Moreover, curcumin facilitates mitophagy, the selective degradation of damaged or depolarized mitochondria via autophagy, thus preserving mitochondrial integrity and cellular bioenergetics. It activates key mitophagy regulators, including PTEN-induced kinase 1 (PINK1) and the E3 ubiquitin ligase Parkin, which coordinate the ubiquitination and lysosomal targeting of dysfunctional mitochondria [<xref rid="B112-nutrients-17-02884" ref-type="bibr">112</xref>]. This enhancement of mitophagy contributes to increased cellular resilience against stress, mitigates apoptotic signaling pathways, and supports neuronal survival. Importantly, curcumin&#8217;s ability to induce autophagy and mitophagy extends beyond neuroprotection, bearing implications in oncology. By promoting the clearance of toxic protein aggregates and damaged mitochondria, curcumin sensitizes cancer cells to chemotherapeutic agents and disrupts tumor cell survival mechanisms [<xref rid="B113-nutrients-17-02884" ref-type="bibr">113</xref>].</p></sec><sec id="sec4dot6-nutrients-17-02884"><title>4.6. Induction of Neurotrophic Factors</title><p>Brain-derived neurotrophic factor (BDNF) is a crucial neurotrophin in the central nervous system, playing a vital role in neuronal survival, differentiation, synaptogenesis, long-term potentiation (LTP), and overall neuroplasticity [<xref rid="B114-nutrients-17-02884" ref-type="bibr">114</xref>,<xref rid="B115-nutrients-17-02884" ref-type="bibr">115</xref>,<xref rid="B116-nutrients-17-02884" ref-type="bibr">116</xref>,<xref rid="B117-nutrients-17-02884" ref-type="bibr">117</xref>,<xref rid="B118-nutrients-17-02884" ref-type="bibr">118</xref>,<xref rid="B119-nutrients-17-02884" ref-type="bibr">119</xref>]. BDNF is abundantly expressed in brain regions integral to cognitive and emotional processing, including the hippocampus, prefrontal cortex, and amygdala [<xref rid="B120-nutrients-17-02884" ref-type="bibr">120</xref>].</p><p>Numerous studies have demonstrated that systemic administration of curcumin significantly upregulates both BDNF mRNA and protein expression, particularly within the hippocampus. This modulation likely underpins the cognitive enhancement and neuroprotective effects observed in preclinical models [<xref rid="B121-nutrients-17-02884" ref-type="bibr">121</xref>]. The upregulation of BDNF is mediated through activation of intracellular signaling pathways, notably the extracellular signal-regulated kinase/mitogen-activated protein kinase (ERK/MAPK) cascade and the cAMP response element-binding protein (CREB), both well-established regulators of BDNF gene transcription [<xref rid="B11-nutrients-17-02884" ref-type="bibr">11</xref>].</p><p>Elevated BDNF levels enhance synaptic plasticity and promote dendritic spine formation, processes essential for memory consolidation and learning. Correspondingly, curcumin treatment is associated with improved cognitive performance and memory restoration in models of neurodegeneration and chronic stress [<xref rid="B122-nutrients-17-02884" ref-type="bibr">122</xref>].</p><p>Beyond Alzheimer&#8217;s disease, increased BDNF expression may also confer neuroprotective effects in Parkinson&#8217;s disease by supporting the survival and function of dopaminergic neurons in the substantia nigra pars compacta. Curcumin-induced elevation of BDNF in this context may contribute to stabilization of dopaminergic neurotransmission and amelioration of motor deficits [<xref rid="B11-nutrients-17-02884" ref-type="bibr">11</xref>]. In summary, induction of BDNF constitutes a pivotal mechanism underlying curcumin&#8217;s neuroprotective actions, reinforcing its therapeutic potential as an adjunctive or preventive strategy in Alzheimer&#8217;s disease, Parkinson&#8217;s disease, and other CNS disorders.</p></sec><sec id="sec4dot7-nutrients-17-02884"><title>4.7. Putative Cerebrovascular Effects of Curcumin and Their Contribution to Neuroprotection</title><p>Cerebrovascular health is a critical determinant of brain function, particularly in aging, where structural and functional alterations in the microvasculature contribute substantially to cognitive decline and neurodegeneration [<xref rid="B123-nutrients-17-02884" ref-type="bibr">123</xref>,<xref rid="B124-nutrients-17-02884" ref-type="bibr">124</xref>,<xref rid="B125-nutrients-17-02884" ref-type="bibr">125</xref>,<xref rid="B126-nutrients-17-02884" ref-type="bibr">126</xref>,<xref rid="B127-nutrients-17-02884" ref-type="bibr">127</xref>,<xref rid="B128-nutrients-17-02884" ref-type="bibr">128</xref>,<xref rid="B129-nutrients-17-02884" ref-type="bibr">129</xref>,<xref rid="B130-nutrients-17-02884" ref-type="bibr">130</xref>,<xref rid="B131-nutrients-17-02884" ref-type="bibr">131</xref>,<xref rid="B132-nutrients-17-02884" ref-type="bibr">132</xref>,<xref rid="B133-nutrients-17-02884" ref-type="bibr">133</xref>,<xref rid="B134-nutrients-17-02884" ref-type="bibr">134</xref>,<xref rid="B135-nutrients-17-02884" ref-type="bibr">135</xref>,<xref rid="B136-nutrients-17-02884" ref-type="bibr">136</xref>,<xref rid="B137-nutrients-17-02884" ref-type="bibr">137</xref>,<xref rid="B138-nutrients-17-02884" ref-type="bibr">138</xref>,<xref rid="B139-nutrients-17-02884" ref-type="bibr">139</xref>,<xref rid="B140-nutrients-17-02884" ref-type="bibr">140</xref>]. Age-related changes in cerebral microcirculation include impaired neurovascular coupling (NVC) [<xref rid="B124-nutrients-17-02884" ref-type="bibr">124</xref>,<xref rid="B127-nutrients-17-02884" ref-type="bibr">127</xref>,<xref rid="B129-nutrients-17-02884" ref-type="bibr">129</xref>,<xref rid="B132-nutrients-17-02884" ref-type="bibr">132</xref>,<xref rid="B134-nutrients-17-02884" ref-type="bibr">134</xref>,<xref rid="B136-nutrients-17-02884" ref-type="bibr">136</xref>,<xref rid="B137-nutrients-17-02884" ref-type="bibr">137</xref>,<xref rid="B138-nutrients-17-02884" ref-type="bibr">138</xref>,<xref rid="B139-nutrients-17-02884" ref-type="bibr">139</xref>,<xref rid="B141-nutrients-17-02884" ref-type="bibr">141</xref>,<xref rid="B142-nutrients-17-02884" ref-type="bibr">142</xref>,<xref rid="B143-nutrients-17-02884" ref-type="bibr">143</xref>,<xref rid="B144-nutrients-17-02884" ref-type="bibr">144</xref>,<xref rid="B145-nutrients-17-02884" ref-type="bibr">145</xref>,<xref rid="B146-nutrients-17-02884" ref-type="bibr">146</xref>,<xref rid="B147-nutrients-17-02884" ref-type="bibr">147</xref>,<xref rid="B148-nutrients-17-02884" ref-type="bibr">148</xref>,<xref rid="B149-nutrients-17-02884" ref-type="bibr">149</xref>,<xref rid="B150-nutrients-17-02884" ref-type="bibr">150</xref>], blood&#8211;brain barrier disruption [<xref rid="B123-nutrients-17-02884" ref-type="bibr">123</xref>,<xref rid="B124-nutrients-17-02884" ref-type="bibr">124</xref>,<xref rid="B127-nutrients-17-02884" ref-type="bibr">127</xref>,<xref rid="B128-nutrients-17-02884" ref-type="bibr">128</xref>,<xref rid="B129-nutrients-17-02884" ref-type="bibr">129</xref>,<xref rid="B131-nutrients-17-02884" ref-type="bibr">131</xref>,<xref rid="B135-nutrients-17-02884" ref-type="bibr">135</xref>,<xref rid="B136-nutrients-17-02884" ref-type="bibr">136</xref>,<xref rid="B141-nutrients-17-02884" ref-type="bibr">141</xref>,<xref rid="B146-nutrients-17-02884" ref-type="bibr">146</xref>,<xref rid="B151-nutrients-17-02884" ref-type="bibr">151</xref>,<xref rid="B152-nutrients-17-02884" ref-type="bibr">152</xref>,<xref rid="B153-nutrients-17-02884" ref-type="bibr">153</xref>,<xref rid="B154-nutrients-17-02884" ref-type="bibr">154</xref>,<xref rid="B155-nutrients-17-02884" ref-type="bibr">155</xref>,<xref rid="B156-nutrients-17-02884" ref-type="bibr">156</xref>,<xref rid="B157-nutrients-17-02884" ref-type="bibr">157</xref>,<xref rid="B158-nutrients-17-02884" ref-type="bibr">158</xref>,<xref rid="B159-nutrients-17-02884" ref-type="bibr">159</xref>,<xref rid="B160-nutrients-17-02884" ref-type="bibr">160</xref>,<xref rid="B161-nutrients-17-02884" ref-type="bibr">161</xref>,<xref rid="B162-nutrients-17-02884" ref-type="bibr">162</xref>,<xref rid="B163-nutrients-17-02884" ref-type="bibr">163</xref>,<xref rid="B164-nutrients-17-02884" ref-type="bibr">164</xref>,<xref rid="B165-nutrients-17-02884" ref-type="bibr">165</xref>,<xref rid="B166-nutrients-17-02884" ref-type="bibr">166</xref>], dysregulation of cerebral blood flow (CBF), endothelial dysfunction [<xref rid="B141-nutrients-17-02884" ref-type="bibr">141</xref>,<xref rid="B167-nutrients-17-02884" ref-type="bibr">167</xref>], endothelial senescence [<xref rid="B168-nutrients-17-02884" ref-type="bibr">168</xref>,<xref rid="B169-nutrients-17-02884" ref-type="bibr">169</xref>,<xref rid="B170-nutrients-17-02884" ref-type="bibr">170</xref>,<xref rid="B171-nutrients-17-02884" ref-type="bibr">171</xref>,<xref rid="B172-nutrients-17-02884" ref-type="bibr">172</xref>,<xref rid="B173-nutrients-17-02884" ref-type="bibr">173</xref>,<xref rid="B174-nutrients-17-02884" ref-type="bibr">174</xref>,<xref rid="B175-nutrients-17-02884" ref-type="bibr">175</xref>,<xref rid="B176-nutrients-17-02884" ref-type="bibr">176</xref>], microvascular rarefaction [<xref rid="B128-nutrients-17-02884" ref-type="bibr">128</xref>,<xref rid="B177-nutrients-17-02884" ref-type="bibr">177</xref>], and chronic low-grade microvascular inflammation [<xref rid="B164-nutrients-17-02884" ref-type="bibr">164</xref>,<xref rid="B178-nutrients-17-02884" ref-type="bibr">178</xref>,<xref rid="B179-nutrients-17-02884" ref-type="bibr">179</xref>]. These pathological processes compromise neuronal homeostasis by impairing oxygen and nutrient delivery, increasing exposure to neurotoxic blood-derived molecules, and disrupting the tightly regulated cellular milieu necessary for synaptic function and neuronal survival. Importantly, these microvascular disturbances are now recognized as major contributors not only to vascular cognitive impairment and dementia [<xref rid="B180-nutrients-17-02884" ref-type="bibr">180</xref>] but also to AD, PD [<xref rid="B181-nutrients-17-02884" ref-type="bibr">181</xref>,<xref rid="B182-nutrients-17-02884" ref-type="bibr">182</xref>], and post-stroke cognitive impairment [<xref rid="B183-nutrients-17-02884" ref-type="bibr">183</xref>,<xref rid="B184-nutrients-17-02884" ref-type="bibr">184</xref>,<xref rid="B185-nutrients-17-02884" ref-type="bibr">185</xref>,<xref rid="B186-nutrients-17-02884" ref-type="bibr">186</xref>,<xref rid="B187-nutrients-17-02884" ref-type="bibr">187</xref>,<xref rid="B188-nutrients-17-02884" ref-type="bibr">188</xref>,<xref rid="B189-nutrients-17-02884" ref-type="bibr">189</xref>,<xref rid="B190-nutrients-17-02884" ref-type="bibr">190</xref>,<xref rid="B191-nutrients-17-02884" ref-type="bibr">191</xref>,<xref rid="B192-nutrients-17-02884" ref-type="bibr">192</xref>], where mixed vascular&#8211;neurodegenerative pathology is common [<xref rid="B127-nutrients-17-02884" ref-type="bibr">127</xref>,<xref rid="B129-nutrients-17-02884" ref-type="bibr">129</xref>,<xref rid="B193-nutrients-17-02884" ref-type="bibr">193</xref>,<xref rid="B194-nutrients-17-02884" ref-type="bibr">194</xref>].</p><p>Curcumin&#8217;s neuroprotective effects may be partly mediated through its capacity to preserve and restore cerebrovascular health. A growing body of preclinical and in vitro evidence indicates that curcumin exerts a broad range of vasoprotective actions that are particularly relevant in the context of age-related microvascular alterations. NVC impairment&#8212;a hallmark of cerebrovascular aging&#8212;reduces the brain&#8217;s ability to match local blood flow to neuronal activity, thereby limiting oxygen and nutrient delivery to metabolically active regions [<xref rid="B124-nutrients-17-02884" ref-type="bibr">124</xref>,<xref rid="B141-nutrients-17-02884" ref-type="bibr">141</xref>,<xref rid="B195-nutrients-17-02884" ref-type="bibr">195</xref>]. By virtue of its potent anti-inflammatory and antioxidant effects, particularly through inhibition of NF-&#954;B [<xref rid="B196-nutrients-17-02884" ref-type="bibr">196</xref>] and activation of Nrf2 signaling [<xref rid="B197-nutrients-17-02884" ref-type="bibr">197</xref>,<xref rid="B198-nutrients-17-02884" ref-type="bibr">198</xref>,<xref rid="B199-nutrients-17-02884" ref-type="bibr">199</xref>,<xref rid="B200-nutrients-17-02884" ref-type="bibr">200</xref>], curcumin can restore endothelial nitric oxide synthase (eNOS) activity, normalize vascular tone, and improve stimulus-induced cerebral blood flow responses. Another critical target is the BBB, which becomes increasingly vulnerable to disruption with age and in neurodegenerative diseases, leading to the extravasation of plasma proteins, infiltration of immune cells, and amplification of neuroinflammation [<xref rid="B127-nutrients-17-02884" ref-type="bibr">127</xref>,<xref rid="B136-nutrients-17-02884" ref-type="bibr">136</xref>,<xref rid="B157-nutrients-17-02884" ref-type="bibr">157</xref>,<xref rid="B160-nutrients-17-02884" ref-type="bibr">160</xref>]. Curcumin has been shown to upregulate tight junction proteins such as claudin-5, occludin, and ZO-1, while suppressing matrix metalloproteinase-9 (MMP-9), a key mediator of BBB breakdown [<xref rid="B201-nutrients-17-02884" ref-type="bibr">201</xref>]. Through these actions, curcumin reduces vascular permeability and protects the delicate microenvironment of the brain parenchyma.</p><p>Age-related endothelial dysfunction and reduced nitric oxide bioavailability also contribute to cerebral hypoperfusion, a well-recognized risk factor for neurodegeneration. Curcumin&#8217;s ability to scavenge reactive oxygen species and suppress vascular NADPH oxidase activity helps preserve nitric oxide signaling, thereby supporting endothelium-dependent vasodilation and stabilizing cerebral blood flow regulation. In addition, curcumin mitigates endothelial senescence&#8212;a process that drives a pro-inflammatory, pro-thrombotic, and vasoconstrictive endothelial phenotype&#8212;by reducing oxidative DNA damage, suppressing the senescence-associated secretory phenotype (SASP), and promoting endothelial cell survival and proliferation, ultimately maintaining microvascular integrity in the aging brain.</p><p>Furthermore, curcumin may counteract microvascular rarefaction, the age-related reduction in capillary density that limits metabolic support to neurons and increases their vulnerability to injury. By modulating angiogenic pathways, particularly through vascular endothelial growth factor (VEGF) and phosphoinositide 3-kinase/protein kinase B (PI3K/Akt) signaling, curcumin supports the maintenance of a functional capillary network. Furthermore, its suppression of chronic, low-grade microvascular inflammation&#8212;achieved through inhibition of pro-inflammatory cytokines such as interleukin-1 beta (IL-1&#946;), tumor necrosis factor-alpha (TNF-&#945;), and interleukin-6 (IL-6), as well as downregulation of adhesion molecules including intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1)&#8212;reduces leukocyte&#8211;endothelial interactions and prevents secondary vascular injury.</p><p>Taken together, these vasoprotective effects complement curcumin&#8217;s direct neuroprotective actions, such as inhibition of amyloid aggregation, enhancement of autophagy, and upregulation of neurotrophic factors. In age-related central nervous system disorders, the preservation of microvascular function may therefore represent a crucial mechanistic link between curcumin&#8217;s systemic vascular benefits and its ability to promote neuronal resilience and cognitive health.</p></sec></sec><sec id="sec5-nutrients-17-02884"><title>5. Preclinical Evidence</title><p>Curcumin has garnered significant scientific interest as a potential adjunct therapy for various neurological and psychiatric disorders [<xref rid="B202-nutrients-17-02884" ref-type="bibr">202</xref>]. Extensive preclinical research has demonstrated its robust anti-inflammatory, antioxidant, anti-apoptotic, and neuroprotective properties across diverse models of nervous system diseases, including Alzheimer&#8217;s disease, Parkinson&#8217;s disease, depression, anxiety, stroke, and autism spectrum disorders.</p><p>These neuroprotective effects are mediated by multiple mechanisms, such as the downregulation of pro-inflammatory cytokines (e.g., TNF-&#945;, IL-1&#946;), reduction of reactive oxygen species (ROS), and inhibition of apoptosis through modulation of the Bax/Bcl-2 ratio. Additionally, curcumin suppresses pathological protein aggregation, notably amyloid-&#946; and &#945;-synuclein, which are pivotal in the pathogenesis of neurodegenerative diseases [<xref rid="B15-nutrients-17-02884" ref-type="bibr">15</xref>,<xref rid="B203-nutrients-17-02884" ref-type="bibr">203</xref>,<xref rid="B204-nutrients-17-02884" ref-type="bibr">204</xref>,<xref rid="B205-nutrients-17-02884" ref-type="bibr">205</xref>]. The following section offers a comprehensive overview of preclinical findings, with a focus on Alzheimer&#8217;s disease, Parkinson&#8217;s disease, and ischemic stroke models.</p><sec id="sec5dot1-nutrients-17-02884"><title>5.1. Animal Model Outcomes</title><sec id="sec5dot1dot1-nutrients-17-02884"><title>5.1.1. Alzheimer&#8217;s Disease</title><p>Numerous studies have demonstrated curcumin&#8217;s neuroprotective effects in various animal models of Alzheimer&#8217;s disease. Sun et al. [<xref rid="B45-nutrients-17-02884" ref-type="bibr">45</xref>] reported that oral administration of curcumin in amyloid precursor protein/presenilin-1 (APP/PS1) transgenic mice improved spatial memory and reduced hippocampal amyloid-beta (A&#946;) plaque deposition, effects linked to modulation of gut microbiota composition. Lin et al. [<xref rid="B206-nutrients-17-02884" ref-type="bibr">206</xref>] found that combined treatment with curcumin and berberine decreased A&#946;<sub>1&#8211;42</sub> levels, neuroinflammation, and oxidative stress, thereby enhancing cognition through modulation of amyloid precursor protein processing and activation of the AMPK&#8211;autophagy pathway. Similarly, Su et al. [<xref rid="B207-nutrients-17-02884" ref-type="bibr">207</xref>] showed that curcumin improved learning performance and reduced A&#946; burden while attenuating microglial activation; these effects were attributed to enhanced bioavailability and regulation of NF-&#954;B, mTOR, and Nrf2 signaling pathways.</p><p>In aluminum chloride-induced AD rat models, curcumin ameliorated cognitive deficits, reduced anxiety-like behavior, restored cholinergic function, and mitigated oxidative stress and inflammation [<xref rid="B208-nutrients-17-02884" ref-type="bibr">208</xref>]. In vitro, curcumin reversed A&#946;-induced mitochondrial dysfunction and promoted mitochondrial biogenesis and synaptic protein preservation [<xref rid="B209-nutrients-17-02884" ref-type="bibr">209</xref>]. Wang et al. [<xref rid="B210-nutrients-17-02884" ref-type="bibr">210</xref>] demonstrated that curcumin suppressed astrocyte activation and neuroinflammation, resulting in improved memory in A&#946;<sub>40</sub>-induced rats.</p><p>Nanocurcumin formulations have shown improved brain bioavailability, reduced amyloid plaque load, and enhanced cognitive performance in transgenic mice [<xref rid="B211-nutrients-17-02884" ref-type="bibr">211</xref>]. Likewise, NanoCurc&#8482; decreased oxidative stress and apoptosis while augmenting antioxidant defenses both in vitro and in vivo [<xref rid="B212-nutrients-17-02884" ref-type="bibr">212</xref>].</p><p>Begum et al. [<xref rid="B213-nutrients-17-02884" ref-type="bibr">213</xref>] and Xiong et al. [<xref rid="B214-nutrients-17-02884" ref-type="bibr">214</xref>] reported that curcumin and its metabolite tetrahydrocurcumin reduced neuroinflammation and oxidative damage; notably, only curcumin prevented amyloid plaque deposition and protein oxidation, underscoring the essential role of its dienone bridge in anti-amyloidogenic activity.</p><p>Additional preclinical studies have further confirmed curcumin&#8217;s neuroprotective effects across diverse AD models. In intracerebroventricular streptozotocin (ICV-STZ)-induced rats, curcumin improved memory performance, attenuated oxidative stress, and enhanced cholinergic activity [<xref rid="B215-nutrients-17-02884" ref-type="bibr">215</xref>]. In D-galactose-induced aged mice, curcumin promoted hippocampal neurogenesis and increased brain-derived neurotrophic factor levels, leading to improved cognitive function [<xref rid="B216-nutrients-17-02884" ref-type="bibr">216</xref>]. Moreover, in behavioral assays including the object recognition test (ORT), object location test (OLT), and Y-maze, administration of curcumin at doses ranging from 50 to 100 mg/kg enhanced recognition memory, accompanied by modest anti-inflammatory effects, although no significant changes in neurogenesis were observed [<xref rid="B217-nutrients-17-02884" ref-type="bibr">217</xref>].</p><p>In human Tau (hTau) transgenic mice, curcumin formulated as Longvida significantly reduced Tau dimer levels, enhanced synaptic function, and upregulated the expression of heat shock proteins 70 and 90 (HSP70/90) [<xref rid="B108-nutrients-17-02884" ref-type="bibr">108</xref>]. Aerosolized curcumin administration decreased amyloid-beta plaque burden and improved spatial memory performance in 5XFAD transgenic mice [<xref rid="B218-nutrients-17-02884" ref-type="bibr">218</xref>]. In vitro studies under A&#946;-induced oxidative stress conditions demonstrated that curcumin reduced lipid peroxidation, increased activities of antioxidant enzymes, and elevated levels of nerve growth factor (NGF) [<xref rid="B219-nutrients-17-02884" ref-type="bibr">219</xref>]. In amyloid precursor protein Swedish mutation (APPSw) transgenic mice, dietary curcumin treatment dose-dependently decreased interleukin-1 beta (IL-1&#946;), oxidative stress markers, amyloid plaque accumulation, and microglial activation [<xref rid="B220-nutrients-17-02884" ref-type="bibr">220</xref>]. Notably, nanoformulated curcumin showed superior efficacy in attenuating neuroinflammation and enhancing cognitive function compared to conventional curcumin in streptozotocin (STZ)-induced Alzheimer&#8217;s disease models [<xref rid="B221-nutrients-17-02884" ref-type="bibr">221</xref>]. A summary of these neuroprotective effects is provided in <xref rid="nutrients-17-02884-t001" ref-type="table">Table 1</xref>.</p></sec><sec id="sec5dot1dot2-nutrients-17-02884"><title>5.1.2. Parkinson&#8217;s Disease</title><p>Numerous preclinical studies highlight the neuroprotective potential of curcumin across various animal and cellular models of Parkinson&#8217;s disease. Curcumin exerts its effects through multiple mechanisms, including attenuation of oxidative stress and inflammation, mitochondrial protection, and modulation of autophagy and protein aggregation.</p><p>In a copper-induced parkinsonism model, Abbaoui et al. [<xref rid="B222-nutrients-17-02884" ref-type="bibr">222</xref>] demonstrated that curcumin restored tyrosine hydroxylase (TH) expression in dopaminergic brain regions and improved motor function, likely through its antioxidant and anti-inflammatory properties. Similarly, Rajeswari et al. [<xref rid="B223-nutrients-17-02884" ref-type="bibr">223</xref>] reported that curcumin and its metabolite tetrahydrocurcumin reversed reductions in dopamine and 3,4-dihydroxyphenylacetic acid (DOPAC) levels, and inhibited monoamine oxidase-B (MAO-B) activity in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model. Pan et al. [<xref rid="B224-nutrients-17-02884" ref-type="bibr">224</xref>] found that curcumin suppressed c-Jun <italic toggle="yes">N</italic>-terminal kinase (JNK) phosphorylation, thereby preventing mitochondrial apoptosis events such as Bcl-2-associated X protein (Bax) translocation and cytochrome c release, ultimately preserving dopaminergic neurons.</p><p>In a human neuroblastoma SH-SY5Y cell line overexpressing the A53T mutant &#945;-synuclein, Jiang et al. [<xref rid="B225-nutrients-17-02884" ref-type="bibr">225</xref>] showed that curcumin restored autophagic activity by inhibiting the mechanistic target of rapamycin (mTOR)/ribosomal protein S6 kinase beta-1 (p70S6K) signaling pathway, reducing &#945;-synuclein accumulation. Similarly, Wang et al. [<xref rid="B226-nutrients-17-02884" ref-type="bibr">226</xref>] demonstrated that curcumin decreased reactive oxygen species production and apoptosis in SH-SY5Y cells treated with &#945;-synuclein oligomers, while stabilizing these aggregates.</p><p>In a rotenone-induced mouse model, Ramires J&#250;nior et al. [<xref rid="B227-nutrients-17-02884" ref-type="bibr">227</xref>] reported that nanoemulsion-formulated curcumin improved motor function, reduced lipid peroxidation, preserved mitochondrial complex I activity, and enhanced endogenous antioxidant defenses. Yang et al. [<xref rid="B228-nutrients-17-02884" ref-type="bibr">228</xref>] observed that curcumin enhanced learning and memory performance and increased hippocampal dopamine and norepinephrine levels, likely via activation of the brain-derived neurotrophic factor (BDNF)/tropomyosin receptor kinase B (TrkB)/phosphoinositide 3-kinase (PI3K) signaling pathway. Fikry et al. [<xref rid="B229-nutrients-17-02884" ref-type="bibr">229</xref>] found that curcumin protected cerebellar Purkinje neurons, attenuated astrogliosis, and restored motor function following prolonged rotenone exposure.</p><p>Jagatha et al. [<xref rid="B230-nutrients-17-02884" ref-type="bibr">230</xref>] demonstrated that curcumin increased glutathione synthesis by activating &#947;-glutamylcysteine ligase (&#947;-GCL), reduced protein oxidation, and stabilized mitochondrial function both in vitro and in a glutathione-deficient mouse model. Sharma et al. [<xref rid="B231-nutrients-17-02884" ref-type="bibr">231</xref>] reported that in a lipopolysaccharide (LPS)-induced rat model, curcumin suppressed inflammatory markers (GFAP, NF-&#954;B, TNF-&#945;, IL-1&#946;), improved redox balance, reduced iron accumulation, and prevented &#945;-synuclein aggregation.</p><p>A systematic review encompassing 13 preclinical studies with 298 animals confirmed curcumin&#8217;s efficacy in reducing dopaminergic neuron loss, elevating striatal dopamine levels, and decreasing oxidative stress, inflammation, and apoptosis in the substantia nigra and striatum (<italic toggle="yes">p</italic> &lt; 0.05) [<xref rid="B232-nutrients-17-02884" ref-type="bibr">232</xref>]. Liu et al. [<xref rid="B233-nutrients-17-02884" ref-type="bibr">233</xref>] demonstrated that high-dose curcumin (160 mg/kg/day) significantly improved motor function and preserved TH-positive dopaminergic neurons in a 6-hydroxydopamine (6-OHDA) rat model, indicating dose-dependent neuroprotection via reduction in oxidative stress and neuroinflammation. Similarly, curcumin oil solution (Curoil) enhanced motor performance and dopaminergic neuron survival in an MPTP-induced PD mouse model, likely due to improved bioavailability [<xref rid="B234-nutrients-17-02884" ref-type="bibr">234</xref>]. Collectively, these findings support curcumin&#8217;s multifaceted neuroprotective actions across key pathogenic mechanisms in PD, underscoring its potential as a candidate for future disease-modifying therapies. A summary of these effects is presented in <xref rid="nutrients-17-02884-t002" ref-type="table">Table 2</xref>.</p></sec><sec id="sec5dot1dot3-nutrients-17-02884"><title>5.1.3. The Effects of Curcumin in Preclinical Models of Ischemic and Hemorrhagic Stroke</title><p>Extensive preclinical studies have demonstrated curcumin&#8217;s neuroprotective effects in various cerebrovascular disorder models, including ischemic and hemorrhagic stroke [<xref rid="B39-nutrients-17-02884" ref-type="bibr">39</xref>]. Despite variability in animal models, dosing, and treatment regimens, these studies consistently highlight curcumin&#8217;s potent anti-inflammatory, antioxidant, and anti-apoptotic properties, along with its ability to modulate microglial polarization.</p><p>In a middle cerebral artery occlusion (MCAO) model, Li et al. [<xref rid="B235-nutrients-17-02884" ref-type="bibr">235</xref>], showed that co-administration of 100 mg/kg curcumin with human umbilical cord mesenchymal stem cells (hUC-MSCs) significantly reduced brain edema and infarct volume while improving neurological function. This neuroprotection was mediated via activation of the AKT/GSK-3&#946;/&#946;-TrCP/Nrf2 signaling pathway, suppression of oxidative stress, and promotion of M2 microglial polarization. Jia et al. [<xref rid="B236-nutrients-17-02884" ref-type="bibr">236</xref>] reported that 300 mg/kg curcumin upregulated peroxiredoxin 6 (Prdx6) through SP1 induction, which was critical for its antioxidant and neuroprotective effects, as inhibition of Prdx6 abolished these benefits.</p><p>In a global cerebral ischemia model, Altinay et al. [<xref rid="B237-nutrients-17-02884" ref-type="bibr">237</xref>], demonstrated that combined pre- and post-treatment with curcumin enhanced antioxidant defenses (SOD, CAT, GPx), reduced oxidative and inflammatory markers (IL-6, TNF-&#945;, MDA), and attenuated neuronal apoptosis. Marques et al. [<xref rid="B238-nutrients-17-02884" ref-type="bibr">238</xref>] showed that nanoemulsified curcumin improved motor function, reduced hematoma volume, and minimized weight loss more effectively than free curcumin in hemorrhagic stroke models, attributed to superior tissue penetration and bioavailability.</p><p>Ran et al. [<xref rid="B239-nutrients-17-02884" ref-type="bibr">239</xref>] found that 150 mg/kg curcumin mitigated white matter injury and improved sensorimotor function via inhibition of the NF-&#954;B/NLRP3 inflammasome pathway and suppression of microglial pyroptosis. Xie et al. [<xref rid="B240-nutrients-17-02884" ref-type="bibr">240</xref>] in both in vivo and in vitro studies, reported that curcumin protected neurons by inhibiting mitochondrial apoptotic pathways&#8212;suppressing Bax activation, upregulating Bcl-2, decreasing caspase-3 activity, and preserving mitochondrial membrane potential.</p><p>Li et al. [<xref rid="B241-nutrients-17-02884" ref-type="bibr">241</xref>] showed that curcumin (300 mg/kg, administered 30 min before reperfusion) significantly reduced infarct size and brain edema and improved neurological scores, effects linked to decreased NF-&#954;B, ICAM-1, MMP-9, and caspase-3 expression, suggesting preservation of blood&#8211;brain barrier (BBB) integrity. Liu et al. [<xref rid="B242-nutrients-17-02884" ref-type="bibr">242</xref>] demonstrated that 7-day curcumin treatment (300 mg/kg) promoted neurogenesis and improved behavioral outcomes through Notch pathway activation, evidenced by increased BrdU<sup>+</sup> and BrdU/DCX<sup>+</sup> cell counts. Wu et al. [<xref rid="B243-nutrients-17-02884" ref-type="bibr">243</xref>] reported that curcumin pretreatment upregulated tight junction proteins (ZO-1, occludin, claudin-5) and inhibited NF-&#954;B and MMP-9, reducing BBB permeability and inflammation.</p><p>In a distal MCAO model, Liu et al. [<xref rid="B244-nutrients-17-02884" ref-type="bibr">244</xref>], found that curcumin (150 mg/kg, twice intraperitoneally) decreased infarct volume, enhanced M2 microglial activation (CD206<sup>+</sup>Iba1<sup>+</sup>), suppressed M1 phenotype (CD16<sup>+</sup>Iba1<sup>+</sup>), and lowered pro-inflammatory cytokines (TNF-&#945;, IL-6, IL-12p70). Wu et al. [<xref rid="B245-nutrients-17-02884" ref-type="bibr">245</xref>] confirmed that curcumin reduced neuronal injury and oxidative stress in oxygen-glucose deprivation/reperfusion (OGD/R) and MCAO models by activating the AKT/Nrf2 signaling axis. Jiang et al. [<xref rid="B246-nutrients-17-02884" ref-type="bibr">246</xref>] demonstrated that intravenous curcumin protected against BBB disruption, brain edema, and neuroinflammation by inhibiting the iNOS/NO pathway in MCAO rats. Zhang et al. [<xref rid="B247-nutrients-17-02884" ref-type="bibr">247</xref>] further validated curcumin&#8217;s anti-inflammatory and anti-apoptotic actions by reducing TNF-&#945; and p53, and increasing Sirt1 and Bcl-2 expression.</p><p>Collectively, these studies (summarized in <xref rid="nutrients-17-02884-t003" ref-type="table">Table 3</xref>) provide robust evidence that curcumin exerts multifaceted neuroprotective effects in experimental ischemic and hemorrhagic stroke models. Future clinical trials are warranted to evaluate the translational potential of these findings for human stroke therapy.</p></sec></sec><sec id="sec5dot2-nutrients-17-02884"><title>5.2. Dose&#8211;Response Relationships</title><p>Preclinical animal studies have generally characterized the dose&#8211;response relationship of curcumin, revealing that moderate but detectable neuroprotective effects typically occur at doses between 25 and 50 mg/kg. At these levels, curcumin primarily enhances antioxidant activity, reduces apoptosis, and improves behavioral outcomes in models of stroke and neurodegenerative diseases. More pronounced and consistent neuroprotection is observed at higher doses, particularly &#8805;100 mg/kg, reflecting stronger activation of mechanisms such as oxidative stress reduction, anti-inflammatory responses, and cytoprotective signaling pathways.</p><p>Several investigations report a sigmoidal dose&#8211;response curve, with biologically significant effects becoming measurable above a threshold dose of approximately 80 mg/kg. Below this threshold, curcumin&#8217;s effects may be subtle or difficult to quantify, whereas efficacy sharply increases beyond it. This dose-dependence corresponds to curcumin&#8217;s modulation of multiple cellular pathways, including the attenuation of reactive oxygen species (ROS) production, mitigation of oxidative stress-induced damage, and regulation of key signaling cascades such as AMP-activated protein kinase (AMPK), AKT/mTOR, and NF-&#954;B. These molecular actions contribute to improved cellular function and may delay the progression of age-related disorders, including neurodegenerative and cardiovascular diseases.</p><p>Despite curcumin&#8217;s inherently low bioavailability and rapid metabolism necessitating higher doses, toxicological studies generally support a favorable safety profile for high-dose administration. To enhance efficacy, various nanoformulations&#8212;such as nanoemulsions and nanoparticles&#8212;are increasingly employed to improve targeted delivery and bioavailability.</p><p>Future research should prioritize the development of curcumin analogs with superior pharmacokinetic properties (e.g., TML-6) and the optimization of dose&#8211;response outcomes through nanotechnology and pharmaceutical innovation. Given that most data derive from preclinical models, further well-designed human clinical trials are critical to safely translate these dose-dependent effects into clinical practice, particularly for the prevention and treatment of age-related diseases [<xref rid="B248-nutrients-17-02884" ref-type="bibr">248</xref>]. In summary, the dose&#8211;response relationship underscores that curcumin&#8217;s therapeutic efficacy is strongly dose-dependent. Identifying the optimal dosing regimen remains essential to maximize its neuroprotective and antioxidant potential, especially in the context of aging and neurodegeneration.</p></sec><sec id="sec5dot3-nutrients-17-02884"><title>5.3. Nanoparticle-Based Formulations</title><p>Despite curcumin&#8217;s promising therapeutic potential, its clinical utility is limited by poor bioavailability, primarily due to low absorption, rapid metabolism, and systemic clearance when administered in conventional forms. To overcome these pharmacokinetic challenges, a variety of nanotechnology-based delivery systems have been developed, substantially enhancing curcumin&#8217;s bioavailability and efficacy. Notably, encapsulation within liposomes, poly(lactic-co-glycolic acid) (PLGA) nanoparticles, and saponin-coated nanocarriers has been shown to increase bioavailability up to nine-fold compared to traditional curcumin formulations, even when co-administered with bioenhancers such as piperine [<xref rid="B249-nutrients-17-02884" ref-type="bibr">249</xref>].</p><p>Key advantages of these nanoformulations include:<list list-type="bullet"><list-item><p>Improved brain targeting: Nanoparticles facilitate curcumin&#8217;s transport across the blood&#8211;brain barrier, ensuring more effective delivery to brain tissues. This capability is crucial for therapeutic applications in neurodegenerative diseases, stroke, and related disorders.</p></list-item><list-item><p>Reduced clearance: Nanoformulations prolong systemic circulation time by slowing curcumin&#8217;s elimination, thereby increasing its bioactive presence and therapeutic impact.</p></list-item><list-item><p>Enhanced neuroprotective effects: Preclinical studies demonstrate that PLGA- or liposome-encapsulated curcumin can achieve similar or superior neuroprotective outcomes at lower doses than free curcumin, improving treatment consistency and reproducibility.</p></list-item></list></p><p>Moreover, liposomal hydrogels have been engineered for injectable, localized, and controlled release of curcumin, such as in promoting wound healing post-tumor resection. Clinical investigations in humans further confirm that nanocurcumin formulations yield superior therapeutic effects compared to conventional preparations, owing to more rapid absorption and improved tissue accumulation [<xref rid="B249-nutrients-17-02884" ref-type="bibr">249</xref>,<xref rid="B250-nutrients-17-02884" ref-type="bibr">250</xref>,<xref rid="B251-nutrients-17-02884" ref-type="bibr">251</xref>].</p><p>Overall, nanoparticle-based curcumin formulations represent a promising strategy to circumvent bioavailability limitations, enabling targeted and efficacious interventions for age-related diseases, neurodegenerative disorders, and cancer. Continued clinical research is essential to identify optimal formulations and administration routes to maximize therapeutic benefits.</p></sec></sec><sec id="sec6-nutrients-17-02884"><title>6. Neurological Effects of Curcumin: Clinical Outcomes</title><p>Clinical trials investigating curcumin&#8217;s neurological effects have yielded variable results, though encouraging trends have emerged across several domains. In the management of depression, curcumin has demonstrated efficacy particularly in mild to moderate cases, likely via modulation of monoaminergic neurotransmission and inflammatory pathways [<xref rid="B203-nutrients-17-02884" ref-type="bibr">203</xref>]. For neuropathic and postoperative pain, diverse formulations&#8212;including nanocurcumin&#8212;have shown analgesic effects by attenuating inflammation and oxidative stress [<xref rid="B204-nutrients-17-02884" ref-type="bibr">204</xref>]. Regarding cognitive decline, Alzheimer&#8217;s disease, and aging-related impairments, multiple studies report that curcumin supplementation improves memory, attention, and learning, especially with long-term use of highly bioavailable formulations [<xref rid="B14-nutrients-17-02884" ref-type="bibr">14</xref>,<xref rid="B15-nutrients-17-02884" ref-type="bibr">15</xref>,<xref rid="B205-nutrients-17-02884" ref-type="bibr">205</xref>,<xref rid="B252-nutrients-17-02884" ref-type="bibr">252</xref>]. Although clinical data on stroke remain limited, preclinical models suggest curcumin may reduce brain injury and promote neural regeneration [<xref rid="B205-nutrients-17-02884" ref-type="bibr">205</xref>]. Additionally, both individuals with neurocognitive disorders and healthy adults have exhibited enhanced information processing, memory, and attention following curcumin intake, despite many studies involving relatively small cohorts [<xref rid="B253-nutrients-17-02884" ref-type="bibr">253</xref>]. Overall, curcumin represents a multifaceted natural compound with compelling neuroprotective potential established in preclinical research. While clinical evidence is promising, it is not yet conclusive. Future well-powered, rigorously controlled randomized trials are warranted to define optimal formulations, dosing strategies, and therapeutic indications to safely and effectively harness curcumin&#8217;s neurological benefits [<xref rid="B203-nutrients-17-02884" ref-type="bibr">203</xref>,<xref rid="B204-nutrients-17-02884" ref-type="bibr">204</xref>,<xref rid="B254-nutrients-17-02884" ref-type="bibr">254</xref>]. A detailed summary of clinical findings is presented in <xref rid="nutrients-17-02884-t004" ref-type="table">Table 4</xref>.</p><sec><title>Human Clinical Trials</title><p>Numerous human clinical trials have investigated the neurological and systemic effects of curcumin, yielding varied but promising results. Small et al. [<xref rid="B255-nutrients-17-02884" ref-type="bibr">255</xref>] conducted an 18-month study involving 40 non-demented middle-aged and older adults (51&#8211;84 years), administering Theracurmin<sup>&#174;</sup> at 90 mg twice daily (180 mg/day). Significant improvements were observed in verbal and visual memory as well as attention. PET imaging revealed reduced amyloid and tau accumulation, likely mediated by anti-inflammatory and anti-amyloid mechanisms involving the Akt/Nrf2 signaling pathway.</p><p>Cox et al. [<xref rid="B256-nutrients-17-02884" ref-type="bibr">256</xref>] evaluated the effects of 400 mg/day Longvida<sup>&#174;</sup> curcumin in healthy adults aged 60&#8211;85 over 4 weeks. Acute supplementation (1 h post-dose) improved attention and working memory, while chronic use reduced fatigue and LDL cholesterol and improved mood, attributed to antioxidant, anti-inflammatory, and lipid metabolism-modulating effects.</p><p>Baum et al. [<xref rid="B257-nutrients-17-02884" ref-type="bibr">257</xref>] administered 1 g or 4 g/day of curcumin to 34 patients with probable or possible Alzheimer&#8217;s disease over 6 months. While no significant cognitive improvements were detected via MMSE, curcuminoids were measurable in plasma, with a trend toward increased A&#946;40 levels. This study underscored the low bioavailability of curcumin and better absorption from capsule formulations.</p><p>A double-blind, placebo-controlled trial with 36 patients [<xref rid="B258-nutrients-17-02884" ref-type="bibr">258</xref>], using Curcumin C3 Complex<sup>&#174;</sup> at 2 g and 4 g/day for 24 weeks reported no significant adverse events. Although no cognitive benefits were observed (ADAS-Cog), the study reinforced curcumin&#8217;s anti-inflammatory and antioxidant properties, as well as its capacity to inhibit amyloid-beta aggregation.</p><p>Conversely, a larger trial of 96 older adults [<xref rid="B259-nutrients-17-02884" ref-type="bibr">259</xref>] showed that daily supplementation with 1500 mg Biocurcumax&#8482; (BCM-95<sup>&#174;</sup>CG) for 12 months prevented cognitive decline measured by Montreal Cognitive Assessment (MoCA) scores compared to placebo. However, other cognitive metrics showed no significant difference. The authors highlighted curcumin&#8217;s antioxidant and anti-inflammatory effects and called for further biomarker research.</p><p>In Parkinson&#8217;s disease, a 9-month study with 60 patients [<xref rid="B260-nutrients-17-02884" ref-type="bibr">260</xref>], administering 80 mg nanomicellar curcumin daily found no significant improvement in motor symptoms (MDS-UPDRS) or quality of life (PDQ-39) compared to placebo, despite a trend toward improvement in the MDS-UPDRS Part III subscore. Some participants reported gastrointestinal side effects, including nausea and reflux.</p><p>In contrast, a 3-month trial with 50 PD patients [<xref rid="B261-nutrients-17-02884" ref-type="bibr">261</xref>], administering 160 mg/day nanomicellar curcumin observed significant improvements in sleep quality and overall quality of life (PDQ-39), although fatigue remained unchanged. These effects were likely mediated by antioxidant, anti-inflammatory, and neuroprotective mechanisms.</p><p>A 12-month study [<xref rid="B262-nutrients-17-02884" ref-type="bibr">262</xref>], involving 19 PD patients treated with 2 g/day of a curcumin&#8211;phospholipid complex (Meriva<sup>&#174;</sup>) showed reductions in autonomic dysfunction (COMPASS-31) and non-motor symptoms (NMSS), with slower clinical progression (MDS-UPDRS, Hoehn and Yahr staging). Skin biopsies revealed decreased phosphorylated alpha-synuclein deposition, supporting curcumin&#8217;s blood&#8211;brain barrier penetration and anti-amyloidogenic, anti-inflammatory effects.</p><p>Lastly, a study of 56 post-stroke rehabilitation patients [<xref rid="B263-nutrients-17-02884" ref-type="bibr">263</xref>], supplementing with 500 mg curcumin plus 5 mg piperine daily for 12 weeks demonstrated significant reductions in hs-CRP, total cholesterol, triglycerides, carotid intima-media thickness (CIMT), body weight, waist circumference, and blood pressure, alongside increased total antioxidant capacity (TAC). Patients receiving curcumin also reported less pain progression relative to placebo. A detailed overview of these clinical trials in Alzheimer&#8217;s disease, Parkinson&#8217;s disease, and stroke is provided in <xref rid="nutrients-17-02884-t004" ref-type="table">Table 4</xref>.</p></sec></sec><sec id="sec7-nutrients-17-02884"><title>7. Neurological Effects of Curcumin: A Critical Synthesis of Clinical Evidence</title><p>The outcomes of human clinical trials investigating the neuroprotective potential of curcumin are heterogeneous. Nevertheless, several studies suggest that beneficial effects may be observed under specific conditions. The aim of this synthesis is to critically examine the main factors influencing trial outcomes.</p><sec id="sec7dot1-nutrients-17-02884"><title>7.1. The Role of Bioavailability</title><p>Trials reporting negative or non-significant findings predominantly employed conventional, poorly bioavailable formulations, such as standard curcumin powder or Curcumin C3 Complex<sup>&#174;</sup> [<xref rid="B257-nutrients-17-02884" ref-type="bibr">257</xref>,<xref rid="B258-nutrients-17-02884" ref-type="bibr">258</xref>]. In these studies, plasma concentrations remained low, thereby limiting the potential for measurable clinical effects.</p><p>In contrast, trials reporting beneficial outcomes generally used advanced formulations designed to enhance absorption, including Theracurmin<sup>&#174;</sup> [<xref rid="B255-nutrients-17-02884" ref-type="bibr">255</xref>], Longvida<sup>&#174;</sup> [<xref rid="B256-nutrients-17-02884" ref-type="bibr">256</xref>], Biocurcumax&#8482; [<xref rid="B259-nutrients-17-02884" ref-type="bibr">259</xref>], and Meriva<sup>&#174;</sup> [<xref rid="B262-nutrients-17-02884" ref-type="bibr">262</xref>]. These findings underscore bioavailability as a critical determinant of clinical efficacy in curcumin trials.</p></sec><sec id="sec7dot2-nutrients-17-02884"><title>7.2. Characteristics of the Study Population</title><p>The characteristics of the study population also strongly influenced outcomes. Studies involving cognitively healthy participants or those with mild cognitive impairment and early-stage disease [<xref rid="B255-nutrients-17-02884" ref-type="bibr">255</xref>,<xref rid="B256-nutrients-17-02884" ref-type="bibr">256</xref>,<xref rid="B259-nutrients-17-02884" ref-type="bibr">259</xref>] were more likely to report favorable effects, such as improvements in memory, attention, and mood.</p><p>By contrast, trials conducted in patients with moderate Alzheimer&#8217;s disease [<xref rid="B257-nutrients-17-02884" ref-type="bibr">257</xref>,<xref rid="B258-nutrients-17-02884" ref-type="bibr">258</xref>] did not demonstrate consistent cognitive improvements, even at high doses. This suggests that curcumin&#8217;s primary value may lie in prevention or early intervention, while its therapeutic potential in advanced neurodegenerative stages appears limited.</p></sec><sec id="sec7dot3-nutrients-17-02884"><title>7.3. Sensitivity of Endpoints and Biomarkers</title><p>Methodological differences across trials further contribute to inconsistent findings. Studies employing more sensitive cognitive tests and biomarker-based endpoints&#8212;such as PET imaging to assess amyloid and tau deposition [<xref rid="B255-nutrients-17-02884" ref-type="bibr">255</xref>] or skin biopsies to detect &#945;-synuclein aggregates [<xref rid="B262-nutrients-17-02884" ref-type="bibr">262</xref>] were more likely to report beneficial effects.</p><p>In contrast, studies relying solely on conventional cognitive scales such as the MMSE or ADAS-Cog [<xref rid="B257-nutrients-17-02884" ref-type="bibr">257</xref>,<xref rid="B258-nutrients-17-02884" ref-type="bibr">258</xref>] often failed to detect significant changes. This suggests that curcumin&#8217;s effects may be more readily captured using sensitive and targeted outcome measures. Overall, current clinical evidence suggests that curcumin possesses neuroprotective potential, though the supporting data remain preliminary. The most consistent benefits are observed when:<list list-type="bullet"><list-item><p>formulations with enhanced bioavailability are used [<xref rid="B255-nutrients-17-02884" ref-type="bibr">255</xref>,<xref rid="B256-nutrients-17-02884" ref-type="bibr">256</xref>,<xref rid="B259-nutrients-17-02884" ref-type="bibr">259</xref>,<xref rid="B262-nutrients-17-02884" ref-type="bibr">262</xref>]</p></list-item><list-item><p>interventions are initiated in early or preclinical stages [<xref rid="B255-nutrients-17-02884" ref-type="bibr">255</xref>,<xref rid="B256-nutrients-17-02884" ref-type="bibr">256</xref>,<xref rid="B259-nutrients-17-02884" ref-type="bibr">259</xref>]</p></list-item><list-item><p>and sensitive cognitive or biomarker-based endpoints are employed [<xref rid="B255-nutrients-17-02884" ref-type="bibr">255</xref>,<xref rid="B262-nutrients-17-02884" ref-type="bibr">262</xref>]</p></list-item></list></p><p>Nonetheless, the overall level of evidence remains low, and methodological heterogeneity across studies significantly limits generalizability. Future research should prioritize larger, longer-duration, randomized, and well-controlled clinical trials to establish the optimal formulation, dosage, and target population for curcumin in the prevention and treatment of neurodegenerative diseases.</p></sec></sec><sec id="sec8-nutrients-17-02884"><title>8. Efficacy and Safety</title><p>Curcumin has emerged as a promising neuroprotective agent against neurodegenerative disorders such as Alzheimer&#8217;s disease, Parkinson&#8217;s disease, and stroke. It exerts multifaceted effects by modulating key cellular and molecular signaling pathways involved in neuronal damage, including amyloid-&#946; aggregation, oxidative stress, and neuroinflammation. Curcumin primarily enhances antioxidant defenses and suppresses inflammatory responses through activation of the nuclear factor erythroid 2&#8211;related factor 2 (Nrf2) pathway and inhibition of NF-&#954;B, which underlie many of its neuroprotective properties. Additionally, curcumin promotes neuronal health and function by stimulating autophagy and neurotrophic factor production. Clinical studies support curcumin&#8217;s capacity to cross the blood&#8211;brain barrier, which is critical for its central nervous system efficacy.</p><p>Despite its potent neuroprotective effects and generally low toxicity, curcumin&#8217;s clinical translation is limited by poor bioavailability, characterized by low absorption, rapid metabolism, and systemic elimination. Nanotechnology-based delivery strategies, including liposomal and nanoparticle formulations, as well as curcumin structural analogs, are emerging approaches to enhance solubility, sustain release, and improve targeted brain delivery. These nanoformulations represent a promising avenue to overcome pharmacokinetic limitations and optimize therapeutic outcomes.</p><p>Curcumin is generally well tolerated, with low toxicity and minimal adverse effects reported in conventional formulations. However, high-bioavailability formulations have occasionally been associated with liver toxicity. Reported adverse effects include nausea, vomiting, gastrointestinal discomfort, and, rarely, hepatotoxicity. Use of curcumin during pregnancy or breastfeeding may not be safe, and further studies are needed to confirm its safety in these populations.</p><p>Nonetheless, further investigations are warranted to confirm long-term safety, optimal dosing, and efficacy, particularly in combination therapies or nanoformulated systems. The precise molecular mechanisms underlying curcumin&#8217;s neuroprotective actions also require further elucidation. Collectively, these considerations highlight the need for well-designed clinical trials and continued research into nano-based delivery strategies to fully harness curcumin&#8217;s therapeutic potential in neurodegenerative disease contexts [<xref rid="B255-nutrients-17-02884" ref-type="bibr">255</xref>,<xref rid="B256-nutrients-17-02884" ref-type="bibr">256</xref>,<xref rid="B257-nutrients-17-02884" ref-type="bibr">257</xref>].</p></sec><sec id="sec9-nutrients-17-02884"><title>9. Bioavailability, Standardization</title><p>Despite its considerable therapeutic potential, curcumin&#8217;s clinical translation is significantly limited by its poor bioavailability, characterized by low oral absorption, rapid metabolism, and systemic elimination. These pharmacokinetic challenges reduce curcumin&#8217;s effective concentration in target tissues and limit its clinical efficacy, particularly in neurodegenerative and metabolic disorders. To address these limitations, a variety of advanced delivery strategies and novel formulations have been developed. Nanotechnology-based approaches&#8212;including liposomal curcumin, solid lipid nanoparticles (SLNP), polymeric nanoparticles, nanomicelles, dendrimers, nanoemulsions, and nanocrystals&#8212;have emerged as particularly promising due to their ability to enhance solubility, protect curcumin from rapid metabolism, facilitate sustained release, and improve targeted tissue and blood&#8211;brain barrier delivery [<xref rid="B264-nutrients-17-02884" ref-type="bibr">264</xref>].</p><p>Clinical and preclinical evidence supports the pharmacological benefits of these formulations [<xref rid="B265-nutrients-17-02884" ref-type="bibr">265</xref>,<xref rid="B266-nutrients-17-02884" ref-type="bibr">266</xref>,<xref rid="B267-nutrients-17-02884" ref-type="bibr">267</xref>]. Liposomal curcumin has been shown to maintain sustained plasma concentrations and elicited favorable tumor marker responses in metastatic cancer patients, indicating its potential for targeted delivery. Nanomicelle formulations improved glycemic control, lipid profiles, and inflammatory markers in diabetic patients undergoing hemodialysis, while also demonstrating bone-strengthening effects in postmenopausal women. Solid lipid curcumin particles (SLCP, e.g., Longvida<sup>&#174;</sup>) increased plasma curcumin levels and were associated with cognitive improvements in healthy older adults. Nanocurcumin formulations have also shown neuroprotective efficacy in amyotrophic lateral sclerosis patients and exhibited immunomodulatory effects in COVID-19, reducing pro-inflammatory cytokine levels and improving clinical outcomes without significant adverse effects [<xref rid="B264-nutrients-17-02884" ref-type="bibr">264</xref>,<xref rid="B265-nutrients-17-02884" ref-type="bibr">265</xref>,<xref rid="B266-nutrients-17-02884" ref-type="bibr">266</xref>,<xref rid="B267-nutrients-17-02884" ref-type="bibr">267</xref>].</p><p>Beyond nanoformulations, other innovative delivery strategies have been investigated to further enhance curcumin&#8217;s pharmacokinetic and pharmacodynamic properties. Curcumin-galactomannoside (CGM) formulations utilize natural dietary fibers to improve absorption and tissue distribution [<xref rid="B268-nutrients-17-02884" ref-type="bibr">268</xref>]. Phytosomal curcumin formulations (e.g., Curserin<sup>&#174;</sup>) leverage amphipathic phospholipids to increase gastrointestinal stability and bioavailability [<xref rid="B269-nutrients-17-02884" ref-type="bibr">269</xref>]. Colloidal and amorphous formulations, such as Theracurmin<sup>&#174;</sup> and CurcuRougeTM, demonstrate superior plasma concentrations and area-under-curve metrics compared to conventional curcumin extracts, translating into improved therapeutic outcomes in musculoskeletal, metabolic, and neurodegenerative disorders [<xref rid="B270-nutrients-17-02884" ref-type="bibr">270</xref>,<xref rid="B271-nutrients-17-02884" ref-type="bibr">271</xref>].</p><p>Collectively, these data underscore that optimizing curcumin formulations is critical to overcoming its intrinsic pharmacokinetic limitations. The integration of nano- and other advanced delivery systems not only enhances bioavailability but also maximizes therapeutic efficacy across a range of disease contexts, including neurodegeneration, metabolic disorders, cardiovascular disease, cancer, and inflammatory conditions. Future research should continue to elucidate the mechanisms by which these formulations enhance curcumin&#8217;s bioavailability, determine optimal dosing regimens, evaluate long-term safety, and validate clinical efficacy in well-controlled, large-scale trials [<xref rid="B272-nutrients-17-02884" ref-type="bibr">272</xref>,<xref rid="B273-nutrients-17-02884" ref-type="bibr">273</xref>].</p></sec><sec id="sec10-nutrients-17-02884"><title>10. Future Perspectives</title><p>Curcumin has demonstrated considerable neuroprotective potential; however, its clinical translation is hindered by pharmacokinetic limitations, including poor bioavailability, rapid metabolism, and limited blood&#8211;brain barrier penetration. To address these challenges, ongoing research is focused on advanced drug delivery strategies, such as nanoparticle-based systems, liposomal formulations, and structural analogues. These approaches have shown promise in improving curcumin&#8217;s solubility, stability, and BBB permeability, thereby enhancing its therapeutic profile in neurodegenerative diseases [<xref rid="B23-nutrients-17-02884" ref-type="bibr">23</xref>]. Prodrug strategies, which involve chemical modification of curcumin to increase systemic stability and prolong circulation time, may further improve its pharmacokinetics and pharmacodynamics, resulting in more consistent therapeutic exposure at target sites [<xref rid="B274-nutrients-17-02884" ref-type="bibr">274</xref>].</p><p>Combination therapy is another promising avenue, whereby curcumin is administered alongside pharmacological agents [<xref rid="B161-nutrients-17-02884" ref-type="bibr">161</xref>,<xref rid="B172-nutrients-17-02884" ref-type="bibr">172</xref>,<xref rid="B275-nutrients-17-02884" ref-type="bibr">275</xref>,<xref rid="B276-nutrients-17-02884" ref-type="bibr">276</xref>,<xref rid="B277-nutrients-17-02884" ref-type="bibr">277</xref>,<xref rid="B278-nutrients-17-02884" ref-type="bibr">278</xref>,<xref rid="B279-nutrients-17-02884" ref-type="bibr">279</xref>,<xref rid="B280-nutrients-17-02884" ref-type="bibr">280</xref>,<xref rid="B281-nutrients-17-02884" ref-type="bibr">281</xref>,<xref rid="B282-nutrients-17-02884" ref-type="bibr">282</xref>], nutraceuticals [<xref rid="B283-nutrients-17-02884" ref-type="bibr">283</xref>], dietary interventions [<xref rid="B284-nutrients-17-02884" ref-type="bibr">284</xref>,<xref rid="B285-nutrients-17-02884" ref-type="bibr">285</xref>,<xref rid="B286-nutrients-17-02884" ref-type="bibr">286</xref>,<xref rid="B287-nutrients-17-02884" ref-type="bibr">287</xref>,<xref rid="B288-nutrients-17-02884" ref-type="bibr">288</xref>,<xref rid="B289-nutrients-17-02884" ref-type="bibr">289</xref>,<xref rid="B290-nutrients-17-02884" ref-type="bibr">290</xref>,<xref rid="B291-nutrients-17-02884" ref-type="bibr">291</xref>,<xref rid="B292-nutrients-17-02884" ref-type="bibr">292</xref>] and lifestyle modifications [<xref rid="B293-nutrients-17-02884" ref-type="bibr">293</xref>,<xref rid="B294-nutrients-17-02884" ref-type="bibr">294</xref>,<xref rid="B295-nutrients-17-02884" ref-type="bibr">295</xref>,<xref rid="B296-nutrients-17-02884" ref-type="bibr">296</xref>,<xref rid="B297-nutrients-17-02884" ref-type="bibr">297</xref>,<xref rid="B298-nutrients-17-02884" ref-type="bibr">298</xref>,<xref rid="B299-nutrients-17-02884" ref-type="bibr">299</xref>,<xref rid="B300-nutrients-17-02884" ref-type="bibr">300</xref>,<xref rid="B301-nutrients-17-02884" ref-type="bibr">301</xref>,<xref rid="B302-nutrients-17-02884" ref-type="bibr">302</xref>,<xref rid="B303-nutrients-17-02884" ref-type="bibr">303</xref>,<xref rid="B304-nutrients-17-02884" ref-type="bibr">304</xref>,<xref rid="B305-nutrients-17-02884" ref-type="bibr">305</xref>,<xref rid="B306-nutrients-17-02884" ref-type="bibr">306</xref>,<xref rid="B307-nutrients-17-02884" ref-type="bibr">307</xref>,<xref rid="B308-nutrients-17-02884" ref-type="bibr">308</xref>,<xref rid="B309-nutrients-17-02884" ref-type="bibr">309</xref>,<xref rid="B310-nutrients-17-02884" ref-type="bibr">310</xref>,<xref rid="B311-nutrients-17-02884" ref-type="bibr">311</xref>] to exploit synergistic effects. This multitarget approach can modulate several pathogenic processes simultaneously&#8212;oxidative stress, neuroinflammation, and protein misfolding&#8212;thereby potentially improving overall treatment efficacy [<xref rid="B312-nutrients-17-02884" ref-type="bibr">312</xref>]. The integration of curcumin into personalized medicine frameworks also holds potential. Biomarker-driven and genotype-based patient stratification could allow treatments to be tailored to individual pathophysiological profiles, maximizing therapeutic benefit while minimizing adverse effects, especially in heterogeneous disorders such as Alzheimer&#8217;s and Parkinson&#8217;s diseases [<xref rid="B313-nutrients-17-02884" ref-type="bibr">313</xref>,<xref rid="B314-nutrients-17-02884" ref-type="bibr">314</xref>].</p><p>Realizing these advances will require multidisciplinary research bridging nanotechnology, neuropharmacology, molecular biology, and clinical sciences. Long-term, well-designed randomized controlled trials are necessary to establish optimal formulations, dosing regimens, and safety profiles. Ultimately, embedding curcumin into combination and precision medicine strategies may substantially enhance its clinical utility in neurodegenerative disease management.</p></sec><sec id="sec11-nutrients-17-02884"><title>11. Limitations</title><p>This review is narrative in nature and was not conducted as a systematic review. Consequently, it does not claim to comprehensively cover all available literature, and relevant studies may have been inadvertently omitted. The primary aim was to summarize and interpret current evidence to highlight key mechanistic insights and potential therapeutic implications, rather than to exhaustively analyze all published data. As such, the conclusions should be interpreted with caution, taking into account the potential for selection bias and the qualitative rather than quantitative synthesis of the findings.</p></sec><sec sec-type="conclusions" id="sec12-nutrients-17-02884"><title>12. Conclusions</title><p>Curcumin&#8217;s neuroprotective potential is increasingly supported by both preclinical and clinical evidence, particularly in Alzheimer&#8217;s disease, Parkinson&#8217;s disease, and stroke. Preclinical models have shown that curcumin modulates multiple disease-relevant pathways, including reduction in oxidative stress, suppression of neuroinflammation, and inhibition of amyloid-&#946; aggregation. Additional mechanisms&#8212;such as stimulation of autophagy and neurotrophic factor production&#8212;further contribute to neuronal survival, regeneration, and improved cognitive performance.</p><p>Despite this strong preclinical foundation, clinical outcomes remain variable, largely due to curcumin&#8217;s low bioavailability, rapid metabolism, and restricted BBB penetration. Advances in nanotechnology, including nanoparticle encapsulation, liposomal delivery, and prodrug development, are promising solutions to these challenges, offering improved pharmacokinetics, stability, and targeted delivery. Combination therapies, leveraging curcumin&#8217;s antioxidant and anti-inflammatory properties alongside conventional pharmacological agents, may yield synergistic benefits and improve patient outcomes.</p><p>Personalized medicine approaches, guided by biomarker profiling and genetic background, may further optimize curcumin therapy for individual patients. While the evidence base is expanding, successful translation into routine clinical practice will require continued multidisciplinary research to refine formulations, elucidate mechanisms of action, and confirm long-term safety and efficacy. As a natural, multifunctional compound with a favorable safety profile, curcumin remains a highly promising candidate for the prevention and management of neurodegenerative disorders&#8212;provided its pharmacological limitations can be effectively addressed.</p></sec></body><back><fn-group><fn><p><bold>Disclaimer/Publisher&#8217;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><notes><title>Author Contributions</title><p>A.L., T.C., &#193;.L., D.M. and V.F.-P. designed the study, and wrote and published the manuscript. A.L., T.J., J.T.V. and V.Z. supplemented and reviewed the manuscript. P.V., J.T.V. and M.F. prepared the manuscript for publication. &#193;.S. contributed to the interpretation of results and critically revised the manuscript. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Institutional Review Board Statement</title><p>Not applicable.</p></notes><notes><title>Informed Consent Statement</title><p>Not applicable.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>Data sharing is not applicable to this article as no new data were created or analyzed in this study.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare that they have no competing interests.</p></notes><glossary><title>Abbreviations</title><p>6-OHDA&#8212;6-Hydroxydopamine, A&#946;&#8212;Amyloid-beta, AD&#8212;Alzheimer&#8217;s disease, AKT/Akt&#8212;Protein kinase B, APP&#8212;Amyloid precursor protein, BDNF&#8212;Brain-derived neurotrophic factor, BBB&#8212;Blood&#8211;brain barrier, CAT&#8212;Catalase, Cur&#8212;Curcumin, Curoil&#8212;Curcumin oil, DOPAC&#8212;3,4-Dihydroxyphenylacetic acid, GFAP&#8212;Glial fibrillary acidic protein, GPx&#8212;Glutathione peroxidase, GSH/GSSG&#8212;Reduced/oxidized glutathione, HSP70/HSP90&#8212;Heat shock proteins, ICV/i.c.v.&#8212;Intracerebroventricular, i.p.&#8212;Intraperitoneal, IL-1&#946;&#8212;Interleukin-1 beta, IL-6&#8212;Interleukin-6, iNOS&#8212;Inducible nitric oxide synthase, JNK&#8212;c-Jun <italic toggle="yes">N</italic>-terminal kinase, MDA&#8212;Malondialdehyde, MCAO&#8212;Middle cerebral artery occlusion, MMP-9&#8212;Matrix metalloproteinase-9, MPTP&#8212;1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine, Nrf2&#8212;Nuclear factor erythroid 2-related factor 2, NMSS&#8212;Non-Motor Symptoms Scale, NGF&#8212;Nerve growth factor, NO&#8212;Nitric oxide, OGD/R&#8212;Oxygen-glucose deprivation/reperfusion, PET&#8212;Positron emission tomography, PD&#8212;Parkinson&#8217;s disease, p-&#945;-syn&#8212;Phosphorylated alpha-synuclein, PI3K&#8212;Phosphoinositide 3-kinase, Prdx6&#8212;Peroxiredoxin 6, ROS&#8212;Reactive oxygen species, SOD&#8212;Superoxide dismutase, STZ&#8212;Streptozotocin, TH&#8212;Tyrosine hydroxylase, TH<sup>+</sup> neurons&#8212;Tyrosine hydroxylase-positive neurons, TNF-&#945;&#8212;Tumor necrosis factor-alpha, Y-maze&#8212;Behavioral test for spatial working memory, ZO-1&#8212;Zonula occludens-1.</p></glossary><ref-list><title>References</title><ref id="B1-nutrients-17-02884"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zaib</surname><given-names>S.</given-names></name><name name-style="western"><surname>Javed</surname><given-names>H.</given-names></name><name name-style="western"><surname>Khan</surname><given-names>I.</given-names></name><name name-style="western"><surname>Jaber</surname><given-names>F.</given-names></name><name name-style="western"><surname>Sohail</surname><given-names>A.</given-names></name><name name-style="western"><surname>Zaib</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Mehboob</surname><given-names>T.</given-names></name><name name-style="western"><surname>Tabassam</surname><given-names>N.</given-names></name><name name-style="western"><surname>Ogaly</surname><given-names>H.A.</given-names></name></person-group><article-title>Neurodegenerative diseases: Their onset, epidemiology, causes and treatment</article-title><source>ChemistrySelect</source><year>2023</year><volume>8</volume><fpage>e202300225</fpage><pub-id pub-id-type="doi">10.1002/slct.202300225</pub-id></element-citation></ref><ref id="B2-nutrients-17-02884"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lamptey</surname><given-names>R.N.</given-names></name><name name-style="western"><surname>Chaulagain</surname><given-names>B.</given-names></name><name name-style="western"><surname>Trivedi</surname><given-names>R.</given-names></name><name name-style="western"><surname>Gothwal</surname><given-names>A.</given-names></name><name name-style="western"><surname>Layek</surname><given-names>B.</given-names></name><name name-style="western"><surname>Singh</surname><given-names>J.</given-names></name></person-group><article-title>A review of the common neurodegenerative disorders: Current therapeutic approaches and the potential role of nanotherapeutics</article-title><source>Int. J. Mol. Sci.</source><year>2022</year><volume>23</volume><elocation-id>1851</elocation-id><pub-id pub-id-type="doi">10.3390/ijms23031851</pub-id><pub-id pub-id-type="pmid">35163773</pub-id><pub-id pub-id-type="pmcid">PMC8837071</pub-id></element-citation></ref><ref id="B3-nutrients-17-02884"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Teleanu</surname><given-names>D.M.</given-names></name><name name-style="western"><surname>Niculescu</surname><given-names>A.-G.</given-names></name><name name-style="western"><surname>Lungu</surname><given-names>I.I.</given-names></name><name name-style="western"><surname>Radu</surname><given-names>C.I.</given-names></name><name name-style="western"><surname>Vlad&#226;cenco</surname><given-names>O.</given-names></name><name name-style="western"><surname>Roza</surname><given-names>E.</given-names></name><name name-style="western"><surname>Cost&#259;chescu</surname><given-names>B.</given-names></name><name name-style="western"><surname>Grumezescu</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Teleanu</surname><given-names>R.I.</given-names></name></person-group><article-title>An overview of oxidative stress, neuroinflammation, and neurodegenerative diseases</article-title><source>Int. J. Mol. Sci.</source><year>2022</year><volume>23</volume><elocation-id>5938</elocation-id><pub-id pub-id-type="doi">10.3390/ijms23115938</pub-id><pub-id pub-id-type="pmid">35682615</pub-id><pub-id pub-id-type="pmcid">PMC9180653</pub-id></element-citation></ref><ref id="B4-nutrients-17-02884"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Di Meo</surname><given-names>F.</given-names></name><name name-style="western"><surname>Valentino</surname><given-names>A.</given-names></name><name name-style="western"><surname>Petillo</surname><given-names>O.</given-names></name><name name-style="western"><surname>Peluso</surname><given-names>G.</given-names></name><name name-style="western"><surname>Filosa</surname><given-names>S.</given-names></name><name name-style="western"><surname>Crispi</surname><given-names>S.</given-names></name></person-group><article-title>Bioactive polyphenols and neuromodulation: Molecular mechanisms in neurodegeneration</article-title><source>Int. J. Mol. Sci.</source><year>2020</year><volume>21</volume><elocation-id>2564</elocation-id><pub-id pub-id-type="doi">10.3390/ijms21072564</pub-id><pub-id pub-id-type="pmid">32272735</pub-id><pub-id pub-id-type="pmcid">PMC7178158</pub-id></element-citation></ref><ref id="B5-nutrients-17-02884"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bhullar</surname><given-names>K.S.</given-names></name><name name-style="western"><surname>Rupasinghe</surname><given-names>H.V.</given-names></name></person-group><article-title>Polyphenols: Multipotent therapeutic agents in neurodegenerative diseases</article-title><source>Oxidative Med. Cell. Longev.</source><year>2013</year><volume>2013</volume><fpage>891748</fpage><pub-id pub-id-type="doi">10.1155/2013/891748</pub-id><pub-id pub-id-type="pmcid">PMC3690243</pub-id><pub-id pub-id-type="pmid">23840922</pub-id></element-citation></ref><ref id="B6-nutrients-17-02884"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Panda</surname><given-names>P.</given-names></name><name name-style="western"><surname>Mohanty</surname><given-names>S.</given-names></name><name name-style="western"><surname>Gouda</surname><given-names>S.R.</given-names></name><name name-style="western"><surname>Baral</surname><given-names>T.C.</given-names></name><name name-style="western"><surname>Mohanty</surname><given-names>A.</given-names></name><name name-style="western"><surname>Nayak</surname><given-names>J.</given-names></name><name name-style="western"><surname>Mohapatra</surname><given-names>R.</given-names></name></person-group><article-title>Advanced strategies for enhancing the neuroprotective potential of curcumin: Delivery systems and mechanistic insights in neurodegenerative disorders</article-title><source>Nutr. Neurosci.</source><year>2025</year><volume>28</volume><fpage>1151</fpage><lpage>1176</lpage><pub-id pub-id-type="doi">10.1080/1028415X.2025.2472773</pub-id><pub-id pub-id-type="pmid">40029926</pub-id></element-citation></ref><ref id="B7-nutrients-17-02884"><label>7.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Akaberi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Sahebkar</surname><given-names>A.</given-names></name><name name-style="western"><surname>Emami</surname><given-names>S.A.</given-names></name></person-group><article-title>Turmeric and curcumin: From traditional to modern medicine</article-title><source>Studies on Biomarkers and New Targets in Aging Research in Iran: Focus on Turmeric and Curcumin</source><publisher-name>Springer</publisher-name><publisher-loc>Cham, Switzerland</publisher-loc><year>2021</year><fpage>15</fpage><lpage>39</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/978-3-030-56153-6_2</pub-id><pub-id pub-id-type="pmid">34331682</pub-id></element-citation></ref><ref id="B8-nutrients-17-02884"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cianciulli</surname><given-names>A.</given-names></name><name name-style="western"><surname>Calvello</surname><given-names>R.</given-names></name><name name-style="western"><surname>Ruggiero</surname><given-names>M.</given-names></name><name name-style="western"><surname>Panaro</surname><given-names>M.A.</given-names></name></person-group><article-title>Inflammaging and brain: Curcumin and its beneficial potential as regulator of microglia activation</article-title><source>Molecules</source><year>2022</year><volume>27</volume><elocation-id>341</elocation-id><pub-id pub-id-type="doi">10.3390/molecules27020341</pub-id><pub-id pub-id-type="pmid">35056657</pub-id><pub-id pub-id-type="pmcid">PMC8780663</pub-id></element-citation></ref><ref id="B9-nutrients-17-02884"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bagheri</surname><given-names>H.</given-names></name><name name-style="western"><surname>Ghasemi</surname><given-names>F.</given-names></name><name name-style="western"><surname>Barreto</surname><given-names>G.E.</given-names></name><name name-style="western"><surname>Rafiee</surname><given-names>R.</given-names></name><name name-style="western"><surname>Sathyapalan</surname><given-names>T.</given-names></name><name name-style="western"><surname>Sahebkar</surname><given-names>A.</given-names></name></person-group><article-title>Effects of curcumin on mitochondria in neurodegenerative diseases</article-title><source>Biofactors</source><year>2020</year><volume>46</volume><fpage>5</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1002/biof.1566</pub-id><pub-id pub-id-type="pmid">31580521</pub-id></element-citation></ref><ref id="B10-nutrients-17-02884"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Piovesana</surname><given-names>R.</given-names></name><name name-style="western"><surname>Salazar Intriago</surname><given-names>M.S.</given-names></name><name name-style="western"><surname>Dini</surname><given-names>L.</given-names></name><name name-style="western"><surname>Tata</surname><given-names>A.M.</given-names></name></person-group><article-title>Cholinergic modulation of neuroinflammation: Focus on &#945;7 nicotinic receptor</article-title><source>Int. J. Mol. Sci.</source><year>2021</year><volume>22</volume><elocation-id>4912</elocation-id><pub-id pub-id-type="doi">10.3390/ijms22094912</pub-id><pub-id pub-id-type="pmid">34066354</pub-id><pub-id pub-id-type="pmcid">PMC8125157</pub-id></element-citation></ref><ref id="B11-nutrients-17-02884"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nebrisi</surname><given-names>E.E.</given-names></name></person-group><article-title>Neuroprotective activities of curcumin in Parkinson&#8217;s disease: A review of the literature</article-title><source>Int. J. Mol. Sci.</source><year>2021</year><volume>22</volume><elocation-id>11248</elocation-id><pub-id pub-id-type="doi">10.3390/ijms222011248</pub-id><pub-id pub-id-type="pmid">34681908</pub-id><pub-id pub-id-type="pmcid">PMC8537234</pub-id></element-citation></ref><ref id="B12-nutrients-17-02884"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Islam</surname><given-names>M.R.</given-names></name><name name-style="western"><surname>Rauf</surname><given-names>A.</given-names></name><name name-style="western"><surname>Akter</surname><given-names>S.</given-names></name><name name-style="western"><surname>Akter</surname><given-names>H.</given-names></name><name name-style="western"><surname>Al-Imran</surname><given-names>M.I.K.</given-names></name><name name-style="western"><surname>Fakir</surname><given-names>M.N.H.</given-names></name><name name-style="western"><surname>Thufa</surname><given-names>G.K.</given-names></name><name name-style="western"><surname>Islam</surname><given-names>M.T.</given-names></name><name name-style="western"><surname>Hemeg</surname><given-names>H.A.</given-names></name><name name-style="western"><surname>Abdulmonem</surname><given-names>W.A.</given-names></name><etal/></person-group><article-title>Neuroprotective Potential of Curcumin in Neurodegenerative Diseases: Clinical Insights Into Cellular and Molecular Signaling Pathways</article-title><source>J. Biochem. Mol. Toxicol.</source><year>2025</year><volume>39</volume><elocation-id>e70369</elocation-id><pub-id pub-id-type="doi">10.1002/jbt.70369</pub-id><pub-id pub-id-type="pmid">40678834</pub-id><pub-id pub-id-type="pmcid">PMC12326297</pub-id></element-citation></ref><ref id="B13-nutrients-17-02884"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>W.</given-names></name><name name-style="western"><surname>Zhai</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Heng</surname><given-names>X.</given-names></name><name name-style="western"><surname>Che</surname><given-names>F.Y.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>W.</given-names></name><name name-style="western"><surname>Sun</surname><given-names>D.</given-names></name><name name-style="western"><surname>Zhai</surname><given-names>G.</given-names></name></person-group><article-title>Oral bioavailability of curcumin: Problems and advancements</article-title><source>J. Drug Target.</source><year>2016</year><volume>24</volume><fpage>694</fpage><lpage>702</lpage><pub-id pub-id-type="doi">10.3109/1061186X.2016.1157883</pub-id><pub-id pub-id-type="pmid">26942997</pub-id></element-citation></ref><ref id="B14-nutrients-17-02884"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sarker</surname><given-names>M.R.</given-names></name><name name-style="western"><surname>Franks</surname><given-names>S.F.</given-names></name></person-group><article-title>Efficacy of curcumin for age-associated cognitive decline: A narrative review of preclinical and clinical studies</article-title><source>Geroscience</source><year>2018</year><volume>40</volume><fpage>73</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1007/s11357-018-0017-z</pub-id><pub-id pub-id-type="pmid">29679204</pub-id><pub-id pub-id-type="pmcid">PMC5964053</pub-id></element-citation></ref><ref id="B15-nutrients-17-02884"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Voulgaropoulou</surname><given-names>S.D.</given-names></name><name name-style="western"><surname>Van Amelsvoort</surname><given-names>T.</given-names></name><name name-style="western"><surname>Prickaerts</surname><given-names>J.</given-names></name><name name-style="western"><surname>Vingerhoets</surname><given-names>C.</given-names></name></person-group><article-title>The effect of curcumin on cognition in Alzheimer&#8217;s disease and healthy aging: A systematic review of pre-clinical and clinical studies</article-title><source>Brain Res.</source><year>2019</year><volume>1725</volume><fpage>146476</fpage><pub-id pub-id-type="doi">10.1016/j.brainres.2019.146476</pub-id><pub-id pub-id-type="pmid">31560864</pub-id></element-citation></ref><ref id="B16-nutrients-17-02884"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Malik</surname><given-names>P.</given-names></name><name name-style="western"><surname>Mukherjee</surname><given-names>T.K.</given-names></name></person-group><article-title>Structure-function elucidation of antioxidative and prooxidative activities of the polyphenolic compound curcumin</article-title><source>Chin. J. Biol.</source><year>2014</year><volume>2014</volume><elocation-id>396708</elocation-id><pub-id pub-id-type="doi">10.1155/2014/396708</pub-id></element-citation></ref><ref id="B17-nutrients-17-02884"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Noureddin</surname><given-names>S.A.</given-names></name><name name-style="western"><surname>El-Shishtawy</surname><given-names>R.M.</given-names></name><name name-style="western"><surname>Al-Footy</surname><given-names>K.O.</given-names></name></person-group><article-title>Curcumin analogues and their hybrid molecules as multifunctional drugs</article-title><source>Eur. J. Med. Chem.</source><year>2019</year><volume>182</volume><fpage>111631</fpage><pub-id pub-id-type="doi">10.1016/j.ejmech.2019.111631</pub-id><pub-id pub-id-type="pmid">31479974</pub-id></element-citation></ref><ref id="B18-nutrients-17-02884"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Priyadarsini</surname><given-names>K.I.</given-names></name></person-group><article-title>The chemistry of curcumin: From extraction to therapeutic agent</article-title><source>Molecules</source><year>2014</year><volume>19</volume><fpage>20091</fpage><lpage>20112</lpage><pub-id pub-id-type="doi">10.3390/molecules191220091</pub-id><pub-id pub-id-type="pmid">25470276</pub-id><pub-id pub-id-type="pmcid">PMC6270789</pub-id></element-citation></ref><ref id="B19-nutrients-17-02884"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rege</surname><given-names>S.A.</given-names></name><name name-style="western"><surname>Arya</surname><given-names>M.</given-names></name><name name-style="western"><surname>Momin</surname><given-names>S.A.</given-names></name></person-group><article-title>Structure activity relationship of tautomers of curcumin: A review</article-title><source>Ukr. Food J.</source><year>2019</year><volume>8</volume><fpage>45</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.24263/2304-974X-2019-8-1-6</pub-id></element-citation></ref><ref id="B20-nutrients-17-02884"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shahrajabian</surname><given-names>M.H.</given-names></name><name name-style="western"><surname>Sun</surname><given-names>W.</given-names></name></person-group><article-title>The golden spice for life: Turmeric with the pharmacological benefits of curcuminoids components, including curcumin, bisdemethoxycurcumin, and demethoxycurcumins</article-title><source>Curr. Org. Synth.</source><year>2024</year><volume>21</volume><fpage>665</fpage><lpage>683</lpage><pub-id pub-id-type="doi">10.2174/1570179420666230607124949</pub-id><pub-id pub-id-type="pmid">37287298</pub-id></element-citation></ref><ref id="B21-nutrients-17-02884"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zieli&#324;ska</surname><given-names>A.</given-names></name><name name-style="western"><surname>Alves</surname><given-names>H.</given-names></name><name name-style="western"><surname>Marques</surname><given-names>V.</given-names></name><name name-style="western"><surname>Durazzo</surname><given-names>A.</given-names></name><name name-style="western"><surname>Lucarini</surname><given-names>M.</given-names></name><name name-style="western"><surname>Alves</surname><given-names>T.F.</given-names></name><name name-style="western"><surname>Morsink</surname><given-names>M.</given-names></name><name name-style="western"><surname>Willemen</surname><given-names>N.</given-names></name><name name-style="western"><surname>Eder</surname><given-names>P.</given-names></name><name name-style="western"><surname>Chaud</surname><given-names>M.V.</given-names></name></person-group><article-title>Properties, extraction methods, and delivery systems for curcumin as a natural source of beneficial health effects</article-title><source>Medicina</source><year>2020</year><volume>56</volume><elocation-id>336</elocation-id><pub-id pub-id-type="doi">10.3390/medicina56070336</pub-id><pub-id pub-id-type="pmid">32635279</pub-id><pub-id pub-id-type="pmcid">PMC7404808</pub-id></element-citation></ref><ref id="B22-nutrients-17-02884"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stani&#263;</surname><given-names>Z.</given-names></name></person-group><article-title>Curcumin, a compound from natural sources, a true scientific challenge&#8212;A review</article-title><source>Plant Foods Hum. Nutr.</source><year>2017</year><volume>72</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1007/s11130-016-0590-1</pub-id><pub-id pub-id-type="pmid">27995378</pub-id></element-citation></ref><ref id="B23-nutrients-17-02884"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Anand</surname><given-names>P.</given-names></name><name name-style="western"><surname>Kunnumakkara</surname><given-names>A.B.</given-names></name><name name-style="western"><surname>Newman</surname><given-names>R.A.</given-names></name><name name-style="western"><surname>Aggarwal</surname><given-names>B.B.</given-names></name></person-group><article-title>Bioavailability of curcumin: Problems and promises</article-title><source>Mol. Pharm.</source><year>2007</year><volume>4</volume><fpage>807</fpage><lpage>818</lpage><pub-id pub-id-type="doi">10.1021/mp700113r</pub-id><pub-id pub-id-type="pmid">17999464</pub-id></element-citation></ref><ref id="B24-nutrients-17-02884"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hsieh</surname><given-names>C.</given-names></name></person-group><article-title>Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions</article-title><source>Anticancer. Res.</source><year>2001</year><volume>21</volume><fpage>e2900</fpage><pub-id pub-id-type="pmid">11712783</pub-id></element-citation></ref><ref id="B25-nutrients-17-02884"><label>25.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Jamil</surname><given-names>Q.A.</given-names></name></person-group><article-title>The Natural Compound Curcumin: Impact of Cellular Uptake and Metabolism on In Vitro Activity</article-title><source>Ph.D. Thesis</source><publisher-name>University of Vienna</publisher-name><publisher-loc>Vienna, Austria</publisher-loc><year>2018</year></element-citation></ref><ref id="B26-nutrients-17-02884"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tabanelli</surname><given-names>R.</given-names></name><name name-style="western"><surname>Brogi</surname><given-names>S.</given-names></name><name name-style="western"><surname>Calderone</surname><given-names>V.</given-names></name></person-group><article-title>Improving curcumin bioavailability: Current strategies and future perspectives</article-title><source>Pharmaceutics</source><year>2021</year><volume>13</volume><elocation-id>1715</elocation-id><pub-id pub-id-type="doi">10.3390/pharmaceutics13101715</pub-id><pub-id pub-id-type="pmid">34684008</pub-id><pub-id pub-id-type="pmcid">PMC8540263</pub-id></element-citation></ref><ref id="B27-nutrients-17-02884"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pan-On</surname><given-names>S.</given-names></name><name name-style="western"><surname>Dilokthornsakul</surname><given-names>P.</given-names></name><name name-style="western"><surname>Tiyaboonchai</surname><given-names>W.</given-names></name></person-group><article-title>Trends in advanced oral drug delivery system for curcumin: A systematic review</article-title><source>J. Control. Release</source><year>2022</year><volume>348</volume><fpage>335</fpage><lpage>345</lpage><pub-id pub-id-type="doi">10.1016/j.jconrel.2022.05.048</pub-id><pub-id pub-id-type="pmid">35654170</pub-id></element-citation></ref><ref id="B28-nutrients-17-02884"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Prasad</surname><given-names>S.</given-names></name><name name-style="western"><surname>Tyagi</surname><given-names>A.K.</given-names></name><name name-style="western"><surname>Aggarwal</surname><given-names>B.B.</given-names></name></person-group><article-title>Recent developments in delivery, bioavailability, absorption and metabolism of curcumin: The golden pigment from golden spice</article-title><source>Cancer Res. Treat. Off. J. Korean Cancer Assoc.</source><year>2014</year><volume>46</volume><fpage>2</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.4143/crt.2014.46.1.2</pub-id><pub-id pub-id-type="pmcid">PMC3918523</pub-id><pub-id pub-id-type="pmid">24520218</pub-id></element-citation></ref><ref id="B29-nutrients-17-02884"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dei Cas</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ghidoni</surname><given-names>R.</given-names></name></person-group><article-title>Dietary curcumin: Correlation between bioavailability and health potential</article-title><source>Nutrients</source><year>2019</year><volume>11</volume><elocation-id>2147</elocation-id><pub-id pub-id-type="doi">10.3390/nu11092147</pub-id><pub-id pub-id-type="pmid">31500361</pub-id><pub-id pub-id-type="pmcid">PMC6770259</pub-id></element-citation></ref><ref id="B30-nutrients-17-02884"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mohi-Ud-Din</surname><given-names>R.</given-names></name><name name-style="western"><surname>Mir</surname><given-names>R.H.</given-names></name><name name-style="western"><surname>Wani</surname><given-names>T.U.</given-names></name><name name-style="western"><surname>Shah</surname><given-names>A.J.</given-names></name><name name-style="western"><surname>Mohi-Ud-Din</surname><given-names>I.</given-names></name><name name-style="western"><surname>Dar</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Pottoo</surname><given-names>F.H.</given-names></name></person-group><article-title>Novel drug delivery system for curcumin: Implementation to improve therapeutic efficacy against neurological disorders</article-title><source>Comb. Chem. High. Throughput Screen.</source><year>2022</year><volume>25</volume><fpage>607</fpage><lpage>615</lpage><pub-id pub-id-type="doi">10.2174/1386207324666210705114058</pub-id><pub-id pub-id-type="pmid">34225614</pub-id></element-citation></ref><ref id="B31-nutrients-17-02884"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aminnezhad</surname><given-names>S.</given-names></name><name name-style="western"><surname>Zonobian</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Moradi Douki</surname><given-names>M.</given-names></name><name name-style="western"><surname>Mohammadi</surname><given-names>M.R.</given-names></name><name name-style="western"><surname>Azarakhsh</surname><given-names>Y.</given-names></name></person-group><article-title>Curcumin and their derivatives with anti-inflammatory, neuroprotective, anticancer, and antimicrobial activities: A review</article-title><source>Micro Nano Bio Asp.</source><year>2023</year><volume>2</volume><fpage>25</fpage><lpage>34</lpage></element-citation></ref><ref id="B32-nutrients-17-02884"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hunyadi</surname><given-names>A.</given-names></name></person-group><article-title>The mechanism (s) of action of antioxidants: From scavenging reactive oxygen/nitrogen species to redox signaling and the generation of bioactive secondary metabolites</article-title><source>Med. Res. Rev.</source><year>2019</year><volume>39</volume><fpage>2505</fpage><lpage>2533</lpage><pub-id pub-id-type="doi">10.1002/med.21592</pub-id><pub-id pub-id-type="pmid">31074028</pub-id></element-citation></ref><ref id="B33-nutrients-17-02884"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wei</surname><given-names>Q.-Y.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>W.-F.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>B.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>L.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Z.-L.</given-names></name></person-group><article-title>Inhibition of lipid peroxidation and protein oxidation in rat liver mitochondria by curcumin and its analogues</article-title><source>Biochim. Biophys. Acta (BBA)-Gen. Subj.</source><year>2006</year><volume>1760</volume><fpage>70</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1016/j.bbagen.2005.09.008</pub-id><pub-id pub-id-type="pmid">16236451</pub-id></element-citation></ref><ref id="B34-nutrients-17-02884"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Surh</surname><given-names>Y.-J.</given-names></name><name name-style="western"><surname>Chun</surname><given-names>K.-S.</given-names></name><name name-style="western"><surname>Cha</surname><given-names>H.-H.</given-names></name><name name-style="western"><surname>Han</surname><given-names>S.S.</given-names></name><name name-style="western"><surname>Keum</surname><given-names>Y.-S.</given-names></name><name name-style="western"><surname>Park</surname><given-names>K.-K.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>S.S.</given-names></name></person-group><article-title>Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: Down-regulation of COX-2 and iNOS through suppression of NF-&#954;B activation</article-title><source>Mutat. Res. Fundam. Mol. Mech. Mutagen.</source><year>2001</year><volume>480</volume><fpage>243</fpage><lpage>268</lpage><pub-id pub-id-type="doi">10.1016/S0027-5107(01)00183-X</pub-id><pub-id pub-id-type="pmid">11506818</pub-id></element-citation></ref><ref id="B35-nutrients-17-02884"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Reuter</surname><given-names>S.</given-names></name><name name-style="western"><surname>Gupta</surname><given-names>S.C.</given-names></name><name name-style="western"><surname>Park</surname><given-names>B.</given-names></name><name name-style="western"><surname>Goel</surname><given-names>A.</given-names></name><name name-style="western"><surname>Aggarwal</surname><given-names>B.B.</given-names></name></person-group><article-title>Epigenetic changes induced by curcumin and other natural compounds</article-title><source>Genes Nutr.</source><year>2011</year><volume>6</volume><fpage>93</fpage><lpage>108</lpage><pub-id pub-id-type="doi">10.1007/s12263-011-0222-1</pub-id><pub-id pub-id-type="pmid">21516481</pub-id><pub-id pub-id-type="pmcid">PMC3092901</pub-id></element-citation></ref><ref id="B36-nutrients-17-02884"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Teiten</surname><given-names>M.H.</given-names></name><name name-style="western"><surname>Dicato</surname><given-names>M.</given-names></name><name name-style="western"><surname>Diederich</surname><given-names>M.</given-names></name></person-group><article-title>Curcumin as a regulator of epigenetic events</article-title><source>Mol. Nutr. Food Res.</source><year>2013</year><volume>57</volume><fpage>1619</fpage><lpage>1629</lpage><pub-id pub-id-type="doi">10.1002/mnfr.201300201</pub-id><pub-id pub-id-type="pmid">23754571</pub-id></element-citation></ref><ref id="B37-nutrients-17-02884"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Boyanapalli</surname><given-names>S.S.</given-names></name><name name-style="western"><surname>Kong</surname><given-names>A.-N.T.</given-names></name></person-group><article-title>&#8220;Curcumin, the king of spices&#8221;: Epigenetic regulatory mechanisms in the prevention of cancer, neurological, and inflammatory diseases</article-title><source>Curr. Pharmacol. Rep.</source><year>2015</year><volume>1</volume><fpage>129</fpage><lpage>139</lpage><pub-id pub-id-type="doi">10.1007/s40495-015-0018-x</pub-id><pub-id pub-id-type="pmid">26457241</pub-id><pub-id pub-id-type="pmcid">PMC4596544</pub-id></element-citation></ref><ref id="B38-nutrients-17-02884"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Azzini</surname><given-names>E.</given-names></name><name name-style="western"><surname>Pe&#241;a-Corona</surname><given-names>S.I.</given-names></name><name name-style="western"><surname>Hern&#225;ndez-Parra</surname><given-names>H.</given-names></name><name name-style="western"><surname>Chandran</surname><given-names>D.</given-names></name><name name-style="western"><surname>Saleena</surname><given-names>L.A.K.</given-names></name><name name-style="western"><surname>Sawikr</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Peluso</surname><given-names>I.</given-names></name><name name-style="western"><surname>Dhumal</surname><given-names>S.</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>M.</given-names></name><name name-style="western"><surname>Leyva-G&#243;mez</surname><given-names>G.</given-names></name></person-group><article-title>Neuroprotective and anti-inflammatory effects of curcumin in Alzheimer&#8217;s disease: Targeting neuroinflammation strategies</article-title><source>Phytother. Res.</source><year>2024</year><volume>38</volume><fpage>3169</fpage><lpage>3189</lpage><pub-id pub-id-type="doi">10.1002/ptr.8200</pub-id><pub-id pub-id-type="pmid">38616356</pub-id></element-citation></ref><ref id="B39-nutrients-17-02884"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moldoveanu</surname><given-names>C.-A.</given-names></name><name name-style="western"><surname>Tomoaia-Cotisel</surname><given-names>M.</given-names></name><name name-style="western"><surname>Sevastre-Berghian</surname><given-names>A.</given-names></name><name name-style="western"><surname>Tomoaia</surname><given-names>G.</given-names></name><name name-style="western"><surname>Mocanu</surname><given-names>A.</given-names></name><name name-style="western"><surname>Pal-Racz</surname><given-names>C.</given-names></name><name name-style="western"><surname>Toma</surname><given-names>V.-A.</given-names></name><name name-style="western"><surname>Roman</surname><given-names>I.</given-names></name><name name-style="western"><surname>Ujica</surname><given-names>M.-A.</given-names></name><name name-style="western"><surname>Pop</surname><given-names>L.-C.</given-names></name></person-group><article-title>A Review on Current Aspects of Curcumin-Based Effects in Relation to Neurodegenerative, Neuroinflammatory and Cerebrovascular Diseases</article-title><source>Molecules</source><year>2024</year><volume>30</volume><elocation-id>43</elocation-id><pub-id pub-id-type="doi">10.3390/molecules30010043</pub-id><pub-id pub-id-type="pmid">39795101</pub-id><pub-id pub-id-type="pmcid">PMC11722367</pub-id></element-citation></ref><ref id="B40-nutrients-17-02884"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mukherjee</surname><given-names>S.</given-names></name><name name-style="western"><surname>Mishra</surname><given-names>A.K.</given-names></name><name name-style="western"><surname>Peer</surname><given-names>G.D.G.</given-names></name><name name-style="western"><surname>Bagabir</surname><given-names>S.A.</given-names></name><name name-style="western"><surname>Haque</surname><given-names>S.</given-names></name><name name-style="western"><surname>Pandey</surname><given-names>R.P.</given-names></name><name name-style="western"><surname>Raj</surname><given-names>V.S.</given-names></name><name name-style="western"><surname>Jain</surname><given-names>N.</given-names></name><name name-style="western"><surname>Pandey</surname><given-names>A.</given-names></name><name name-style="western"><surname>Kar</surname><given-names>S.K.</given-names></name></person-group><article-title>The Interplay of the Unfolded Protein Response in Neurodegenerative Diseases: A Therapeutic Role of Curcumin</article-title><source>Front. Aging Neurosci.</source><year>2021</year><volume>13</volume><elocation-id>767493</elocation-id><pub-id pub-id-type="doi">10.3389/fnagi.2021.767493</pub-id><pub-id pub-id-type="pmid">34867295</pub-id><pub-id pub-id-type="pmcid">PMC8640216</pub-id></element-citation></ref><ref id="B41-nutrients-17-02884"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ng</surname><given-names>T.P.</given-names></name><name name-style="western"><surname>Nyunt</surname><given-names>S.Z.</given-names></name><name name-style="western"><surname>Gao</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Gwee</surname><given-names>X.</given-names></name><name name-style="western"><surname>Chua</surname><given-names>D.Q.L.</given-names></name><name name-style="western"><surname>Yap</surname><given-names>K.B.</given-names></name></person-group><article-title>Curcumin-rich curry consumption and life expectancy: Singapore longitudinal ageing study</article-title><source>Geroscience</source><year>2024</year><volume>46</volume><fpage>969</fpage><lpage>980</lpage><pub-id pub-id-type="doi">10.1007/s11357-023-00842-1</pub-id><pub-id pub-id-type="pmid">37306893</pub-id><pub-id pub-id-type="pmcid">PMC10828228</pub-id></element-citation></ref><ref id="B42-nutrients-17-02884"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Izadi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Sadri</surname><given-names>N.</given-names></name><name name-style="western"><surname>Abdi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Zadeh</surname><given-names>M.M.R.</given-names></name><name name-style="western"><surname>Jalaei</surname><given-names>D.</given-names></name><name name-style="western"><surname>Ghazimoradi</surname><given-names>M.M.</given-names></name><name name-style="western"><surname>Shouri</surname><given-names>S.</given-names></name><name name-style="western"><surname>Tahmasebi</surname><given-names>S.</given-names></name></person-group><article-title>Longevity and anti-aging effects of curcumin supplementation</article-title><source>Geroscience</source><year>2024</year><volume>46</volume><fpage>2933</fpage><lpage>2950</lpage><pub-id pub-id-type="doi">10.1007/s11357-024-01092-5</pub-id><pub-id pub-id-type="pmid">38409646</pub-id><pub-id pub-id-type="pmcid">PMC11009219</pub-id></element-citation></ref><ref id="B43-nutrients-17-02884"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Strong</surname><given-names>R.</given-names></name><name name-style="western"><surname>Miller</surname><given-names>R.A.</given-names></name><name name-style="western"><surname>Astle</surname><given-names>C.M.</given-names></name><name name-style="western"><surname>Baur</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>de Cabo</surname><given-names>R.</given-names></name><name name-style="western"><surname>Fernandez</surname><given-names>E.</given-names></name><name name-style="western"><surname>Guo</surname><given-names>W.</given-names></name><name name-style="western"><surname>Javors</surname><given-names>M.</given-names></name><name name-style="western"><surname>Kirkland</surname><given-names>J.L.</given-names></name><name name-style="western"><surname>Nelson</surname><given-names>J.F.</given-names></name><etal/></person-group><article-title>Evaluation of resveratrol, green tea extract, curcumin, oxaloacetic acid, and medium-chain triglyceride oil on life span of genetically heterogeneous mice</article-title><source>J. Gerontol. A Biol. Sci. Med. Sci.</source><year>2013</year><volume>68</volume><fpage>6</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1093/gerona/gls070</pub-id><pub-id pub-id-type="pmid">22451473</pub-id><pub-id pub-id-type="pmcid">PMC3598361</pub-id></element-citation></ref><ref id="B44-nutrients-17-02884"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pospiech</surname><given-names>E.</given-names></name><name name-style="western"><surname>Bar</surname><given-names>A.</given-names></name><name name-style="western"><surname>Pisarek-Pacek</surname><given-names>A.</given-names></name><name name-style="western"><surname>Karas</surname><given-names>A.</given-names></name><name name-style="western"><surname>Branicki</surname><given-names>W.</given-names></name><name name-style="western"><surname>Chlopicki</surname><given-names>S.</given-names></name></person-group><article-title>Epigenetic clock in the aorta and age-related endothelial dysfunction in mice</article-title><source>Geroscience</source><year>2024</year><volume>46</volume><fpage>3993</fpage><lpage>4002</lpage><pub-id pub-id-type="doi">10.1007/s11357-024-01086-3</pub-id><pub-id pub-id-type="pmid">38381284</pub-id><pub-id pub-id-type="pmcid">PMC11226569</pub-id></element-citation></ref><ref id="B45-nutrients-17-02884"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sun</surname><given-names>Z.Z.</given-names></name><name name-style="western"><surname>Li</surname><given-names>X.Y.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>S.</given-names></name><name name-style="western"><surname>Shen</surname><given-names>L.</given-names></name><name name-style="western"><surname>Ji</surname><given-names>H.F.</given-names></name></person-group><article-title>Bidirectional interactions between curcumin and gut microbiota in transgenic mice with Alzheimer&#8217;s disease</article-title><source>Appl. Microbiol. Biotechnol.</source><year>2020</year><volume>104</volume><fpage>3507</fpage><lpage>3515</lpage><pub-id pub-id-type="doi">10.1007/s00253-020-10461-x</pub-id><pub-id pub-id-type="pmid">32095862</pub-id></element-citation></ref><ref id="B46-nutrients-17-02884"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhu</surname><given-names>J.</given-names></name><name name-style="western"><surname>He</surname><given-names>L.</given-names></name></person-group><article-title>The modulatory effects of curcumin on the gut microbiota: A potential strategy for disease treatment and health promotion</article-title><source>Microorganisms</source><year>2024</year><volume>12</volume><elocation-id>642</elocation-id><pub-id pub-id-type="doi">10.3390/microorganisms12040642</pub-id><pub-id pub-id-type="pmid">38674587</pub-id><pub-id pub-id-type="pmcid">PMC11052165</pub-id></element-citation></ref><ref id="B47-nutrients-17-02884"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Balaji</surname><given-names>S.</given-names></name><name name-style="western"><surname>Jeyaraman</surname><given-names>N.</given-names></name><name name-style="western"><surname>Jeyaraman</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ramasubramanian</surname><given-names>S.</given-names></name><name name-style="western"><surname>Muthu</surname><given-names>S.</given-names></name><name name-style="western"><surname>Santos</surname><given-names>G.S.</given-names></name><name name-style="western"><surname>da Fonseca</surname><given-names>L.F.</given-names></name><name name-style="western"><surname>Lana</surname><given-names>J.F.</given-names></name></person-group><article-title>Impact of curcumin on gut microbiome</article-title><source>World J. Exp. Med.</source><year>2025</year><volume>15</volume><fpage>100275</fpage><pub-id pub-id-type="doi">10.5493/wjem.v15.i1.100275</pub-id><pub-id pub-id-type="pmid">40115756</pub-id><pub-id pub-id-type="pmcid">PMC11718586</pub-id></element-citation></ref><ref id="B48-nutrients-17-02884"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zam</surname><given-names>W.</given-names></name></person-group><article-title>Gut microbiota as a prospective therapeutic target for curcumin: A review of mutual influence</article-title><source>J. Nutr. Metab.</source><year>2018</year><volume>2018</volume><fpage>1367984</fpage><pub-id pub-id-type="doi">10.1155/2018/1367984</pub-id><pub-id pub-id-type="pmid">30647970</pub-id><pub-id pub-id-type="pmcid">PMC6311836</pub-id></element-citation></ref><ref id="B49-nutrients-17-02884"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cerullo</surname><given-names>M.</given-names></name><name name-style="western"><surname>Armeli</surname><given-names>F.</given-names></name><name name-style="western"><surname>Mengoni</surname><given-names>B.</given-names></name><name name-style="western"><surname>Menin</surname><given-names>M.</given-names></name><name name-style="western"><surname>Crudeli</surname><given-names>M.L.</given-names></name><name name-style="western"><surname>Businaro</surname><given-names>R.</given-names></name></person-group><article-title>Curcumin Modulation of the Gut&#8211;Brain Axis for Neuroinflammation and Metabolic Disorders Prevention and Treatment</article-title><source>Nutrients</source><year>2025</year><volume>17</volume><elocation-id>1430</elocation-id><pub-id pub-id-type="doi">10.3390/nu17091430</pub-id><pub-id pub-id-type="pmid">40362738</pub-id><pub-id pub-id-type="pmcid">PMC12073396</pub-id></element-citation></ref><ref id="B50-nutrients-17-02884"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ghosh</surname><given-names>S.S.</given-names></name><name name-style="western"><surname>He</surname><given-names>H.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Gehr</surname><given-names>T.W.</given-names></name><name name-style="western"><surname>Ghosh</surname><given-names>S.</given-names></name></person-group><article-title>Curcumin-mediated regulation of intestinal barrier function: The mechanism underlying its beneficial effects</article-title><source>Tissue Barriers</source><year>2018</year><volume>6</volume><fpage>e1425085</fpage><pub-id pub-id-type="doi">10.1080/21688370.2018.1425085</pub-id><pub-id pub-id-type="pmid">29420166</pub-id><pub-id pub-id-type="pmcid">PMC5823546</pub-id></element-citation></ref><ref id="B51-nutrients-17-02884"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Ghosh</surname><given-names>S.S.</given-names></name><name name-style="western"><surname>Ghosh</surname><given-names>S.</given-names></name></person-group><article-title>Curcumin improves intestinal barrier function: Modulation of intracellular signaling, and organization of tight junctions</article-title><source>Am. J. Physiol.-Cell Physiol.</source><year>2017</year><volume>312</volume><fpage>C438</fpage><lpage>C445</lpage><pub-id pub-id-type="doi">10.1152/ajpcell.00235.2016</pub-id><pub-id pub-id-type="pmid">28249988</pub-id><pub-id pub-id-type="pmcid">PMC5407015</pub-id></element-citation></ref><ref id="B52-nutrients-17-02884"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Di Meo</surname><given-names>F.</given-names></name><name name-style="western"><surname>Margarucci</surname><given-names>S.</given-names></name><name name-style="western"><surname>Galderisi</surname><given-names>U.</given-names></name><name name-style="western"><surname>Crispi</surname><given-names>S.</given-names></name><name name-style="western"><surname>Peluso</surname><given-names>G.</given-names></name></person-group><article-title>Curcumin, gut microbiota, and neuroprotection</article-title><source>Nutrients</source><year>2019</year><volume>11</volume><elocation-id>2426</elocation-id><pub-id pub-id-type="doi">10.3390/nu11102426</pub-id><pub-id pub-id-type="pmid">31614630</pub-id><pub-id pub-id-type="pmcid">PMC6835970</pub-id></element-citation></ref><ref id="B53-nutrients-17-02884"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ramalingam</surname><given-names>M.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>S.-J.</given-names></name></person-group><article-title>Reactive oxygen/nitrogen species and their functional correlations in neurodegenerative diseases</article-title><source>J. Neural Transm.</source><year>2012</year><volume>119</volume><fpage>891</fpage><lpage>910</lpage><pub-id pub-id-type="doi">10.1007/s00702-011-0758-7</pub-id><pub-id pub-id-type="pmid">22212484</pub-id></element-citation></ref><ref id="B54-nutrients-17-02884"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tabner</surname><given-names>B.J.</given-names></name><name name-style="western"><surname>Turnbull</surname><given-names>S.</given-names></name><name name-style="western"><surname>El-Aganf</surname><given-names>O.</given-names></name><name name-style="western"><surname>Allsop</surname><given-names>D.</given-names></name></person-group><article-title>Production of reactive oxygen species from aggregating proteins implicated in Alzheimer&#8217;s disease, Parkinson&#8217;s disease and other neurodegenerative diseases</article-title><source>Curr. Top. Med. Chem.</source><year>2001</year><volume>1</volume><fpage>507</fpage><lpage>517</lpage><pub-id pub-id-type="doi">10.2174/1568026013394822</pub-id><pub-id pub-id-type="pmid">11895127</pub-id></element-citation></ref><ref id="B55-nutrients-17-02884"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bhat</surname><given-names>A.H.</given-names></name><name name-style="western"><surname>Dar</surname><given-names>K.B.</given-names></name><name name-style="western"><surname>Anees</surname><given-names>S.</given-names></name><name name-style="western"><surname>Zargar</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Masood</surname><given-names>A.</given-names></name><name name-style="western"><surname>Sofi</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Ganie</surname><given-names>S.A.</given-names></name></person-group><article-title>Oxidative stress, mitochondrial dysfunction and neurodegenerative diseases; a mechanistic insight</article-title><source>Biomed. Pharmacother.</source><year>2015</year><volume>74</volume><fpage>101</fpage><lpage>110</lpage><pub-id pub-id-type="doi">10.1016/j.biopha.2015.07.025</pub-id><pub-id pub-id-type="pmid">26349970</pub-id></element-citation></ref><ref id="B56-nutrients-17-02884"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Borra</surname><given-names>S.K.</given-names></name><name name-style="western"><surname>Mahendra</surname><given-names>J.</given-names></name><name name-style="western"><surname>Gurumurthy</surname><given-names>P.</given-names></name><name name-style="western"><surname>Iqbal</surname><given-names>S.S.</given-names></name><name name-style="western"><surname>Mahendra</surname><given-names>L.</given-names></name></person-group><article-title>Effect of curcumin against oxidation of biomolecules by hydroxyl radicals</article-title><source>J. Clin. Diagn. Res. JCDR</source><year>2014</year><volume>8</volume><fpage>CC01</fpage><pub-id pub-id-type="doi">10.7860/JCDR/2014/8517.4967</pub-id><pub-id pub-id-type="pmid">25478334</pub-id><pub-id pub-id-type="pmcid">PMC4253152</pub-id></element-citation></ref><ref id="B57-nutrients-17-02884"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gupta</surname><given-names>N.</given-names></name><name name-style="western"><surname>Verma</surname><given-names>K.</given-names></name><name name-style="western"><surname>Nalla</surname><given-names>S.</given-names></name><name name-style="western"><surname>Kulshreshtha</surname><given-names>A.</given-names></name><name name-style="western"><surname>Lall</surname><given-names>R.</given-names></name><name name-style="western"><surname>Prasad</surname><given-names>S.</given-names></name></person-group><article-title>Free radicals as a double-edged sword: The cancer preventive and therapeutic roles of curcumin</article-title><source>Molecules</source><year>2020</year><volume>25</volume><elocation-id>5390</elocation-id><pub-id pub-id-type="doi">10.3390/molecules25225390</pub-id><pub-id pub-id-type="pmid">33217990</pub-id><pub-id pub-id-type="pmcid">PMC7698794</pub-id></element-citation></ref><ref id="B58-nutrients-17-02884"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wolnicka-Glubisz</surname><given-names>A.</given-names></name><name name-style="western"><surname>Wisniewska-Becker</surname><given-names>A.</given-names></name></person-group><article-title>Dual action of curcumin as an anti-and pro-oxidant from a biophysical perspective</article-title><source>Antioxidants</source><year>2023</year><volume>12</volume><elocation-id>1725</elocation-id><pub-id pub-id-type="doi">10.3390/antiox12091725</pub-id><pub-id pub-id-type="pmid">37760028</pub-id><pub-id pub-id-type="pmcid">PMC10525529</pub-id></element-citation></ref><ref id="B59-nutrients-17-02884"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Y.-M.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>P.-Y.</given-names></name></person-group><article-title>Protective effects of curcumin and quercetin during benzo (a) pyrene induced lung carcinogenesis in mice</article-title><source>Eur. Rev. Med. Pharmacol. Sci.</source><year>2015</year><volume>19</volume><fpage>1736</fpage><lpage>1743</lpage><pub-id pub-id-type="pmid">26004618</pub-id></element-citation></ref><ref id="B60-nutrients-17-02884"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Biswas</surname><given-names>J.</given-names></name><name name-style="western"><surname>Sinha</surname><given-names>D.</given-names></name><name name-style="western"><surname>Mukherjee</surname><given-names>S.</given-names></name><name name-style="western"><surname>Roy</surname><given-names>S.</given-names></name><name name-style="western"><surname>Siddiqi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Roy</surname><given-names>M.</given-names></name></person-group><article-title>Curcumin protects DNA damage in a chronically arsenic-exposed population of West Bengal</article-title><source>Hum. Exp. Toxicol.</source><year>2010</year><volume>29</volume><fpage>513</fpage><lpage>524</lpage><pub-id pub-id-type="doi">10.1177/0960327109359020</pub-id><pub-id pub-id-type="pmid">20056736</pub-id></element-citation></ref><ref id="B61-nutrients-17-02884"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Iqbal</surname><given-names>M.</given-names></name><name name-style="western"><surname>Sharma</surname><given-names>S.D.</given-names></name><name name-style="western"><surname>Okazaki</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Fujisawa</surname><given-names>M.</given-names></name><name name-style="western"><surname>Okada</surname><given-names>S.</given-names></name></person-group><article-title>Dietary supplementation of curcumin enhances antioxidant and phase II metabolizing enzymes in ddY male mice: Possible role in protection against chemical carcinogenesis and toxicity</article-title><source>Pharmacol. Toxicol.</source><year>2003</year><volume>92</volume><fpage>33</fpage><lpage>38</lpage><pub-id pub-id-type="doi">10.1034/j.1600-0773.2003.920106.x</pub-id><pub-id pub-id-type="pmid">12710595</pub-id></element-citation></ref><ref id="B62-nutrients-17-02884"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Piper</surname><given-names>J.T.</given-names></name><name name-style="western"><surname>Singhal</surname><given-names>S.S.</given-names></name><name name-style="western"><surname>Salameh</surname><given-names>M.S.</given-names></name><name name-style="western"><surname>Torman</surname><given-names>R.T.</given-names></name><name name-style="western"><surname>Awasthi</surname><given-names>Y.C.</given-names></name><name name-style="western"><surname>Awasthi</surname><given-names>S.</given-names></name></person-group><article-title>Mechanisms of anticarcinogenic properties of curcumin: The effect of curcumin on glutathione linked detoxification enzymes in rat liver</article-title><source>Int. J. Biochem. Cell Biol.</source><year>1998</year><volume>30</volume><fpage>445</fpage><lpage>456</lpage><pub-id pub-id-type="doi">10.1016/S1357-2725(98)00015-6</pub-id><pub-id pub-id-type="pmid">9675878</pub-id></element-citation></ref><ref id="B63-nutrients-17-02884"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shahcheraghi</surname><given-names>S.H.</given-names></name><name name-style="western"><surname>Salemi</surname><given-names>F.</given-names></name><name name-style="western"><surname>Peirovi</surname><given-names>N.</given-names></name><name name-style="western"><surname>Ayatollahi</surname><given-names>J.</given-names></name><name name-style="western"><surname>Alam</surname><given-names>W.</given-names></name><name name-style="western"><surname>Khan</surname><given-names>H.</given-names></name><name name-style="western"><surname>Saso</surname><given-names>L.</given-names></name></person-group><article-title>Nrf2 regulation by curcumin: Molecular aspects for therapeutic prospects</article-title><source>Molecules</source><year>2021</year><volume>27</volume><elocation-id>167</elocation-id><pub-id pub-id-type="doi">10.3390/molecules27010167</pub-id><pub-id pub-id-type="pmid">35011412</pub-id><pub-id pub-id-type="pmcid">PMC8746993</pub-id></element-citation></ref><ref id="B64-nutrients-17-02884"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shen</surname><given-names>G.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>C.</given-names></name><name name-style="western"><surname>Hu</surname><given-names>R.</given-names></name><name name-style="western"><surname>Jain</surname><given-names>M.R.</given-names></name><name name-style="western"><surname>Gopalkrishnan</surname><given-names>A.</given-names></name><name name-style="western"><surname>Nair</surname><given-names>S.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>M.T.</given-names></name><name name-style="western"><surname>Chan</surname><given-names>J.Y.</given-names></name><name name-style="western"><surname>Kong</surname><given-names>A.N.</given-names></name></person-group><article-title>Modulation of nuclear factor E2-related factor 2-mediated gene expression in mice liver and small intestine by cancer chemopreventive agent curcumin</article-title><source>Mol. Cancer Ther.</source><year>2006</year><volume>5</volume><fpage>39</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1158/1535-7163.MCT-05-0293</pub-id><pub-id pub-id-type="pmid">16432161</pub-id></element-citation></ref><ref id="B65-nutrients-17-02884"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Balogun</surname><given-names>E.</given-names></name><name name-style="western"><surname>Hoque</surname><given-names>M.</given-names></name><name name-style="western"><surname>Gong</surname><given-names>P.</given-names></name><name name-style="western"><surname>Killeen</surname><given-names>E.</given-names></name><name name-style="western"><surname>Green</surname><given-names>C.J.</given-names></name><name name-style="western"><surname>Foresti</surname><given-names>R.</given-names></name><name name-style="western"><surname>Alam</surname><given-names>J.</given-names></name><name name-style="western"><surname>Motterlini</surname><given-names>R.</given-names></name></person-group><article-title>Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element</article-title><source>Biochem. J.</source><year>2003</year><volume>371</volume><fpage>887</fpage><lpage>895</lpage><pub-id pub-id-type="doi">10.1042/bj20021619</pub-id><pub-id pub-id-type="pmid">12570874</pub-id><pub-id pub-id-type="pmcid">PMC1223348</pub-id></element-citation></ref><ref id="B66-nutrients-17-02884"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gonz&#225;lez-Reyes</surname><given-names>S.</given-names></name><name name-style="western"><surname>Guzm&#225;n-Beltr&#225;n</surname><given-names>S.</given-names></name><name name-style="western"><surname>Medina-Campos</surname><given-names>O.N.</given-names></name><name name-style="western"><surname>Pedraza-Chaverri</surname><given-names>J.</given-names></name></person-group><article-title>Curcumin pretreatment induces Nrf2 and an antioxidant response and prevents hemin-induced toxicity in primary cultures of cerebellar granule neurons of rats</article-title><source>Oxidative Med. Cell. Longev.</source><year>2013</year><volume>2013</volume><fpage>801418</fpage><pub-id pub-id-type="doi">10.1155/2013/801418</pub-id><pub-id pub-id-type="pmcid">PMC3885319</pub-id><pub-id pub-id-type="pmid">24454990</pub-id></element-citation></ref><ref id="B67-nutrients-17-02884"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kocyigit</surname><given-names>A.</given-names></name><name name-style="western"><surname>Guler</surname><given-names>E.M.</given-names></name></person-group><article-title>Curcumin induce DNA damage and apoptosis through generation of reactive oxygen species and reducing mitochondrial membrane potential in melanoma cancer cells</article-title><source>Cell. Mol. Biol.</source><year>2017</year><volume>63</volume><fpage>97</fpage><lpage>105</lpage><pub-id pub-id-type="doi">10.14715/cmb/2017.63.11.17</pub-id><pub-id pub-id-type="pmid">29208180</pub-id></element-citation></ref><ref id="B68-nutrients-17-02884"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Naserzadeh</surname><given-names>P.</given-names></name><name name-style="western"><surname>Mehr</surname><given-names>S.N.</given-names></name><name name-style="western"><surname>Sadabadi</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Seydi</surname><given-names>E.</given-names></name><name name-style="western"><surname>Salimi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Pourahmad</surname><given-names>J.</given-names></name></person-group><article-title>Curcumin protects mitochondria and cardiomyocytes from oxidative damage and apoptosis induced by hemiscorpius lepturus venom</article-title><source>Drug Res.</source><year>2018</year><volume>68</volume><fpage>113</fpage><lpage>120</lpage><pub-id pub-id-type="doi">10.1055/s-0043-119073</pub-id><pub-id pub-id-type="pmid">29017188</pub-id></element-citation></ref><ref id="B69-nutrients-17-02884"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ghosh</surname><given-names>D.</given-names></name><name name-style="western"><surname>Choudhury</surname><given-names>S.T.</given-names></name><name name-style="western"><surname>Ghosh</surname><given-names>S.</given-names></name><name name-style="western"><surname>Mandal</surname><given-names>A.K.</given-names></name><name name-style="western"><surname>Sarkar</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ghosh</surname><given-names>A.</given-names></name><name name-style="western"><surname>Saha</surname><given-names>K.D.</given-names></name><name name-style="western"><surname>Das</surname><given-names>N.</given-names></name></person-group><article-title>Nanocapsulated curcumin: Oral chemopreventive formulation against diethylnitrosamine induced hepatocellular carcinoma in rat</article-title><source>Chem.-Biol. Interact.</source><year>2012</year><volume>195</volume><fpage>206</fpage><lpage>214</lpage><pub-id pub-id-type="doi">10.1016/j.cbi.2011.12.004</pub-id><pub-id pub-id-type="pmid">22197969</pub-id></element-citation></ref><ref id="B70-nutrients-17-02884"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shishodia</surname><given-names>S.</given-names></name><name name-style="western"><surname>Potdar</surname><given-names>P.</given-names></name><name name-style="western"><surname>Gairola</surname><given-names>C.G.</given-names></name><name name-style="western"><surname>Aggarwal</surname><given-names>B.B.</given-names></name></person-group><article-title>Curcumin (diferuloylmethane) down-regulates cigarette smoke-induced NF-kappaB activation through inhibition of IkappaBalpha kinase in human lung epithelial cells: Correlation with suppression of COX-2, MMP-9 and cyclin D1</article-title><source>Carcinogenesis</source><year>2003</year><volume>24</volume><fpage>1269</fpage><lpage>1279</lpage><pub-id pub-id-type="doi">10.1093/carcin/bgg078</pub-id><pub-id pub-id-type="pmid">12807725</pub-id></element-citation></ref><ref id="B71-nutrients-17-02884"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kao</surname><given-names>N.-J.</given-names></name><name name-style="western"><surname>Hu</surname><given-names>J.-Y.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>C.-S.</given-names></name><name name-style="western"><surname>Kong</surname><given-names>Z.-L.</given-names></name></person-group><article-title>Curcumin represses the activity of inhibitor-&#954;B kinase in dextran sulfate sodium-induced colitis by S-nitrosylation</article-title><source>Int. Immunopharmacol.</source><year>2016</year><volume>38</volume><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1016/j.intimp.2016.05.015</pub-id><pub-id pub-id-type="pmid">27233000</pub-id></element-citation></ref><ref id="B72-nutrients-17-02884"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Shen</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Lai</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Park</surname><given-names>S.Y.</given-names></name><name name-style="western"><surname>Ou</surname><given-names>X.</given-names></name><name name-style="western"><surname>Lin</surname><given-names>D.</given-names></name><name name-style="western"><surname>Jin</surname><given-names>M.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>W.</given-names></name></person-group><article-title>Anti-inflammatory effects of curcumin in microglial cells</article-title><source>Front. Pharmacol.</source><year>2018</year><volume>9</volume><elocation-id>386</elocation-id><pub-id pub-id-type="doi">10.3389/fphar.2018.00386</pub-id><pub-id pub-id-type="pmid">29731715</pub-id><pub-id pub-id-type="pmcid">PMC5922181</pub-id></element-citation></ref><ref id="B73-nutrients-17-02884"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>L.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Hand</surname><given-names>T.</given-names></name><name name-style="western"><surname>Bilak</surname><given-names>M.</given-names></name><name name-style="western"><surname>McCullough</surname><given-names>L.</given-names></name><name name-style="western"><surname>Andreasson</surname><given-names>K.</given-names></name></person-group><article-title>Function of COX-2 and prostaglandins in neurological disease</article-title><source>J. Mol. Neurosci.</source><year>2007</year><volume>33</volume><fpage>94</fpage><lpage>99</lpage><pub-id pub-id-type="doi">10.1007/s12031-007-0058-8</pub-id><pub-id pub-id-type="pmid">17901552</pub-id></element-citation></ref><ref id="B74-nutrients-17-02884"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Coleman</surname><given-names>J.W.</given-names></name></person-group><article-title>Nitric oxide in immunity and inflammation</article-title><source>Int. Immunopharmacol.</source><year>2001</year><volume>1</volume><fpage>1397</fpage><lpage>1406</lpage><pub-id pub-id-type="doi">10.1016/S1567-5769(01)00086-8</pub-id><pub-id pub-id-type="pmid">11515807</pub-id></element-citation></ref><ref id="B75-nutrients-17-02884"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Habib</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ali</surname><given-names>R.</given-names></name></person-group><article-title>Acquired antigenicity of DNA after modification with peroxynitrite</article-title><source>Int. J. Biol. Macromol.</source><year>2005</year><volume>35</volume><fpage>221</fpage><lpage>225</lpage><pub-id pub-id-type="doi">10.1016/j.ijbiomac.2005.02.005</pub-id><pub-id pub-id-type="pmid">15871167</pub-id></element-citation></ref><ref id="B76-nutrients-17-02884"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shishodia</surname><given-names>S.</given-names></name></person-group><article-title>Molecular mechanisms of curcumin action: Gene expression</article-title><source>Biofactors</source><year>2013</year><volume>39</volume><fpage>37</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1002/biof.1041</pub-id><pub-id pub-id-type="pmid">22996381</pub-id></element-citation></ref><ref id="B77-nutrients-17-02884"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chan</surname><given-names>M.M.-Y.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>H.-I.</given-names></name><name name-style="western"><surname>Fenton</surname><given-names>M.R.</given-names></name><name name-style="western"><surname>Fong</surname><given-names>D.</given-names></name></person-group><article-title>In vivo inhibition of nitric oxide synthase gene expression by curcumin, a cancer preventive natural product with anti-inflammatory properties</article-title><source>Biochem. Pharmacol.</source><year>1998</year><volume>55</volume><fpage>1955</fpage><lpage>1962</lpage><pub-id pub-id-type="doi">10.1016/S0006-2952(98)00114-2</pub-id><pub-id pub-id-type="pmid">9714315</pub-id></element-citation></ref><ref id="B78-nutrients-17-02884"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jung</surname><given-names>K.K.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>H.S.</given-names></name><name name-style="western"><surname>Cho</surname><given-names>J.Y.</given-names></name><name name-style="western"><surname>Shin</surname><given-names>W.C.</given-names></name><name name-style="western"><surname>Rhee</surname><given-names>M.H.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>T.G.</given-names></name><name name-style="western"><surname>Kang</surname><given-names>J.H.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>S.H.</given-names></name><name name-style="western"><surname>Hong</surname><given-names>S.</given-names></name><name name-style="western"><surname>Kang</surname><given-names>S.Y.</given-names></name></person-group><article-title>Inhibitory effect of curcumin on nitric oxide production from lipopolysaccharide-activated primary microglia</article-title><source>Life Sci.</source><year>2006</year><volume>79</volume><fpage>2022</fpage><lpage>2031</lpage><pub-id pub-id-type="doi">10.1016/j.lfs.2006.06.048</pub-id><pub-id pub-id-type="pmid">16934299</pub-id></element-citation></ref><ref id="B79-nutrients-17-02884"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>C.</given-names></name><name name-style="western"><surname>Takada</surname><given-names>K.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>D.</given-names></name></person-group><article-title>Targeting Wnt/&#946;-catenin pathway for drug therapy</article-title><source>Med. Drug Discov.</source><year>2020</year><volume>8</volume><fpage>100066</fpage></element-citation></ref><ref id="B80-nutrients-17-02884"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Martin</surname><given-names>D.A.</given-names></name><name name-style="western"><surname>Bolling</surname><given-names>B.W.</given-names></name></person-group><article-title>A review of the efficacy of dietary polyphenols in experimental models of inflammatory bowel diseases</article-title><source>Food Funct.</source><year>2015</year><volume>6</volume><fpage>1773</fpage><lpage>1786</lpage><pub-id pub-id-type="doi">10.1039/C5FO00202H</pub-id><pub-id pub-id-type="pmid">25986932</pub-id></element-citation></ref><ref id="B81-nutrients-17-02884"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kannan</surname><given-names>K.</given-names></name><name name-style="western"><surname>Jain</surname><given-names>S.K.</given-names></name></person-group><article-title>Oxidative stress and apoptosis</article-title><source>Pathophysiology</source><year>2000</year><volume>7</volume><fpage>153</fpage><lpage>163</lpage><pub-id pub-id-type="doi">10.1016/S0928-4680(00)00053-5</pub-id><pub-id pub-id-type="pmid">10996508</pub-id></element-citation></ref><ref id="B82-nutrients-17-02884"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>X.</given-names></name><name name-style="western"><surname>He</surname><given-names>X.</given-names></name><name name-style="western"><surname>Dai</surname><given-names>M.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Q.</given-names></name></person-group><article-title>Curcumin induces apoptosis involving bax/bcl-2 in human hepatoma SMMC-7721 cells</article-title><source>Asian Pac. J. Cancer Prev.</source><year>2011</year><volume>12</volume><fpage>1925</fpage><lpage>1929</lpage><pub-id pub-id-type="pmid">22292626</pub-id></element-citation></ref><ref id="B83-nutrients-17-02884"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kuttikrishnan</surname><given-names>S.</given-names></name><name name-style="western"><surname>Siveen</surname><given-names>K.S.</given-names></name><name name-style="western"><surname>Prabhu</surname><given-names>K.S.</given-names></name><name name-style="western"><surname>Khan</surname><given-names>A.Q.</given-names></name><name name-style="western"><surname>Ahmed</surname><given-names>E.I.</given-names></name><name name-style="western"><surname>Akhtar</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ali</surname><given-names>T.A.</given-names></name><name name-style="western"><surname>Merhi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Dermime</surname><given-names>S.</given-names></name><name name-style="western"><surname>Steinhoff</surname><given-names>M.</given-names></name></person-group><article-title>Curcumin induces apoptotic cell death via inhibition of PI3-kinase/AKT pathway in B-precursor acute lymphoblastic leukemia</article-title><source>Front. Oncol.</source><year>2019</year><volume>9</volume><elocation-id>484</elocation-id><pub-id pub-id-type="doi">10.3389/fonc.2019.00484</pub-id><pub-id pub-id-type="pmid">31275848</pub-id><pub-id pub-id-type="pmcid">PMC6593070</pub-id></element-citation></ref><ref id="B84-nutrients-17-02884"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bai</surname><given-names>C.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>J.</given-names></name><name name-style="western"><surname>Su</surname><given-names>J.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>J.</given-names></name><name name-style="western"><surname>Cui</surname><given-names>X.</given-names></name><name name-style="western"><surname>Sun</surname><given-names>M.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X.</given-names></name></person-group><article-title>Curcumin induces mitochondrial apoptosis in human hepatoma cells through BCLAF1-mediated modulation of PI3K/AKT/GSK-3&#946; signaling</article-title><source>Life Sci.</source><year>2022</year><volume>306</volume><fpage>120804</fpage><pub-id pub-id-type="doi">10.1016/j.lfs.2022.120804</pub-id><pub-id pub-id-type="pmid">35882275</pub-id></element-citation></ref><ref id="B85-nutrients-17-02884"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chang</surname><given-names>R.</given-names></name><name name-style="western"><surname>Sun</surname><given-names>L.</given-names></name><name name-style="western"><surname>Webster</surname><given-names>T.J.</given-names></name></person-group><article-title>Selective cytotoxicity of curcumin on osteosarcoma cells compared to healthy osteoblasts</article-title><source>Int. J. Nanomed.</source><year>2014</year><volume>9</volume><fpage>461</fpage><lpage>465</lpage><pub-id pub-id-type="doi">10.2147/IJN.S55505</pub-id><pub-id pub-id-type="pmcid">PMC3894136</pub-id><pub-id pub-id-type="pmid">24453488</pub-id></element-citation></ref><ref id="B86-nutrients-17-02884"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Syng-Ai</surname><given-names>C.</given-names></name><name name-style="western"><surname>Kumari</surname><given-names>A.L.</given-names></name><name name-style="western"><surname>Khar</surname><given-names>A.</given-names></name></person-group><article-title>Effect of curcumin on normal and tumor cells: Role of glutathione and bcl-2</article-title><source>Mol. Cancer Ther.</source><year>2004</year><volume>3</volume><fpage>1101</fpage><lpage>1108</lpage><pub-id pub-id-type="doi">10.1158/1535-7163.1101.3.9</pub-id><pub-id pub-id-type="pmid">15367704</pub-id></element-citation></ref><ref id="B87-nutrients-17-02884"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ismail</surname><given-names>N.I.</given-names></name><name name-style="western"><surname>Othman</surname><given-names>I.</given-names></name><name name-style="western"><surname>Abas</surname><given-names>F.</given-names></name><name name-style="western"><surname>H Lajis</surname><given-names>N.</given-names></name><name name-style="western"><surname>Naidu</surname><given-names>R.</given-names></name></person-group><article-title>Mechanism of apoptosis induced by curcumin in colorectal cancer</article-title><source>Int. J. Mol. Sci.</source><year>2019</year><volume>20</volume><elocation-id>2454</elocation-id><pub-id pub-id-type="doi">10.3390/ijms20102454</pub-id><pub-id pub-id-type="pmid">31108984</pub-id><pub-id pub-id-type="pmcid">PMC6566943</pub-id></element-citation></ref><ref id="B88-nutrients-17-02884"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jiang</surname><given-names>A.J.</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>G.</given-names></name><name name-style="western"><surname>Li</surname><given-names>L.T.</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>J.N.</given-names></name></person-group><article-title>Curcumin induces apoptosis through mitochondrial pathway and caspases activation in human melanoma cells</article-title><source>Mol. Biol. Rep.</source><year>2015</year><volume>42</volume><fpage>267</fpage><lpage>275</lpage><pub-id pub-id-type="pmid">25262359</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11033-014-3769-2</pub-id></element-citation></ref><ref id="B89-nutrients-17-02884"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bush</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Cheung</surname><given-names>K.J.</given-names><suffix>Jr.</suffix></name><name name-style="western"><surname>Li</surname><given-names>G.</given-names></name></person-group><article-title>Curcumin induces apoptosis in human melanoma cells through a Fas receptor/caspase-8 pathway independent of p53</article-title><source>Exp. Cell Res.</source><year>2001</year><volume>271</volume><fpage>305</fpage><lpage>314</lpage><pub-id pub-id-type="doi">10.1006/excr.2001.5381</pub-id><pub-id pub-id-type="pmid">11716543</pub-id></element-citation></ref><ref id="B90-nutrients-17-02884"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wahl</surname><given-names>H.</given-names></name><name name-style="western"><surname>Tan</surname><given-names>L.</given-names></name><name name-style="western"><surname>Griffith</surname><given-names>K.</given-names></name><name name-style="western"><surname>Choi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>J.R.</given-names></name></person-group><article-title>Curcumin enhances Apo2L/TRAIL-induced apoptosis in chemoresistant ovarian cancer cells</article-title><source>Gynecol. Oncol.</source><year>2007</year><volume>105</volume><fpage>104</fpage><lpage>112</lpage><pub-id pub-id-type="doi">10.1016/j.ygyno.2006.10.050</pub-id><pub-id pub-id-type="pmid">17174384</pub-id></element-citation></ref><ref id="B91-nutrients-17-02884"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Prakobwong</surname><given-names>S.</given-names></name><name name-style="western"><surname>Gupta</surname><given-names>S.C.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>J.H.</given-names></name><name name-style="western"><surname>Sung</surname><given-names>B.</given-names></name><name name-style="western"><surname>Pinlaor</surname><given-names>P.</given-names></name><name name-style="western"><surname>Hiraku</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Wongkham</surname><given-names>S.</given-names></name><name name-style="western"><surname>Sripa</surname><given-names>B.</given-names></name><name name-style="western"><surname>Pinlaor</surname><given-names>S.</given-names></name><name name-style="western"><surname>Aggarwal</surname><given-names>B.B.</given-names></name></person-group><article-title>Curcumin suppresses proliferation and induces apoptosis in human biliary cancer cells through modulation of multiple cell signaling pathways</article-title><source>Carcinogenesis</source><year>2011</year><volume>32</volume><fpage>1372</fpage><lpage>1380</lpage><pub-id pub-id-type="pmid">21325634</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/carcin/bgr032</pub-id><pub-id pub-id-type="pmcid">PMC3165121</pub-id></element-citation></ref><ref id="B92-nutrients-17-02884"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Choudhuri</surname><given-names>T.</given-names></name><name name-style="western"><surname>Pal</surname><given-names>S.</given-names></name><name name-style="western"><surname>Agwarwal</surname><given-names>M.L.</given-names></name><name name-style="western"><surname>Das</surname><given-names>T.</given-names></name><name name-style="western"><surname>Sa</surname><given-names>G.</given-names></name></person-group><article-title>Curcumin induces apoptosis in human breast cancer cells through p53-dependent Bax induction</article-title><source>FEBS Lett.</source><year>2002</year><volume>512</volume><fpage>334</fpage><lpage>340</lpage><pub-id pub-id-type="doi">10.1016/S0014-5793(02)02292-5</pub-id><pub-id pub-id-type="pmid">11852106</pub-id></element-citation></ref><ref id="B93-nutrients-17-02884"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>M.F.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>Y.H.</given-names></name><name name-style="western"><surname>Chiu</surname><given-names>L.Y.</given-names></name><name name-style="western"><surname>Cherng</surname><given-names>S.H.</given-names></name><name name-style="western"><surname>Sheu</surname><given-names>G.T.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>T.Y.</given-names></name></person-group><article-title>Curcumin Induces Apoptosis of Chemoresistant Lung Cancer Cells via ROS-Regulated p38 MAPK Phosphorylation</article-title><source>Int. J. Mol. Sci.</source><year>2022</year><volume>23</volume><elocation-id>8248</elocation-id><pub-id pub-id-type="doi">10.3390/ijms23158248</pub-id><pub-id pub-id-type="pmid">35897820</pub-id><pub-id pub-id-type="pmcid">PMC9367815</pub-id></element-citation></ref><ref id="B94-nutrients-17-02884"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhu</surname><given-names>L.</given-names></name><name name-style="western"><surname>Han</surname><given-names>M.B.</given-names></name><name name-style="western"><surname>Gao</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>H.</given-names></name><name name-style="western"><surname>Dai</surname><given-names>L.</given-names></name><name name-style="western"><surname>Wen</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Na</surname><given-names>L.X.</given-names></name></person-group><article-title>Curcumin triggers apoptosis via upregulation of Bax/Bcl-2 ratio and caspase activation in SW872 human adipocytes</article-title><source>Mol. Med. Rep.</source><year>2015</year><volume>12</volume><fpage>1151</fpage><lpage>1156</lpage><pub-id pub-id-type="doi">10.3892/mmr.2015.3450</pub-id><pub-id pub-id-type="pmid">25760477</pub-id></element-citation></ref><ref id="B95-nutrients-17-02884"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>F.</given-names></name><name name-style="western"><surname>Lim</surname><given-names>G.P.</given-names></name><name name-style="western"><surname>Begum</surname><given-names>A.N.</given-names></name><name name-style="western"><surname>Ubeda</surname><given-names>O.J.</given-names></name><name name-style="western"><surname>Simmons</surname><given-names>M.R.</given-names></name><name name-style="western"><surname>Ambegaokar</surname><given-names>S.S.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>P.P.</given-names></name><name name-style="western"><surname>Kayed</surname><given-names>R.</given-names></name><name name-style="western"><surname>Glabe</surname><given-names>C.G.</given-names></name><name name-style="western"><surname>Frautschy</surname><given-names>S.A.</given-names></name></person-group><article-title>Curcumin inhibits formation of amyloid &#946; oligomers and fibrils, binds plaques, and reduces amyloid in vivo</article-title><source>J. Biol. Chem.</source><year>2005</year><volume>280</volume><fpage>5892</fpage><lpage>5901</lpage><pub-id pub-id-type="doi">10.1074/jbc.M404751200</pub-id><pub-id pub-id-type="pmid">15590663</pub-id></element-citation></ref><ref id="B96-nutrients-17-02884"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Reinke</surname><given-names>A.A.</given-names></name><name name-style="western"><surname>Gestwicki</surname><given-names>J.E.</given-names></name></person-group><article-title>Structure&#8211;activity Relationships of amyloid beta-aggregation inhibitors based on curcumin: Influence of linker length and flexibility</article-title><source>Chem. Biol. Drug Des.</source><year>2007</year><volume>70</volume><fpage>206</fpage><lpage>215</lpage><pub-id pub-id-type="doi">10.1111/j.1747-0285.2007.00557.x</pub-id><pub-id pub-id-type="pmid">17718715</pub-id></element-citation></ref><ref id="B97-nutrients-17-02884"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lakey-Beitia</surname><given-names>J.</given-names></name><name name-style="western"><surname>Gonz&#225;lez</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Doens</surname><given-names>D.</given-names></name><name name-style="western"><surname>Stephens</surname><given-names>D.E.</given-names></name><name name-style="western"><surname>Santamar&#237;a</surname><given-names>R.</given-names></name><name name-style="western"><surname>Murillo</surname><given-names>E.</given-names></name><name name-style="western"><surname>Guti&#233;rrez</surname><given-names>M.</given-names></name><name name-style="western"><surname>Fern&#225;ndez</surname><given-names>P.L.</given-names></name><name name-style="western"><surname>Rao</surname><given-names>K.</given-names></name><name name-style="western"><surname>Larionov</surname><given-names>O.V.</given-names></name></person-group><article-title>Assessment of novel curcumin derivatives as potent inhibitors of inflammation and amyloid-&#946; aggregation in Alzheimer&#8217;s disease</article-title><source>J. Alzheimer&#8217;s Dis.</source><year>2017</year><volume>60</volume><fpage>S59</fpage><lpage>S68</lpage><pub-id pub-id-type="doi">10.3233/JAD-170071</pub-id><pub-id pub-id-type="pmid">28453488</pub-id><pub-id pub-id-type="pmcid">PMC5737775</pub-id></element-citation></ref><ref id="B98-nutrients-17-02884"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Orteca</surname><given-names>G.</given-names></name><name name-style="western"><surname>Tavanti</surname><given-names>F.</given-names></name><name name-style="western"><surname>Bednarikova</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Gazova</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Rigillo</surname><given-names>G.</given-names></name><name name-style="western"><surname>Imbriano</surname><given-names>C.</given-names></name><name name-style="western"><surname>Basile</surname><given-names>V.</given-names></name><name name-style="western"><surname>Asti</surname><given-names>M.</given-names></name><name name-style="western"><surname>Rigamonti</surname><given-names>L.</given-names></name><name name-style="western"><surname>Saladini</surname><given-names>M.</given-names></name></person-group><article-title>Curcumin derivatives and A&#946;-fibrillar aggregates: An interactions&#8217; study for diagnostic/therapeutic purposes in neurodegenerative diseases</article-title><source>Bioorganic Med. Chem.</source><year>2018</year><volume>26</volume><fpage>4288</fpage><lpage>4300</lpage><pub-id pub-id-type="doi">10.1016/j.bmc.2018.07.027</pub-id><pub-id pub-id-type="pmid">30031653</pub-id></element-citation></ref><ref id="B99-nutrients-17-02884"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baum</surname><given-names>L.</given-names></name><name name-style="western"><surname>Ng</surname><given-names>A.</given-names></name></person-group><article-title>Curcumin interaction with copper and iron suggests one possible mechanism of action in Alzheimer&#8217;s disease animal models</article-title><source>J. Alzheimer&#8217;s Dis.</source><year>2004</year><volume>6</volume><fpage>367</fpage><lpage>377</lpage><pub-id pub-id-type="doi">10.3233/JAD-2004-6403</pub-id><pub-id pub-id-type="pmid">15345806</pub-id></element-citation></ref><ref id="B100-nutrients-17-02884"><label>100.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Ferrari</surname><given-names>E.</given-names></name></person-group><article-title>Curcumin derivatives as metal-chelating agents: Implications for potential therapeutic agents for neurological disorders</article-title><source>Curcumin for Neurological and Psychiatric Disorders: Neurochemical and Pharmacological Properties</source><publisher-name>Elsevier</publisher-name><publisher-loc>Amsterdam, The Netherlands</publisher-loc><year>2019</year><fpage>275</fpage><lpage>299</lpage></element-citation></ref><ref id="B101-nutrients-17-02884"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schulz-Schaeffer</surname><given-names>W.J.</given-names></name></person-group><article-title>The synaptic pathology of &#945;-synuclein aggregation in dementia with Lewy bodies, Parkinson&#8217;s disease and Parkinson&#8217;s disease dementia</article-title><source>Acta Neuropathol.</source><year>2010</year><volume>120</volume><fpage>131</fpage><lpage>143</lpage><pub-id pub-id-type="doi">10.1007/s00401-010-0711-0</pub-id><pub-id pub-id-type="pmid">20563819</pub-id><pub-id pub-id-type="pmcid">PMC2892607</pub-id></element-citation></ref><ref id="B102-nutrients-17-02884"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Genchi</surname><given-names>G.</given-names></name><name name-style="western"><surname>Lauria</surname><given-names>G.</given-names></name><name name-style="western"><surname>Catalano</surname><given-names>A.</given-names></name><name name-style="western"><surname>Carocci</surname><given-names>A.</given-names></name><name name-style="western"><surname>Sinicropi</surname><given-names>M.S.</given-names></name></person-group><article-title>Neuroprotective effects of curcumin in neurodegenerative diseases</article-title><source>Foods</source><year>2024</year><volume>13</volume><elocation-id>1774</elocation-id><pub-id pub-id-type="doi">10.3390/foods13111774</pub-id><pub-id pub-id-type="pmid">38891002</pub-id><pub-id pub-id-type="pmcid">PMC11172163</pub-id></element-citation></ref><ref id="B103-nutrients-17-02884"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Javed</surname><given-names>H.</given-names></name><name name-style="western"><surname>Nagoor Meeran</surname><given-names>M.F.</given-names></name><name name-style="western"><surname>Azimullah</surname><given-names>S.</given-names></name><name name-style="western"><surname>Adem</surname><given-names>A.</given-names></name><name name-style="western"><surname>Sadek</surname><given-names>B.</given-names></name><name name-style="western"><surname>Ojha</surname><given-names>S.K.</given-names></name></person-group><article-title>Plant extracts and phytochemicals targeting &#945;-synuclein aggregation in Parkinson&#8217;s disease models</article-title><source>Front. Pharmacol.</source><year>2019</year><volume>9</volume><elocation-id>1555</elocation-id><pub-id pub-id-type="doi">10.3389/fphar.2018.01555</pub-id><pub-id pub-id-type="pmid">30941047</pub-id><pub-id pub-id-type="pmcid">PMC6433754</pub-id></element-citation></ref><ref id="B104-nutrients-17-02884"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sajjad</surname><given-names>R.</given-names></name><name name-style="western"><surname>Arif</surname><given-names>R.</given-names></name><name name-style="western"><surname>Shah</surname><given-names>A.</given-names></name><name name-style="western"><surname>Manzoor</surname><given-names>I.</given-names></name><name name-style="western"><surname>Mustafa</surname><given-names>G.</given-names></name></person-group><article-title>Pathogenesis of Alzheimer&#8217;s Disease: Role of Amyloid-&#946; and Hyperphosphorylated Tau Protein</article-title><source>Indian. J. Pharm. Sci.</source><year>2018</year><volume>80</volume><fpage>581</fpage><lpage>591</lpage><pub-id pub-id-type="doi">10.4172/pharmaceutical-sciences.1000397</pub-id></element-citation></ref><ref id="B105-nutrients-17-02884"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dubey</surname><given-names>T.</given-names></name><name name-style="western"><surname>Sonawane</surname><given-names>S.K.</given-names></name><name name-style="western"><surname>Mannava</surname><given-names>M.C.</given-names></name><name name-style="western"><surname>Nangia</surname><given-names>A.K.</given-names></name><name name-style="western"><surname>Chandrashekar</surname><given-names>M.</given-names></name><name name-style="western"><surname>Chinnathambi</surname><given-names>S.</given-names></name></person-group><article-title>The inhibitory effect of Curcumin-Artemisinin co-amorphous on Tau aggregation and Tau phosphorylation</article-title><source>Colloids Surf. B Biointerfaces</source><year>2023</year><volume>221</volume><elocation-id>112970</elocation-id><pub-id pub-id-type="doi">10.1016/j.colsurfb.2022.112970</pub-id><pub-id pub-id-type="pmid">36332313</pub-id></element-citation></ref><ref id="B106-nutrients-17-02884"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rane</surname><given-names>J.S.</given-names></name><name name-style="western"><surname>Bhaumik</surname><given-names>P.</given-names></name><name name-style="western"><surname>Panda</surname><given-names>D.</given-names></name></person-group><article-title>Curcumin inhibits tau aggregation and disintegrates preformed tau filaments in vitro</article-title><source>J. Alzheimer&#8217;s Dis.</source><year>2017</year><volume>60</volume><fpage>999</fpage><lpage>1014</lpage><pub-id pub-id-type="doi">10.3233/JAD-170351</pub-id><pub-id pub-id-type="pmid">28984591</pub-id></element-citation></ref><ref id="B107-nutrients-17-02884"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sivanantharajah</surname><given-names>L.</given-names></name><name name-style="western"><surname>Mudher</surname><given-names>A.</given-names></name></person-group><article-title>Curcumin as a holistic treatment for tau pathology</article-title><source>Front. Pharmacol.</source><year>2022</year><volume>13</volume><elocation-id>903119</elocation-id><pub-id pub-id-type="doi">10.3389/fphar.2022.903119</pub-id><pub-id pub-id-type="pmid">35662729</pub-id><pub-id pub-id-type="pmcid">PMC9160965</pub-id></element-citation></ref><ref id="B108-nutrients-17-02884"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ma</surname><given-names>Q.-L.</given-names></name><name name-style="western"><surname>Zuo</surname><given-names>X.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>F.</given-names></name><name name-style="western"><surname>Ubeda</surname><given-names>O.J.</given-names></name><name name-style="western"><surname>Gant</surname><given-names>D.J.</given-names></name><name name-style="western"><surname>Alaverdyan</surname><given-names>M.</given-names></name><name name-style="western"><surname>Teng</surname><given-names>E.</given-names></name><name name-style="western"><surname>Hu</surname><given-names>S.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>P.-P.</given-names></name><name name-style="western"><surname>Maiti</surname><given-names>P.</given-names></name><etal/></person-group><article-title>Curcumin suppresses soluble tau dimers and corrects molecular chaperone, synaptic, and behavioral deficits in aged human tau transgenic mice</article-title><source>J. Biol. Chem.</source><year>2013</year><volume>288</volume><fpage>4056</fpage><lpage>4065</lpage><pub-id pub-id-type="doi">10.1074/jbc.M112.393751</pub-id><pub-id pub-id-type="pmid">23264626</pub-id><pub-id pub-id-type="pmcid">PMC3567657</pub-id></element-citation></ref><ref id="B109-nutrients-17-02884"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ullah</surname><given-names>F.</given-names></name><name name-style="western"><surname>Asgarov</surname><given-names>R.</given-names></name><name name-style="western"><surname>Venigalla</surname><given-names>M.</given-names></name><name name-style="western"><surname>Liang</surname><given-names>H.</given-names></name><name name-style="western"><surname>Niedermayer</surname><given-names>G.</given-names></name><name name-style="western"><surname>M&#252;nch</surname><given-names>G.</given-names></name><name name-style="western"><surname>Gyengesi</surname><given-names>E.</given-names></name></person-group><article-title>Effects of a solid lipid curcumin particle formulation on chronic activation of microglia and astroglia in the GFAP-IL6 mouse model</article-title><source>Sci. Rep.</source><year>2020</year><volume>10</volume><elocation-id>2365</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-020-58838-2</pub-id><pub-id pub-id-type="pmid">32047191</pub-id><pub-id pub-id-type="pmcid">PMC7012877</pub-id></element-citation></ref><ref id="B110-nutrients-17-02884"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhou</surname><given-names>H.</given-names></name><name name-style="western"><surname>S Beevers</surname><given-names>C.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>S.</given-names></name></person-group><article-title>The targets of curcumin</article-title><source>Curr. Drug Targets</source><year>2011</year><volume>12</volume><fpage>332</fpage><lpage>347</lpage><pub-id pub-id-type="doi">10.2174/138945011794815356</pub-id><pub-id pub-id-type="pmid">20955148</pub-id><pub-id pub-id-type="pmcid">PMC3025067</pub-id></element-citation></ref><ref id="B111-nutrients-17-02884"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>B.</given-names></name><name name-style="western"><surname>Xiong</surname><given-names>P.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>C.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Tian</surname><given-names>X.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>Y.</given-names></name></person-group><article-title>Curcumin induces autophagy via inhibition of yes-associated protein (YAP) in human colon cancer cells</article-title><source>Med. Sci. Monit. Int. Med. J. Exp. Clin. Res.</source><year>2018</year><volume>24</volume><fpage>7035</fpage><pub-id pub-id-type="doi">10.12659/MSM.910650</pub-id><pub-id pub-id-type="pmcid">PMC6354647</pub-id><pub-id pub-id-type="pmid">30281585</pub-id></element-citation></ref><ref id="B112-nutrients-17-02884"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cao</surname><given-names>S.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>C.</given-names></name><name name-style="western"><surname>Yan</surname><given-names>J.</given-names></name><name name-style="western"><surname>Li</surname><given-names>X.</given-names></name><name name-style="western"><surname>Wen</surname><given-names>J.</given-names></name><name name-style="western"><surname>Hu</surname><given-names>C.</given-names></name></person-group><article-title>Curcumin ameliorates oxidative stress-induced intestinal barrier injury and mitochondrial damage by promoting Parkin dependent mitophagy through AMPK-TFEB signal pathway</article-title><source>Free Radic. Biol. Med.</source><year>2020</year><volume>147</volume><fpage>8</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2019.12.004</pub-id><pub-id pub-id-type="pmid">31816386</pub-id></element-citation></ref><ref id="B113-nutrients-17-02884"><label>113.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>J.Y.</given-names></name><name name-style="western"><surname>Cho</surname><given-names>T.J.</given-names></name><name name-style="western"><surname>Woo</surname><given-names>B.H.</given-names></name><name name-style="western"><surname>Choi</surname><given-names>K.U.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>C.H.</given-names></name><name name-style="western"><surname>Ryu</surname><given-names>M.H.</given-names></name><name name-style="western"><surname>Park</surname><given-names>H.R.</given-names></name></person-group><article-title>Curcumin-induced autophagy contributes to the decreased survival of oral cancer cells</article-title><source>Arch. Oral. Biol.</source><year>2012</year><volume>57</volume><fpage>1018</fpage><lpage>1025</lpage><pub-id pub-id-type="doi">10.1016/j.archoralbio.2012.04.005</pub-id><pub-id pub-id-type="pmid">22554995</pub-id></element-citation></ref><ref id="B114-nutrients-17-02884"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Takei</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Amagase</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Goto</surname><given-names>A.</given-names></name><name name-style="western"><surname>Kambayashi</surname><given-names>R.</given-names></name><name name-style="western"><surname>Izumi-Nakaseko</surname><given-names>H.</given-names></name><name name-style="western"><surname>Hirasawa</surname><given-names>A.</given-names></name><name name-style="western"><surname>Sugiyama</surname><given-names>A.</given-names></name></person-group><article-title>Adipose chemokine ligand CX3CL1 contributes to maintaining the hippocampal BDNF level, and the effect is attenuated in advanced age</article-title><source>Geroscience</source><year>2025</year><volume>47</volume><fpage>5969</fpage><lpage>5983</lpage><pub-id pub-id-type="doi">10.1007/s11357-025-01546-4</pub-id><pub-id pub-id-type="pmid">39939506</pub-id><pub-id pub-id-type="pmcid">PMC12397004</pub-id></element-citation></ref><ref id="B115-nutrients-17-02884"><label>115.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tait</surname><given-names>J.L.</given-names></name><name name-style="western"><surname>Duckham</surname><given-names>R.L.</given-names></name><name name-style="western"><surname>Rantalainen</surname><given-names>T.</given-names></name><name name-style="western"><surname>Milte</surname><given-names>C.M.</given-names></name><name name-style="western"><surname>Main</surname><given-names>L.C.</given-names></name><name name-style="western"><surname>Nowson</surname><given-names>C.A.</given-names></name><name name-style="western"><surname>Sanders</surname><given-names>K.M.</given-names></name><name name-style="western"><surname>Taaffe</surname><given-names>D.R.</given-names></name><name name-style="western"><surname>Hill</surname><given-names>K.D.</given-names></name><name name-style="western"><surname>Abbott</surname><given-names>G.</given-names></name><etal/></person-group><article-title>Effects of a 6-month dual-task, power-based exercise program on cognitive function, neurological and inflammatory markers in older adults: Secondary analysis of a cluster randomised controlled trial</article-title><source>Geroscience</source><year>2024</year><volume>47</volume><fpage>1251</fpage><lpage>1268</lpage><pub-id pub-id-type="doi">10.1007/s11357-024-01316-8</pub-id><pub-id pub-id-type="pmid">39198381</pub-id><pub-id pub-id-type="pmcid">PMC11872956</pub-id></element-citation></ref><ref id="B116-nutrients-17-02884"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bali</surname><given-names>Z.K.</given-names></name><name name-style="western"><surname>Nagy</surname><given-names>L.V.</given-names></name><name name-style="western"><surname>Bruszt</surname><given-names>N.</given-names></name><name name-style="western"><surname>Bodo</surname><given-names>K.</given-names></name><name name-style="western"><surname>Engelmann</surname><given-names>P.</given-names></name><name name-style="western"><surname>Hernadi</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Gonter</surname><given-names>K.</given-names></name><name name-style="western"><surname>Tadepalli</surname><given-names>S.A.</given-names></name><name name-style="western"><surname>Hernadi</surname><given-names>I.</given-names></name></person-group><article-title>Increased brain cytokine level associated impairment of vigilance and memory in aged rats can be alleviated by alpha7 nicotinic acetylcholine receptor agonist treatment</article-title><source>Geroscience</source><year>2024</year><volume>46</volume><fpage>645</fpage><lpage>664</lpage><pub-id pub-id-type="doi">10.1007/s11357-023-01019-6</pub-id><pub-id pub-id-type="pmid">37994990</pub-id><pub-id pub-id-type="pmcid">PMC10828177</pub-id></element-citation></ref><ref id="B117-nutrients-17-02884"><label>117.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Eroglu</surname><given-names>B.</given-names></name><name name-style="western"><surname>Isales</surname><given-names>C.</given-names></name><name name-style="western"><surname>Eroglu</surname><given-names>A.</given-names></name></person-group><article-title>Age and duration of obesity modulate the inflammatory response and expression of neuroprotective factors in mammalian female brain</article-title><source>Aging Cell</source><year>2024</year><volume>23</volume><fpage>e14313</fpage><pub-id pub-id-type="doi">10.1111/acel.14313</pub-id><pub-id pub-id-type="pmid">39230054</pub-id><pub-id pub-id-type="pmcid">PMC11634740</pub-id></element-citation></ref><ref id="B118-nutrients-17-02884"><label>118.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lautrup</surname><given-names>S.</given-names></name><name name-style="western"><surname>Myrup Holst</surname><given-names>C.</given-names></name><name name-style="western"><surname>Yde</surname><given-names>A.</given-names></name><name name-style="western"><surname>Asmussen</surname><given-names>S.</given-names></name><name name-style="western"><surname>Thinggaard</surname><given-names>V.</given-names></name><name name-style="western"><surname>Larsen</surname><given-names>K.</given-names></name><name name-style="western"><surname>Laursen</surname><given-names>L.S.</given-names></name><name name-style="western"><surname>Richner</surname><given-names>M.</given-names></name><name name-style="western"><surname>Vaegter</surname><given-names>C.B.</given-names></name><name name-style="western"><surname>Prieto</surname><given-names>G.A.</given-names></name><etal/></person-group><article-title>The role of aging and brain-derived neurotrophic factor signaling in expression of base excision repair genes in the human brain</article-title><source>Aging Cell</source><year>2023</year><volume>22</volume><fpage>e13905</fpage><pub-id pub-id-type="doi">10.1111/acel.13905</pub-id><pub-id pub-id-type="pmid">37334527</pub-id><pub-id pub-id-type="pmcid">PMC10497833</pub-id></element-citation></ref><ref id="B119-nutrients-17-02884"><label>119.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jia</surname><given-names>P.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Ren</surname><given-names>X.</given-names></name><name name-style="western"><surname>He</surname><given-names>J.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>S.</given-names></name><name name-style="western"><surname>Xing</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>D.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>S.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>X.</given-names></name><etal/></person-group><article-title>An enriched environment improves long-term functional outcomes in mice after intracerebral hemorrhage by mechanisms that involve the Nrf2/BDNF/glutaminase pathway</article-title><source>J. Cereb. Blood Flow. Metab.</source><year>2023</year><volume>43</volume><fpage>694</fpage><lpage>711</lpage><pub-id pub-id-type="doi">10.1177/0271678X221135419</pub-id><pub-id pub-id-type="pmid">36635875</pub-id><pub-id pub-id-type="pmcid">PMC10108193</pub-id></element-citation></ref><ref id="B120-nutrients-17-02884"><label>120.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Park</surname><given-names>H.</given-names></name><name name-style="western"><surname>Poo</surname><given-names>M.-m.</given-names></name></person-group><article-title>Neurotrophin regulation of neural circuit development and function</article-title><source>Nat. Rev. Neurosci.</source><year>2013</year><volume>14</volume><fpage>7</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1038/nrn3379</pub-id><pub-id pub-id-type="pmid">23254191</pub-id></element-citation></ref><ref id="B121-nutrients-17-02884"><label>121.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Ku</surname><given-names>B.</given-names></name><name name-style="western"><surname>Tie</surname><given-names>L.</given-names></name><name name-style="western"><surname>Yao</surname><given-names>H.</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>W.</given-names></name><name name-style="western"><surname>Ma</surname><given-names>X.</given-names></name><name name-style="western"><surname>Li</surname><given-names>X.</given-names></name></person-group><article-title>Curcumin reverses the effects of chronic stress on behavior, the HPA axis, BDNF expression and phosphorylation of CREB</article-title><source>Brain Res.</source><year>2006</year><volume>1122</volume><fpage>56</fpage><lpage>64</lpage><pub-id pub-id-type="doi">10.1016/j.brainres.2006.09.009</pub-id><pub-id pub-id-type="pmid">17022948</pub-id></element-citation></ref><ref id="B122-nutrients-17-02884"><label>122.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>R.</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y.B.</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y.H.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>H.L.</given-names></name><name name-style="western"><surname>Li</surname><given-names>X.J.</given-names></name></person-group><article-title>Curcumin protects against glutamate excitotoxicity in rat cerebral cortical neurons by increasing brain-derived neurotrophic factor level and activating TrkB</article-title><source>Brain Res.</source><year>2008</year><volume>1210</volume><fpage>84</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1016/j.brainres.2008.01.104</pub-id><pub-id pub-id-type="pmid">18420184</pub-id></element-citation></ref><ref id="B123-nutrients-17-02884"><label>123.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zachariou</surname><given-names>V.</given-names></name><name name-style="western"><surname>Pappas</surname><given-names>C.</given-names></name><name name-style="western"><surname>Bauer</surname><given-names>C.E.</given-names></name><name name-style="western"><surname>Shao</surname><given-names>X.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>P.</given-names></name><name name-style="western"><surname>Lu</surname><given-names>H.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>D.J.J.</given-names></name><name name-style="western"><surname>Gold</surname><given-names>B.T.</given-names></name></person-group><article-title>Regional differences in the link between water exchange rate across the blood-brain barrier and cognitive performance in normal aging</article-title><source>Geroscience</source><year>2024</year><volume>46</volume><fpage>265</fpage><lpage>282</lpage><pub-id pub-id-type="doi">10.1007/s11357-023-00930-2</pub-id><pub-id pub-id-type="pmid">37713089</pub-id><pub-id pub-id-type="pmcid">PMC10828276</pub-id></element-citation></ref><ref id="B124-nutrients-17-02884"><label>124.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van Dinther</surname><given-names>M.</given-names></name><name name-style="western"><surname>Voorter</surname><given-names>P.H.M.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>E.</given-names></name><name name-style="western"><surname>van Kuijk</surname><given-names>S.M.J.</given-names></name><name name-style="western"><surname>Jansen</surname><given-names>J.F.A.</given-names></name><name name-style="western"><surname>van Oostenbrugge</surname><given-names>R.J.</given-names></name><name name-style="western"><surname>Backes</surname><given-names>W.H.</given-names></name><name name-style="western"><surname>Staals</surname><given-names>J.</given-names></name></person-group><article-title>The neurovascular unit and its correlation with cognitive performance in patients with cerebral small vessel disease: A canonical correlation analysis approach</article-title><source>Geroscience</source><year>2024</year><volume>46</volume><fpage>5061</fpage><lpage>5073</lpage><pub-id pub-id-type="doi">10.1007/s11357-024-01235-8</pub-id><pub-id pub-id-type="pmid">38888875</pub-id><pub-id pub-id-type="pmcid">PMC11335703</pub-id></element-citation></ref><ref id="B125-nutrients-17-02884"><label>125.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stankovics</surname><given-names>L.</given-names></name><name name-style="western"><surname>Ungvari</surname><given-names>A.</given-names></name><name name-style="western"><surname>Fekete</surname><given-names>M.</given-names></name><name name-style="western"><surname>Nyul-Toth</surname><given-names>A.</given-names></name><name name-style="western"><surname>Mukli</surname><given-names>P.</given-names></name><name name-style="western"><surname>Patai</surname><given-names>R.</given-names></name><name name-style="western"><surname>Csik</surname><given-names>B.</given-names></name><name name-style="western"><surname>Gulej</surname><given-names>R.</given-names></name><name name-style="western"><surname>Conley</surname><given-names>S.</given-names></name><name name-style="western"><surname>Csiszar</surname><given-names>A.</given-names></name><etal/></person-group><article-title>The vasoprotective role of IGF-1 signaling in the cerebral microcirculation: Prevention of cerebral microhemorrhages in aging</article-title><source>Geroscience</source><year>2024</year><volume>47</volume><fpage>445</fpage><pub-id pub-id-type="doi">10.1007/s11357-024-01343-5</pub-id><pub-id pub-id-type="pmid">39271571</pub-id><pub-id pub-id-type="pmcid">PMC11872839</pub-id></element-citation></ref><ref id="B126-nutrients-17-02884"><label>126.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Salwierz</surname><given-names>P.</given-names></name><name name-style="western"><surname>Thapa</surname><given-names>S.</given-names></name><name name-style="western"><surname>Taghdiri</surname><given-names>F.</given-names></name><name name-style="western"><surname>Vasilevskaya</surname><given-names>A.</given-names></name><name name-style="western"><surname>Anastassiadis</surname><given-names>C.</given-names></name><name name-style="western"><surname>Tang-Wai</surname><given-names>D.F.</given-names></name><name name-style="western"><surname>Golas</surname><given-names>A.C.</given-names></name><name name-style="western"><surname>Tartaglia</surname><given-names>M.C.</given-names></name></person-group><article-title>Investigating the association between a history of depression and biomarkers of Alzheimer&#8217;s disease, cerebrovascular disease, and neurodegeneration in patients with dementia</article-title><source>Geroscience</source><year>2024</year><volume>46</volume><fpage>783</fpage><lpage>793</lpage><pub-id pub-id-type="doi">10.1007/s11357-023-01030-x</pub-id><pub-id pub-id-type="pmid">38097855</pub-id><pub-id pub-id-type="pmcid">PMC10828163</pub-id></element-citation></ref><ref id="B127-nutrients-17-02884"><label>127.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nyul-Toth</surname><given-names>A.</given-names></name><name name-style="western"><surname>Patai</surname><given-names>R.</given-names></name><name name-style="western"><surname>Csiszar</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ungvari</surname><given-names>A.</given-names></name><name name-style="western"><surname>Gulej</surname><given-names>R.</given-names></name><name name-style="western"><surname>Mukli</surname><given-names>P.</given-names></name><name name-style="western"><surname>Yabluchanskiy</surname><given-names>A.</given-names></name><name name-style="western"><surname>Benyo</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Sotonyi</surname><given-names>P.</given-names></name><name name-style="western"><surname>Prodan</surname><given-names>C.I.</given-names></name><etal/></person-group><article-title>Linking peripheral atherosclerosis to blood-brain barrier disruption: Elucidating its role as a manifestation of cerebral small vessel disease in vascular cognitive impairment</article-title><source>Geroscience</source><year>2024</year><volume>46</volume><fpage>6511</fpage><lpage>6536</lpage><pub-id pub-id-type="doi">10.1007/s11357-024-01194-0</pub-id><pub-id pub-id-type="pmid">38831182</pub-id><pub-id pub-id-type="pmcid">PMC11494622</pub-id></element-citation></ref><ref id="B128-nutrients-17-02884"><label>128.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gulej</surname><given-names>R.</given-names></name><name name-style="western"><surname>Nyul-Toth</surname><given-names>A.</given-names></name><name name-style="western"><surname>Csik</surname><given-names>B.</given-names></name><name name-style="western"><surname>Patai</surname><given-names>R.</given-names></name><name name-style="western"><surname>Petersen</surname><given-names>B.</given-names></name><name name-style="western"><surname>Negri</surname><given-names>S.</given-names></name><name name-style="western"><surname>Chandragiri</surname><given-names>S.S.</given-names></name><name name-style="western"><surname>Shanmugarama</surname><given-names>S.</given-names></name><name name-style="western"><surname>Mukli</surname><given-names>P.</given-names></name><name name-style="western"><surname>Yabluchanskiy</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Young blood-mediated cerebromicrovascular rejuvenation through heterochronic parabiosis: Enhancing blood-brain barrier integrity and capillarization in the aged mouse brain</article-title><source>Geroscience</source><year>2024</year><volume>46</volume><fpage>4415</fpage><lpage>4442</lpage><pub-id pub-id-type="doi">10.1007/s11357-024-01154-8</pub-id><pub-id pub-id-type="pmid">38727872</pub-id><pub-id pub-id-type="pmcid">PMC11336025</pub-id></element-citation></ref><ref id="B129-nutrients-17-02884"><label>129.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Csiszar</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ungvari</surname><given-names>A.</given-names></name><name name-style="western"><surname>Patai</surname><given-names>R.</given-names></name><name name-style="western"><surname>Gulej</surname><given-names>R.</given-names></name><name name-style="western"><surname>Yabluchanskiy</surname><given-names>A.</given-names></name><name name-style="western"><surname>Benyo</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Kovacs</surname><given-names>I.</given-names></name><name name-style="western"><surname>Sotonyi</surname><given-names>P.</given-names></name><name name-style="western"><surname>Kirkpartrick</surname><given-names>A.C.</given-names></name><name name-style="western"><surname>Prodan</surname><given-names>C.I.</given-names></name><etal/></person-group><article-title>Atherosclerotic burden and cerebral small vessel disease: Exploring the link through microvascular aging and cerebral microhemorrhages</article-title><source>Geroscience</source><year>2024</year><volume>46</volume><fpage>5103</fpage><lpage>5132</lpage><pub-id pub-id-type="doi">10.1007/s11357-024-01139-7</pub-id><pub-id pub-id-type="pmid">38639833</pub-id><pub-id pub-id-type="pmcid">PMC11336042</pub-id></element-citation></ref><ref id="B130-nutrients-17-02884"><label>130.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weijs</surname><given-names>R.W.J.</given-names></name><name name-style="western"><surname>Oudegeest-Sander</surname><given-names>M.H.</given-names></name><name name-style="western"><surname>Vloet</surname><given-names>J.I.A.</given-names></name><name name-style="western"><surname>Hopman</surname><given-names>M.T.E.</given-names></name><name name-style="western"><surname>Claassen</surname><given-names>J.</given-names></name><name name-style="western"><surname>Thijssen</surname><given-names>D.H.J.</given-names></name></person-group><article-title>A decade of aging in healthy older adults: Longitudinal findings on cerebrovascular and cognitive health</article-title><source>Geroscience</source><year>2023</year><volume>45</volume><fpage>2629</fpage><lpage>2641</lpage><pub-id pub-id-type="doi">10.1007/s11357-023-00790-w</pub-id><pub-id pub-id-type="pmid">37052769</pub-id><pub-id pub-id-type="pmcid">PMC10651595</pub-id></element-citation></ref><ref id="B131-nutrients-17-02884"><label>131.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gulej</surname><given-names>R.</given-names></name><name name-style="western"><surname>Nyul-Toth</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ahire</surname><given-names>C.</given-names></name><name name-style="western"><surname>DelFavero</surname><given-names>J.</given-names></name><name name-style="western"><surname>Balasubramanian</surname><given-names>P.</given-names></name><name name-style="western"><surname>Kiss</surname><given-names>T.</given-names></name><name name-style="western"><surname>Tarantini</surname><given-names>S.</given-names></name><name name-style="western"><surname>Benyo</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Pacher</surname><given-names>P.</given-names></name><name name-style="western"><surname>Csik</surname><given-names>B.</given-names></name><etal/></person-group><article-title>Elimination of senescent cells by treatment with Navitoclax/ABT263 reverses whole brain irradiation-induced blood-brain barrier disruption in the mouse brain</article-title><source>Geroscience</source><year>2023</year><volume>45</volume><fpage>2983</fpage><lpage>3002</lpage><pub-id pub-id-type="doi">10.1007/s11357-023-00870-x</pub-id><pub-id pub-id-type="pmid">37642933</pub-id><pub-id pub-id-type="pmcid">PMC10643778</pub-id></element-citation></ref><ref id="B132-nutrients-17-02884"><label>132.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>H.</given-names></name><name name-style="western"><surname>Roman</surname><given-names>R.J.</given-names></name><name name-style="western"><surname>Fan</surname><given-names>F.</given-names></name></person-group><article-title>Hippocampus is more susceptible to hypoxic injury: Has the Rosetta Stone of regional variation in neurovascular coupling been deciphered?</article-title><source>Geroscience</source><year>2022</year><volume>44</volume><fpage>127</fpage><lpage>130</lpage><pub-id pub-id-type="doi">10.1007/s11357-021-00449-4</pub-id><pub-id pub-id-type="pmid">34453273</pub-id><pub-id pub-id-type="pmcid">PMC8810993</pub-id></element-citation></ref><ref id="B133-nutrients-17-02884"><label>133.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nyul-Toth</surname><given-names>A.</given-names></name><name name-style="western"><surname>Fulop</surname><given-names>G.A.</given-names></name><name name-style="western"><surname>Tarantini</surname><given-names>S.</given-names></name><name name-style="western"><surname>Kiss</surname><given-names>T.</given-names></name><name name-style="western"><surname>Ahire</surname><given-names>C.</given-names></name><name name-style="western"><surname>Faakye</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Ungvari</surname><given-names>A.</given-names></name><name name-style="western"><surname>Toth</surname><given-names>P.</given-names></name><name name-style="western"><surname>Toth</surname><given-names>A.</given-names></name><name name-style="western"><surname>Csiszar</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Cerebral venous congestion exacerbates cerebral microhemorrhages in mice</article-title><source>Geroscience</source><year>2022</year><volume>44</volume><fpage>805</fpage><lpage>816</lpage><pub-id pub-id-type="doi">10.1007/s11357-021-00504-0</pub-id><pub-id pub-id-type="pmid">34989944</pub-id><pub-id pub-id-type="pmcid">PMC9135950</pub-id></element-citation></ref><ref id="B134-nutrients-17-02884"><label>134.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sabayan</surname><given-names>B.</given-names></name><name name-style="western"><surname>Westendorp</surname><given-names>R.G.J.</given-names></name></person-group><article-title>Neurovascular-glymphatic dysfunction and white matter lesions</article-title><source>Geroscience</source><year>2021</year><volume>43</volume><fpage>1635</fpage><lpage>1642</lpage><pub-id pub-id-type="doi">10.1007/s11357-021-00361-x</pub-id><pub-id pub-id-type="pmid">33851307</pub-id><pub-id pub-id-type="pmcid">PMC8492845</pub-id></element-citation></ref><ref id="B135-nutrients-17-02884"><label>135.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>S.</given-names></name><name name-style="western"><surname>Lv</surname><given-names>W.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>H.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Li</surname><given-names>L.</given-names></name><name name-style="western"><surname>Jefferson</surname><given-names>J.R.</given-names></name><name name-style="western"><surname>Guo</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Li</surname><given-names>M.</given-names></name><name name-style="western"><surname>Gao</surname><given-names>W.</given-names></name><name name-style="western"><surname>Fang</surname><given-names>X.</given-names></name><etal/></person-group><article-title>Aging exacerbates impairments of cerebral blood flow autoregulation and cognition in diabetic rats</article-title><source>Geroscience</source><year>2020</year><volume>42</volume><fpage>1387</fpage><lpage>1410</lpage><pub-id pub-id-type="doi">10.1007/s11357-020-00233-w</pub-id><pub-id pub-id-type="pmid">32696219</pub-id><pub-id pub-id-type="pmcid">PMC7525432</pub-id></element-citation></ref><ref id="B136-nutrients-17-02884"><label>136.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Verheggen</surname><given-names>I.C.M.</given-names></name><name name-style="western"><surname>de Jong</surname><given-names>J.J.A.</given-names></name><name name-style="western"><surname>van Boxtel</surname><given-names>M.P.J.</given-names></name><name name-style="western"><surname>Postma</surname><given-names>A.A.</given-names></name><name name-style="western"><surname>Jansen</surname><given-names>J.F.A.</given-names></name><name name-style="western"><surname>Verhey</surname><given-names>F.R.J.</given-names></name><name name-style="western"><surname>Backes</surname><given-names>W.H.</given-names></name></person-group><article-title>Imaging the role of blood-brain barrier disruption in normal cognitive ageing</article-title><source>Geroscience</source><year>2020</year><volume>42</volume><fpage>1751</fpage><lpage>1764</lpage><pub-id pub-id-type="doi">10.1007/s11357-020-00282-1</pub-id><pub-id pub-id-type="pmid">33025410</pub-id><pub-id pub-id-type="pmcid">PMC7732959</pub-id></element-citation></ref><ref id="B137-nutrients-17-02884"><label>137.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sorond</surname><given-names>F.A.</given-names></name><name name-style="western"><surname>Whitehead</surname><given-names>S.</given-names></name><name name-style="western"><surname>Arai</surname><given-names>K.</given-names></name><name name-style="western"><surname>Arnold</surname><given-names>D.</given-names></name><name name-style="western"><surname>Carmichael</surname><given-names>S.T.</given-names></name><name name-style="western"><surname>De Carli</surname><given-names>C.</given-names></name><name name-style="western"><surname>Duering</surname><given-names>M.</given-names></name><name name-style="western"><surname>Fornage</surname><given-names>M.</given-names></name><name name-style="western"><surname>Flores-Obando</surname><given-names>R.E.</given-names></name><name name-style="western"><surname>Graff-Radford</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Proceedings from the Albert Charitable Trust Inaugural Workshop on white matter and cognition in aging</article-title><source>Geroscience</source><year>2020</year><volume>42</volume><fpage>81</fpage><lpage>96</lpage><pub-id pub-id-type="doi">10.1007/s11357-019-00141-8</pub-id><pub-id pub-id-type="pmid">31811528</pub-id><pub-id pub-id-type="pmcid">PMC7031447</pub-id></element-citation></ref><ref id="B138-nutrients-17-02884"><label>138.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Levit</surname><given-names>A.</given-names></name><name name-style="western"><surname>Hachinski</surname><given-names>V.</given-names></name><name name-style="western"><surname>Whitehead</surname><given-names>S.N.</given-names></name></person-group><article-title>Neurovascular unit dysregulation, white matter disease, and executive dysfunction: The shared triad of vascular cognitive impairment and Alzheimer disease</article-title><source>Geroscience</source><year>2020</year><volume>42</volume><fpage>445</fpage><lpage>465</lpage><pub-id pub-id-type="doi">10.1007/s11357-020-00164-6</pub-id><pub-id pub-id-type="pmid">32002785</pub-id><pub-id pub-id-type="pmcid">PMC7205943</pub-id></element-citation></ref><ref id="B139-nutrients-17-02884"><label>139.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jor&#8217;dan</surname><given-names>A.J.</given-names></name><name name-style="western"><surname>Manor</surname><given-names>B.</given-names></name><name name-style="western"><surname>Iloputaife</surname><given-names>I.</given-names></name><name name-style="western"><surname>Habtemariam</surname><given-names>D.A.</given-names></name><name name-style="western"><surname>Bean</surname><given-names>J.F.</given-names></name><name name-style="western"><surname>Sorond</surname><given-names>F.A.</given-names></name><name name-style="western"><surname>Lipsitz</surname><given-names>L.A.</given-names></name></person-group><article-title>Diminished Locomotor Control Is Associated With Reduced Neurovascular Coupling in Older Adults</article-title><source>J. Gerontol. A Biol. Sci. Med. Sci.</source><year>2020</year><volume>75</volume><fpage>1516</fpage><lpage>1522</lpage><pub-id pub-id-type="doi">10.1093/gerona/glz006</pub-id><pub-id pub-id-type="pmid">30629129</pub-id><pub-id pub-id-type="pmcid">PMC7357586</pub-id></element-citation></ref><ref id="B140-nutrients-17-02884"><label>140.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cermakova</surname><given-names>P.</given-names></name><name name-style="western"><surname>Ding</surname><given-names>J.</given-names></name><name name-style="western"><surname>Meirelles</surname><given-names>O.</given-names></name><name name-style="western"><surname>Reis</surname><given-names>J.</given-names></name><name name-style="western"><surname>Religa</surname><given-names>D.</given-names></name><name name-style="western"><surname>Schreiner</surname><given-names>P.J.</given-names></name><name name-style="western"><surname>Jacobs</surname><given-names>D.R.</given-names></name><name name-style="western"><surname>Bryan</surname><given-names>R.N.</given-names></name><name name-style="western"><surname>Launer</surname><given-names>L.J.</given-names></name></person-group><article-title>Carotid Intima-Media Thickness and Markers of Brain Health in a Biracial Middle-Aged Cohort: CARDIA Brain MRI Sub-study</article-title><source>J. Gerontol. A Biol. Sci. Med. Sci.</source><year>2020</year><volume>75</volume><fpage>380</fpage><lpage>386</lpage><pub-id pub-id-type="doi">10.1093/gerona/glz039</pub-id><pub-id pub-id-type="pmid">30796828</pub-id><pub-id pub-id-type="pmcid">PMC7176059</pub-id></element-citation></ref><ref id="B141-nutrients-17-02884"><label>141.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gulej</surname><given-names>R.</given-names></name><name name-style="western"><surname>Nyul-Toth</surname><given-names>A.</given-names></name><name name-style="western"><surname>Csik</surname><given-names>B.</given-names></name><name name-style="western"><surname>Petersen</surname><given-names>B.</given-names></name><name name-style="western"><surname>Faakye</surname><given-names>J.</given-names></name><name name-style="western"><surname>Negri</surname><given-names>S.</given-names></name><name name-style="western"><surname>Chandragiri</surname><given-names>S.S.</given-names></name><name name-style="western"><surname>Mukli</surname><given-names>P.</given-names></name><name name-style="western"><surname>Yabluchanskiy</surname><given-names>A.</given-names></name><name name-style="western"><surname>Conley</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Rejuvenation of cerebromicrovascular function in aged mice through heterochronic parabiosis: Insights into neurovascular coupling and the impact of young blood factors</article-title><source>Geroscience</source><year>2024</year><volume>46</volume><fpage>327</fpage><lpage>347</lpage><pub-id pub-id-type="doi">10.1007/s11357-023-01039-2</pub-id><pub-id pub-id-type="pmid">38123890</pub-id><pub-id pub-id-type="pmcid">PMC10828280</pub-id></element-citation></ref><ref id="B142-nutrients-17-02884"><label>142.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>B.</given-names></name><name name-style="western"><surname>Yabluchanskiy</surname><given-names>A.</given-names></name><name name-style="western"><surname>Tarantini</surname><given-names>S.</given-names></name><name name-style="western"><surname>Allu</surname><given-names>S.R.</given-names></name><name name-style="western"><surname>Sencan-Egilmez</surname><given-names>I.</given-names></name><name name-style="western"><surname>Leng</surname><given-names>J.</given-names></name><name name-style="western"><surname>Alfadhel</surname><given-names>M.A.H.</given-names></name><name name-style="western"><surname>Porter</surname><given-names>J.E.</given-names></name><name name-style="western"><surname>Fu</surname><given-names>B.</given-names></name><name name-style="western"><surname>Ran</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Measurements of cerebral microvascular blood flow, oxygenation, and morphology in a mouse model of whole-brain irradiation-induced cognitive impairment by two-photon microscopy and optical coherence tomography: Evidence for microvascular injury in the cerebral white matter</article-title><source>Geroscience</source><year>2023</year><volume>45</volume><fpage>1491</fpage><lpage>1510</lpage><pub-id pub-id-type="pmid">36792820</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11357-023-00735-3</pub-id><pub-id pub-id-type="pmcid">PMC10400746</pub-id></element-citation></ref><ref id="B143-nutrients-17-02884"><label>143.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Border</surname><given-names>J.J.</given-names></name><name name-style="western"><surname>Rivers</surname><given-names>P.L.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>H.</given-names></name><name name-style="western"><surname>Williams</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Fan</surname><given-names>F.</given-names></name><name name-style="western"><surname>Roman</surname><given-names>R.J.</given-names></name></person-group><article-title>Amyloid beta accumulation in TgF344-AD rats is associated with reduced cerebral capillary endothelial Kir2.1 expression and neurovascular uncoupling</article-title><source>Geroscience</source><year>2023</year><volume>45</volume><fpage>2909</fpage><lpage>2926</lpage><pub-id pub-id-type="doi">10.1007/s11357-023-00841-2</pub-id><pub-id pub-id-type="pmid">37326915</pub-id><pub-id pub-id-type="pmcid">PMC10643802</pub-id></element-citation></ref><ref id="B144-nutrients-17-02884"><label>144.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vestergaard</surname><given-names>M.B.</given-names></name><name name-style="western"><surname>Lindberg</surname><given-names>U.</given-names></name><name name-style="western"><surname>Knudsen</surname><given-names>M.H.</given-names></name><name name-style="western"><surname>Urdanibia-Centelles</surname><given-names>O.</given-names></name><name name-style="western"><surname>Bakhtiari</surname><given-names>A.</given-names></name><name name-style="western"><surname>Mortensen</surname><given-names>E.L.</given-names></name><name name-style="western"><surname>Osler</surname><given-names>M.</given-names></name><name name-style="western"><surname>Fagerlund</surname><given-names>B.</given-names></name><name name-style="western"><surname>Benedek</surname><given-names>K.</given-names></name><name name-style="western"><surname>Lauritzen</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Subclinical cognitive deficits are associated with reduced cerebrovascular response to visual stimulation in mid-sixties men</article-title><source>Geroscience</source><year>2022</year><volume>44</volume><fpage>1905</fpage><lpage>1923</lpage><pub-id pub-id-type="doi">10.1007/s11357-022-00596-2</pub-id><pub-id pub-id-type="pmid">35648331</pub-id><pub-id pub-id-type="pmcid">PMC9617000</pub-id></element-citation></ref><ref id="B145-nutrients-17-02884"><label>145.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Toth</surname><given-names>L.</given-names></name><name name-style="western"><surname>Czigler</surname><given-names>A.</given-names></name><name name-style="western"><surname>Hegedus</surname><given-names>E.</given-names></name><name name-style="western"><surname>Komaromy</surname><given-names>H.</given-names></name><name name-style="western"><surname>Amrein</surname><given-names>K.</given-names></name><name name-style="western"><surname>Czeiter</surname><given-names>E.</given-names></name><name name-style="western"><surname>Yabluchanskiy</surname><given-names>A.</given-names></name><name name-style="western"><surname>Koller</surname><given-names>A.</given-names></name><name name-style="western"><surname>Orsi</surname><given-names>G.</given-names></name><name name-style="western"><surname>Perlaki</surname><given-names>G.</given-names></name><etal/></person-group><article-title>Age-related decline in circulating IGF-1 associates with impaired neurovascular coupling responses in older adults</article-title><source>Geroscience</source><year>2022</year><volume>44</volume><fpage>2771</fpage><lpage>2783</lpage><pub-id pub-id-type="doi">10.1007/s11357-022-00623-2</pub-id><pub-id pub-id-type="pmid">35869380</pub-id><pub-id pub-id-type="pmcid">PMC9768079</pub-id></element-citation></ref><ref id="B146-nutrients-17-02884"><label>146.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Montagne</surname><given-names>A.</given-names></name><name name-style="western"><surname>Barnes</surname><given-names>S.R.</given-names></name><name name-style="western"><surname>Nation</surname><given-names>D.A.</given-names></name><name name-style="western"><surname>Kisler</surname><given-names>K.</given-names></name><name name-style="western"><surname>Toga</surname><given-names>A.W.</given-names></name><name name-style="western"><surname>Zlokovic</surname><given-names>B.V.</given-names></name></person-group><article-title>Imaging subtle leaks in the blood-brain barrier in the aging human brain: Potential pitfalls, challenges, and possible solutions</article-title><source>Geroscience</source><year>2022</year><volume>44</volume><fpage>1339</fpage><lpage>1351</lpage><pub-id pub-id-type="doi">10.1007/s11357-022-00571-x</pub-id><pub-id pub-id-type="pmid">35469116</pub-id><pub-id pub-id-type="pmcid">PMC9213625</pub-id></element-citation></ref><ref id="B147-nutrients-17-02884"><label>147.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tarantini</surname><given-names>S.</given-names></name><name name-style="western"><surname>Nyul-Toth</surname><given-names>A.</given-names></name><name name-style="western"><surname>Yabluchanskiy</surname><given-names>A.</given-names></name><name name-style="western"><surname>Csipo</surname><given-names>T.</given-names></name><name name-style="western"><surname>Mukli</surname><given-names>P.</given-names></name><name name-style="western"><surname>Balasubramanian</surname><given-names>P.</given-names></name><name name-style="western"><surname>Ungvari</surname><given-names>A.</given-names></name><name name-style="western"><surname>Toth</surname><given-names>P.</given-names></name><name name-style="western"><surname>Benyo</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Sonntag</surname><given-names>W.E.</given-names></name><etal/></person-group><article-title>Endothelial deficiency of insulin-like growth factor-1 receptor (IGF1R) impairs neurovascular coupling responses in mice, mimicking aspects of the brain aging phenotype</article-title><source>Geroscience</source><year>2021</year><volume>43</volume><fpage>2387</fpage><lpage>2394</lpage><pub-id pub-id-type="doi">10.1007/s11357-021-00405-2</pub-id><pub-id pub-id-type="pmid">34383203</pub-id><pub-id pub-id-type="pmcid">PMC8599783</pub-id></element-citation></ref><ref id="B148-nutrients-17-02884"><label>148.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Istvan</surname><given-names>L.</given-names></name><name name-style="western"><surname>Czako</surname><given-names>C.</given-names></name><name name-style="western"><surname>Elo</surname><given-names>A.</given-names></name><name name-style="western"><surname>Mihaly</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Sotonyi</surname><given-names>P.</given-names></name><name name-style="western"><surname>Varga</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ungvari</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Csiszar</surname><given-names>A.</given-names></name><name name-style="western"><surname>Yabluchanskiy</surname><given-names>A.</given-names></name><name name-style="western"><surname>Conley</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Imaging retinal microvascular manifestations of carotid artery disease in older adults: From diagnosis of ocular complications to understanding microvascular contributions to cognitive impairment</article-title><source>Geroscience</source><year>2021</year><volume>43</volume><fpage>1703</fpage><lpage>1723</lpage><pub-id pub-id-type="doi">10.1007/s11357-021-00392-4</pub-id><pub-id pub-id-type="pmid">34100219</pub-id><pub-id pub-id-type="pmcid">PMC8492863</pub-id></element-citation></ref><ref id="B149-nutrients-17-02884"><label>149.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fan</surname><given-names>F.</given-names></name><name name-style="western"><surname>Roman</surname><given-names>R.J.</given-names></name></person-group><article-title>Reversal of cerebral hypoperfusion: A novel therapeutic target for the treatment of AD/ADRD?</article-title><source>Geroscience</source><year>2021</year><volume>43</volume><fpage>1065</fpage><lpage>1067</lpage><pub-id pub-id-type="doi">10.1007/s11357-021-00357-7</pub-id><pub-id pub-id-type="pmid">33772733</pub-id><pub-id pub-id-type="pmcid">PMC8110616</pub-id></element-citation></ref><ref id="B150-nutrients-17-02884"><label>150.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kiss</surname><given-names>T.</given-names></name><name name-style="western"><surname>Nyul-Toth</surname><given-names>A.</given-names></name><name name-style="western"><surname>Balasubramanian</surname><given-names>P.</given-names></name><name name-style="western"><surname>Tarantini</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ahire</surname><given-names>C.</given-names></name><name name-style="western"><surname>Yabluchanskiy</surname><given-names>A.</given-names></name><name name-style="western"><surname>Csipo</surname><given-names>T.</given-names></name><name name-style="western"><surname>Farkas</surname><given-names>E.</given-names></name><name name-style="western"><surname>Wren</surname><given-names>J.D.</given-names></name><name name-style="western"><surname>Garman</surname><given-names>L.</given-names></name><etal/></person-group><article-title>Nicotinamide mononucleotide (NMN) supplementation promotes neurovascular rejuvenation in aged mice: Transcriptional footprint of SIRT1 activation, mitochondrial protection, anti-inflammatory, and anti-apoptotic effects</article-title><source>Geroscience</source><year>2020</year><volume>42</volume><fpage>527</fpage><lpage>546</lpage><pub-id pub-id-type="doi">10.1007/s11357-020-00165-5</pub-id><pub-id pub-id-type="pmid">32056076</pub-id><pub-id pub-id-type="pmcid">PMC7206476</pub-id></element-citation></ref><ref id="B151-nutrients-17-02884"><label>151.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cao</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>W.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Q.</given-names></name></person-group><article-title>Alterations of the blood-brain barrier during aging</article-title><source>J. Cereb. Blood Flow. Metab.</source><year>2024</year><volume>44</volume><fpage>881</fpage><lpage>895</lpage><pub-id pub-id-type="doi">10.1177/0271678X241240843</pub-id><pub-id pub-id-type="pmid">38513138</pub-id><pub-id pub-id-type="pmcid">PMC11318406</pub-id></element-citation></ref><ref id="B152-nutrients-17-02884"><label>152.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moon</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Jeon</surname><given-names>H.J.</given-names></name><name name-style="western"><surname>Han</surname><given-names>S.H.</given-names></name><name name-style="western"><surname>Min-Young</surname><given-names>N.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>H.J.</given-names></name><name name-style="western"><surname>Kwon</surname><given-names>K.J.</given-names></name><name name-style="western"><surname>Moon</surname><given-names>W.J.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>S.H.</given-names></name></person-group><article-title>Blood-brain barrier breakdown is linked to tau pathology and neuronal injury in a differential manner according to amyloid deposition</article-title><source>J. Cereb. Blood Flow. Metab.</source><year>2023</year><volume>43</volume><fpage>1813</fpage><lpage>1825</lpage><pub-id pub-id-type="doi">10.1177/0271678X231180035</pub-id><pub-id pub-id-type="pmid">37283062</pub-id><pub-id pub-id-type="pmcid">PMC10676138</pub-id></element-citation></ref><ref id="B153-nutrients-17-02884"><label>153.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Du</surname><given-names>W.</given-names></name><name name-style="western"><surname>Sun</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Ma</surname><given-names>C.</given-names></name><name name-style="western"><surname>Jin</surname><given-names>X.</given-names></name></person-group><article-title>CRTC1 is a potential target to delay aging-induced cognitive deficit by protecting the integrity of the blood-brain barrier via inhibiting inflammation</article-title><source>J. Cereb. Blood Flow. Metab.</source><year>2023</year><volume>43</volume><fpage>1042</fpage><lpage>1059</lpage><pub-id pub-id-type="doi">10.1177/0271678X231169133</pub-id><pub-id pub-id-type="pmid">37086081</pub-id><pub-id pub-id-type="pmcid">PMC10291461</pub-id></element-citation></ref><ref id="B154-nutrients-17-02884"><label>154.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Preininger</surname><given-names>M.K.</given-names></name><name name-style="western"><surname>Zaytseva</surname><given-names>D.</given-names></name><name name-style="western"><surname>Lin</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Kaufer</surname><given-names>D.</given-names></name></person-group><article-title>Blood-brain barrier dysfunction promotes astrocyte senescence through albumin-induced TGFbeta signaling activation</article-title><source>Aging Cell</source><year>2023</year><volume>22</volume><fpage>e13747</fpage><pub-id pub-id-type="doi">10.1111/acel.13747</pub-id><pub-id pub-id-type="pmid">36606305</pub-id><pub-id pub-id-type="pmcid">PMC9924950</pub-id></element-citation></ref><ref id="B155-nutrients-17-02884"><label>155.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Udo</surname><given-names>M.S.B.</given-names></name><name name-style="western"><surname>Zaccarelli-Magalhaes</surname><given-names>J.</given-names></name><name name-style="western"><surname>Clemons</surname><given-names>G.A.</given-names></name><name name-style="western"><surname>Citadin</surname><given-names>C.T.</given-names></name><name name-style="western"><surname>Langman</surname><given-names>J.</given-names></name><name name-style="western"><surname>Smith</surname><given-names>D.J.</given-names></name><name name-style="western"><surname>Matuguma</surname><given-names>L.H.</given-names></name><name name-style="western"><surname>Tesic</surname><given-names>V.</given-names></name><name name-style="western"><surname>Lin</surname><given-names>H.W.</given-names></name></person-group><article-title>Blockade of A(2A)R improved brain perfusion and cognitive function in a mouse model of Alzheimer&#8217;s disease</article-title><source>Geroscience</source><year>2025</year><volume>47</volume><fpage>4153</fpage><lpage>4167</lpage><pub-id pub-id-type="doi">10.1007/s11357-025-01526-8</pub-id><pub-id pub-id-type="pmid">39843732</pub-id><pub-id pub-id-type="pmcid">PMC12181614</pub-id></element-citation></ref><ref id="B156-nutrients-17-02884"><label>156.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Patai</surname><given-names>R.</given-names></name><name name-style="western"><surname>Csik</surname><given-names>B.</given-names></name><name name-style="western"><surname>Nyul-Toth</surname><given-names>A.</given-names></name><name name-style="western"><surname>Gulej</surname><given-names>R.</given-names></name><name name-style="western"><surname>Vali Kordestan</surname><given-names>K.</given-names></name><name name-style="western"><surname>Chandragiri</surname><given-names>S.S.</given-names></name><name name-style="western"><surname>Shanmugarama</surname><given-names>S.</given-names></name><name name-style="western"><surname>Tarantini</surname><given-names>S.</given-names></name><name name-style="western"><surname>Mukli</surname><given-names>P.</given-names></name><name name-style="western"><surname>Ungvari</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Persisting blood-brain barrier disruption following cisplatin treatment in a mouse model of chemotherapy-associated cognitive impairment</article-title><source>Geroscience</source><year>2025</year><volume>47</volume><fpage>3835</fpage><lpage>3847</lpage><pub-id pub-id-type="doi">10.1007/s11357-025-01569-x</pub-id><pub-id pub-id-type="pmid">39982666</pub-id><pub-id pub-id-type="pmcid">PMC12181602</pub-id></element-citation></ref><ref id="B157-nutrients-17-02884"><label>157.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cummins</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Cresswell</surname><given-names>E.T.</given-names></name><name name-style="western"><surname>Bevege</surname><given-names>R.J.</given-names></name><name name-style="western"><surname>Smith</surname><given-names>D.W.</given-names></name></person-group><article-title>Aging disrupts blood-brain and blood-spinal cord barrier homeostasis, but does not increase paracellular permeability</article-title><source>Geroscience</source><year>2024</year><volume>47</volume><fpage>263</fpage><lpage>285</lpage><pub-id pub-id-type="doi">10.1007/s11357-024-01404-9</pub-id><pub-id pub-id-type="pmid">39476323</pub-id><pub-id pub-id-type="pmcid">PMC11872845</pub-id></element-citation></ref><ref id="B158-nutrients-17-02884"><label>158.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chandra</surname><given-names>P.K.</given-names></name><name name-style="western"><surname>Panner Selvam</surname><given-names>M.K.</given-names></name><name name-style="western"><surname>Castorena-Gonzalez</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Rutkai</surname><given-names>I.</given-names></name><name name-style="western"><surname>Sikka</surname><given-names>S.C.</given-names></name><name name-style="western"><surname>Mostany</surname><given-names>R.</given-names></name><name name-style="western"><surname>Busija</surname><given-names>D.W.</given-names></name></person-group><article-title>Fibrinogen in mice cerebral microvessels induces blood-brain barrier dysregulation with aging via a dynamin-related protein 1-dependent pathway</article-title><source>Geroscience</source><year>2024</year><volume>46</volume><fpage>395</fpage><lpage>415</lpage><pub-id pub-id-type="doi">10.1007/s11357-023-00988-y</pub-id><pub-id pub-id-type="pmid">37897653</pub-id><pub-id pub-id-type="pmcid">PMC10828490</pub-id></element-citation></ref><ref id="B159-nutrients-17-02884"><label>159.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ayyanar</surname><given-names>M.P.</given-names></name><name name-style="western"><surname>Vijayan</surname><given-names>M.</given-names></name></person-group><article-title>A review on gut microbiota and miRNA crosstalk: Implications for Alzheimer&#8217;s disease</article-title><source>Geroscience</source><year>2024</year><volume>47</volume><fpage>339</fpage><lpage>385</lpage><pub-id pub-id-type="doi">10.1007/s11357-024-01432-5</pub-id><pub-id pub-id-type="pmid">39562408</pub-id><pub-id pub-id-type="pmcid">PMC11872870</pub-id></element-citation></ref><ref id="B160-nutrients-17-02884"><label>160.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ting</surname><given-names>K.K.</given-names></name><name name-style="western"><surname>Coleman</surname><given-names>P.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>H.J.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Mulangala</surname><given-names>J.</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>N.C.</given-names></name><name name-style="western"><surname>Li</surname><given-names>W.</given-names></name><name name-style="western"><surname>Gunatilake</surname><given-names>D.</given-names></name><name name-style="western"><surname>Johnstone</surname><given-names>D.M.</given-names></name><name name-style="western"><surname>Loo</surname><given-names>L.</given-names></name><etal/></person-group><article-title>Vascular senescence and leak are features of the early breakdown of the blood-brain barrier in Alzheimer&#8217;s disease models</article-title><source>Geroscience</source><year>2023</year><volume>45</volume><fpage>3307</fpage><lpage>3331</lpage><pub-id pub-id-type="doi">10.1007/s11357-023-00927-x</pub-id><pub-id pub-id-type="pmid">37782439</pub-id><pub-id pub-id-type="pmcid">PMC10643714</pub-id></element-citation></ref><ref id="B161-nutrients-17-02884"><label>161.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ruggiero</surname><given-names>A.D.</given-names></name><name name-style="western"><surname>Vemuri</surname><given-names>R.</given-names></name><name name-style="western"><surname>Blawas</surname><given-names>M.</given-names></name><name name-style="western"><surname>Long</surname><given-names>M.</given-names></name><name name-style="western"><surname>DeStephanis</surname><given-names>D.</given-names></name><name name-style="western"><surname>Williams</surname><given-names>A.G.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>H.</given-names></name><name name-style="western"><surname>Justice</surname><given-names>J.N.</given-names></name><name name-style="western"><surname>Macauley</surname><given-names>S.L.</given-names></name><name name-style="western"><surname>Day</surname><given-names>S.M.</given-names></name><etal/></person-group><article-title>Long-term dasatinib plus quercetin effects on aging outcomes and inflammation in nonhuman primates: Implications for senolytic clinical trial design</article-title><source>Geroscience</source><year>2023</year><volume>45</volume><fpage>2785</fpage><lpage>2803</lpage><pub-id pub-id-type="doi">10.1007/s11357-023-00830-5</pub-id><pub-id pub-id-type="pmid">37261678</pub-id><pub-id pub-id-type="pmcid">PMC10643765</pub-id></element-citation></ref><ref id="B162-nutrients-17-02884"><label>162.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pandics</surname><given-names>T.</given-names></name><name name-style="western"><surname>Major</surname><given-names>D.</given-names></name><name name-style="western"><surname>Fazekas-Pongor</surname><given-names>V.</given-names></name><name name-style="western"><surname>Szarvas</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Peterfi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Mukli</surname><given-names>P.</given-names></name><name name-style="western"><surname>Gulej</surname><given-names>R.</given-names></name><name name-style="western"><surname>Ungvari</surname><given-names>A.</given-names></name><name name-style="western"><surname>Fekete</surname><given-names>M.</given-names></name><name name-style="western"><surname>Tompa</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Exposome and unhealthy aging: Environmental drivers from air pollution to occupational exposures</article-title><source>Geroscience</source><year>2023</year><volume>45</volume><fpage>3381</fpage><lpage>3408</lpage><pub-id pub-id-type="doi">10.1007/s11357-023-00913-3</pub-id><pub-id pub-id-type="pmid">37688657</pub-id><pub-id pub-id-type="pmcid">PMC10643494</pub-id></element-citation></ref><ref id="B163-nutrients-17-02884"><label>163.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bakhtiari</surname><given-names>A.</given-names></name><name name-style="western"><surname>Vestergaard</surname><given-names>M.B.</given-names></name><name name-style="western"><surname>Benedek</surname><given-names>K.</given-names></name><name name-style="western"><surname>Fagerlund</surname><given-names>B.</given-names></name><name name-style="western"><surname>Mortensen</surname><given-names>E.L.</given-names></name><name name-style="western"><surname>Osler</surname><given-names>M.</given-names></name><name name-style="western"><surname>Lauritzen</surname><given-names>M.</given-names></name><name name-style="western"><surname>Larsson</surname><given-names>H.B.W.</given-names></name><name name-style="western"><surname>Lindberg</surname><given-names>U.</given-names></name></person-group><article-title>Changes in hippocampal volume during a preceding 10-year period do not correlate with cognitive performance and hippocampal blood&#8211;brain barrier permeability in cognitively normal late-middle-aged men</article-title><source>Geroscience</source><year>2023</year><volume>45</volume><fpage>1161</fpage><lpage>1175</lpage><pub-id pub-id-type="doi">10.1007/s11357-022-00712-2</pub-id><pub-id pub-id-type="pmid">36534276</pub-id><pub-id pub-id-type="pmcid">PMC9886720</pub-id></element-citation></ref><ref id="B164-nutrients-17-02884"><label>164.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Towner</surname><given-names>R.A.</given-names></name><name name-style="western"><surname>Gulej</surname><given-names>R.</given-names></name><name name-style="western"><surname>Zalles</surname><given-names>M.</given-names></name><name name-style="western"><surname>Saunders</surname><given-names>D.</given-names></name><name name-style="western"><surname>Smith</surname><given-names>N.</given-names></name><name name-style="western"><surname>Lerner</surname><given-names>M.</given-names></name><name name-style="western"><surname>Morton</surname><given-names>K.A.</given-names></name><name name-style="western"><surname>Richardson</surname><given-names>A.</given-names></name></person-group><article-title>Rapamycin restores brain vasculature, metabolism, and blood-brain barrier in an inflammaging model</article-title><source>Geroscience</source><year>2021</year><volume>43</volume><fpage>563</fpage><lpage>578</lpage><pub-id pub-id-type="doi">10.1007/s11357-021-00363-9</pub-id><pub-id pub-id-type="pmid">33846885</pub-id><pub-id pub-id-type="pmcid">PMC8110648</pub-id></element-citation></ref><ref id="B165-nutrients-17-02884"><label>165.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kerkhofs</surname><given-names>D.</given-names></name><name name-style="western"><surname>Wong</surname><given-names>S.M.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>E.</given-names></name><name name-style="western"><surname>Uiterwijk</surname><given-names>R.</given-names></name><name name-style="western"><surname>Hoff</surname><given-names>E.I.</given-names></name><name name-style="western"><surname>Jansen</surname><given-names>J.F.A.</given-names></name><name name-style="western"><surname>Staals</surname><given-names>J.</given-names></name><name name-style="western"><surname>Backes</surname><given-names>W.H.</given-names></name><name name-style="western"><surname>van Oostenbrugge</surname><given-names>R.J.</given-names></name></person-group><article-title>Blood-brain barrier leakage at baseline and cognitive decline in cerebral small vessel disease: A 2-year follow-up study</article-title><source>Geroscience</source><year>2021</year><volume>43</volume><fpage>1643</fpage><lpage>1652</lpage><pub-id pub-id-type="doi">10.1007/s11357-021-00399-x</pub-id><pub-id pub-id-type="pmid">34160780</pub-id><pub-id pub-id-type="pmcid">PMC8492799</pub-id></element-citation></ref><ref id="B166-nutrients-17-02884"><label>166.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Verheggen</surname><given-names>I.C.M.</given-names></name><name name-style="western"><surname>de Jong</surname><given-names>J.J.A.</given-names></name><name name-style="western"><surname>van Boxtel</surname><given-names>M.P.J.</given-names></name><name name-style="western"><surname>Gronenschild</surname><given-names>E.</given-names></name><name name-style="western"><surname>Palm</surname><given-names>W.M.</given-names></name><name name-style="western"><surname>Postma</surname><given-names>A.A.</given-names></name><name name-style="western"><surname>Jansen</surname><given-names>J.F.A.</given-names></name><name name-style="western"><surname>Verhey</surname><given-names>F.R.J.</given-names></name><name name-style="western"><surname>Backes</surname><given-names>W.H.</given-names></name></person-group><article-title>Increase in blood-brain barrier leakage in healthy, older adults</article-title><source>Geroscience</source><year>2020</year><volume>42</volume><fpage>1183</fpage><lpage>1193</lpage><pub-id pub-id-type="doi">10.1007/s11357-020-00211-2</pub-id><pub-id pub-id-type="pmid">32601792</pub-id><pub-id pub-id-type="pmcid">PMC7394987</pub-id></element-citation></ref><ref id="B167-nutrients-17-02884"><label>167.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Islam</surname><given-names>M.T.</given-names></name><name name-style="western"><surname>Hall</surname><given-names>S.A.</given-names></name><name name-style="western"><surname>Dutson</surname><given-names>T.</given-names></name><name name-style="western"><surname>Bloom</surname><given-names>S.I.</given-names></name><name name-style="western"><surname>Bramwell</surname><given-names>R.C.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>J.</given-names></name><name name-style="western"><surname>Tucker</surname><given-names>J.R.</given-names></name><name name-style="western"><surname>Machin</surname><given-names>D.R.</given-names></name><name name-style="western"><surname>Donato</surname><given-names>A.J.</given-names></name><name name-style="western"><surname>Lesniewski</surname><given-names>L.A.</given-names></name></person-group><article-title>Endothelial cell-specific reduction in mTOR ameliorates age-related arterial and metabolic dysfunction</article-title><source>Aging Cell</source><year>2024</year><volume>23</volume><fpage>e14040</fpage><pub-id pub-id-type="doi">10.1111/acel.14040</pub-id><pub-id pub-id-type="pmid">38017701</pub-id><pub-id pub-id-type="pmcid">PMC10861194</pub-id></element-citation></ref><ref id="B168-nutrients-17-02884"><label>168.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kiss</surname><given-names>T.</given-names></name><name name-style="western"><surname>Nyul-Toth</surname><given-names>A.</given-names></name><name name-style="western"><surname>Balasubramanian</surname><given-names>P.</given-names></name><name name-style="western"><surname>Tarantini</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ahire</surname><given-names>C.</given-names></name><name name-style="western"><surname>DelFavero</surname><given-names>J.</given-names></name><name name-style="western"><surname>Yabluchanskiy</surname><given-names>A.</given-names></name><name name-style="western"><surname>Csipo</surname><given-names>T.</given-names></name><name name-style="western"><surname>Farkas</surname><given-names>E.</given-names></name><name name-style="western"><surname>Wiley</surname><given-names>G.</given-names></name><etal/></person-group><article-title>Single-cell RNA sequencing identifies senescent cerebromicrovascular endothelial cells in the aged mouse brain</article-title><source>Geroscience</source><year>2020</year><volume>42</volume><fpage>429</fpage><lpage>444</lpage><pub-id pub-id-type="doi">10.1007/s11357-020-00177-1</pub-id><pub-id pub-id-type="pmid">32236824</pub-id><pub-id pub-id-type="pmcid">PMC7205992</pub-id></element-citation></ref><ref id="B169-nutrients-17-02884"><label>169.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tarantini</surname><given-names>S.</given-names></name><name name-style="western"><surname>Balasubramanian</surname><given-names>P.</given-names></name><name name-style="western"><surname>Delfavero</surname><given-names>J.</given-names></name><name name-style="western"><surname>Csipo</surname><given-names>T.</given-names></name><name name-style="western"><surname>Yabluchanskiy</surname><given-names>A.</given-names></name><name name-style="western"><surname>Kiss</surname><given-names>T.</given-names></name><name name-style="western"><surname>Nyul-Toth</surname><given-names>A.</given-names></name><name name-style="western"><surname>Mukli</surname><given-names>P.</given-names></name><name name-style="western"><surname>Toth</surname><given-names>P.</given-names></name><name name-style="western"><surname>Ahire</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Treatment with the BCL-2/BCL-xL inhibitor senolytic drug ABT263/Navitoclax improves functional hyperemia in aged mice</article-title><source>Geroscience</source><year>2021</year><volume>43</volume><fpage>2427</fpage><lpage>2440</lpage><pub-id pub-id-type="doi">10.1007/s11357-021-00440-z</pub-id><pub-id pub-id-type="pmid">34427858</pub-id><pub-id pub-id-type="pmcid">PMC8599595</pub-id></element-citation></ref><ref id="B170-nutrients-17-02884"><label>170.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Faakye</surname><given-names>J.</given-names></name><name name-style="western"><surname>Nyul-Toth</surname><given-names>A.</given-names></name><name name-style="western"><surname>Muranyi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Gulej</surname><given-names>R.</given-names></name><name name-style="western"><surname>Csik</surname><given-names>B.</given-names></name><name name-style="western"><surname>Shanmugarama</surname><given-names>S.</given-names></name><name name-style="western"><surname>Tarantini</surname><given-names>S.</given-names></name><name name-style="western"><surname>Negri</surname><given-names>S.</given-names></name><name name-style="western"><surname>Prodan</surname><given-names>C.</given-names></name><name name-style="western"><surname>Mukli</surname><given-names>P.</given-names></name><etal/></person-group><article-title>Preventing spontaneous cerebral microhemorrhages in aging mice: A novel approach targeting cellular senescence with ABT263/navitoclax</article-title><source>Geroscience</source><year>2024</year><volume>46</volume><fpage>21</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1007/s11357-023-01024-9</pub-id><pub-id pub-id-type="pmid">38044400</pub-id><pub-id pub-id-type="pmcid">PMC10828142</pub-id></element-citation></ref><ref id="B171-nutrients-17-02884"><label>171.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cummings</surname><given-names>S.R.</given-names></name><name name-style="western"><surname>Lui</surname><given-names>L.Y.</given-names></name><name name-style="western"><surname>Zaira</surname><given-names>A.</given-names></name><name name-style="western"><surname>Mau</surname><given-names>T.</given-names></name><name name-style="western"><surname>Fielding</surname><given-names>R.A.</given-names></name><name name-style="western"><surname>Atkinson</surname><given-names>E.J.</given-names></name><name name-style="western"><surname>Patel</surname><given-names>S.</given-names></name><name name-style="western"><surname>LeBrasseur</surname><given-names>N.</given-names></name></person-group><article-title>Biomarkers of cellular senescence and major health outcomes in older adults</article-title><source>Geroscience</source><year>2024</year><volume>47</volume><fpage>3407</fpage><lpage>3415</lpage><pub-id pub-id-type="doi">10.1007/s11357-024-01474-9</pub-id><pub-id pub-id-type="pmid">39695064</pub-id><pub-id pub-id-type="pmcid">PMC12181601</pub-id></element-citation></ref><ref id="B172-nutrients-17-02884"><label>172.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mahoney</surname><given-names>S.A.</given-names></name><name name-style="western"><surname>Venkatasubramanian</surname><given-names>R.</given-names></name><name name-style="western"><surname>Darrah</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Ludwig</surname><given-names>K.R.</given-names></name><name name-style="western"><surname>VanDongen</surname><given-names>N.S.</given-names></name><name name-style="western"><surname>Greenberg</surname><given-names>N.T.</given-names></name><name name-style="western"><surname>Longtine</surname><given-names>A.G.</given-names></name><name name-style="western"><surname>Hutton</surname><given-names>D.A.</given-names></name><name name-style="western"><surname>Brunt</surname><given-names>V.E.</given-names></name><name name-style="western"><surname>Campisi</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Intermittent supplementation with fisetin improves arterial function in old mice by decreasing cellular senescence</article-title><source>Aging Cell</source><year>2024</year><volume>23</volume><fpage>e14060</fpage><pub-id pub-id-type="doi">10.1111/acel.14060</pub-id><pub-id pub-id-type="pmid">38062873</pub-id><pub-id pub-id-type="pmcid">PMC10928570</pub-id></element-citation></ref><ref id="B173-nutrients-17-02884"><label>173.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Novo</surname><given-names>J.P.</given-names></name><name name-style="western"><surname>Gee</surname><given-names>L.</given-names></name><name name-style="western"><surname>Caetano</surname><given-names>C.A.</given-names></name><name name-style="western"><surname>Tome</surname><given-names>I.</given-names></name><name name-style="western"><surname>Vilaca</surname><given-names>A.</given-names></name><name name-style="western"><surname>von Zglinicki</surname><given-names>T.</given-names></name><name name-style="western"><surname>Moreira</surname><given-names>I.S.</given-names></name><name name-style="western"><surname>Jurk</surname><given-names>D.</given-names></name><name name-style="western"><surname>Rosa</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ferreira</surname><given-names>L.</given-names></name></person-group><article-title>Blood-brain barrier dysfunction in aging is mediated by brain endothelial senescence</article-title><source>Aging Cell</source><year>2024</year><volume>23</volume><fpage>e14270</fpage><pub-id pub-id-type="doi">10.1111/acel.14270</pub-id><pub-id pub-id-type="pmid">39143890</pub-id><pub-id pub-id-type="pmcid">PMC11488312</pub-id></element-citation></ref><ref id="B174-nutrients-17-02884"><label>174.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Budamagunta</surname><given-names>V.</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>A.</given-names></name><name name-style="western"><surname>Rani</surname><given-names>A.</given-names></name><name name-style="western"><surname>Bean</surname><given-names>L.</given-names></name><name name-style="western"><surname>Manohar-Sindhu</surname><given-names>S.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>D.</given-names></name><name name-style="western"><surname>Foster</surname><given-names>T.C.</given-names></name></person-group><article-title>Effect of peripheral cellular senescence on brain aging and cognitive decline</article-title><source>Aging Cell</source><year>2023</year><volume>22</volume><fpage>e13817</fpage><pub-id pub-id-type="doi">10.1111/acel.13817</pub-id><pub-id pub-id-type="pmid">36959691</pub-id><pub-id pub-id-type="pmcid">PMC10186609</pub-id></element-citation></ref><ref id="B175-nutrients-17-02884"><label>175.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ahire</surname><given-names>C.</given-names></name><name name-style="western"><surname>Nyul-Toth</surname><given-names>A.</given-names></name><name name-style="western"><surname>DelFavero</surname><given-names>J.</given-names></name><name name-style="western"><surname>Gulej</surname><given-names>R.</given-names></name><name name-style="western"><surname>Faakye</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Tarantini</surname><given-names>S.</given-names></name><name name-style="western"><surname>Kiss</surname><given-names>T.</given-names></name><name name-style="western"><surname>Kuan-Celarier</surname><given-names>A.</given-names></name><name name-style="western"><surname>Balasubramanian</surname><given-names>P.</given-names></name><name name-style="western"><surname>Ungvari</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Accelerated cerebromicrovascular senescence contributes to cognitive decline in a mouse model of paclitaxel (Taxol)-induced chemobrain</article-title><source>Aging Cell</source><year>2023</year><volume>22</volume><fpage>e13832</fpage><pub-id pub-id-type="doi">10.1111/acel.13832</pub-id><pub-id pub-id-type="pmid">37243381</pub-id><pub-id pub-id-type="pmcid">PMC10352561</pub-id></element-citation></ref><ref id="B176-nutrients-17-02884"><label>176.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bloom</surname><given-names>S.I.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Tucker</surname><given-names>J.R.</given-names></name><name name-style="western"><surname>Islam</surname><given-names>M.T.</given-names></name><name name-style="western"><surname>Machin</surname><given-names>D.R.</given-names></name><name name-style="western"><surname>Abdeahad</surname><given-names>H.</given-names></name><name name-style="western"><surname>Thomas</surname><given-names>T.G.</given-names></name><name name-style="western"><surname>Bramwell</surname><given-names>R.C.</given-names></name><name name-style="western"><surname>Lesniewski</surname><given-names>L.A.</given-names></name><name name-style="western"><surname>Donato</surname><given-names>A.J.</given-names></name></person-group><article-title>Endothelial cell telomere dysfunction induces senescence and results in vascular and metabolic impairments</article-title><source>Aging Cell</source><year>2023</year><volume>22</volume><fpage>e13875</fpage><pub-id pub-id-type="doi">10.1111/acel.13875</pub-id><pub-id pub-id-type="pmid">37259606</pub-id><pub-id pub-id-type="pmcid">PMC10410008</pub-id></element-citation></ref><ref id="B177-nutrients-17-02884"><label>177.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nyul-Toth</surname><given-names>A.</given-names></name><name name-style="western"><surname>Negri</surname><given-names>S.</given-names></name><name name-style="western"><surname>Sanford</surname><given-names>M.</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>R.</given-names></name><name name-style="western"><surname>Patai</surname><given-names>R.</given-names></name><name name-style="western"><surname>Budda</surname><given-names>M.</given-names></name><name name-style="western"><surname>Petersen</surname><given-names>B.</given-names></name><name name-style="western"><surname>Pinckard</surname><given-names>J.</given-names></name><name name-style="western"><surname>Chandragiri</surname><given-names>S.S.</given-names></name><name name-style="western"><surname>Shi</surname><given-names>H.</given-names></name><etal/></person-group><article-title>Novel intravital approaches to quantify deep vascular structure and perfusion in the aging mouse brain using ultrasound localization microscopy (ULM)</article-title><source>J. Cereb. Blood Flow. Metab.</source><year>2024</year><volume>44</volume><fpage>1378</fpage><lpage>1396</lpage><pub-id pub-id-type="doi">10.1177/0271678X241260526</pub-id><pub-id pub-id-type="pmid">38867576</pub-id><pub-id pub-id-type="pmcid">PMC11542130</pub-id></element-citation></ref><ref id="B178-nutrients-17-02884"><label>178.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Andonian</surname><given-names>B.J.</given-names></name><name name-style="western"><surname>Hippensteel</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Abuabara</surname><given-names>K.</given-names></name><name name-style="western"><surname>Boyle</surname><given-names>E.M.</given-names></name><name name-style="western"><surname>Colbert</surname><given-names>J.F.</given-names></name><name name-style="western"><surname>Devinney</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Faye</surname><given-names>A.S.</given-names></name><name name-style="western"><surname>Kochar</surname><given-names>B.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>J.</given-names></name><name name-style="western"><surname>Litke</surname><given-names>R.</given-names></name><etal/></person-group><article-title>Inflammation and aging-related disease: A transdisciplinary inflammaging framework</article-title><source>Geroscience</source><year>2024</year><volume>47</volume><fpage>515</fpage><lpage>542</lpage><pub-id pub-id-type="doi">10.1007/s11357-024-01364-0</pub-id><pub-id pub-id-type="pmid">39352664</pub-id><pub-id pub-id-type="pmcid">PMC11872841</pub-id></element-citation></ref><ref id="B179-nutrients-17-02884"><label>179.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gotz</surname><given-names>L.</given-names></name><name name-style="western"><surname>Rueckschloss</surname><given-names>U.</given-names></name><name name-style="western"><surname>Reimer</surname><given-names>A.</given-names></name><name name-style="western"><surname>Bommel</surname><given-names>H.</given-names></name><name name-style="western"><surname>Beilhack</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ergun</surname><given-names>S.</given-names></name><name name-style="western"><surname>Kleefeldt</surname><given-names>F.</given-names></name></person-group><article-title>Vascular inflammaging: Endothelial CEACAM1 expression is upregulated by TNF-alpha via independent activation of NF-kappaB and beta-catenin signaling</article-title><source>Aging Cell</source><year>2025</year><volume>24</volume><fpage>e14384</fpage><pub-id pub-id-type="doi">10.1111/acel.14384</pub-id><pub-id pub-id-type="pmid">39434463</pub-id><pub-id pub-id-type="pmcid">PMC11822634</pub-id></element-citation></ref><ref id="B180-nutrients-17-02884"><label>180.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shirzadi</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Boyle</surname><given-names>R.</given-names></name><name name-style="western"><surname>Yau</surname><given-names>W.W.</given-names></name><name name-style="western"><surname>Coughlan</surname><given-names>G.</given-names></name><name name-style="western"><surname>Fu</surname><given-names>J.F.</given-names></name><name name-style="western"><surname>Properzi</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Buckley</surname><given-names>R.F.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>H.S.</given-names></name><name name-style="western"><surname>Scanlon</surname><given-names>C.E.</given-names></name><name name-style="western"><surname>Hsieh</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Vascular contributions to cognitive decline: Beyond amyloid and tau in the Harvard Aging Brain Study</article-title><source>J. Cereb. Blood Flow. Metab.</source><year>2024</year><volume>44</volume><fpage>1319</fpage><lpage>1328</lpage><pub-id pub-id-type="doi">10.1177/0271678X241237624</pub-id><pub-id pub-id-type="pmid">38452039</pub-id><pub-id pub-id-type="pmcid">PMC11342726</pub-id></element-citation></ref><ref id="B181-nutrients-17-02884"><label>181.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van Dijk</surname><given-names>S.E.</given-names></name><name name-style="western"><surname>Drenth</surname><given-names>N.</given-names></name><name name-style="western"><surname>Hafkemeijer</surname><given-names>A.</given-names></name><name name-style="western"><surname>Labadie</surname><given-names>G.</given-names></name><name name-style="western"><surname>Witjes-Ane</surname><given-names>M.W.</given-names></name><name name-style="western"><surname>Blauw</surname><given-names>G.J.</given-names></name><name name-style="western"><surname>Rombouts</surname><given-names>S.A.</given-names></name><name name-style="western"><surname>van der Grond</surname><given-names>J.</given-names></name><name name-style="western"><surname>van Rooden</surname><given-names>S.</given-names></name></person-group><article-title>Neurovascular coupling in early stage dementia&#8212;A case-control study</article-title><source>J. Cereb. Blood Flow. Metab.</source><year>2024</year><volume>44</volume><fpage>1013</fpage><lpage>1023</lpage><pub-id pub-id-type="doi">10.1177/0271678X231214102</pub-id><pub-id pub-id-type="pmid">37994030</pub-id><pub-id pub-id-type="pmcid">PMC11318393</pub-id></element-citation></ref><ref id="B182-nutrients-17-02884"><label>182.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van der Horn</surname><given-names>H.J.</given-names></name><name name-style="western"><surname>Vakhtin</surname><given-names>A.A.</given-names></name><name name-style="western"><surname>Julio</surname><given-names>K.</given-names></name><name name-style="western"><surname>Nitschke</surname><given-names>S.</given-names></name><name name-style="western"><surname>Shaff</surname><given-names>N.</given-names></name><name name-style="western"><surname>Dodd</surname><given-names>A.B.</given-names></name><name name-style="western"><surname>Erhardt</surname><given-names>E.</given-names></name><name name-style="western"><surname>Phillips</surname><given-names>J.P.</given-names></name><name name-style="western"><surname>Pirio Richardson</surname><given-names>S.</given-names></name><name name-style="western"><surname>Deligtisch</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Parkinson&#8217;s disease cerebrovascular reactivity pattern: A feasibility study</article-title><source>J. Cereb. Blood Flow. Metab.</source><year>2024</year><volume>44</volume><fpage>1774</fpage><lpage>1786</lpage><pub-id pub-id-type="doi">10.1177/0271678X241241895</pub-id><pub-id pub-id-type="pmid">38578669</pub-id><pub-id pub-id-type="pmcid">PMC11494834</pub-id></element-citation></ref><ref id="B183-nutrients-17-02884"><label>183.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jones</surname><given-names>O.A.</given-names></name><name name-style="western"><surname>Mohamed</surname><given-names>S.</given-names></name><name name-style="western"><surname>Hinz</surname><given-names>R.</given-names></name><name name-style="western"><surname>Paterson</surname><given-names>A.</given-names></name><name name-style="western"><surname>Sobowale</surname><given-names>O.A.</given-names></name><name name-style="western"><surname>Dickie</surname><given-names>B.R.</given-names></name><name name-style="western"><surname>Parkes</surname><given-names>L.M.</given-names></name><name name-style="western"><surname>Parry-Jones</surname><given-names>A.R.</given-names></name></person-group><article-title>Neuroinflammation and blood-brain barrier breakdown in acute, clinical intracerebral hemorrhage</article-title><source>J. Cereb. Blood Flow. Metab.</source><year>2025</year><volume>45</volume><fpage>233</fpage><lpage>243</lpage><pub-id pub-id-type="doi">10.1177/0271678X241274685</pub-id><pub-id pub-id-type="pmid">39360420</pub-id><pub-id pub-id-type="pmcid">PMC11563506</pub-id></element-citation></ref><ref id="B184-nutrients-17-02884"><label>184.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhou</surname><given-names>S.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>C.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Ye</surname><given-names>J.</given-names></name><name name-style="western"><surname>Lian</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Gan</surname><given-names>L.</given-names></name><name name-style="western"><surname>Deng</surname><given-names>S.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>T.</given-names></name><name name-style="western"><surname>Guo</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Li</surname><given-names>W.</given-names></name><etal/></person-group><article-title>CCL5 mediated astrocyte-T cell interaction disrupts blood-brain barrier in mice after hemorrhagic stroke</article-title><source>J. Cereb. Blood Flow. Metab.</source><year>2024</year><volume>44</volume><fpage>367</fpage><lpage>383</lpage><pub-id pub-id-type="doi">10.1177/0271678X231214838</pub-id><pub-id pub-id-type="pmid">37974301</pub-id><pub-id pub-id-type="pmcid">PMC10870968</pub-id></element-citation></ref><ref id="B185-nutrients-17-02884"><label>185.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>S.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>J.</given-names></name><name name-style="western"><surname>Sha</surname><given-names>W.M.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X.P.</given-names></name><name name-style="western"><surname>Mai</surname><given-names>J.Y.</given-names></name><name name-style="western"><surname>Bartlett</surname><given-names>P.F.</given-names></name><name name-style="western"><surname>Hou</surname><given-names>S.T.</given-names></name></person-group><article-title>Inhibition of EphA4 reduces vasogenic edema after experimental stroke in mice by protecting the blood-brain barrier integrity</article-title><source>J. Cereb. Blood Flow. Metab.</source><year>2024</year><volume>44</volume><fpage>419</fpage><lpage>433</lpage><pub-id pub-id-type="doi">10.1177/0271678X231209607</pub-id><pub-id pub-id-type="pmid">37871622</pub-id><pub-id pub-id-type="pmcid">PMC10870966</pub-id></element-citation></ref><ref id="B186-nutrients-17-02884"><label>186.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ren</surname><given-names>X.S.</given-names></name><name name-style="western"><surname>Shi</surname><given-names>Y.</given-names></name></person-group><article-title>Early and enduring: Targeting the endothelium for blood-brain barrier protection</article-title><source>J. Cereb. Blood Flow. Metab.</source><year>2024</year><volume>44</volume><fpage>1674</fpage><lpage>1676</lpage><pub-id pub-id-type="doi">10.1177/0271678X241264086</pub-id><pub-id pub-id-type="pmid">38907363</pub-id><pub-id pub-id-type="pmcid">PMC11418723</pub-id></element-citation></ref><ref id="B187-nutrients-17-02884"><label>187.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mandeville</surname><given-names>E.T.</given-names></name><name name-style="western"><surname>Buchan</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Tiedt</surname><given-names>S.</given-names></name></person-group><article-title>Not open and shut: Complex and prolonged blood-brain barrier responses after stroke</article-title><source>J. Cereb. Blood Flow. Metab.</source><year>2024</year><volume>44</volume><fpage>446</fpage><lpage>448</lpage><pub-id pub-id-type="doi">10.1177/0271678X231216153</pub-id><pub-id pub-id-type="pmid">38000041</pub-id><pub-id pub-id-type="pmcid">PMC10870962</pub-id></element-citation></ref><ref id="B188-nutrients-17-02884"><label>188.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>C.</given-names></name><name name-style="western"><surname>Guo</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Deng</surname><given-names>S.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>S.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>S.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>T.</given-names></name><name name-style="western"><surname>Shi</surname><given-names>X.</given-names></name><name name-style="western"><surname>Mamtilahun</surname><given-names>M.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>T.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Z.</given-names></name><etal/></person-group><article-title>Hemorrhagic stroke-induced subtype of inflammatory reactive astrocytes disrupts blood-brain barrier</article-title><source>J. Cereb. Blood Flow. Metab.</source><year>2024</year><volume>44</volume><fpage>1102</fpage><lpage>1116</lpage><pub-id pub-id-type="doi">10.1177/0271678X241235008</pub-id><pub-id pub-id-type="pmid">38388375</pub-id><pub-id pub-id-type="pmcid">PMC11179611</pub-id></element-citation></ref><ref id="B189-nutrients-17-02884"><label>189.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Roth</surname><given-names>M.</given-names></name><name name-style="western"><surname>Carlsson</surname><given-names>R.</given-names></name><name name-style="western"><surname>Buizza</surname><given-names>C.</given-names></name><name name-style="western"><surname>Enstrom</surname><given-names>A.</given-names></name><name name-style="western"><surname>Paul</surname><given-names>G.</given-names></name></person-group><article-title>Pericyte response to ischemic stroke precedes endothelial cell death and blood-brain barrier breakdown</article-title><source>J. Cereb. Blood Flow. Metab.</source><year>2025</year><volume>45</volume><fpage>617</fpage><lpage>629</lpage><pub-id pub-id-type="doi">10.1177/0271678X241261946</pub-id><pub-id pub-id-type="pmid">39053491</pub-id><pub-id pub-id-type="pmcid">PMC11571979</pub-id></element-citation></ref><ref id="B190-nutrients-17-02884"><label>190.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tudor</surname><given-names>T.</given-names></name><name name-style="western"><surname>Spinazzi</surname><given-names>E.F.</given-names></name><name name-style="western"><surname>Alexander</surname><given-names>J.E.</given-names></name><name name-style="western"><surname>Mandigo</surname><given-names>G.K.</given-names></name><name name-style="western"><surname>Lavine</surname><given-names>S.D.</given-names></name><name name-style="western"><surname>Grinband</surname><given-names>J.</given-names></name><name name-style="western"><surname>Connolly</surname><given-names>E.S.</given-names><suffix>Jr.</suffix></name></person-group><article-title>Progressive microvascular failure in acute ischemic stroke: A systematic review, meta-analysis, and time-course analysis</article-title><source>J. Cereb. Blood Flow. Metab.</source><year>2024</year><volume>44</volume><fpage>192</fpage><lpage>208</lpage><pub-id pub-id-type="doi">10.1177/0271678X231216766</pub-id><pub-id pub-id-type="pmid">38016953</pub-id><pub-id pub-id-type="pmcid">PMC10993872</pub-id></element-citation></ref><ref id="B191-nutrients-17-02884"><label>191.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schmitzer</surname><given-names>L.</given-names></name><name name-style="western"><surname>Kaczmarz</surname><given-names>S.</given-names></name><name name-style="western"><surname>Gottler</surname><given-names>J.</given-names></name><name name-style="western"><surname>Hoffmann</surname><given-names>G.</given-names></name><name name-style="western"><surname>Kallmayer</surname><given-names>M.</given-names></name><name name-style="western"><surname>Eckstein</surname><given-names>H.H.</given-names></name><name name-style="western"><surname>Hedderich</surname><given-names>D.M.</given-names></name><name name-style="western"><surname>Kufer</surname><given-names>J.</given-names></name><name name-style="western"><surname>Zimmer</surname><given-names>C.</given-names></name><name name-style="western"><surname>Preibisch</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Macro- and microvascular contributions to cerebral structural alterations in patients with asymptomatic carotid artery stenosis</article-title><source>J. Cereb. Blood Flow. Metab.</source><year>2024</year><volume>44</volume><fpage>1629</fpage><lpage>1642</lpage><pub-id pub-id-type="doi">10.1177/0271678X241238935</pub-id><pub-id pub-id-type="pmid">38506325</pub-id><pub-id pub-id-type="pmcid">PMC11418673</pub-id></element-citation></ref><ref id="B192-nutrients-17-02884"><label>192.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>S.</given-names></name><name name-style="western"><surname>Tian</surname><given-names>X.</given-names></name><name name-style="western"><surname>Ip</surname><given-names>B.</given-names></name><name name-style="western"><surname>Feng</surname><given-names>X.</given-names></name><name name-style="western"><surname>Ip</surname><given-names>H.L.</given-names></name><name name-style="western"><surname>Abrigo</surname><given-names>J.</given-names></name><name name-style="western"><surname>Lan</surname><given-names>L.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>H.</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>L.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>Cerebral hemodynamics and stroke risks in symptomatic intracranial atherosclerotic stenosis with internal versus cortical borderzone infarcts: A computational fluid dynamics study</article-title><source>J. Cereb. Blood Flow. Metab.</source><year>2024</year><volume>44</volume><fpage>516</fpage><lpage>526</lpage><pub-id pub-id-type="doi">10.1177/0271678X231211449</pub-id><pub-id pub-id-type="pmid">37898104</pub-id><pub-id pub-id-type="pmcid">PMC10981396</pub-id></element-citation></ref><ref id="B193-nutrients-17-02884"><label>193.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bagi</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Kroenke</surname><given-names>C.D.</given-names></name><name name-style="western"><surname>Fopiano</surname><given-names>K.A.</given-names></name><name name-style="western"><surname>Tian</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Filosa</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Sherman</surname><given-names>L.S.</given-names></name><name name-style="western"><surname>Larson</surname><given-names>E.B.</given-names></name><name name-style="western"><surname>Keene</surname><given-names>C.D.</given-names></name><name name-style="western"><surname>Degener O&#8217;Brien</surname><given-names>K.</given-names></name><name name-style="western"><surname>Adeniyi</surname><given-names>P.A.</given-names></name><etal/></person-group><article-title>Association of cerebral microvascular dysfunction and white matter injury in Alzheimer&#8217;s disease</article-title><source>Geroscience</source><year>2022</year><volume>44</volume><fpage>1</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1007/s11357-022-00585-5</pub-id><pub-id pub-id-type="pmcid">PMC9617002</pub-id><pub-id pub-id-type="pmid">35612774</pub-id></element-citation></ref><ref id="B194-nutrients-17-02884"><label>194.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Czak&#243;</surname><given-names>C.</given-names></name><name name-style="western"><surname>Kov&#225;cs</surname><given-names>T.</given-names></name><name name-style="western"><surname>Ungvari</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Csiszar</surname><given-names>A.</given-names></name><name name-style="western"><surname>Yabluchanskiy</surname><given-names>A.</given-names></name><name name-style="western"><surname>Conley</surname><given-names>S.</given-names></name><name name-style="western"><surname>Csipo</surname><given-names>T.</given-names></name><name name-style="western"><surname>Lipecz</surname><given-names>A.</given-names></name><name name-style="western"><surname>Horv&#225;th</surname><given-names>H.</given-names></name><name name-style="western"><surname>S&#225;ndor</surname><given-names>G.L.</given-names></name><etal/></person-group><article-title>Retinal biomarkers for Alzheimer&#8217;s disease and vascular cognitive impairment and dementia (VCID): Implication for early diagnosis and prognosis</article-title><source>Geroscience</source><year>2020</year><volume>42</volume><fpage>1499</fpage><lpage>1525</lpage><pub-id pub-id-type="doi">10.1007/s11357-020-00252-7</pub-id><pub-id pub-id-type="pmid">33011937</pub-id><pub-id pub-id-type="pmcid">PMC7732888</pub-id></element-citation></ref><ref id="B195-nutrients-17-02884"><label>195.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fekete</surname><given-names>M.</given-names></name><name name-style="western"><surname>Lehoczki</surname><given-names>A.</given-names></name><name name-style="western"><surname>Szappanos</surname><given-names>A.</given-names></name><name name-style="western"><surname>Toth</surname><given-names>A.</given-names></name><name name-style="western"><surname>Mahdi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Sotonyi</surname><given-names>P.</given-names></name><name name-style="western"><surname>Benyo</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Yabluchanskiy</surname><given-names>A.</given-names></name><name name-style="western"><surname>Tarantini</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ungvari</surname><given-names>Z.</given-names></name></person-group><article-title>Cerebromicrovascular mechanisms contributing to long COVID: Implications for neurocognitive health</article-title><source>Geroscience</source><year>2025</year><volume>47</volume><fpage>745</fpage><lpage>779</lpage><pub-id pub-id-type="doi">10.1007/s11357-024-01487-4</pub-id><pub-id pub-id-type="pmid">39777702</pub-id><pub-id pub-id-type="pmcid">PMC11872997</pub-id></element-citation></ref><ref id="B196-nutrients-17-02884"><label>196.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Elmansi</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Kassem</surname><given-names>A.</given-names></name><name name-style="western"><surname>Castilla</surname><given-names>R.M.</given-names></name><name name-style="western"><surname>Miller</surname><given-names>R.A.</given-names></name></person-group><article-title>Downregulation of the NF-kappaB protein p65 is a shared phenotype among most anti-aging interventions</article-title><source>Geroscience</source><year>2024</year><volume>47</volume><fpage>3077</fpage><lpage>3094</lpage><pub-id pub-id-type="doi">10.1007/s11357-024-01466-9</pub-id><pub-id pub-id-type="pmid">39666139</pub-id><pub-id pub-id-type="pmcid">PMC12181462</pub-id></element-citation></ref><ref id="B197-nutrients-17-02884"><label>197.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Riordan</surname><given-names>R.</given-names></name><name name-style="western"><surname>Rong</surname><given-names>W.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Ross</surname><given-names>G.</given-names></name><name name-style="western"><surname>Valerio</surname><given-names>J.</given-names></name><name name-style="western"><surname>Dimas-Munoz</surname><given-names>J.</given-names></name><name name-style="western"><surname>Heredia</surname><given-names>V.</given-names></name><name name-style="western"><surname>Magnusson</surname><given-names>K.</given-names></name><name name-style="western"><surname>Galvan</surname><given-names>V.</given-names></name><name name-style="western"><surname>Perez</surname><given-names>V.I.</given-names></name></person-group><article-title>Effect of Nrf2 loss on senescence and cognition of tau-based P301S mice</article-title><source>Geroscience</source><year>2023</year><volume>45</volume><fpage>1451</fpage><lpage>1469</lpage><pub-id pub-id-type="doi">10.1007/s11357-023-00760-2</pub-id><pub-id pub-id-type="pmid">36976489</pub-id><pub-id pub-id-type="pmcid">PMC10400516</pub-id></element-citation></ref><ref id="B198-nutrients-17-02884"><label>198.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shin</surname><given-names>J.W.</given-names></name><name name-style="western"><surname>Chun</surname><given-names>K.S.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>D.H.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>S.J.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>S.H.</given-names></name><name name-style="western"><surname>Cho</surname><given-names>N.C.</given-names></name><name name-style="western"><surname>Na</surname><given-names>H.K.</given-names></name><name name-style="western"><surname>Surh</surname><given-names>Y.J.</given-names></name></person-group><article-title>Curcumin induces stabilization of Nrf2 protein through Keap1 cysteine modification</article-title><source>Biochem. Pharmacol.</source><year>2020</year><volume>173</volume><elocation-id>113820</elocation-id><pub-id pub-id-type="doi">10.1016/j.bcp.2020.113820</pub-id><pub-id pub-id-type="pmid">31972171</pub-id></element-citation></ref><ref id="B199-nutrients-17-02884"><label>199.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>C.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Fan</surname><given-names>H.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></name></person-group><article-title>Curcumin upregulates transcription factor Nrf2, HO-1 expression and protects rat brains against focal ischemia</article-title><source>Brain Res.</source><year>2009</year><volume>1282</volume><fpage>133</fpage><lpage>141</lpage><pub-id pub-id-type="doi">10.1016/j.brainres.2009.05.009</pub-id><pub-id pub-id-type="pmid">19445907</pub-id></element-citation></ref><ref id="B200-nutrients-17-02884"><label>200.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Khor</surname><given-names>T.O.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>T.Y.</given-names></name><name name-style="western"><surname>Shu</surname><given-names>L.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>J.</given-names></name><name name-style="western"><surname>Kong</surname><given-names>A.N.</given-names></name></person-group><article-title>Pharmacodynamics of curcumin as DNA hypomethylation agent in restoring the expression of Nrf2 via promoter CpGs demethylation</article-title><source>Biochem. Pharmacol.</source><year>2011</year><volume>82</volume><fpage>1073</fpage><lpage>1078</lpage><pub-id pub-id-type="doi">10.1016/j.bcp.2011.07.065</pub-id><pub-id pub-id-type="pmid">21787756</pub-id></element-citation></ref><ref id="B201-nutrients-17-02884"><label>201.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kobutree</surname><given-names>P.</given-names></name><name name-style="western"><surname>Tothonglor</surname><given-names>A.</given-names></name><name name-style="western"><surname>Roumwong</surname><given-names>A.</given-names></name><name name-style="western"><surname>Jindatip</surname><given-names>D.</given-names></name><name name-style="western"><surname>Agthong</surname><given-names>S.</given-names></name></person-group><article-title>Curcumin reduces blood-nerve barrier abnormalities and cytotoxicity to endothelial cells and pericytes induced by cisplatin</article-title><source>Folia Morphol.</source><year>2023</year><volume>82</volume><fpage>533</fpage><lpage>542</lpage><pub-id pub-id-type="doi">10.5603/FM.a2022.0065</pub-id><pub-id pub-id-type="pmid">35818807</pub-id></element-citation></ref><ref id="B202-nutrients-17-02884"><label>202.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moore</surname><given-names>T.L.</given-names></name><name name-style="western"><surname>Bowley</surname><given-names>B.</given-names></name><name name-style="western"><surname>Shultz</surname><given-names>P.</given-names></name><name name-style="western"><surname>Calderazzo</surname><given-names>S.</given-names></name><name name-style="western"><surname>Shobin</surname><given-names>E.</given-names></name><name name-style="western"><surname>Killiany</surname><given-names>R.J.</given-names></name><name name-style="western"><surname>Rosene</surname><given-names>D.L.</given-names></name><name name-style="western"><surname>Moss</surname><given-names>M.B.</given-names></name></person-group><article-title>Chronic curcumin treatment improves spatial working memory but not recognition memory in middle-aged rhesus monkeys</article-title><source>Geroscience</source><year>2017</year><volume>39</volume><fpage>571</fpage><lpage>584</lpage><pub-id pub-id-type="doi">10.1007/s11357-017-9998-2</pub-id><pub-id pub-id-type="pmid">29047012</pub-id><pub-id pub-id-type="pmcid">PMC5745216</pub-id></element-citation></ref><ref id="B203-nutrients-17-02884"><label>203.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kaufmann</surname><given-names>F.N.</given-names></name><name name-style="western"><surname>Gazal</surname><given-names>M.</given-names></name><name name-style="western"><surname>Bastos</surname><given-names>C.R.</given-names></name><name name-style="western"><surname>Kaster</surname><given-names>M.P.</given-names></name><name name-style="western"><surname>Ghisleni</surname><given-names>G.</given-names></name></person-group><article-title>Curcumin in depressive disorders: An overview of potential mechanisms, preclinical and clinical findings</article-title><source>Eur. J. Pharmacol.</source><year>2016</year><volume>784</volume><fpage>192</fpage><lpage>198</lpage><pub-id pub-id-type="doi">10.1016/j.ejphar.2016.05.026</pub-id><pub-id pub-id-type="pmid">27235294</pub-id></element-citation></ref><ref id="B204-nutrients-17-02884"><label>204.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Basu</surname><given-names>P.</given-names></name><name name-style="western"><surname>Maier</surname><given-names>C.</given-names></name><name name-style="western"><surname>Basu</surname><given-names>A.</given-names></name></person-group><article-title>Effects of Curcumin and Its Different Formulations in Preclinical and Clinical Studies of Peripheral Neuropathic and Postoperative Pain: A Comprehensive Review</article-title><source>Int. J. Mol. Sci.</source><year>2021</year><volume>22</volume><elocation-id>4666</elocation-id><pub-id pub-id-type="doi">10.3390/ijms22094666</pub-id><pub-id pub-id-type="pmid">33925121</pub-id><pub-id pub-id-type="pmcid">PMC8125634</pub-id></element-citation></ref><ref id="B205-nutrients-17-02884"><label>205.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Marques</surname><given-names>M.</given-names></name><name name-style="western"><surname>Marinho</surname><given-names>M.</given-names></name><name name-style="western"><surname>Vian</surname><given-names>C.</given-names></name><name name-style="western"><surname>Horn</surname><given-names>A.</given-names></name></person-group><article-title>The action of curcumin against damage resulting from cerebral stroke: A systematic review</article-title><source>Pharmacol. Res.</source><year>2022</year><volume>183</volume><fpage>106369</fpage><pub-id pub-id-type="doi">10.1016/j.phrs.2022.106369</pub-id><pub-id pub-id-type="pmid">35914679</pub-id></element-citation></ref><ref id="B206-nutrients-17-02884"><label>206.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lin</surname><given-names>L.</given-names></name><name name-style="western"><surname>Li</surname><given-names>C.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>D.</given-names></name><name name-style="western"><surname>Yuan</surname><given-names>M.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>C.-h.</given-names></name><name name-style="western"><surname>Li</surname><given-names>M.</given-names></name></person-group><article-title>Synergic effects of berberine and curcumin on improving cognitive function in an Alzheimer&#8217;s disease mouse model</article-title><source>Neurochem. Res.</source><year>2020</year><volume>45</volume><fpage>1130</fpage><lpage>1141</lpage><pub-id pub-id-type="doi">10.1007/s11064-020-02992-6</pub-id><pub-id pub-id-type="pmid">32080784</pub-id></element-citation></ref><ref id="B207-nutrients-17-02884"><label>207.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Su</surname><given-names>I.J.</given-names></name><name name-style="western"><surname>Chang</surname><given-names>H.Y.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>H.C.</given-names></name><name name-style="western"><surname>Tsai</surname><given-names>K.J.</given-names></name></person-group><article-title>A Curcumin Analog Exhibits Multiple Biologic Effects on the Pathogenesis of Alzheimer&#8217;s Disease and Improves Behavior, Inflammation, and &#946;-Amyloid Accumulation in a Mouse Model</article-title><source>Int. J. Mol. Sci.</source><year>2020</year><volume>21</volume><elocation-id>5459</elocation-id><pub-id pub-id-type="doi">10.3390/ijms21155459</pub-id><pub-id pub-id-type="pmid">32751716</pub-id><pub-id pub-id-type="pmcid">PMC7432838</pub-id></element-citation></ref><ref id="B208-nutrients-17-02884"><label>208.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>ELBini-Dhouib</surname><given-names>I.</given-names></name><name name-style="western"><surname>Doghri</surname><given-names>R.</given-names></name><name name-style="western"><surname>Ellefi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Degrach</surname><given-names>I.</given-names></name><name name-style="western"><surname>Srairi-Abid</surname><given-names>N.</given-names></name><name name-style="western"><surname>Gati</surname><given-names>A.</given-names></name></person-group><article-title>Curcumin Attenuated Neurotoxicity in Sporadic Animal Model of Alzheimer&#8217;s Disease</article-title><source>Molecules</source><year>2021</year><volume>26</volume><elocation-id>3001</elocation-id><pub-id pub-id-type="doi">10.3390/molecules26103011</pub-id><pub-id pub-id-type="pmid">34070220</pub-id><pub-id pub-id-type="pmcid">PMC8158738</pub-id></element-citation></ref><ref id="B209-nutrients-17-02884"><label>209.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Reddy</surname><given-names>P.H.</given-names></name><name name-style="western"><surname>Manczak</surname><given-names>M.</given-names></name><name name-style="western"><surname>Yin</surname><given-names>X.</given-names></name><name name-style="western"><surname>Grady</surname><given-names>M.C.</given-names></name><name name-style="western"><surname>Mitchell</surname><given-names>A.</given-names></name><name name-style="western"><surname>Kandimalla</surname><given-names>R.</given-names></name><name name-style="western"><surname>Kuruva</surname><given-names>C.S.</given-names></name></person-group><article-title>Protective effects of a natural product, curcumin, against amyloid &#946; induced mitochondrial and synaptic toxicities in Alzheimer&#8217;s disease</article-title><source>J. Investig. Med.</source><year>2016</year><volume>64</volume><fpage>1220</fpage><lpage>1234</lpage><pub-id pub-id-type="doi">10.1136/jim-2016-000240</pub-id><pub-id pub-id-type="pmid">27521081</pub-id><pub-id pub-id-type="pmcid">PMC5256118</pub-id></element-citation></ref><ref id="B210-nutrients-17-02884"><label>210.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Yin</surname><given-names>H.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>L.</given-names></name><name name-style="western"><surname>Shuboy</surname><given-names>A.</given-names></name><name name-style="western"><surname>Lou</surname><given-names>J.</given-names></name><name name-style="western"><surname>Han</surname><given-names>B.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Li</surname><given-names>J.</given-names></name></person-group><article-title>Curcumin as a potential treatment for Alzheimer&#8217;s disease: A study of the effects of curcumin on hippocampal expression of glial fibrillary acidic protein</article-title><source>Am. J. Chin. Med.</source><year>2013</year><volume>41</volume><fpage>59</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1142/S0192415X13500055</pub-id><pub-id pub-id-type="pmid">23336507</pub-id></element-citation></ref><ref id="B211-nutrients-17-02884"><label>211.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cheng</surname><given-names>K.K.</given-names></name><name name-style="western"><surname>Yeung</surname><given-names>C.F.</given-names></name><name name-style="western"><surname>Ho</surname><given-names>S.W.</given-names></name><name name-style="western"><surname>Chow</surname><given-names>S.F.</given-names></name><name name-style="western"><surname>Chow</surname><given-names>A.H.</given-names></name><name name-style="western"><surname>Baum</surname><given-names>L.</given-names></name></person-group><article-title>Highly stabilized curcumin nanoparticles tested in an in vitro blood-brain barrier model and in Alzheimer&#8217;s disease Tg2576 mice</article-title><source>Aaps J.</source><year>2013</year><volume>15</volume><fpage>324</fpage><lpage>336</lpage><pub-id pub-id-type="doi">10.1208/s12248-012-9444-4</pub-id><pub-id pub-id-type="pmid">23229335</pub-id><pub-id pub-id-type="pmcid">PMC3675736</pub-id></element-citation></ref><ref id="B212-nutrients-17-02884"><label>212.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ray</surname><given-names>B.</given-names></name><name name-style="western"><surname>Bisht</surname><given-names>S.</given-names></name><name name-style="western"><surname>Maitra</surname><given-names>A.</given-names></name><name name-style="western"><surname>Maitra</surname><given-names>A.</given-names></name><name name-style="western"><surname>Lahiri</surname><given-names>D.K.</given-names></name></person-group><article-title>Neuroprotective and neurorescue effects of a novel polymeric nanoparticle formulation of curcumin (NanoCurc&#8482;) in the neuronal cell culture and animal model: Implications for Alzheimer&#8217;s disease</article-title><source>J. Alzheimers Dis.</source><year>2011</year><volume>23</volume><fpage>61</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.3233/JAD-2010-101374</pub-id><pub-id pub-id-type="pmid">20930270</pub-id><pub-id pub-id-type="pmcid">PMC3303195</pub-id></element-citation></ref><ref id="B213-nutrients-17-02884"><label>213.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Begum</surname><given-names>A.N.</given-names></name><name name-style="western"><surname>Jones</surname><given-names>M.R.</given-names></name><name name-style="western"><surname>Lim</surname><given-names>G.P.</given-names></name><name name-style="western"><surname>Morihara</surname><given-names>T.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>P.</given-names></name><name name-style="western"><surname>Heath</surname><given-names>D.D.</given-names></name><name name-style="western"><surname>Rock</surname><given-names>C.L.</given-names></name><name name-style="western"><surname>Pruitt</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>F.</given-names></name><name name-style="western"><surname>Hudspeth</surname><given-names>B.</given-names></name><etal/></person-group><article-title>Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer&#8217;s disease</article-title><source>J. Pharmacol. Exp. Ther.</source><year>2008</year><volume>326</volume><fpage>196</fpage><lpage>208</lpage><pub-id pub-id-type="doi">10.1124/jpet.108.137455</pub-id><pub-id pub-id-type="pmid">18417733</pub-id><pub-id pub-id-type="pmcid">PMC2527621</pub-id></element-citation></ref><ref id="B214-nutrients-17-02884"><label>214.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xiong</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Hongmei</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Lu</surname><given-names>S.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>L.</given-names></name></person-group><article-title>Curcumin mediates presenilin-1 activity to reduce &#946;-amyloid production in a model of Alzheimer&#8217;s Disease</article-title><source>Pharmacol. Rep.</source><year>2011</year><volume>63</volume><fpage>1101</fpage><lpage>1108</lpage><pub-id pub-id-type="doi">10.1016/S1734-1140(11)70629-6</pub-id><pub-id pub-id-type="pmid">22180352</pub-id></element-citation></ref><ref id="B215-nutrients-17-02884"><label>215.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ishrat</surname><given-names>T.</given-names></name><name name-style="western"><surname>Hoda</surname><given-names>M.N.</given-names></name><name name-style="western"><surname>Khan</surname><given-names>M.B.</given-names></name><name name-style="western"><surname>Yousuf</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ahmad</surname><given-names>M.</given-names></name><name name-style="western"><surname>Khan</surname><given-names>M.M.</given-names></name><name name-style="western"><surname>Ahmad</surname><given-names>A.</given-names></name><name name-style="western"><surname>Islam</surname><given-names>F.</given-names></name></person-group><article-title>Amelioration of cognitive deficits and neurodegeneration by curcumin in rat model of sporadic dementia of Alzheimer&#8217;s type (SDAT)</article-title><source>Eur. Neuropsychopharmacol.</source><year>2009</year><volume>19</volume><fpage>636</fpage><lpage>647</lpage><pub-id pub-id-type="doi">10.1016/j.euroneuro.2009.02.002</pub-id><pub-id pub-id-type="pmid">19329286</pub-id></element-citation></ref><ref id="B216-nutrients-17-02884"><label>216.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nam</surname><given-names>S.M.</given-names></name><name name-style="western"><surname>Choi</surname><given-names>J.H.</given-names></name><name name-style="western"><surname>Yoo</surname><given-names>D.Y.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>W.</given-names></name><name name-style="western"><surname>Jung</surname><given-names>H.Y.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>J.W.</given-names></name><name name-style="western"><surname>Yoo</surname><given-names>M.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>S.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>C.J.</given-names></name><name name-style="western"><surname>Yoon</surname><given-names>Y.S.</given-names></name><etal/></person-group><article-title>Effects of curcumin (<italic toggle="yes">Curcuma longa</italic>) on learning and spatial memory as well as cell proliferation and neuroblast differentiation in adult and aged mice by upregulating brain-derived neurotrophic factor and CREB signaling</article-title><source>J. Med. Food</source><year>2014</year><volume>17</volume><fpage>641</fpage><lpage>649</lpage><pub-id pub-id-type="doi">10.1089/jmf.2013.2965</pub-id><pub-id pub-id-type="pmid">24712702</pub-id><pub-id pub-id-type="pmcid">PMC4060834</pub-id></element-citation></ref><ref id="B217-nutrients-17-02884"><label>217.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bassani</surname><given-names>T.B.</given-names></name><name name-style="western"><surname>Turnes</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Moura</surname><given-names>E.L.R.</given-names></name><name name-style="western"><surname>Bonato</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>C&#243;ppola-Segovia</surname><given-names>V.</given-names></name><name name-style="western"><surname>Zanata</surname><given-names>S.M.</given-names></name><name name-style="western"><surname>Oliveira</surname><given-names>R.</given-names></name><name name-style="western"><surname>Vital</surname><given-names>M.</given-names></name></person-group><article-title>Effects of curcumin on short-term spatial and recognition memory, adult neurogenesis and neuroinflammation in a streptozotocin-induced rat model of dementia of Alzheimer&#8217;s type</article-title><source>Behav. Brain Res.</source><year>2017</year><volume>335</volume><fpage>41</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1016/j.bbr.2017.08.014</pub-id><pub-id pub-id-type="pmid">28801114</pub-id></element-citation></ref><ref id="B218-nutrients-17-02884"><label>218.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McClure</surname><given-names>R.</given-names></name><name name-style="western"><surname>Ong</surname><given-names>H.</given-names></name><name name-style="western"><surname>Janve</surname><given-names>V.</given-names></name><name name-style="western"><surname>Barton</surname><given-names>S.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>M.</given-names></name><name name-style="western"><surname>Li</surname><given-names>B.</given-names></name><name name-style="western"><surname>Dawes</surname><given-names>M.</given-names></name><name name-style="western"><surname>Jerome</surname><given-names>W.G.</given-names></name><name name-style="western"><surname>Anderson</surname><given-names>A.</given-names></name><name name-style="western"><surname>Massion</surname><given-names>P.</given-names></name></person-group><article-title>Aerosol delivery of curcumin reduced amyloid-&#946; deposition and improved cognitive performance in a transgenic model of Alzheimer&#8217;s disease</article-title><source>J. Alzheimer&#8217;s Dis.</source><year>2016</year><volume>55</volume><fpage>797</fpage><lpage>811</lpage><pub-id pub-id-type="doi">10.3233/JAD-160289</pub-id><pub-id pub-id-type="pmid">27802223</pub-id><pub-id pub-id-type="pmcid">PMC5848215</pub-id></element-citation></ref><ref id="B219-nutrients-17-02884"><label>219.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alamro</surname><given-names>A.A.</given-names></name><name name-style="western"><surname>Alsulami</surname><given-names>E.A.</given-names></name><name name-style="western"><surname>Almutlaq</surname><given-names>M.</given-names></name><name name-style="western"><surname>Alghamedi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Alokail</surname><given-names>M.</given-names></name><name name-style="western"><surname>Haq</surname><given-names>S.H.</given-names></name></person-group><article-title>Therapeutic Potential of Vitamin D and Curcumin in an In Vitro Model of Alzheimer Disease</article-title><source>J. Cent. Nerv. Syst. Dis.</source><year>2020</year><volume>12</volume><fpage>1179573520924311</fpage><pub-id pub-id-type="doi">10.1177/1179573520924311</pub-id><pub-id pub-id-type="pmid">32528227</pub-id><pub-id pub-id-type="pmcid">PMC7262829</pub-id></element-citation></ref><ref id="B220-nutrients-17-02884"><label>220.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lim</surname><given-names>G.P.</given-names></name><name name-style="western"><surname>Chu</surname><given-names>T.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>F.</given-names></name><name name-style="western"><surname>Beech</surname><given-names>W.</given-names></name><name name-style="western"><surname>Frautschy</surname><given-names>S.A.</given-names></name><name name-style="western"><surname>Cole</surname><given-names>G.M.</given-names></name></person-group><article-title>The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse</article-title><source>J. Neurosci.</source><year>2001</year><volume>21</volume><fpage>8370</fpage><lpage>8377</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.21-21-08370.2001</pub-id><pub-id pub-id-type="pmid">11606625</pub-id><pub-id pub-id-type="pmcid">PMC6762797</pub-id></element-citation></ref><ref id="B221-nutrients-17-02884"><label>221.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Savall</surname><given-names>A.S.P.</given-names></name><name name-style="western"><surname>de Mello</surname><given-names>J.D.</given-names></name><name name-style="western"><surname>Fidelis</surname><given-names>E.M.</given-names></name><name name-style="western"><surname>Comis-Neto</surname><given-names>A.A.</given-names></name><name name-style="western"><surname>Nepomuceno</surname><given-names>M.R.</given-names></name><name name-style="western"><surname>Pacheco</surname><given-names>C.d.O.</given-names></name><name name-style="western"><surname>Haas</surname><given-names>S.E.</given-names></name><name name-style="western"><surname>Pinton</surname><given-names>S.</given-names></name></person-group><article-title>Nanoencapsulated curcumin: Enhanced efficacy in reversing memory loss in an Alzheimer disease model</article-title><source>Brain Sci.</source><year>2024</year><volume>14</volume><elocation-id>130</elocation-id><pub-id pub-id-type="doi">10.3390/brainsci14020130</pub-id><pub-id pub-id-type="pmid">38391705</pub-id><pub-id pub-id-type="pmcid">PMC10886961</pub-id></element-citation></ref><ref id="B222-nutrients-17-02884"><label>222.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abbaoui</surname><given-names>A.</given-names></name><name name-style="western"><surname>Chatoui</surname><given-names>H.</given-names></name><name name-style="western"><surname>El Hiba</surname><given-names>O.</given-names></name><name name-style="western"><surname>Gamrani</surname><given-names>H.</given-names></name></person-group><article-title>Neuroprotective effect of curcumin-I in copper-induced dopaminergic neurotoxicity in rats: A possible link with Parkinson&#8217;s disease</article-title><source>Neurosci. Lett.</source><year>2017</year><volume>660</volume><fpage>103</fpage><lpage>108</lpage><pub-id pub-id-type="doi">10.1016/j.neulet.2017.09.032</pub-id><pub-id pub-id-type="pmid">28919537</pub-id></element-citation></ref><ref id="B223-nutrients-17-02884"><label>223.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rajeswari</surname><given-names>A.</given-names></name><name name-style="western"><surname>Sabesan</surname><given-names>M.</given-names></name></person-group><article-title>Inhibition of monoamine oxidase-B by the polyphenolic compound, curcumin and its metabolite tetrahydrocurcumin, in a model of Parkinson&#8217;s disease induced by MPTP neurodegeneration in mice</article-title><source>Inflammopharmacology</source><year>2008</year><volume>16</volume><fpage>96</fpage><lpage>99</lpage><pub-id pub-id-type="doi">10.1007/s10787-007-1614-0</pub-id><pub-id pub-id-type="pmid">18408903</pub-id></element-citation></ref><ref id="B224-nutrients-17-02884"><label>224.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pan</surname><given-names>J.</given-names></name><name name-style="western"><surname>Li</surname><given-names>H.</given-names></name><name name-style="western"><surname>Ma</surname><given-names>J.F.</given-names></name><name name-style="western"><surname>Tan</surname><given-names>Y.Y.</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Ding</surname><given-names>J.Q.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>S.D.</given-names></name></person-group><article-title>Curcumin inhibition of JNKs prevents dopaminergic neuronal loss in a mouse model of Parkinson&#8217;s disease through suppressing mitochondria dysfunction</article-title><source>Transl. Neurodegener.</source><year>2012</year><volume>1</volume><fpage>16</fpage><pub-id pub-id-type="doi">10.1186/2047-9158-1-16</pub-id><pub-id pub-id-type="pmid">23210631</pub-id><pub-id pub-id-type="pmcid">PMC3514118</pub-id></element-citation></ref><ref id="B225-nutrients-17-02884"><label>225.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jiang</surname><given-names>T.F.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y.J.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>H.Y.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>H.M.</given-names></name><name name-style="western"><surname>Tian</surname><given-names>L.P.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Ding</surname><given-names>J.Q.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>S.D.</given-names></name></person-group><article-title>Curcumin ameliorates the neurodegenerative pathology in A53T &#945;-synuclein cell model of Parkinson&#8217;s disease through the downregulation of mTOR/p70S6K signaling and the recovery of macroautophagy</article-title><source>J. Neuroimmune Pharmacol.</source><year>2013</year><volume>8</volume><fpage>356</fpage><lpage>369</lpage><pub-id pub-id-type="doi">10.1007/s11481-012-9431-7</pub-id><pub-id pub-id-type="pmid">23325107</pub-id></element-citation></ref><ref id="B226-nutrients-17-02884"><label>226.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>M.S.</given-names></name><name name-style="western"><surname>Boddapati</surname><given-names>S.</given-names></name><name name-style="western"><surname>Emadi</surname><given-names>S.</given-names></name><name name-style="western"><surname>Sierks</surname><given-names>M.R.</given-names></name></person-group><article-title>Curcumin reduces alpha-synuclein induced cytotoxicity in Parkinson&#8217;s disease cell model</article-title><source>BMC Neurosci.</source><year>2010</year><volume>11</volume><elocation-id>57</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2202-11-57</pub-id><pub-id pub-id-type="pmid">20433710</pub-id><pub-id pub-id-type="pmcid">PMC2879277</pub-id></element-citation></ref><ref id="B227-nutrients-17-02884"><label>227.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ramires J&#250;nior</surname><given-names>O.V.</given-names></name><name name-style="western"><surname>Alves</surname><given-names>B.D.S.</given-names></name><name name-style="western"><surname>Barros</surname><given-names>P.A.B.</given-names></name><name name-style="western"><surname>Rodrigues</surname><given-names>J.L.</given-names></name><name name-style="western"><surname>Ferreira</surname><given-names>S.P.</given-names></name><name name-style="western"><surname>Monteiro</surname><given-names>L.K.S.</given-names></name><name name-style="western"><surname>Ara&#250;jo</surname><given-names>G.M.S.</given-names></name><name name-style="western"><surname>Fernandes</surname><given-names>S.S.</given-names></name><name name-style="western"><surname>Vaz</surname><given-names>G.R.</given-names></name><name name-style="western"><surname>Dora</surname><given-names>C.L.</given-names></name><etal/></person-group><article-title>Nanoemulsion Improves the Neuroprotective Effects of Curcumin in an Experimental Model of Parkinson&#8217;s Disease</article-title><source>Neurotox. Res.</source><year>2021</year><volume>39</volume><fpage>787</fpage><lpage>799</lpage><pub-id pub-id-type="doi">10.1007/s12640-021-00362-w</pub-id><pub-id pub-id-type="pmid">33860897</pub-id></element-citation></ref><ref id="B228-nutrients-17-02884"><label>228.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Song</surname><given-names>S.</given-names></name><name name-style="western"><surname>Li</surname><given-names>J.</given-names></name><name name-style="western"><surname>Liang</surname><given-names>T.</given-names></name></person-group><article-title>Neuroprotective effect of curcumin on hippocampal injury in 6-OHDA-induced Parkinson&#8217;s disease rat</article-title><source>Pathol. Res. Pract.</source><year>2014</year><volume>210</volume><fpage>357</fpage><lpage>362</lpage><pub-id pub-id-type="doi">10.1016/j.prp.2014.02.005</pub-id><pub-id pub-id-type="pmid">24642369</pub-id></element-citation></ref><ref id="B229-nutrients-17-02884"><label>229.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fikry</surname><given-names>H.</given-names></name><name name-style="western"><surname>Saleh</surname><given-names>L.A.</given-names></name><name name-style="western"><surname>Abdel Gawad</surname><given-names>S.</given-names></name></person-group><article-title>Neuroprotective effects of curcumin on the cerebellum in a rotenone-induced Parkinson&#8217;s Disease Model</article-title><source>CNS Neurosci. Ther.</source><year>2022</year><volume>28</volume><fpage>732</fpage><lpage>748</lpage><pub-id pub-id-type="doi">10.1111/cns.13805</pub-id><pub-id pub-id-type="pmid">35068069</pub-id><pub-id pub-id-type="pmcid">PMC8981438</pub-id></element-citation></ref><ref id="B230-nutrients-17-02884"><label>230.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jagatha</surname><given-names>B.</given-names></name><name name-style="western"><surname>Mythri</surname><given-names>R.B.</given-names></name><name name-style="western"><surname>Vali</surname><given-names>S.</given-names></name><name name-style="western"><surname>Bharath</surname><given-names>M.M.</given-names></name></person-group><article-title>Curcumin treatment alleviates the effects of glutathione depletion in vitro and in vivo: Therapeutic implications for Parkinson&#8217;s disease explained via in silico studies</article-title><source>Free Radic. Biol. Med.</source><year>2008</year><volume>44</volume><fpage>907</fpage><lpage>917</lpage><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2007.11.011</pub-id><pub-id pub-id-type="pmid">18166164</pub-id></element-citation></ref><ref id="B231-nutrients-17-02884"><label>231.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sharma</surname><given-names>N.</given-names></name><name name-style="western"><surname>Nehru</surname><given-names>B.</given-names></name></person-group><article-title>Curcumin affords neuroprotection and inhibits &#945;-synuclein aggregation in lipopolysaccharide-induced Parkinson&#8217;s disease model</article-title><source>Inflammopharmacology</source><year>2018</year><volume>26</volume><fpage>349</fpage><lpage>360</lpage><pub-id pub-id-type="doi">10.1007/s10787-017-0402-8</pub-id><pub-id pub-id-type="pmid">29027056</pub-id></element-citation></ref><ref id="B232-nutrients-17-02884"><label>232.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>X.-S.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Z.-R.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>M.-M.</given-names></name><name name-style="western"><surname>Sun</surname><given-names>M.-X.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>W.-W.</given-names></name><name name-style="western"><surname>Xie</surname><given-names>C.-L.</given-names></name></person-group><article-title>Neuroprotective properties of curcumin in toxin-base animal models of Parkinson&#8217;s disease: A systematic experiment literatures review</article-title><source>BMC Complement. Altern. Med.</source><year>2017</year><volume>17</volume><elocation-id>412</elocation-id><pub-id pub-id-type="doi">10.1186/s12906-017-1922-x</pub-id><pub-id pub-id-type="pmid">28818104</pub-id><pub-id pub-id-type="pmcid">PMC5561616</pub-id></element-citation></ref><ref id="B233-nutrients-17-02884"><label>233.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>X.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>H.</given-names></name><name name-style="western"><surname>Li</surname><given-names>C.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Gao</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Han</surname><given-names>M.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>F.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>D.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Hu</surname><given-names>M.</given-names></name></person-group><article-title>The dosage of curcumin to alleviate movement symptoms in a 6-hydroxydopamine-induced Parkinson&#8217;s disease rat model</article-title><source>Heliyon</source><year>2023</year><volume>9</volume><fpage>e16921</fpage><pub-id pub-id-type="doi">10.1016/j.heliyon.2023.e16921</pub-id><pub-id pub-id-type="pmid">37484231</pub-id><pub-id pub-id-type="pmcid">PMC10360947</pub-id></element-citation></ref><ref id="B234-nutrients-17-02884"><label>234.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Geng</surname><given-names>X.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>H.</given-names></name><name name-style="western"><surname>Hu</surname><given-names>M.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>X.</given-names></name><name name-style="western"><surname>Han</surname><given-names>M.</given-names></name><name name-style="western"><surname>Xie</surname><given-names>J.</given-names></name><name name-style="western"><surname>Li</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>F.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>W.</given-names></name><name name-style="western"><surname>Wei</surname><given-names>S.</given-names></name></person-group><article-title>A novel curcumin oil solution can better alleviate the motor activity defects and neuropathological damage of a Parkinson&#8217;s disease mouse model</article-title><source>Front. Aging Neurosci.</source><year>2022</year><volume>14</volume><elocation-id>984895</elocation-id><pub-id pub-id-type="doi">10.3389/fnagi.2022.984895</pub-id><pub-id pub-id-type="pmid">35966793</pub-id><pub-id pub-id-type="pmcid">PMC9372469</pub-id></element-citation></ref><ref id="B235-nutrients-17-02884"><label>235.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Xia</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ran</surname><given-names>H.</given-names></name><name name-style="western"><surname>Gao</surname><given-names>L.</given-names></name><name name-style="western"><surname>Feng</surname><given-names>C.</given-names></name><name name-style="western"><surname>Gui</surname><given-names>L.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Yuan</surname><given-names>J.</given-names></name></person-group><article-title>Human umbilical cord-derived mesenchymal stem cell transplantation supplemented with curcumin improves the outcomes of ischemic stroke via AKT/GSK-3&#946;/&#946;-TrCP/Nrf2 axis</article-title><source>J. Neuroinflamm.</source><year>2023</year><volume>20</volume><fpage>49</fpage><pub-id pub-id-type="doi">10.1186/s12974-023-02738-5</pub-id><pub-id pub-id-type="pmid">36829224</pub-id><pub-id pub-id-type="pmcid">PMC9951499</pub-id></element-citation></ref><ref id="B236-nutrients-17-02884"><label>236.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jia</surname><given-names>G.</given-names></name><name name-style="western"><surname>Tan</surname><given-names>B.</given-names></name><name name-style="western"><surname>Ma</surname><given-names>J.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>L.</given-names></name><name name-style="western"><surname>Jin</surname><given-names>X.</given-names></name><name name-style="western"><surname>Li</surname><given-names>C.</given-names></name></person-group><article-title>Prdx6 Upregulation by Curcumin Attenuates Ischemic Oxidative Damage via SP1 in Rats after Stroke</article-title><source>Biomed. Res. Int.</source><year>2017</year><volume>2017</volume><elocation-id>6597401</elocation-id><pub-id pub-id-type="doi">10.1155/2017/6597401</pub-id><pub-id pub-id-type="pmid">28596967</pub-id><pub-id pub-id-type="pmcid">PMC5449737</pub-id></element-citation></ref><ref id="B237-nutrients-17-02884"><label>237.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Altinay</surname><given-names>S.</given-names></name><name name-style="western"><surname>Cabalar</surname><given-names>M.</given-names></name><name name-style="western"><surname>Isler</surname><given-names>C.</given-names></name><name name-style="western"><surname>Yildirim</surname><given-names>F.</given-names></name><name name-style="western"><surname>Celik</surname><given-names>D.S.</given-names></name><name name-style="western"><surname>Zengi</surname><given-names>O.</given-names></name><name name-style="western"><surname>Tas</surname><given-names>A.</given-names></name><name name-style="western"><surname>Gulcubuk</surname><given-names>A.</given-names></name></person-group><article-title>Is Chronic Curcumin Supplementation Neuroprotective Against Ischemia for Antioxidant Activity, Neurological Deficit, or Neuronal Apoptosis in an Experimental Stroke Model?</article-title><source>Turk. Neurosurg.</source><year>2017</year><volume>27</volume><fpage>537</fpage><lpage>545</lpage><pub-id pub-id-type="pmid">27593816</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.5137/1019-5149.JTN.17405-16.0</pub-id></element-citation></ref><ref id="B238-nutrients-17-02884"><label>238.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Marques</surname><given-names>M.S.</given-names></name><name name-style="western"><surname>Cordeiro</surname><given-names>M.F.</given-names></name><name name-style="western"><surname>Marinho</surname><given-names>M.A.G.</given-names></name><name name-style="western"><surname>Vian</surname><given-names>C.O.</given-names></name><name name-style="western"><surname>Vaz</surname><given-names>G.R.</given-names></name><name name-style="western"><surname>Alves</surname><given-names>B.S.</given-names></name><name name-style="western"><surname>Jardim</surname><given-names>R.D.</given-names></name><name name-style="western"><surname>Hort</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Dora</surname><given-names>C.L.</given-names></name><name name-style="western"><surname>Horn</surname><given-names>A.P.</given-names></name></person-group><article-title>Curcumin-loaded nanoemulsion improves haemorrhagic stroke recovery in wistar rats</article-title><source>Brain Res.</source><year>2020</year><volume>1746</volume><fpage>147007</fpage><pub-id pub-id-type="doi">10.1016/j.brainres.2020.147007</pub-id><pub-id pub-id-type="pmid">32645380</pub-id></element-citation></ref><ref id="B239-nutrients-17-02884"><label>239.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ran</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Su</surname><given-names>W.</given-names></name><name name-style="western"><surname>Gao</surname><given-names>F.</given-names></name><name name-style="western"><surname>Ding</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ye</surname><given-names>L.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>X.</given-names></name><name name-style="western"><surname>Tian</surname><given-names>G.</given-names></name><name name-style="western"><surname>Xi</surname><given-names>J.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Z.</given-names></name></person-group><article-title>Curcumin Ameliorates White Matter Injury after Ischemic Stroke by Inhibiting Microglia/Macrophage Pyroptosis through NF-&#954;B Suppression and NLRP3 Inflammasome Inhibition</article-title><source>Oxid. Med. Cell Longev.</source><year>2021</year><volume>2021</volume><fpage>1552127</fpage><pub-id pub-id-type="doi">10.1155/2021/1552127</pub-id><pub-id pub-id-type="pmid">34630845</pub-id><pub-id pub-id-type="pmcid">PMC8497115</pub-id></element-citation></ref><ref id="B240-nutrients-17-02884"><label>240.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xie</surname><given-names>C.J.</given-names></name><name name-style="western"><surname>Gu</surname><given-names>A.P.</given-names></name><name name-style="western"><surname>Cai</surname><given-names>J.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>R.C.</given-names></name></person-group><article-title>Curcumin protects neural cells against ischemic injury in N2a cells and mouse brain with ischemic stroke</article-title><source>Brain Behav.</source><year>2018</year><volume>8</volume><fpage>e00921</fpage><pub-id pub-id-type="doi">10.1002/brb3.921</pub-id><pub-id pub-id-type="pmid">29484272</pub-id><pub-id pub-id-type="pmcid">PMC5822585</pub-id></element-citation></ref><ref id="B241-nutrients-17-02884"><label>241.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>W.</given-names></name><name name-style="western"><surname>Suwanwela</surname><given-names>N.C.</given-names></name><name name-style="western"><surname>Patumraj</surname><given-names>S.</given-names></name></person-group><article-title>Curcumin prevents reperfusion injury following ischemic stroke in rats via inhibition of NF-&#954;B, ICAM-1, MMP-9 and caspase-3 expression</article-title><source>Mol. Med. Rep.</source><year>2017</year><volume>16</volume><fpage>4710</fpage><lpage>4720</lpage><pub-id pub-id-type="doi">10.3892/mmr.2017.7205</pub-id><pub-id pub-id-type="pmid">28849007</pub-id><pub-id pub-id-type="pmcid">PMC5647023</pub-id></element-citation></ref><ref id="B242-nutrients-17-02884"><label>242.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>S.</given-names></name><name name-style="western"><surname>Cao</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Qu</surname><given-names>M.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Feng</surname><given-names>L.</given-names></name><name name-style="western"><surname>Ye</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>M.</given-names></name><name name-style="western"><surname>Hou</surname><given-names>S.T.</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>R.</given-names></name><name name-style="western"><surname>Han</surname><given-names>Z.</given-names></name></person-group><article-title>Curcumin protects against stroke and increases levels of Notch intracellular domain</article-title><source>Neurol. Res.</source><year>2016</year><volume>38</volume><fpage>553</fpage><lpage>559</lpage><pub-id pub-id-type="doi">10.1080/01616412.2016.1187804</pub-id><pub-id pub-id-type="pmid">27320251</pub-id></element-citation></ref><ref id="B243-nutrients-17-02884"><label>243.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>S.</given-names></name><name name-style="western"><surname>Guo</surname><given-names>T.</given-names></name><name name-style="western"><surname>Qi</surname><given-names>W.</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Gu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>C.</given-names></name><name name-style="western"><surname>Sha</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>B.</given-names></name><name name-style="western"><surname>Hu</surname><given-names>S.</given-names></name><name name-style="western"><surname>Zong</surname><given-names>X.</given-names></name></person-group><article-title>Curcumin ameliorates ischemic stroke injury in rats by protecting the integrity of the blood-brain barrier</article-title><source>Exp. Ther. Med.</source><year>2021</year><volume>22</volume><fpage>783</fpage><pub-id pub-id-type="doi">10.3892/etm.2021.10215</pub-id><pub-id pub-id-type="pmid">34055082</pub-id><pub-id pub-id-type="pmcid">PMC8145684</pub-id></element-citation></ref><ref id="B244-nutrients-17-02884"><label>244.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Ran</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>S.</given-names></name><name name-style="western"><surname>Wen</surname><given-names>S.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>W.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>X.</given-names></name><name name-style="western"><surname>Ji</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Geng</surname><given-names>X.</given-names></name><name name-style="western"><surname>Ji</surname><given-names>X.</given-names></name><name name-style="western"><surname>Du</surname><given-names>H.</given-names></name><etal/></person-group><article-title>Curcumin Protects against Ischemic Stroke by Titrating Microglia/Macrophage Polarization</article-title><source>Front. Aging Neurosci.</source><year>2017</year><volume>9</volume><elocation-id>233</elocation-id><pub-id pub-id-type="doi">10.3389/fnagi.2017.00233</pub-id><pub-id pub-id-type="pmid">28785217</pub-id><pub-id pub-id-type="pmcid">PMC5519528</pub-id></element-citation></ref><ref id="B245-nutrients-17-02884"><label>245.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Li</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>S.</given-names></name><name name-style="western"><surname>Li</surname><given-names>L.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>X.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>J.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>Y.</given-names></name></person-group><article-title>Neuroprotection by curcumin in ischemic brain injury involves the Akt/Nrf2 pathway</article-title><source>PLoS ONE</source><year>2013</year><volume>8</volume><elocation-id>e59843</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0059843</pub-id><pub-id pub-id-type="pmid">23555802</pub-id><pub-id pub-id-type="pmcid">PMC3610879</pub-id></element-citation></ref><ref id="B246-nutrients-17-02884"><label>246.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jiang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>W.</given-names></name><name name-style="western"><surname>Sun</surname><given-names>Y.J.</given-names></name><name name-style="western"><surname>Hu</surname><given-names>M.</given-names></name><name name-style="western"><surname>Li</surname><given-names>F.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>D.Y.</given-names></name></person-group><article-title>Neuroprotective effect of curcumin on focal cerebral ischemic rats by preventing blood-brain barrier damage</article-title><source>Eur. J. Pharmacol.</source><year>2007</year><volume>561</volume><fpage>54</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1016/j.ejphar.2006.12.028</pub-id><pub-id pub-id-type="pmid">17303117</pub-id></element-citation></ref><ref id="B247-nutrients-17-02884"><label>247.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Yan</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Cao</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Jing</surname><given-names>R.</given-names></name><name name-style="western"><surname>Hu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Bao</surname><given-names>J.</given-names></name></person-group><article-title>Potential therapeutic and protective effect of curcumin against stroke in the male albino stroke-induced model rats</article-title><source>Life Sci.</source><year>2017</year><volume>183</volume><fpage>45</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1016/j.lfs.2017.06.023</pub-id><pub-id pub-id-type="pmid">28663065</pub-id></element-citation></ref><ref id="B248-nutrients-17-02884"><label>248.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>He</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>M.</given-names></name></person-group><article-title>The beneficial effects of curcumin on aging and age-related diseases: From oxidative stress to antioxidant mechanisms, brain health and apoptosis</article-title><source>Front. Aging Neurosci.</source><year>2025</year><volume>17</volume><elocation-id>1533963</elocation-id><pub-id pub-id-type="doi">10.3389/fnagi.2025.1533963</pub-id><pub-id pub-id-type="pmid">39906716</pub-id><pub-id pub-id-type="pmcid">PMC11788355</pub-id></element-citation></ref><ref id="B249-nutrients-17-02884"><label>249.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dutta</surname><given-names>A.</given-names></name><name name-style="western"><surname>Patil</surname><given-names>R.</given-names></name><name name-style="western"><surname>Pati</surname><given-names>H.l.L.</given-names></name></person-group><article-title>Curcumin: Its bioavailability and nanoparticle formulation: A review</article-title><source>Int. J. Health Sci. Res.</source><year>2021</year><volume>11</volume><fpage>228</fpage><lpage>238</lpage><pub-id pub-id-type="doi">10.52403/ijhsr.20211030</pub-id></element-citation></ref><ref id="B250-nutrients-17-02884"><label>250.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sharifi-Rad</surname><given-names>J.</given-names></name><name name-style="western"><surname>Rayess</surname><given-names>Y.E.</given-names></name><name name-style="western"><surname>Rizk</surname><given-names>A.A.</given-names></name><name name-style="western"><surname>Sadaka</surname><given-names>C.</given-names></name><name name-style="western"><surname>Zgheib</surname><given-names>R.</given-names></name><name name-style="western"><surname>Zam</surname><given-names>W.</given-names></name><name name-style="western"><surname>Sestito</surname><given-names>S.</given-names></name><name name-style="western"><surname>Rapposelli</surname><given-names>S.</given-names></name><name name-style="western"><surname>Neffe-Skoci&#324;ska</surname><given-names>K.</given-names></name><name name-style="western"><surname>Zieli&#324;ska</surname><given-names>D.</given-names></name></person-group><article-title>Turmeric and its major compound curcumin on health: Bioactive effects and safety profiles for food, pharmaceutical, biotechnological and medicinal applications</article-title><source>Front. Pharmacol.</source><year>2020</year><volume>11</volume><elocation-id>1021</elocation-id><pub-id pub-id-type="doi">10.3389/fphar.2020.01021</pub-id><pub-id pub-id-type="pmid">33041781</pub-id><pub-id pub-id-type="pmcid">PMC7522354</pub-id></element-citation></ref><ref id="B251-nutrients-17-02884"><label>251.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gagliardi</surname><given-names>S.</given-names></name><name name-style="western"><surname>Morasso</surname><given-names>C.</given-names></name><name name-style="western"><surname>Stivaktakis</surname><given-names>P.</given-names></name><name name-style="western"><surname>Pandini</surname><given-names>C.</given-names></name><name name-style="western"><surname>Tinelli</surname><given-names>V.</given-names></name><name name-style="western"><surname>Tsatsakis</surname><given-names>A.</given-names></name><name name-style="western"><surname>Prosperi</surname><given-names>D.</given-names></name><name name-style="western"><surname>Hickey</surname><given-names>M.</given-names></name><name name-style="western"><surname>Corsi</surname><given-names>F.</given-names></name><name name-style="western"><surname>Cereda</surname><given-names>C.</given-names></name></person-group><article-title>Curcumin formulations and trials: What&#8217;s new in neurological diseases</article-title><source>Molecules</source><year>2020</year><volume>25</volume><elocation-id>5389</elocation-id><pub-id pub-id-type="doi">10.3390/molecules25225389</pub-id><pub-id pub-id-type="pmid">33217959</pub-id><pub-id pub-id-type="pmcid">PMC7698610</pub-id></element-citation></ref><ref id="B252-nutrients-17-02884"><label>252.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>W.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>R.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>B.</given-names></name><name name-style="western"><surname>Li</surname><given-names>K.</given-names></name></person-group><article-title>The effect of curcumin supplementation on cognitive function: An updated systematic review and meta-analysis</article-title><source>Front. Nutr.</source><year>2025</year><volume>12</volume><elocation-id>1549509</elocation-id><pub-id pub-id-type="doi">10.3389/fnut.2025.1549509</pub-id><pub-id pub-id-type="pmid">40308636</pub-id><pub-id pub-id-type="pmcid">PMC12040662</pub-id></element-citation></ref><ref id="B253-nutrients-17-02884"><label>253.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Francis</surname><given-names>A.J.</given-names></name><name name-style="western"><surname>Sreenivasan</surname><given-names>C.</given-names></name><name name-style="western"><surname>Parikh</surname><given-names>A.</given-names></name><name name-style="western"><surname>AlQassab</surname><given-names>O.</given-names></name><name name-style="western"><surname>Kanthajan</surname><given-names>T.</given-names></name><name name-style="western"><surname>Pandey</surname><given-names>M.</given-names></name><name name-style="western"><surname>Nwosu</surname><given-names>M.</given-names></name></person-group><article-title>Curcumin and Cognitive Function: A Systematic Review of the Effects of Curcumin on Adults With and Without Neurocognitive Disorders</article-title><source>Cureus</source><year>2024</year><volume>16</volume><fpage>e67706</fpage><pub-id pub-id-type="doi">10.7759/cureus.67706</pub-id><pub-id pub-id-type="pmid">39318960</pub-id><pub-id pub-id-type="pmcid">PMC11421876</pub-id></element-citation></ref><ref id="B254-nutrients-17-02884"><label>254.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Li</surname><given-names>L.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J.</given-names></name></person-group><article-title>Curcumin in antidepressant treatments: An overview of potential mechanisms, pre-clinical/clinical trials and ongoing challenges</article-title><source>Basic. Clin. Pharmacol. Toxicol.</source><year>2020</year><volume>127</volume><fpage>243</fpage><lpage>253</lpage><pub-id pub-id-type="doi">10.1111/bcpt.13455</pub-id><pub-id pub-id-type="pmid">32544307</pub-id></element-citation></ref><ref id="B255-nutrients-17-02884"><label>255.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Small</surname><given-names>G.W.</given-names></name><name name-style="western"><surname>Siddarth</surname><given-names>P.</given-names></name><name name-style="western"><surname>Li</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Miller</surname><given-names>K.J.</given-names></name><name name-style="western"><surname>Ercoli</surname><given-names>L.</given-names></name><name name-style="western"><surname>Emerson</surname><given-names>N.D.</given-names></name><name name-style="western"><surname>Martinez</surname><given-names>J.</given-names></name><name name-style="western"><surname>Wong</surname><given-names>K.P.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Merrill</surname><given-names>D.A.</given-names></name><etal/></person-group><article-title>Memory and Brain Amyloid and Tau Effects of a Bioavailable Form of Curcumin in Non-Demented Adults: A Double-Blind, Placebo-Controlled 18-Month Trial</article-title><source>Am. J. Geriatr. Psychiatry</source><year>2018</year><volume>26</volume><fpage>266</fpage><lpage>277</lpage><pub-id pub-id-type="doi">10.1016/j.jagp.2017.10.010</pub-id><pub-id pub-id-type="pmid">29246725</pub-id></element-citation></ref><ref id="B256-nutrients-17-02884"><label>256.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cox</surname><given-names>K.H.</given-names></name><name name-style="western"><surname>Pipingas</surname><given-names>A.</given-names></name><name name-style="western"><surname>Scholey</surname><given-names>A.B.</given-names></name></person-group><article-title>Investigation of the effects of solid lipid curcumin on cognition and mood in a healthy older population</article-title><source>J. Psychopharmacol.</source><year>2015</year><volume>29</volume><fpage>642</fpage><lpage>651</lpage><pub-id pub-id-type="doi">10.1177/0269881114552744</pub-id><pub-id pub-id-type="pmid">25277322</pub-id></element-citation></ref><ref id="B257-nutrients-17-02884"><label>257.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baum</surname><given-names>L.</given-names></name><name name-style="western"><surname>Lam</surname><given-names>C.W.</given-names></name><name name-style="western"><surname>Cheung</surname><given-names>S.K.</given-names></name><name name-style="western"><surname>Kwok</surname><given-names>T.</given-names></name><name name-style="western"><surname>Lui</surname><given-names>V.</given-names></name><name name-style="western"><surname>Tsoh</surname><given-names>J.</given-names></name><name name-style="western"><surname>Lam</surname><given-names>L.</given-names></name><name name-style="western"><surname>Leung</surname><given-names>V.</given-names></name><name name-style="western"><surname>Hui</surname><given-names>E.</given-names></name><name name-style="western"><surname>Ng</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease</article-title><source>J. Clin. Psychopharmacol.</source><year>2008</year><volume>28</volume><fpage>110</fpage><lpage>113</lpage><pub-id pub-id-type="doi">10.1097/jcp.0b013e318160862c</pub-id><pub-id pub-id-type="pmid">18204357</pub-id></element-citation></ref><ref id="B258-nutrients-17-02884"><label>258.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ringman</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Frautschy</surname><given-names>S.A.</given-names></name><name name-style="western"><surname>Teng</surname><given-names>E.</given-names></name><name name-style="western"><surname>Begum</surname><given-names>A.N.</given-names></name><name name-style="western"><surname>Bardens</surname><given-names>J.</given-names></name><name name-style="western"><surname>Beigi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Gylys</surname><given-names>K.H.</given-names></name><name name-style="western"><surname>Badmaev</surname><given-names>V.</given-names></name><name name-style="western"><surname>Heath</surname><given-names>D.D.</given-names></name><name name-style="western"><surname>Apostolova</surname><given-names>L.G.</given-names></name><etal/></person-group><article-title>Oral curcumin for Alzheimer&#8217;s disease: Tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study</article-title><source>Alzheimers Res. Ther.</source><year>2012</year><volume>4</volume><fpage>43</fpage><pub-id pub-id-type="doi">10.1186/alzrt146</pub-id><pub-id pub-id-type="pmid">23107780</pub-id><pub-id pub-id-type="pmcid">PMC3580400</pub-id></element-citation></ref><ref id="B259-nutrients-17-02884"><label>259.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rainey-Smith</surname><given-names>S.R.</given-names></name><name name-style="western"><surname>Brown</surname><given-names>B.M.</given-names></name><name name-style="western"><surname>Sohrabi</surname><given-names>H.R.</given-names></name><name name-style="western"><surname>Shah</surname><given-names>T.</given-names></name><name name-style="western"><surname>Goozee</surname><given-names>K.G.</given-names></name><name name-style="western"><surname>Gupta</surname><given-names>V.B.</given-names></name><name name-style="western"><surname>Martins</surname><given-names>R.N.</given-names></name></person-group><article-title>Curcumin and cognition: A randomised, placebo-controlled, double-blind study of community-dwelling older adults</article-title><source>Br. J. Nutr.</source><year>2016</year><volume>115</volume><fpage>2106</fpage><lpage>2113</lpage><pub-id pub-id-type="doi">10.1017/S0007114516001203</pub-id><pub-id pub-id-type="pmid">27102361</pub-id></element-citation></ref><ref id="B260-nutrients-17-02884"><label>260.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ghodsi</surname><given-names>H.</given-names></name><name name-style="western"><surname>Rahimi</surname><given-names>H.R.</given-names></name><name name-style="western"><surname>Aghili</surname><given-names>S.M.</given-names></name><name name-style="western"><surname>Saberi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Shoeibi</surname><given-names>A.</given-names></name></person-group><article-title>Evaluation of curcumin as add-on therapy in patients with Parkinson&#8217;s disease: A pilot randomized, triple-blind, placebo-controlled trial</article-title><source>Clin. Neurol. Neurosurg.</source><year>2022</year><volume>218</volume><fpage>107300</fpage><pub-id pub-id-type="doi">10.1016/j.clineuro.2022.107300</pub-id><pub-id pub-id-type="pmid">35636380</pub-id></element-citation></ref><ref id="B261-nutrients-17-02884"><label>261.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maghbooli</surname><given-names>M.</given-names></name><name name-style="western"><surname>Safarnejad</surname><given-names>B.</given-names></name><name name-style="western"><surname>Mostafavi</surname><given-names>H.</given-names></name><name name-style="western"><surname>Mazloomzadeh</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ghoreishi</surname><given-names>A.</given-names></name></person-group><article-title>Effect of nanomicelle curcumin on quality of life and sleep in patients with Parkinson&#8217;s disease: A double-blind, randomized, and PlaceboControlled trial</article-title><source>Int. Clin. Neurosci. J.</source><year>2019</year><volume>6</volume><fpage>140</fpage><lpage>145</lpage><pub-id pub-id-type="doi">10.15171/icnj.2019.26</pub-id></element-citation></ref><ref id="B262-nutrients-17-02884"><label>262.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Donadio</surname><given-names>V.</given-names></name><name name-style="western"><surname>Incensi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Rizzo</surname><given-names>G.</given-names></name><name name-style="western"><surname>Fileccia</surname><given-names>E.</given-names></name><name name-style="western"><surname>Ventruto</surname><given-names>F.</given-names></name><name name-style="western"><surname>Riva</surname><given-names>A.</given-names></name><name name-style="western"><surname>Tiso</surname><given-names>D.</given-names></name><name name-style="western"><surname>Recchia</surname><given-names>M.</given-names></name><name name-style="western"><surname>Vacchiano</surname><given-names>V.</given-names></name><name name-style="western"><surname>Infante</surname><given-names>R.</given-names></name><etal/></person-group><article-title>The Effect of Curcumin on Idiopathic Parkinson Disease: A Clinical and Skin Biopsy Study</article-title><source>J. Neuropathol. Exp. Neurol.</source><year>2022</year><volume>81</volume><fpage>545</fpage><lpage>552</lpage><pub-id pub-id-type="doi">10.1093/jnen/nlac034</pub-id><pub-id pub-id-type="pmid">35556131</pub-id><pub-id pub-id-type="pmcid">PMC9210322</pub-id></element-citation></ref><ref id="B263-nutrients-17-02884"><label>263.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Boshagh</surname><given-names>K.</given-names></name><name name-style="western"><surname>Khorvash</surname><given-names>F.</given-names></name><name name-style="western"><surname>Sahebkar</surname><given-names>A.</given-names></name><name name-style="western"><surname>Majeed</surname><given-names>M.</given-names></name><name name-style="western"><surname>Bahreini</surname><given-names>N.</given-names></name><name name-style="western"><surname>Askari</surname><given-names>G.</given-names></name><name name-style="western"><surname>Bagherniya</surname><given-names>M.</given-names></name></person-group><article-title>The effects of curcumin-piperine supplementation on inflammatory, oxidative stress and metabolic indices in patients with ischemic stroke in the rehabilitation phase: A randomized controlled trial</article-title><source>Nutr. J.</source><year>2023</year><volume>22</volume><fpage>69</fpage><pub-id pub-id-type="doi">10.1186/s12937-023-00905-1</pub-id><pub-id pub-id-type="pmid">38082237</pub-id><pub-id pub-id-type="pmcid">PMC10712118</pub-id></element-citation></ref><ref id="B264-nutrients-17-02884"><label>264.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yakubu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Pandey</surname><given-names>A.V.</given-names></name></person-group><article-title>Innovative delivery systems for curcumin: Exploring nanosized and conventional formulations</article-title><source>Pharmaceutics</source><year>2024</year><volume>16</volume><elocation-id>637</elocation-id><pub-id pub-id-type="doi">10.3390/pharmaceutics16050637</pub-id><pub-id pub-id-type="pmid">38794299</pub-id><pub-id pub-id-type="pmcid">PMC11125045</pub-id></element-citation></ref><ref id="B265-nutrients-17-02884"><label>265.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gota</surname><given-names>V.S.</given-names></name><name name-style="western"><surname>Maru</surname><given-names>G.B.</given-names></name><name name-style="western"><surname>Soni</surname><given-names>T.G.</given-names></name><name name-style="western"><surname>Gandhi</surname><given-names>T.R.</given-names></name><name name-style="western"><surname>Kochar</surname><given-names>N.</given-names></name><name name-style="western"><surname>Agarwal</surname><given-names>M.G.</given-names></name></person-group><article-title>Safety and pharmacokinetics of a solid lipid curcumin particle formulation in osteosarcoma patients and healthy volunteers</article-title><source>J. Agric. Food Chem.</source><year>2010</year><volume>58</volume><fpage>2095</fpage><lpage>2099</lpage><pub-id pub-id-type="doi">10.1021/jf9024807</pub-id><pub-id pub-id-type="pmid">20092313</pub-id></element-citation></ref><ref id="B266-nutrients-17-02884"><label>266.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nahar</surname><given-names>P.P.</given-names></name><name name-style="western"><surname>Slitt</surname><given-names>A.L.</given-names></name><name name-style="western"><surname>Seeram</surname><given-names>N.P.</given-names></name></person-group><article-title>Anti-Inflammatory Effects of Novel Standardized Solid Lipid Curcumin Formulations</article-title><source>J. Med. Food</source><year>2015</year><volume>18</volume><fpage>786</fpage><lpage>792</lpage><pub-id pub-id-type="doi">10.1089/jmf.2014.0053</pub-id><pub-id pub-id-type="pmid">25490740</pub-id><pub-id pub-id-type="pmcid">PMC4492550</pub-id></element-citation></ref><ref id="B267-nutrients-17-02884"><label>267.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gupte</surname><given-names>P.A.</given-names></name><name name-style="western"><surname>Giramkar</surname><given-names>S.A.</given-names></name><name name-style="western"><surname>Harke</surname><given-names>S.M.</given-names></name><name name-style="western"><surname>Kulkarni</surname><given-names>S.K.</given-names></name><name name-style="western"><surname>Deshmukh</surname><given-names>A.P.</given-names></name><name name-style="western"><surname>Hingorani</surname><given-names>L.L.</given-names></name><name name-style="western"><surname>Mahajan</surname><given-names>M.P.</given-names></name><name name-style="western"><surname>Bhalerao</surname><given-names>S.S.</given-names></name></person-group><article-title>Evaluation of the efficacy and safety of Capsule Longvida(<sup>&#174;</sup>) Optimized Curcumin (solid lipid curcumin particles) in knee osteoarthritis: A pilot clinical study</article-title><source>J. Inflamm. Res.</source><year>2019</year><volume>12</volume><fpage>145</fpage><lpage>152</lpage><pub-id pub-id-type="doi">10.2147/JIR.S205390</pub-id><pub-id pub-id-type="pmid">31239749</pub-id><pub-id pub-id-type="pmcid">PMC6559772</pub-id></element-citation></ref><ref id="B268-nutrients-17-02884"><label>268.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pancholi</surname><given-names>V.</given-names></name><name name-style="western"><surname>Smina</surname><given-names>T.P.</given-names></name><name name-style="western"><surname>Kunnumakkara</surname><given-names>A.B.</given-names></name><name name-style="western"><surname>Maliakel</surname><given-names>B.</given-names></name><name name-style="western"><surname>Krishnakumar</surname><given-names>I.M.</given-names></name></person-group><article-title>Safety assessment of a highly bioavailable curcumin-galactomannoside complex (CurQfen) in healthy volunteers, with a special reference to the recent hepatotoxic reports of curcumin supplements: A 90-days prospective study</article-title><source>Toxicol. Rep.</source><year>2021</year><volume>8</volume><fpage>1255</fpage><lpage>1264</lpage><pub-id pub-id-type="doi">10.1016/j.toxrep.2021.06.008</pub-id><pub-id pub-id-type="pmid">34195017</pub-id><pub-id pub-id-type="pmcid">PMC8233102</pub-id></element-citation></ref><ref id="B269-nutrients-17-02884"><label>269.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cicero</surname><given-names>A.F.G.</given-names></name><name name-style="western"><surname>Sahebkar</surname><given-names>A.</given-names></name><name name-style="western"><surname>Fogacci</surname><given-names>F.</given-names></name><name name-style="western"><surname>Bove</surname><given-names>M.</given-names></name><name name-style="western"><surname>Giovannini</surname><given-names>M.</given-names></name><name name-style="western"><surname>Borghi</surname><given-names>C.</given-names></name></person-group><article-title>Effects of phytosomal curcumin on anthropometric parameters, insulin resistance, cortisolemia and non-alcoholic fatty liver disease indices: A double-blind, placebo-controlled clinical trial</article-title><source>Eur. J. Nutr.</source><year>2020</year><volume>59</volume><fpage>477</fpage><lpage>483</lpage><pub-id pub-id-type="doi">10.1007/s00394-019-01916-7</pub-id><pub-id pub-id-type="pmid">30796508</pub-id><pub-id pub-id-type="pmcid">PMC7058573</pub-id></element-citation></ref><ref id="B270-nutrients-17-02884"><label>270.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nakagawa</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Mukai</surname><given-names>S.</given-names></name><name name-style="western"><surname>Yamada</surname><given-names>S.</given-names></name><name name-style="western"><surname>Murata</surname><given-names>S.</given-names></name><name name-style="western"><surname>Yabumoto</surname><given-names>H.</given-names></name><name name-style="western"><surname>Maeda</surname><given-names>T.</given-names></name><name name-style="western"><surname>Akamatsu</surname><given-names>S.</given-names></name></person-group><article-title>The Efficacy and Safety of Highly-Bioavailable Curcumin for Treating Knee Osteoarthritis: A 6-Month Open-Labeled Prospective Study</article-title><source>Clin. Med. Insights Arthritis Musculoskelet. Disord.</source><year>2020</year><volume>13</volume><fpage>1179544120948471</fpage><pub-id pub-id-type="doi">10.1177/1179544120948471</pub-id><pub-id pub-id-type="pmid">32848491</pub-id><pub-id pub-id-type="pmcid">PMC7425263</pub-id></element-citation></ref><ref id="B271-nutrients-17-02884"><label>271.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sunagawa</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Miyazaki</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Funamoto</surname><given-names>M.</given-names></name><name name-style="western"><surname>Shimizu</surname><given-names>K.</given-names></name><name name-style="western"><surname>Shimizu</surname><given-names>S.</given-names></name><name name-style="western"><surname>Nurmila</surname><given-names>S.</given-names></name><name name-style="western"><surname>Katanasaka</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Ito</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ogawa</surname><given-names>T.</given-names></name><name name-style="western"><surname>Ozawa-Umeta</surname><given-names>H.</given-names></name></person-group><article-title>A novel amorphous preparation improved curcumin bioavailability in healthy volunteers: A single-dose, double-blind, two-way crossover study</article-title><source>J. Funct. Foods</source><year>2021</year><volume>81</volume><fpage>104443</fpage><pub-id pub-id-type="doi">10.1016/j.jff.2021.104443</pub-id></element-citation></ref><ref id="B272-nutrients-17-02884"><label>272.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tagde</surname><given-names>P.</given-names></name><name name-style="western"><surname>Tagde</surname><given-names>P.</given-names></name><name name-style="western"><surname>Islam</surname><given-names>F.</given-names></name><name name-style="western"><surname>Tagde</surname><given-names>S.</given-names></name><name name-style="western"><surname>Shah</surname><given-names>M.</given-names></name><name name-style="western"><surname>Hussain</surname><given-names>Z.D.</given-names></name><name name-style="western"><surname>Rahman</surname><given-names>M.H.</given-names></name><name name-style="western"><surname>Najda</surname><given-names>A.</given-names></name><name name-style="western"><surname>Alanazi</surname><given-names>I.S.</given-names></name><name name-style="western"><surname>Germoush</surname><given-names>M.O.</given-names></name></person-group><article-title>The multifaceted role of curcumin in advanced nanocurcumin form in the treatment and management of chronic disorders</article-title><source>Molecules</source><year>2021</year><volume>26</volume><elocation-id>7109</elocation-id><pub-id pub-id-type="doi">10.3390/molecules26237109</pub-id><pub-id pub-id-type="pmid">34885693</pub-id><pub-id pub-id-type="pmcid">PMC8659038</pub-id></element-citation></ref><ref id="B273-nutrients-17-02884"><label>273.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mandal</surname><given-names>M.</given-names></name><name name-style="western"><surname>Jaiswal</surname><given-names>P.</given-names></name><name name-style="western"><surname>Mishra</surname><given-names>A.</given-names></name></person-group><article-title>Role of curcumin and its nanoformulations in neurotherapeutics: A comprehensive review</article-title><source>J. Biochem. Mol. Toxicol.</source><year>2020</year><volume>34</volume><elocation-id>e22478</elocation-id><pub-id pub-id-type="doi">10.1002/jbt.22478</pub-id><pub-id pub-id-type="pmid">32124518</pub-id></element-citation></ref><ref id="B274-nutrients-17-02884"><label>274.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhao</surname><given-names>L.</given-names></name><name name-style="western"><surname>Ciallella</surname><given-names>H.L.</given-names></name><name name-style="western"><surname>Aleksunes</surname><given-names>L.M.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>H.</given-names></name></person-group><article-title>Advancing computer-aided drug discovery (CADD) by big data and data-driven machine learning modeling</article-title><source>Drug Discov. Today</source><year>2020</year><volume>25</volume><fpage>1624</fpage><lpage>1638</lpage><pub-id pub-id-type="doi">10.1016/j.drudis.2020.07.005</pub-id><pub-id pub-id-type="pmid">32663517</pub-id><pub-id pub-id-type="pmcid">PMC7572559</pub-id></element-citation></ref><ref id="B275-nutrients-17-02884"><label>275.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vinicki</surname><given-names>M.</given-names></name><name name-style="western"><surname>Pribic</surname><given-names>T.</given-names></name><name name-style="western"><surname>Vuckovic</surname><given-names>F.</given-names></name><name name-style="western"><surname>Frkatovic-Hodzic</surname><given-names>A.</given-names></name><name name-style="western"><surname>Plaza-Andrades</surname><given-names>I.</given-names></name><name name-style="western"><surname>Tinahones</surname><given-names>F.</given-names></name><name name-style="western"><surname>Raffaele</surname><given-names>J.</given-names></name><name name-style="western"><surname>Fernandez-Garcia</surname><given-names>J.C.</given-names></name><name name-style="western"><surname>Lauc</surname><given-names>G.</given-names></name></person-group><article-title>Effects of testosterone and metformin on the GlycanAge index of biological age and the composition of the IgG glycome</article-title><source>Geroscience</source><year>2024</year><volume>47</volume><fpage>1777</fpage><lpage>1788</lpage><pub-id pub-id-type="doi">10.1007/s11357-024-01349-z</pub-id><pub-id pub-id-type="pmid">39363095</pub-id><pub-id pub-id-type="pmcid">PMC11979073</pub-id></element-citation></ref><ref id="B276-nutrients-17-02884"><label>276.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Malavolta</surname><given-names>M.</given-names></name></person-group><article-title>Anti-aging interventions in geriatric mice: Insights into the timing of treatment, benefits, and limitations</article-title><source>Geroscience</source><year>2024</year><volume>47</volume><fpage>109</fpage><lpage>119</lpage><pub-id pub-id-type="doi">10.1007/s11357-024-01309-7</pub-id><pub-id pub-id-type="pmid">39112719</pub-id><pub-id pub-id-type="pmcid">PMC11872812</pub-id></element-citation></ref><ref id="B277-nutrients-17-02884"><label>277.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Landsberger</surname><given-names>T.</given-names></name><name name-style="western"><surname>Amit</surname><given-names>I.</given-names></name><name name-style="western"><surname>Alon</surname><given-names>U.</given-names></name></person-group><article-title>Geroprotective interventions converge on gene expression programs of reduced inflammation and restored fatty acid metabolism</article-title><source>Geroscience</source><year>2024</year><volume>46</volume><fpage>1627</fpage><lpage>1639</lpage><pub-id pub-id-type="doi">10.1007/s11357-023-00915-1</pub-id><pub-id pub-id-type="pmid">37698783</pub-id><pub-id pub-id-type="pmcid">PMC10828297</pub-id></element-citation></ref><ref id="B278-nutrients-17-02884"><label>278.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shintani</surname><given-names>T.</given-names></name><name name-style="western"><surname>Shintani</surname><given-names>H.</given-names></name><name name-style="western"><surname>Sato</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ashida</surname><given-names>H.</given-names></name></person-group><article-title>Calorie restriction mimetic drugs could favorably influence gut microbiota leading to lifespan extension</article-title><source>Geroscience</source><year>2023</year><volume>45</volume><fpage>3475</fpage><lpage>3490</lpage><pub-id pub-id-type="doi">10.1007/s11357-023-00851-0</pub-id><pub-id pub-id-type="pmid">37389698</pub-id><pub-id pub-id-type="pmcid">PMC10643761</pub-id></element-citation></ref><ref id="B279-nutrients-17-02884"><label>279.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>X.</given-names></name><name name-style="western"><surname>McPherson</surname><given-names>M.</given-names></name><name name-style="western"><surname>Hager</surname><given-names>M.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>M.</given-names></name><name name-style="western"><surname>Chang</surname><given-names>P.</given-names></name><name name-style="western"><surname>Miller</surname><given-names>R.A.</given-names></name></person-group><article-title>Four anti-aging drugs and calorie-restricted diet produce parallel effects in fat, brain, muscle, macrophages, and plasma of young mice</article-title><source>Geroscience</source><year>2023</year><volume>45</volume><fpage>2495</fpage><lpage>2510</lpage><pub-id pub-id-type="doi">10.1007/s11357-023-00770-0</pub-id><pub-id pub-id-type="pmid">36920743</pub-id><pub-id pub-id-type="pmcid">PMC10651632</pub-id></element-citation></ref><ref id="B280-nutrients-17-02884"><label>280.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Katsube</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ishimoto</surname><given-names>T.</given-names></name><name name-style="western"><surname>Fukushima</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Kagami</surname><given-names>A.</given-names></name><name name-style="western"><surname>Shuto</surname><given-names>T.</given-names></name><name name-style="western"><surname>Kato</surname><given-names>Y.</given-names></name></person-group><article-title>Ergothioneine promotes longevity and healthy aging in male mice</article-title><source>Geroscience</source><year>2024</year><volume>46</volume><fpage>3889</fpage><lpage>3909</lpage><pub-id pub-id-type="doi">10.1007/s11357-024-01111-5</pub-id><pub-id pub-id-type="pmid">38446314</pub-id><pub-id pub-id-type="pmcid">PMC11226696</pub-id></element-citation></ref><ref id="B281-nutrients-17-02884"><label>281.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sonsalla</surname><given-names>M.M.</given-names></name><name name-style="western"><surname>Lamming</surname><given-names>D.W.</given-names></name></person-group><article-title>Geroprotective interventions in the 3xTg mouse model of Alzheimer&#8217;s disease</article-title><source>Geroscience</source><year>2023</year><volume>45</volume><fpage>1343</fpage><lpage>1381</lpage><pub-id pub-id-type="doi">10.1007/s11357-023-00782-w</pub-id><pub-id pub-id-type="pmid">37022634</pub-id><pub-id pub-id-type="pmcid">PMC10400530</pub-id></element-citation></ref><ref id="B282-nutrients-17-02884"><label>282.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sandalova</surname><given-names>E.</given-names></name><name name-style="western"><surname>Goh</surname><given-names>J.</given-names></name><name name-style="western"><surname>Lim</surname><given-names>Z.X.</given-names></name><name name-style="western"><surname>Lim</surname><given-names>Z.M.</given-names></name><name name-style="western"><surname>Barardo</surname><given-names>D.</given-names></name><name name-style="western"><surname>Dorajoo</surname><given-names>R.</given-names></name><name name-style="western"><surname>Kennedy</surname><given-names>B.K.</given-names></name><name name-style="western"><surname>Maier</surname><given-names>A.B.</given-names></name></person-group><article-title>Alpha-ketoglutarate supplementation and BiologicaL agE in middle-aged adults (ABLE)-intervention study protocol</article-title><source>Geroscience</source><year>2023</year><volume>45</volume><fpage>2897</fpage><lpage>2907</lpage><pub-id pub-id-type="doi">10.1007/s11357-023-00813-6</pub-id><pub-id pub-id-type="pmid">37217632</pub-id><pub-id pub-id-type="pmcid">PMC10643463</pub-id></element-citation></ref><ref id="B283-nutrients-17-02884"><label>283.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McGee</surname><given-names>K.C.</given-names></name><name name-style="western"><surname>Sullivan</surname><given-names>J.</given-names></name><name name-style="western"><surname>Hazeldine</surname><given-names>J.</given-names></name><name name-style="western"><surname>Schmunk</surname><given-names>L.J.</given-names></name><name name-style="western"><surname>Martin-Herranz</surname><given-names>D.E.</given-names></name><name name-style="western"><surname>Jackson</surname><given-names>T.</given-names></name><name name-style="western"><surname>Lord</surname><given-names>J.M.</given-names></name></person-group><article-title>A combination nutritional supplement reduces DNA methylation age only in older adults with a raised epigenetic age</article-title><source>Geroscience</source><year>2024</year><volume>46</volume><fpage>4333</fpage><lpage>4347</lpage><pub-id pub-id-type="doi">10.1007/s11357-024-01138-8</pub-id><pub-id pub-id-type="pmid">38528176</pub-id><pub-id pub-id-type="pmcid">PMC11336001</pub-id></element-citation></ref><ref id="B284-nutrients-17-02884"><label>284.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dai</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>S.Y.</given-names></name><name name-style="western"><surname>Sharma</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ullah</surname><given-names>S.</given-names></name><name name-style="western"><surname>Tan</surname><given-names>E.C.K.</given-names></name><name name-style="western"><surname>Brodaty</surname><given-names>H.</given-names></name><name name-style="western"><surname>Schutte</surname><given-names>A.E.</given-names></name><name name-style="western"><surname>Sachdev</surname><given-names>P.S.</given-names></name></person-group><article-title>A systematic review of diet and medication use among centenarians and near-centenarians worldwide</article-title><source>Geroscience</source><year>2024</year><volume>46</volume><fpage>6625</fpage><lpage>6639</lpage><pub-id pub-id-type="doi">10.1007/s11357-024-01247-4</pub-id><pub-id pub-id-type="pmid">38967696</pub-id><pub-id pub-id-type="pmcid">PMC11493889</pub-id></element-citation></ref><ref id="B285-nutrients-17-02884"><label>285.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bizzozero-Peroni</surname><given-names>B.</given-names></name><name name-style="western"><surname>Diaz-Goni</surname><given-names>V.</given-names></name><name name-style="western"><surname>Beneit</surname><given-names>N.</given-names></name><name name-style="western"><surname>Oliveira</surname><given-names>A.</given-names></name><name name-style="western"><surname>Jimenez-Lopez</surname><given-names>E.</given-names></name><name name-style="western"><surname>Martinez-Vizcaino</surname><given-names>V.</given-names></name><name name-style="western"><surname>Mesas</surname><given-names>A.E.</given-names></name></person-group><article-title>Nut consumption is associated with a lower risk of all-cause dementia in adults: A community-based cohort study from the UK Biobank</article-title><source>Geroscience</source><year>2024</year><volume>47</volume><fpage>1721</fpage><lpage>1733</lpage><pub-id pub-id-type="doi">10.1007/s11357-024-01365-z</pub-id><pub-id pub-id-type="pmid">39343863</pub-id><pub-id pub-id-type="pmcid">PMC11979034</pub-id></element-citation></ref><ref id="B286-nutrients-17-02884"><label>286.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zupo</surname><given-names>R.</given-names></name><name name-style="western"><surname>Donghia</surname><given-names>R.</given-names></name><name name-style="western"><surname>Castellana</surname><given-names>F.</given-names></name><name name-style="western"><surname>Bortone</surname><given-names>I.</given-names></name><name name-style="western"><surname>De Nucci</surname><given-names>S.</given-names></name><name name-style="western"><surname>Sila</surname><given-names>A.</given-names></name><name name-style="western"><surname>Tatoli</surname><given-names>R.</given-names></name><name name-style="western"><surname>Lampignano</surname><given-names>L.</given-names></name><name name-style="western"><surname>Sborgia</surname><given-names>G.</given-names></name><name name-style="western"><surname>Panza</surname><given-names>F.</given-names></name><etal/></person-group><article-title>Ultra-processed food consumption and nutritional frailty in older age</article-title><source>Geroscience</source><year>2023</year><volume>45</volume><fpage>2229</fpage><lpage>2243</lpage><pub-id pub-id-type="doi">10.1007/s11357-023-00753-1</pub-id><pub-id pub-id-type="pmid">36826622</pub-id><pub-id pub-id-type="pmcid">PMC10651811</pub-id></element-citation></ref><ref id="B287-nutrients-17-02884"><label>287.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhou</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>K.</given-names></name><name name-style="western"><surname>Ramsey</surname><given-names>J.J.</given-names></name><name name-style="western"><surname>Rutkowsky</surname><given-names>J.M.</given-names></name></person-group><article-title>Ketogenic diets initiated in late mid-life improved measures of spatial memory in male mice</article-title><source>Geroscience</source><year>2023</year><volume>45</volume><fpage>2481</fpage><lpage>2494</lpage><pub-id pub-id-type="doi">10.1007/s11357-023-00769-7</pub-id><pub-id pub-id-type="pmid">36933143</pub-id><pub-id pub-id-type="pmcid">PMC10651563</pub-id></element-citation></ref><ref id="B288-nutrients-17-02884"><label>288.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aversa</surname><given-names>Z.</given-names></name><name name-style="western"><surname>White</surname><given-names>T.A.</given-names></name><name name-style="western"><surname>Heeren</surname><given-names>A.A.</given-names></name><name name-style="western"><surname>Hulshizer</surname><given-names>C.A.</given-names></name><name name-style="western"><surname>Saul</surname><given-names>D.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Molina</surname><given-names>A.J.A.</given-names></name><name name-style="western"><surname>Redman</surname><given-names>L.M.</given-names></name><name name-style="western"><surname>Martin</surname><given-names>C.K.</given-names></name><name name-style="western"><surname>Racette</surname><given-names>S.B.</given-names></name><etal/></person-group><article-title>Calorie restriction reduces biomarkers of cellular senescence in humans</article-title><source>Aging Cell</source><year>2024</year><volume>23</volume><fpage>e14038</fpage><pub-id pub-id-type="doi">10.1111/acel.14038</pub-id><pub-id pub-id-type="pmid">37961856</pub-id><pub-id pub-id-type="pmcid">PMC10861196</pub-id></element-citation></ref><ref id="B289-nutrients-17-02884"><label>289.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Das</surname><given-names>S.K.</given-names></name><name name-style="western"><surname>Silver</surname><given-names>R.E.</given-names></name><name name-style="western"><surname>Senior</surname><given-names>A.</given-names></name><name name-style="western"><surname>Gilhooly</surname><given-names>C.H.</given-names></name><name name-style="western"><surname>Bhapkar</surname><given-names>M.</given-names></name><name name-style="western"><surname>Le Couteur</surname><given-names>D.</given-names></name></person-group><article-title>Diet composition, adherence to calorie restriction, and cardiometabolic disease risk modification</article-title><source>Aging Cell</source><year>2023</year><volume>22</volume><fpage>e14018</fpage><pub-id pub-id-type="doi">10.1111/acel.14018</pub-id><pub-id pub-id-type="pmid">37873687</pub-id><pub-id pub-id-type="pmcid">PMC10726801</pub-id></element-citation></ref><ref id="B290-nutrients-17-02884"><label>290.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fiorito</surname><given-names>G.</given-names></name><name name-style="western"><surname>Tosti</surname><given-names>V.</given-names></name><name name-style="western"><surname>Polidoro</surname><given-names>S.</given-names></name><name name-style="western"><surname>Bertozzi</surname><given-names>B.</given-names></name><name name-style="western"><surname>Veronese</surname><given-names>N.</given-names></name><name name-style="western"><surname>Cava</surname><given-names>E.</given-names></name><name name-style="western"><surname>Spelta</surname><given-names>F.</given-names></name><name name-style="western"><surname>Piccio</surname><given-names>L.</given-names></name><name name-style="western"><surname>Early</surname><given-names>D.S.</given-names></name><name name-style="western"><surname>Raftery</surname><given-names>D.</given-names></name><etal/></person-group><article-title>Multi-omic analysis of biological aging biomarkers in long-term calorie restriction and endurance exercise practitioners: A cross-sectional study</article-title><source>Aging Cell</source><year>2025</year><volume>24</volume><fpage>e14442</fpage><pub-id pub-id-type="doi">10.1111/acel.14442</pub-id><pub-id pub-id-type="pmid">39692728</pub-id><pub-id pub-id-type="pmcid">PMC11984672</pub-id></element-citation></ref><ref id="B291-nutrients-17-02884"><label>291.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Han</surname><given-names>W.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>B.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>W.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>W.</given-names></name><name name-style="western"><surname>He</surname><given-names>J.</given-names></name><name name-style="western"><surname>Qiu</surname><given-names>X.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>L.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Lu</surname><given-names>H.</given-names></name><etal/></person-group><article-title>Ketogenic beta-hydroxybutyrate regulates beta-hydroxybutyrylation of TCA cycle-associated enzymes and attenuates disease-associated pathologies in Alzheimer&#8217;s mice</article-title><source>Aging Cell</source><year>2025</year><volume>24</volume><fpage>e14368</fpage><pub-id pub-id-type="doi">10.1111/acel.14368</pub-id><pub-id pub-id-type="pmid">39411885</pub-id><pub-id pub-id-type="pmcid">PMC11709107</pub-id></element-citation></ref><ref id="B292-nutrients-17-02884"><label>292.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ribeiro</surname><given-names>R.V.</given-names></name><name name-style="western"><surname>Senior</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Simpson</surname><given-names>S.J.</given-names></name><name name-style="western"><surname>Tan</surname><given-names>J.</given-names></name><name name-style="western"><surname>Raubenheimer</surname><given-names>D.</given-names></name><name name-style="western"><surname>Le Couteur</surname><given-names>D.</given-names></name><name name-style="western"><surname>Macia</surname><given-names>L.</given-names></name><name name-style="western"><surname>Holmes</surname><given-names>A.</given-names></name><name name-style="western"><surname>Eberhard</surname><given-names>J.</given-names></name><name name-style="western"><surname>O&#8217;Sullivan</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Rapid benefits in older age from transition to whole food diet regardless of protein source or fat to carbohydrate ratio: Arandomised control trial</article-title><source>Aging Cell</source><year>2024</year><volume>23</volume><fpage>e14276</fpage><pub-id pub-id-type="doi">10.1111/acel.14276</pub-id><pub-id pub-id-type="pmid">39011855</pub-id><pub-id pub-id-type="pmcid">PMC11561649</pub-id></element-citation></ref><ref id="B293-nutrients-17-02884"><label>293.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ungvari</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Fazekas-Pongor</surname><given-names>V.</given-names></name><name name-style="western"><surname>Csiszar</surname><given-names>A.</given-names></name><name name-style="western"><surname>Kunutsor</surname><given-names>S.K.</given-names></name></person-group><article-title>The multifaceted benefits of walking for healthy aging: From Blue Zones to molecular mechanisms</article-title><source>Geroscience</source><year>2023</year><volume>45</volume><fpage>3211</fpage><lpage>3239</lpage><pub-id pub-id-type="doi">10.1007/s11357-023-00873-8</pub-id><pub-id pub-id-type="pmid">37495893</pub-id><pub-id pub-id-type="pmcid">PMC10643563</pub-id></element-citation></ref><ref id="B294-nutrients-17-02884"><label>294.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ungvari</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Fekete</surname><given-names>M.</given-names></name><name name-style="western"><surname>Varga</surname><given-names>P.</given-names></name><name name-style="western"><surname>Fekete</surname><given-names>J.T.</given-names></name><name name-style="western"><surname>Buda</surname><given-names>A.</given-names></name><name name-style="western"><surname>Szappanos</surname><given-names>A.</given-names></name><name name-style="western"><surname>Lehoczki</surname><given-names>A.</given-names></name><name name-style="western"><surname>Mozes</surname><given-names>N.</given-names></name><name name-style="western"><surname>Grosso</surname><given-names>G.</given-names></name><name name-style="western"><surname>Menyhart</surname><given-names>O.</given-names></name><etal/></person-group><article-title>Impact of adherence to the Mediterranean diet on stroke risk</article-title><source>Geroscience</source><year>2025</year><volume>47</volume><fpage>3565</fpage><lpage>3581</lpage><pub-id pub-id-type="doi">10.1007/s11357-024-01491-8</pub-id><pub-id pub-id-type="pmid">39777701</pub-id><pub-id pub-id-type="pmcid">PMC12181503</pub-id></element-citation></ref><ref id="B295-nutrients-17-02884"><label>295.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fekete</surname><given-names>M.</given-names></name><name name-style="western"><surname>Varga</surname><given-names>P.</given-names></name><name name-style="western"><surname>Ungvari</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Fekete</surname><given-names>J.T.</given-names></name><name name-style="western"><surname>Buda</surname><given-names>A.</given-names></name><name name-style="western"><surname>Szappanos</surname><given-names>A.</given-names></name><name name-style="western"><surname>Lehoczki</surname><given-names>A.</given-names></name><name name-style="western"><surname>Mozes</surname><given-names>N.</given-names></name><name name-style="western"><surname>Grosso</surname><given-names>G.</given-names></name><name name-style="western"><surname>Godos</surname><given-names>J.</given-names></name><etal/></person-group><article-title>The role of the Mediterranean diet in reducing the risk of cognitive impairement, dementia, and Alzheimer&#8217;s disease: A meta-analysis</article-title><source>Geroscience</source><year>2025</year><volume>47</volume><fpage>3111</fpage><lpage>3130</lpage><pub-id pub-id-type="doi">10.1007/s11357-024-01488-3</pub-id><pub-id pub-id-type="pmid">39797935</pub-id><pub-id pub-id-type="pmcid">PMC12181514</pub-id></element-citation></ref><ref id="B296-nutrients-17-02884"><label>296.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Talavera-Rodriguez</surname><given-names>I.</given-names></name><name name-style="western"><surname>Banegas</surname><given-names>J.R.</given-names></name><name name-style="western"><surname>de la Cruz</surname><given-names>J.J.</given-names></name><name name-style="western"><surname>Martinez-Gomez</surname><given-names>D.</given-names></name><name name-style="western"><surname>Ruiz-Canela</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ortola</surname><given-names>R.</given-names></name><name name-style="western"><surname>Hershey</surname><given-names>M.S.</given-names></name><name name-style="western"><surname>Artalejo</surname><given-names>F.R.</given-names></name><name name-style="western"><surname>Sotos-Prieto</surname><given-names>M.</given-names></name></person-group><article-title>Mediterranean lifestyle index and 24-h systolic blood pressure and heart rate in community-dwelling older adults</article-title><source>Geroscience</source><year>2024</year><volume>46</volume><fpage>1357</fpage><lpage>1369</lpage><pub-id pub-id-type="doi">10.1007/s11357-023-00898-z</pub-id><pub-id pub-id-type="pmid">37561386</pub-id><pub-id pub-id-type="pmcid">PMC10828285</pub-id></element-citation></ref><ref id="B297-nutrients-17-02884"><label>297.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dobreva</surname><given-names>I.</given-names></name><name name-style="western"><surname>Marston</surname><given-names>L.</given-names></name><name name-style="western"><surname>Mukadam</surname><given-names>N.</given-names></name></person-group><article-title>Which components of the Mediterranean diet are associated with dementia? A UK Biobank cohort study</article-title><source>Geroscience</source><year>2022</year><volume>44</volume><fpage>2541</fpage><lpage>2554</lpage><pub-id pub-id-type="doi">10.1007/s11357-022-00615-2</pub-id><pub-id pub-id-type="pmid">35794436</pub-id><pub-id pub-id-type="pmcid">PMC9768046</pub-id></element-citation></ref><ref id="B298-nutrients-17-02884"><label>298.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gensous</surname><given-names>N.</given-names></name><name name-style="western"><surname>Garagnani</surname><given-names>P.</given-names></name><name name-style="western"><surname>Santoro</surname><given-names>A.</given-names></name><name name-style="western"><surname>Giuliani</surname><given-names>C.</given-names></name><name name-style="western"><surname>Ostan</surname><given-names>R.</given-names></name><name name-style="western"><surname>Fabbri</surname><given-names>C.</given-names></name><name name-style="western"><surname>Milazzo</surname><given-names>M.</given-names></name><name name-style="western"><surname>Gentilini</surname><given-names>D.</given-names></name><name name-style="western"><surname>di Blasio</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Pietruszka</surname><given-names>B.</given-names></name><etal/></person-group><article-title>One-year Mediterranean diet promotes epigenetic rejuvenation with country- and sex-specific effects: A pilot study from the NU-AGE project</article-title><source>Geroscience</source><year>2020</year><volume>42</volume><fpage>687</fpage><lpage>701</lpage><pub-id pub-id-type="doi">10.1007/s11357-019-00149-0</pub-id><pub-id pub-id-type="pmid">31981007</pub-id><pub-id pub-id-type="pmcid">PMC7205853</pub-id></element-citation></ref><ref id="B299-nutrients-17-02884"><label>299.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Martens</surname><given-names>C.R.</given-names></name><name name-style="western"><surname>Rossman</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Mazzo</surname><given-names>M.R.</given-names></name><name name-style="western"><surname>Jankowski</surname><given-names>L.R.</given-names></name><name name-style="western"><surname>Nagy</surname><given-names>E.E.</given-names></name><name name-style="western"><surname>Denman</surname><given-names>B.A.</given-names></name><name name-style="western"><surname>Richey</surname><given-names>J.J.</given-names></name><name name-style="western"><surname>Johnson</surname><given-names>S.A.</given-names></name><name name-style="western"><surname>Ziemba</surname><given-names>B.P.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>Short-term time-restricted feeding is safe and feasible in non-obese healthy midlife and older adults</article-title><source>Geroscience</source><year>2020</year><volume>42</volume><fpage>667</fpage><lpage>686</lpage><pub-id pub-id-type="doi">10.1007/s11357-020-00156-6</pub-id><pub-id pub-id-type="pmid">31975053</pub-id><pub-id pub-id-type="pmcid">PMC7206473</pub-id></element-citation></ref><ref id="B300-nutrients-17-02884"><label>300.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gonzalez-Armenta</surname><given-names>J.L.</given-names></name><name name-style="western"><surname>Bergstrom</surname><given-names>J.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>J.</given-names></name><name name-style="western"><surname>Furdui</surname><given-names>C.M.</given-names></name><name name-style="western"><surname>Nicklas</surname><given-names>B.J.</given-names></name><name name-style="western"><surname>Molina</surname><given-names>A.J.A.</given-names></name></person-group><article-title>Serum factors mediate changes in mitochondrial bioenergetics associated with diet and exercise interventions</article-title><source>Geroscience</source><year>2024</year><volume>46</volume><fpage>349</fpage><lpage>365</lpage><pub-id pub-id-type="doi">10.1007/s11357-023-00855-w</pub-id><pub-id pub-id-type="pmid">37368157</pub-id><pub-id pub-id-type="pmcid">PMC10828137</pub-id></element-citation></ref><ref id="B301-nutrients-17-02884"><label>301.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Szilagyi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Takacs</surname><given-names>B.</given-names></name><name name-style="western"><surname>Szekeres</surname><given-names>R.</given-names></name><name name-style="western"><surname>Tarjanyi</surname><given-names>V.</given-names></name><name name-style="western"><surname>Nagy</surname><given-names>D.</given-names></name><name name-style="western"><surname>Priksz</surname><given-names>D.</given-names></name><name name-style="western"><surname>Bombicz</surname><given-names>M.</given-names></name><name name-style="western"><surname>Kiss</surname><given-names>R.</given-names></name><name name-style="western"><surname>Szabo</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Lehoczki</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Effects of voluntary and forced physical exercise on the retinal health of aging Wistar rats</article-title><source>Geroscience</source><year>2024</year><volume>46</volume><fpage>4707</fpage><lpage>4728</lpage><pub-id pub-id-type="doi">10.1007/s11357-024-01208-x</pub-id><pub-id pub-id-type="pmid">38795184</pub-id><pub-id pub-id-type="pmcid">PMC11336036</pub-id></element-citation></ref><ref id="B302-nutrients-17-02884"><label>302.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Roslund</surname><given-names>K.J.</given-names></name><name name-style="western"><surname>Ramsey</surname><given-names>J.J.</given-names></name><name name-style="western"><surname>Rutkowsky</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Slupsky</surname><given-names>C.M.</given-names></name></person-group><article-title>Two-month ketogenic diet alters systemic and brain metabolism in middle-aged female mice</article-title><source>Geroscience</source><year>2024</year><volume>47</volume><fpage>935</fpage><lpage>952</lpage><pub-id pub-id-type="doi">10.1007/s11357-024-01314-w</pub-id><pub-id pub-id-type="pmid">39180613</pub-id><pub-id pub-id-type="pmcid">PMC11872878</pub-id></element-citation></ref><ref id="B303-nutrients-17-02884"><label>303.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Frohlich</surname><given-names>S.</given-names></name><name name-style="western"><surname>Kutz</surname><given-names>D.F.</given-names></name><name name-style="western"><surname>Muller</surname><given-names>K.</given-names></name><name name-style="western"><surname>Voelcker-Rehage</surname><given-names>C.</given-names></name></person-group><article-title>Cardiorespiratory fitness is associated with cognitive performance in 80+-year-olds: Detangling processing levels</article-title><source>Geroscience</source><year>2024</year><volume>46</volume><fpage>3297</fpage><lpage>3310</lpage><pub-id pub-id-type="doi">10.1007/s11357-024-01065-8</pub-id><pub-id pub-id-type="pmid">38261111</pub-id><pub-id pub-id-type="pmcid">PMC11009210</pub-id></element-citation></ref><ref id="B304-nutrients-17-02884"><label>304.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chauquet</surname><given-names>S.</given-names></name><name name-style="western"><surname>Willis</surname><given-names>E.F.</given-names></name><name name-style="western"><surname>Grice</surname><given-names>L.</given-names></name><name name-style="western"><surname>Harley</surname><given-names>S.B.R.</given-names></name><name name-style="western"><surname>Powell</surname><given-names>J.E.</given-names></name><name name-style="western"><surname>Wray</surname><given-names>N.R.</given-names></name><name name-style="western"><surname>Nguyen</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Ruitenberg</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Shah</surname><given-names>S.</given-names></name><name name-style="western"><surname>Vukovic</surname><given-names>J.</given-names></name></person-group><article-title>Exercise rejuvenates microglia and reverses T cell accumulation in the aged female mouse brain</article-title><source>Aging Cell</source><year>2024</year><volume>23</volume><fpage>e14172</fpage><pub-id pub-id-type="doi">10.1111/acel.14172</pub-id><pub-id pub-id-type="pmid">38747044</pub-id><pub-id pub-id-type="pmcid">PMC11258432</pub-id></element-citation></ref><ref id="B305-nutrients-17-02884"><label>305.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fox</surname><given-names>F.A.U.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>D.</given-names></name><name name-style="western"><surname>Breteler</surname><given-names>M.M.B.</given-names></name><name name-style="western"><surname>Aziz</surname><given-names>N.A.</given-names></name></person-group><article-title>Physical activity is associated with slower epigenetic ageing-Findings from the Rhineland study</article-title><source>Aging Cell</source><year>2023</year><volume>22</volume><fpage>e13828</fpage><pub-id pub-id-type="doi">10.1111/acel.13828</pub-id><pub-id pub-id-type="pmid">37036021</pub-id><pub-id pub-id-type="pmcid">PMC10265180</pub-id></element-citation></ref><ref id="B306-nutrients-17-02884"><label>306.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kawamura</surname><given-names>T.</given-names></name><name name-style="western"><surname>Radak</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Tabata</surname><given-names>H.</given-names></name><name name-style="western"><surname>Akiyama</surname><given-names>H.</given-names></name><name name-style="western"><surname>Nakamura</surname><given-names>N.</given-names></name><name name-style="western"><surname>Kawakami</surname><given-names>R.</given-names></name><name name-style="western"><surname>Ito</surname><given-names>T.</given-names></name><name name-style="western"><surname>Usui</surname><given-names>C.</given-names></name><name name-style="western"><surname>Jokai</surname><given-names>M.</given-names></name><name name-style="western"><surname>Torma</surname><given-names>F.</given-names></name><etal/></person-group><article-title>Associations between cardiorespiratory fitness and lifestyle-related factors with DNA methylation-based ageing clocks in older men: WASEDA&#8217;S Health Study</article-title><source>Aging Cell</source><year>2024</year><volume>23</volume><fpage>e13960</fpage><pub-id pub-id-type="doi">10.1111/acel.13960</pub-id><pub-id pub-id-type="pmid">37584423</pub-id><pub-id pub-id-type="pmcid">PMC10776125</pub-id></element-citation></ref><ref id="B307-nutrients-17-02884"><label>307.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lohman</surname><given-names>T.</given-names></name><name name-style="western"><surname>Bains</surname><given-names>G.</given-names></name><name name-style="western"><surname>Cole</surname><given-names>S.</given-names></name><name name-style="western"><surname>Gharibvand</surname><given-names>L.</given-names></name><name name-style="western"><surname>Berk</surname><given-names>L.</given-names></name><name name-style="western"><surname>Lohman</surname><given-names>E.</given-names></name></person-group><article-title>High-Intensity interval training reduces transcriptomic age: A randomized controlled trial</article-title><source>Aging Cell</source><year>2023</year><volume>22</volume><fpage>e13841</fpage><pub-id pub-id-type="doi">10.1111/acel.13841</pub-id><pub-id pub-id-type="pmid">37078430</pub-id><pub-id pub-id-type="pmcid">PMC10265161</pub-id></element-citation></ref><ref id="B308-nutrients-17-02884"><label>308.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Malin</surname><given-names>S.K.</given-names></name><name name-style="western"><surname>Battillo</surname><given-names>D.J.</given-names></name><name name-style="western"><surname>Beeri</surname><given-names>M.S.</given-names></name><name name-style="western"><surname>Mustapic</surname><given-names>M.</given-names></name><name name-style="western"><surname>Delgado-Peraza</surname><given-names>F.</given-names></name><name name-style="western"><surname>Kapogiannis</surname><given-names>D.</given-names></name></person-group><article-title>Two weeks of exercise alters neuronal extracellular vesicle insulin signaling proteins and pro-BDNF in older adults with prediabetes</article-title><source>Aging Cell</source><year>2025</year><volume>24</volume><fpage>e14369</fpage><pub-id pub-id-type="doi">10.1111/acel.14369</pub-id><pub-id pub-id-type="pmid">39421964</pub-id><pub-id pub-id-type="pmcid">PMC11709104</pub-id></element-citation></ref><ref id="B309-nutrients-17-02884"><label>309.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Manning</surname><given-names>K.M.</given-names></name><name name-style="western"><surname>Hall</surname><given-names>K.S.</given-names></name><name name-style="western"><surname>Sloane</surname><given-names>R.</given-names></name><name name-style="western"><surname>Magistro</surname><given-names>D.</given-names></name><name name-style="western"><surname>Rabaglietti</surname><given-names>E.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>C.C.</given-names></name><name name-style="western"><surname>Castle</surname><given-names>S.</given-names></name><name name-style="western"><surname>Kopp</surname><given-names>T.</given-names></name><name name-style="western"><surname>Giffuni</surname><given-names>J.</given-names></name><name name-style="western"><surname>Katzel</surname><given-names>L.</given-names></name><etal/></person-group><article-title>Longitudinal analysis of physical function in older adults: The effects of physical inactivity and exercise training</article-title><source>Aging Cell</source><year>2024</year><volume>23</volume><fpage>e13987</fpage><pub-id pub-id-type="doi">10.1111/acel.13987</pub-id><pub-id pub-id-type="pmid">37681737</pub-id><pub-id pub-id-type="pmcid">PMC10776115</pub-id></element-citation></ref><ref id="B310-nutrients-17-02884"><label>310.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moore</surname><given-names>A.Z.</given-names></name><name name-style="western"><surname>Simonsick</surname><given-names>E.M.</given-names></name><name name-style="western"><surname>Landman</surname><given-names>B.</given-names></name><name name-style="western"><surname>Schrack</surname><given-names>J.</given-names></name><name name-style="western"><surname>Wanigatunga</surname><given-names>A.A.</given-names></name><name name-style="western"><surname>Ferrucci</surname><given-names>L.</given-names></name></person-group><article-title>Correlates of life course physical activity in participants of the Baltimore longitudinal study of aging</article-title><source>Aging Cell</source><year>2024</year><volume>23</volume><fpage>e14078</fpage><pub-id pub-id-type="doi">10.1111/acel.14078</pub-id><pub-id pub-id-type="pmid">38226778</pub-id><pub-id pub-id-type="pmcid">PMC11019133</pub-id></element-citation></ref><ref id="B311-nutrients-17-02884"><label>311.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Voisin</surname><given-names>S.</given-names></name><name name-style="western"><surname>Seale</surname><given-names>K.</given-names></name><name name-style="western"><surname>Jacques</surname><given-names>M.</given-names></name><name name-style="western"><surname>Landen</surname><given-names>S.</given-names></name><name name-style="western"><surname>Harvey</surname><given-names>N.R.</given-names></name><name name-style="western"><surname>Haupt</surname><given-names>L.M.</given-names></name><name name-style="western"><surname>Griffiths</surname><given-names>L.R.</given-names></name><name name-style="western"><surname>Ashton</surname><given-names>K.J.</given-names></name><name name-style="western"><surname>Coffey</surname><given-names>V.G.</given-names></name><name name-style="western"><surname>Thompson</surname><given-names>J.M.</given-names></name><etal/></person-group><article-title>Exercise is associated with younger methylome and transcriptome profiles in human skeletal muscle</article-title><source>Aging Cell</source><year>2024</year><volume>23</volume><fpage>e13859</fpage><pub-id pub-id-type="doi">10.1111/acel.13859</pub-id><pub-id pub-id-type="pmid">37128843</pub-id><pub-id pub-id-type="pmcid">PMC10776126</pub-id></element-citation></ref><ref id="B312-nutrients-17-02884"><label>312.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kunnumakkara</surname><given-names>A.B.</given-names></name><name name-style="western"><surname>Bordoloi</surname><given-names>D.</given-names></name><name name-style="western"><surname>Padmavathi</surname><given-names>G.</given-names></name><name name-style="western"><surname>Monisha</surname><given-names>J.</given-names></name><name name-style="western"><surname>Roy</surname><given-names>N.K.</given-names></name><name name-style="western"><surname>Prasad</surname><given-names>S.</given-names></name><name name-style="western"><surname>Aggarwal</surname><given-names>B.B.</given-names></name></person-group><article-title>Curcumin, the golden nutraceutical: Multitargeting for multiple chronic diseases</article-title><source>Br. J. Pharmacol.</source><year>2017</year><volume>174</volume><fpage>1325</fpage><lpage>1348</lpage><pub-id pub-id-type="doi">10.1111/bph.13621</pub-id><pub-id pub-id-type="pmid">27638428</pub-id><pub-id pub-id-type="pmcid">PMC5429333</pub-id></element-citation></ref><ref id="B313-nutrients-17-02884"><label>313.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Far</surname><given-names>B.F.</given-names></name><name name-style="western"><surname>Safaei</surname><given-names>M.</given-names></name><name name-style="western"><surname>Pourmolaei</surname><given-names>A.</given-names></name><name name-style="western"><surname>Adibamini</surname><given-names>S.</given-names></name><name name-style="western"><surname>Shirdel</surname><given-names>S.</given-names></name><name name-style="western"><surname>Shirdel</surname><given-names>S.</given-names></name><name name-style="western"><surname>Emadi</surname><given-names>R.</given-names></name><name name-style="western"><surname>Kaushik</surname><given-names>A.K.</given-names></name></person-group><article-title>Exploring curcumin-loaded lipid-based nanomedicine as efficient targeted therapy for Alzheimer&#8217;s diseases</article-title><source>ACS Appl. Bio Mater.</source><year>2024</year><volume>7</volume><fpage>3535</fpage><lpage>3555</lpage><pub-id pub-id-type="doi">10.1021/acsabm.4c00112</pub-id><pub-id pub-id-type="pmid">38768054</pub-id></element-citation></ref><ref id="B314-nutrients-17-02884"><label>314.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Naoi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Maruyama</surname><given-names>W.</given-names></name><name name-style="western"><surname>Shamoto-Nagai</surname><given-names>M.</given-names></name></person-group><article-title>Disease-modifying treatment of Parkinson&#8217;s disease by phytochemicals: Targeting multiple pathogenic factors</article-title><source>J. Neural Transm.</source><year>2022</year><volume>129</volume><fpage>737</fpage><lpage>753</lpage><pub-id pub-id-type="doi">10.1007/s00702-021-02427-8</pub-id><pub-id pub-id-type="pmid">34654977</pub-id></element-citation></ref></ref-list></back><floats-group><fig position="float" id="nutrients-17-02884-f001" orientation="portrait"><label>Figure 1</label><caption><p>Pharmacokinetic challenges of oral curcumin.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nutrients-17-02884-g001.jpg"/></fig><fig position="float" id="nutrients-17-02884-f002" orientation="portrait"><label>Figure 2</label><caption><p>Anti-Inflammatory Mechanisms of Curcumin: Inhibition of NF-&#954;B, COX-2, and iNOS: Curcumin reduces inflammation by inhibiting the NF-&#954;B (nuclear factor kappa B) signaling pathway, as well as COX-2 (cyclooxygenase-2) and iNOS (inducible nitric oxide synthase) activity, thereby lowering pro-inflammatory cytokine and nitric oxide production. Arrow indicates the direction of change: &#8595;&#8212;decrease.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nutrients-17-02884-g002.jpg"/></fig><table-wrap position="float" id="nutrients-17-02884-t001" orientation="portrait"><object-id pub-id-type="pii">nutrients-17-02884-t001_Table 1</object-id><label>Table 1</label><caption><p>Preclinical studies on curcumin in Alzheimer&#8217;s disease models.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Ref.</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Model</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Dose</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Duration</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Route</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Key Effects</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Mechanisms</th></tr></thead><tbody><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sun et al. [<xref rid="B45-nutrients-17-02884" ref-type="bibr">45</xref>]</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">APP/PS1 male mice</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">50 or 200 mg/kg</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3 months</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Oral gavage (daily)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Improved spatial memory; reduced hippocampal A&#946; plaques</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Modulated gut microbiota (&#8593; Lactobacillaceae, &#8595; Bacteroidaceae); curcumin biotransformation to neuroprotective metabolites</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lin et al. [<xref rid="B206-nutrients-17-02884" ref-type="bibr">206</xref>]</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">APPswe/PSEN1dE9 mice (both sexes)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Curcumin 200 mg/kg; Berberine 100 mg/kg</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3 months</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Oral gavage (daily)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Improved cognition; &#8595; A&#946;1&#8211;42, inflammation (IL-1&#946;, TNF-&#945;, IL-6), oxidative stress; &#8593; AMPK&#945; phosphorylation and autophagy</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Synergistic anti-amyloid, anti-inflammatory, antioxidative effects; modulation of APP processing and AMPK&#8211;autophagy pathway</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Su et al. [<xref rid="B207-nutrients-17-02884" ref-type="bibr">207</xref>]</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Triple-transgenic Alzheimer&#8217;s disease mice</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">150 mg/kg (TML-6)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4 months</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Oral</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Improved learning; reduced brain A&#946; and microglial activation</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Enhanced bioavailability; reduced A&#946; synthesis; &#8593; ApoE; NF-&#954;B/mTOR suppression; Nrf2 pathway activation</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ELBini-Dhouib et al. [<xref rid="B208-nutrients-17-02884" ref-type="bibr">208</xref>]</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AlCl<sub>3</sub>-induced sporadic AD rats</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100 mg/kg (CUR1 co-treatment; CUR2 post-treatment)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">90 days</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Oral</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Improved cognition; reduced anxiety; restored AChE activity; improved oxidative markers; &#8595; apoptosis and inflammation</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antioxidant and anti-inflammatory actions; neuroprotection; restored cholinergic function</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reddy et al. [<xref rid="B209-nutrients-17-02884" ref-type="bibr">209</xref>]</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SH-SY5Y cells + A&#946;<sub>25&#8211;35</sub></td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">66.3 &#956;M</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">24 h (pretreatment)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Improved cell viability; &#8593; MFN1/2, OPA1; &#8595; DRP1, FIS1; &#8593; PGC1&#945;, Nrf1/2, TFAM; &#8593; synaptic markers</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Enhanced mitochondrial biogenesis and dynamics; synaptic protection; reduced oxidative stress</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Wang et al. [<xref rid="B210-nutrients-17-02884" ref-type="bibr">210</xref>]</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A&#946;<sub>1&#8211;40</sub>-induced AD in Sprague&#8211;Dawley rats</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">300 mg/kg</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7 days</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Intraperitoneal</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Improved spatial memory; reduced hippocampal GFAP mRNA; less reactive astrocytosis</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Suppression of astrogliosis and neuroinflammation via GFAP downregulation</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cheng et al. [<xref rid="B211-nutrients-17-02884" ref-type="bibr">211</xref>]</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tg2576 AD mice</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100 mg/kg</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3 months</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Oral gavage (weekly)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Improved cue memory; trend to improved working memory; &#8595; amyloid plaques; &#8593; brain/plasma curcumin</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nanoparticle formulation enhanced BBB penetration, pharmacokinetics, and bioavailability</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ray et al. [<xref rid="B212-nutrients-17-02884" ref-type="bibr">212</xref>]</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SK-N-SH cells and athymic mice</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">25 mg/kg NanoCurc&#8482; i.p. twice daily; 1 nM&#8211;5 &#956;M in vitro</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro: 24 h; in vivo: &#8804;16 h post-dose</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro; i.p.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Neuroprotection from ROS; rescued injured cells; &#8593; brain curcumin; &#8595; ROS and caspase 3/7; &#8593; GSH</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Polymeric nanoparticles improved bioavailability; enhanced redox balance; antioxidant and anti-apoptotic effects</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Begum et al. [<xref rid="B213-nutrients-17-02884" ref-type="bibr">213</xref>]</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tg2576 APPsw mice; LPS-injected WT mice; neuron/microglia cultures</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chronic: ~83 mg/kg diet (~500 ppm); Acute: 0.4 &#956;mol</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chronic: ~4 months; Acute: 2 days pre-LPS</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Oral (diet/gavage), i.p., i.m.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Both regimens reduced neuroinflammation (iNOS, IL-1&#946;); Cur reduced plaques/insoluble A&#946;, TC reduced soluble A&#946; and JNK phosphorylation</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cur dienone bridge essential for plaque reduction; TC selectively inhibits JNK phosphorylation; both antioxidant/anti-inflammatory</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Xiong et al. [<xref rid="B214-nutrients-17-02884" ref-type="bibr">214</xref>]</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SH-SY5Y neuroblastoma cells (APP-transfected)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0&#8211;20 &#956;M (24 h), or 5 &#956;M (12&#8211;48 h)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">24&#8211;48 h</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dose- and time-dependent reduction in extracellular A&#946;40/42</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibition of A&#946; generation via PS1 and GSK-3&#946; suppression; &#8593; GSK-3&#946; Ser9 phosphorylation; downregulation of APP-processing enzymes</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ishrat et al. [<xref rid="B215-nutrients-17-02884" ref-type="bibr">215</xref>]</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ICV-STZ-infused male Wistar rats</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">80 mg/kg</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3 weeks</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Oral gavage</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Improved cognition; &#8595; oxidative stress (&#8595; 4-HNE, MDA, TBARS, H<sub>2</sub>O<sub>2</sub>, PC, GSSG; &#8593; GSH, GPx, GR); &#8593; choline acetyltransferase</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antioxidant activity; restored glutathione system; reduced lipid peroxidation; enhanced cholinergic function</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nam et al. [<xref rid="B216-nutrients-17-02884" ref-type="bibr">216</xref>]</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Adult and D-galactose-induced aged male C57BL/6 mice</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">300 mg/kg Curcuma longa extract; 100 mg/kg D-galactose</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10 weeks D-gal; 3 weeks C. longa</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Oral gavage; subcutaneous (D-gal)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reduced escape latency; &#8593; cell proliferation (Ki67), neuroblast differentiation (DCX); &#8593; pCREB, &#8593; BDNF in hippocampus</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CREB pathway activation; enhanced neurogenesis; increased neurotrophic factors</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bassani et al. [<xref rid="B217-nutrients-17-02884" ref-type="bibr">217</xref>]</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Male Wistar rats</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">25, 50, or 100 mg/kg</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">30 days</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Oral gavage</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Improved object recognition (50/100 mg/kg) in ICV-STZ dementia; mild anti-inflammatory effect</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Memory improvement unrelated to hippocampal neurogenesis; mild anti-inflammatory action</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ma et al. [<xref rid="B108-nutrients-17-02884" ref-type="bibr">108</xref>]</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">hTau transgenic mice (15&#8211;16 months) and controls</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">500 ppm curcumin (Longvida SLN)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4&#8211;5 months</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Diet (ad libitum)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reduced behavioral, synaptic, and chaperone deficits; &#8595; soluble Tau dimers; &#8593; HSP90/HSC70 in synaptic fractions</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Increased HSP proteins; modulation of HSP90 client kinases; enhanced Tau clearance</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">McClure et al. [<xref rid="B218-nutrients-17-02884" ref-type="bibr">218</xref>]</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5XFAD transgenic mice</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5 mg/kg</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">18 weeks</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhalation (aerosol)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reduced A&#946; plaques in hippocampus/subiculum; improved memory; no toxicity</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#8595; A&#946; and COX-2; prevention of neuritic dystrophy and autophagic vesicle formation</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Alamro et al. [<xref rid="B219-nutrients-17-02884" ref-type="bibr">219</xref>]</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Primary cortical neurons (Wistar rat pups)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1 &#956;M A&#946;1&#8211;42 + 1 nM vitamin D<sub>3</sub> + 5 &#956;M curcumin</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#8804;72 h</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reduced lipid peroxidation; &#8593; GST, catalase, SOD; improved viability; &#8593; NGF</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reduced oxidative stress; enhanced antioxidant defense; increased NGF</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lim et al. [<xref rid="B220-nutrients-17-02884" ref-type="bibr">220</xref>]</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">APPSw Tg+ mice</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">160 or 5000 ppm curcumin</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6 months</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Diet</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#8595; oxidized proteins, IL-1&#946;, A&#946; plaques; &#8595; GFAP (low dose); &#8595; microglial activation</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-inflammatory (IL-1&#946;); reduced oxidative stress and plaque formation; microglial suppression</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Savall et al. [<xref rid="B221-nutrients-17-02884" ref-type="bibr">221</xref>]</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">STZ-induced AD male Wistar rats</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6 mg/kg</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14 days treatment (total 36 days)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Oral gavage; STZ i.c.v.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nanoencapsulated curcumin improved memory; both forms &#8595; AChE activity; NC reduced oxidative stress</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reduced neuroinflammation (GFAP); antioxidant effects; cognitive improvement</td></tr></tbody></table><table-wrap-foot><fn><p>4-HNE&#8212;4-hydroxynonenal, A&#946;&#8212;amyloid-beta, AChE&#8212;acetylcholinesterase, AMPK&#945;&#8212;AMP-activated protein kinase alpha, APP&#8212;amyloid precursor protein, APPswe&#8212;Swedish mutant of APP, BDNF&#8212;brain-derived neurotrophic factor, BBB&#8212;blood&#8211;brain barrier, COX-2&#8212;cyclooxygenase-2, CREB&#8212;cAMP response element-binding protein, DCX&#8212;doublecortin, DRP1&#8212;dynamin-related protein 1, FIS1&#8212;mitochondrial fission 1 protein, GFAP&#8212;glial fibrillary acidic protein, GSH&#8212;glutathione, GSSG&#8212;glutathione disulfide; GPx&#8212;glutathione peroxidase, GR&#8212;glutathione reductase, GSK-3&#946;&#8212;glycogen synthase kinase-3 beta, HSP&#8212;heat shock protein, IL-1&#946;&#8212;interleukin-1 beta, iNOS&#8212;inducible nitric oxide synthase, JNK&#8212;c-Jun N-terminal kinase, LPS&#8212;lipopolysaccharide, MDA&#8212;malondialdehyde, MFN1/2&#8212;mitofusin 1/2, mTOR&#8212;mechanistic target of rapamycin, NC&#8212;nanoencapsulated curcumin, Nrf2&#8212;nuclear factor erythroid 2-related factor 2, NGF&#8212;nerve growth factor, NF-&#954;B&#8212;nuclear factor kappa-light-chain-enhancer of activated B cells, OPA1&#8212;optic atrophy 1, PC&#8212;protein carbonyl, PGC1&#945;&#8212;peroxisome proliferator-activated receptor gamma coactivator 1-alpha, PS1&#8212;presenilin-1, pCREB&#8212;phosphorylated CREB, ROS&#8212;reactive oxygen species, SLN&#8212;solid lipid nanoparticles, STZ&#8212;streptozotocin, TC&#8212;Tetrahydrocurcumin, TBARS&#8212;thiobarbituric acid reactive substances, Tg&#8212;transgenic, TFAM&#8212;mitochondrial transcription factor A, WT&#8212;wild type. Arrows indicate the direction of change: &#8593; increase, &#8595; decrease.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="nutrients-17-02884-t002" orientation="portrait"><object-id pub-id-type="pii">nutrients-17-02884-t002_Table 2</object-id><label>Table 2</label><caption><p>Preclinical studies on curcumin in experimental Parkinson&#8217;s disease models.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Reference</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Model</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Dose</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Duration</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Route</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Key Effects</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Proposed Mechanisms</th></tr></thead><tbody><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Abbaoui et al. [<xref rid="B222-nutrients-17-02884" ref-type="bibr">222</xref>]</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Wistar rats (copper-induced Parkinson&#8217;s disease)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cu: 10 mg/kg i.p.; Curcumin: 30 mg/kg oral</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3 days</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">i.p., oral</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Restored tyrosine hydroxylase (TH) expression and locomotor function</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antioxidant and anti-inflammatory activity; protection of TH+ neurons from copper-induced neurotoxicity</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rajeswari et al. [<xref rid="B223-nutrients-17-02884" ref-type="bibr">223</xref>] </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mice (MPTP model)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MPTP: 40 mg/kg; Curcumin: 80 mg/kg; ThC: 60 mg/kg</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7 days</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">i.p.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Restored dopamine (DA) and DOPAC levels; reduced MAO-B activity</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dopaminergic neuron preservation via MAO-B inhibition and dopamine metabolism protection</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pan et al. [<xref rid="B224-nutrients-17-02884" ref-type="bibr">224</xref>]</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">C57BL/6 mice (MPTP model)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">50 mg/kg</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5 days</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">i.p.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reduced dopaminergic neuron loss; improved TH levels</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibition of JNK-mediated mitochondrial apoptosis</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Jiang et al. [<xref rid="B225-nutrients-17-02884" ref-type="bibr">225</xref>]</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SH-SY5Y cells (A53T &#945;-syn overexpression)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6 &#956;M</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">24&#8211;48 h</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reduced &#945;-synuclein accumulation; restored autophagic flux; improved neuronal viability</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Downregulation of mTOR/p70S6K signaling; increased LC3-II; enhanced autophagosome formation</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ramires J&#250;nior et al. [<xref rid="B227-nutrients-17-02884" ref-type="bibr">227</xref>]</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mice (rotenone model)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">25&#8211;50 mg/kg</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">30 days</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Oral</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Improved motor function; preserved mitochondrial complex I activity</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Oxidative stress reduction; mitochondrial protection; enhanced efficacy via nanoemulsion formulation</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yang et al. [<xref rid="B228-nutrients-17-02884" ref-type="bibr">228</xref>]</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rats (6-OHDA model)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5&#8211;20 mg/kg</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">37 days</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Oral</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Improved behavior, cognition, DA and NE levels</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Activation of BDNF/TrkB/PI3K pathway; neurogenesis; monoaminergic system support</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fikry et al. [<xref rid="B229-nutrients-17-02884" ref-type="bibr">229</xref>]</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rats (rotenone model)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">30 mg/kg</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">60 days</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">i.p.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Preserved cerebellar structure and motor function; reduced oxidative stress</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antioxidant defense restoration (&#8593;GSH, &#8593;SOD, &#8595;MDA); reduced gliosis; improved acetylcholinesterase (AChE) activity</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Wang et al. [<xref rid="B226-nutrients-17-02884" ref-type="bibr">226</xref>]</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SH-SY5Y cells (&#945;-syn oligomers)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4 &#956;M</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">48&#8211;72 h</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reduced ROS and apoptosis; stabilized &#945;-syn aggregates</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Caspase-3 inhibition; ROS suppression; attenuation of &#945;-syn toxicity</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Jagatha et al. [<xref rid="B230-nutrients-17-02884" ref-type="bibr">230</xref>]</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N27 cells (in vitro) and GSH-deficient mice (BSO-induced)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10 &#956;M (in vitro); 50 mg/kg i.p. (in vivo)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1&#8211;3 days</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro, i.p.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Restored GSH; protected mitochondrial complex I; reduced protein oxidation</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#947;-GCL activation; mitochondrial stabilization; redox balance normalization</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sharma et al. [<xref rid="B231-nutrients-17-02884" ref-type="bibr">231</xref>]</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rats (LPS-induced PD)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">40 mg/kg</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">21 days</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">i.p.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reduced astrocytosis, cytokines, iron deposition, and &#945;-syn aggregation</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NF-&#954;B inhibition; antioxidant effects; apoptosis regulation; iron metabolism normalization</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Liu et al. [<xref rid="B233-nutrients-17-02884" ref-type="bibr">233</xref>]</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Wistar rats (6-OHDA model)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">40, 80, or 160 mg/kg/day</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14 days</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Oral (gavage)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">High dose improved motor performance; preserved TH+ neurons in substantia nigra</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dose- and time-dependent neuroprotection; dopaminergic preservation; reduced oxidative stress and inflammation</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Geng et al. [<xref rid="B234-nutrients-17-02884" ref-type="bibr">234</xref>]</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Male C57BL/6J mice (MPTP model)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MPTP: 30 mg/kg/day i.p.; Curcumin or Curoil: 120 mg/kg/day oral</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7 days</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">i.p., oral</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Curoil improved motor function; protected TH+ neurons in substantia nigra</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Enhanced curcumin bioavailability; antioxidant and neuroprotective effects; TH+ neuron preservation</td></tr></tbody></table><table-wrap-foot><fn><p>6-OHDA&#8212;6-hydroxydopamine, AChE&#8212;acetylcholinesterase, &#945;-syn&#8212;alpha-synuclein, BDNF&#8212;brain-derived neurotrophic factor, BDNF/TrkB/PI3K: brain-derived neurotrophic factor/tropomyosin receptor kinase B/phosphoinositide 3-kinase; BSO&#8212;buthionine sulfoximine, Curcumin&#8212;diferuloylmethane, DA&#8212;dopamine, DOPAC&#8212;3,4-dihydroxyphenylacetic acid, GSH&#8212;glutathione, &#947;-GCL&#8212;gamma-glutamylcysteine ligase, i.p.&#8212;intraperitoneal, JNK&#8212;c-Jun <italic toggle="yes">N</italic>-terminal kinase, LC3-II&#8212;microtubule-associated proteins 1A/1B light chain 3B (lipidated form), LPS&#8212;lipopolysaccharide, MPTP&#8212;1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, MAO-B&#8212;monoamine oxidase B, mTOR&#8212;mechanistic target of rapamycin, NE&#8212;norepinephrine, NF-&#954;B&#8212;nuclear factor kappa-light-chain-enhancer of activated B cells, ROS&#8212;reactive oxygen species, TH&#8212;tyrosine hydroxylase. Arrows indicate the direction of change: &#8593; increase, &#8595; decrease.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="nutrients-17-02884-t003" orientation="portrait"><object-id pub-id-type="pii">nutrients-17-02884-t003_Table 3</object-id><label>Table 3</label><caption><p>Preclinical studies on curcumin in experimental stroke models.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Ref.</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Model</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Dose</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Duration</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Route</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Key Effects</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Mechanisms</th></tr></thead><tbody><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Li et al. [<xref rid="B235-nutrients-17-02884" ref-type="bibr">235</xref>]</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MCAO in mice; neuronal cultures</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100 mg/kg i.p. (in vivo); 4 &#956;M (in vitro)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3 days (in vivo); 24 h (in vitro)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">i.p., i.v.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Improved neurological function; reduced brain edema and infarct volume</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Activation of AKT/GSK-3&#946;/Nrf2 pathway; M2 microglia polarization; reduced oxidative stress</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Jia et al. [<xref rid="B236-nutrients-17-02884" ref-type="bibr">236</xref>]</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Transient MCAO in rats + MTM</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">300 mg/kg i.p. + 250 &#956;g/kg MTM i.c.v.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">24 h</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">i.p., i.c.v.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reduced infarct size and oxidative stress; improved neurological outcomes</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SP1-mediated upregulation of Prdx6; antioxidant protection</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Altinay et al. [<xref rid="B237-nutrients-17-02884" ref-type="bibr">237</xref>]</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Global ischemia (BCCAO)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">300 mg/kg oral or i.p.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">21 days (oral); 72 h (i.p.)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Oral, i.p.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Increased antioxidant enzymes; reduced inflammation; improved outcome</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Increased SOD, CAT, GPx; reduced IL-6, TNF-&#945;, apoptosis</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Marques et al. [<xref rid="B238-nutrients-17-02884" ref-type="bibr">238</xref>]</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ICH in rats</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">30 mg/kg</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3 doses/48 h</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">i.p.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Improved motor recovery; reduced hematoma volume</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Enhanced antioxidant activity; improved bioavailability</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ran et al. [<xref rid="B239-nutrients-17-02884" ref-type="bibr">239</xref>]</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MCAO in mice</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">150 mg/kg</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7 days</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">i.p.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reduced white matter damage; improved sensorimotor function</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibition of NF-&#954;B/NLRP3; reduced pyroptosis</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Xie et al. [<xref rid="B240-nutrients-17-02884" ref-type="bibr">240</xref>]</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MCAO in mice; OGD/R in cells</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100&#8211;400 mg/kg (in vivo); 5&#8211;35 &#956;M (in vitro)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Single dose</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">i.p., in vitro</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reduced apoptosis; improved mitochondrial function</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Downregulation of Bax, upregulation of Bcl-2; preserved mitochondrial membrane potential</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Li et al. [<xref rid="B241-nutrients-17-02884" ref-type="bibr">241</xref>]</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MCAO/reperfusion in rats</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">300 mg/kg</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Single dose, pre-reperfusion</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">i.p.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reduced infarct size, brain edema, and inflammation</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibition of NF-&#954;B, MMP-9, and caspase-3; BBB protection</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Liu et al. [<xref rid="B242-nutrients-17-02884" ref-type="bibr">242</xref>]</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MCAO in rats</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">300 mg/kg</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7 days</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">i.p.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Increased neurogenesis; reduced neurological deficits</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Activation of Notch signaling</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Wu et al. [<xref rid="B243-nutrients-17-02884" ref-type="bibr">243</xref>]</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MCAO/reperfusion in rats</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">300 mg/kg</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Single dose, pre-MCAO</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">i.p.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reduced BBB leakage; increased tight junction protein expression</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Upregulation of ZO-1 and occludin; inhibition of NF-&#954;B, MMP-9</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Liu et al. [<xref rid="B244-nutrients-17-02884" ref-type="bibr">244</xref>]</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Distal MCAO in mice</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">150 mg/kg</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10 days</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">i.p.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reduced infarct size; improved sensorimotor recovery; M2 microglia shift</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-inflammatory activity; enhanced M2 polarization</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Wu et al. [<xref rid="B245-nutrients-17-02884" ref-type="bibr">245</xref>]</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Primary cortical neurons (OGD/R); MCAO in rats</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.5&#8211;25 &#956;M (in vitro); dose not specified (in vivo)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1 h OGD + 24 h reoxygenation (in vitro); 60 min MCAO (in vivo)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro; likely i.p. (in vivo)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reduced neuronal injury and oxidative stress; improved cell viability; reduced infarct volume</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Activation of Akt/Nrf2 pathway; NQO1 upregulation; effect blocked by PI3K inhibitor LY294002</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Jiang et al. [<xref rid="B246-nutrients-17-02884" ref-type="bibr">246</xref>]</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MCAO in rats; astrocytes; brain capillary endothelial cells (BCECs)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.5&#8211;2.0 mg/kg</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Single i.v. injection, 30 min post-reperfusion (effects at 48 h)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">i.v.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reduced infarct size, BBB permeability, brain edema, and mortality; protected BCECs</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BBB preservation via ONOO<sup>&#8722;</sup> inhibition; suppression of iNOS/NO pathway</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Zhang et al. [<xref rid="B247-nutrients-17-02884" ref-type="bibr">247</xref>]</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MCAO in rats</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">25 mg/kg</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Single dose</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">i.p.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reduced brain edema and infarct size; decreased TNF-&#945;, IL-6, p53, Bax; increased Bcl-2 and Sirt1; improved mitochondrial function</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-inflammatory and anti-apoptotic activity; mitochondrial protection</td></tr></tbody></table><table-wrap-foot><fn><p>AKT&#8212;protein kinase B, Bax&#8212;Bcl-2-associated X protein, Bcl-2&#8212;B-cell lymphoma 2, BBB&#8212;blood&#8211;brain barrier, BCCAO&#8212;bilateral common carotid artery occlusion, BCECs&#8212;brain capillary endothelial cells, CAT&#8212;catalase, GPx&#8212;glutathione peroxidase, ICH&#8212;intracerebral hemorrhage, IL-6&#8212;interleukin-6, i.c.v.&#8212;intracerebroventricular, iNOS&#8212;inducible nitric oxide synthase, i.p.&#8212;intraperitoneal, i.v.&#8212;intravenous, MCAO&#8212;middle cerebral artery occlusion, MMP-9&#8212;matrix metalloproteinase-9, MTM&#8212;metformin, NF-&#954;B&#8212;nuclear factor kappa-light-chain-enhancer of activated B cells, NLRP3&#8212;NOD-like receptor pyrin domain-containing protein 3, NQO1&#8212;NAD(P)H quinone oxidoreductase 1, Nrf2&#8212;nuclear factor erythroid 2&#8211;related factor 2, OGD/R&#8212;oxygen&#8211;glucose deprivation/reoxygenation, ONOO<sup>&#8722;</sup>&#8212;peroxynitrite, p53&#8212;tumor suppressor protein p53, PI3K&#8212;phosphoinositide 3-kinase, Prdx6&#8212;peroxiredoxin 6, Sirt1&#8212;sirtuin 1, SOD&#8212;superoxide dismutase, SP1&#8212;specificity protein 1, TNF-&#945;&#8212;tumor necrosis factor alpha, ZO-1&#8212;zonula occludens-1.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="nutrients-17-02884-t004" orientation="portrait"><object-id pub-id-type="pii">nutrients-17-02884-t004_Table 4</object-id><label>Table 4</label><caption><p>Summary of human clinical trials investigating the effects of curcumin in Alzheimer&#8217;s disease, Parkinson&#8217;s disease, and stroke.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Ref.</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Population</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Dose</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Duration</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Route</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Key Effects</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Mechanisms</th></tr></thead><tbody><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Small et al. [<xref rid="B255-nutrients-17-02884" ref-type="bibr">255</xref>]</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">40 non-demented adults (51&#8211;84 y)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">180 mg/day Theracurmin<sup>&#174;</sup> (90 mg BID)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">18 months</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Oral</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Improved verbal and visual memory; enhanced attention; reduced amyloid and tau deposition (PET)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-inflammatory; anti-amyloidogenic; Akt/Nrf2 activation</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cox et al. [<xref rid="B256-nutrients-17-02884" ref-type="bibr">256</xref>]</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">60 healthy adults (60&#8211;85 y)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">400 mg/day Longvida<sup>&#174;</sup></td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4 weeks</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Oral</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Acute: improved attention and working memory (1 h); Chronic: improved mood, reduced fatigue and LDL</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antioxidant; anti-inflammatory; modulation of lipid metabolism</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Baum et al. [<xref rid="B257-nutrients-17-02884" ref-type="bibr">257</xref>]</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">34 probable/possible AD patients</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1 g or 4 g/day</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6 months</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Oral</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No cognitive improvement (MMSE); safe; curcuminoids detected in plasma</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Possible A&#946; disaggregation; antioxidant; low bioavailability; improved capsule absorption</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ringman et al. [<xref rid="B258-nutrients-17-02884" ref-type="bibr">258</xref>]</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">36 mild-to-moderate AD patients</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2 g or 4 g/day Curcumin C3 Complex<sup>&#174;</sup></td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">24 weeks double-blind + 24 weeks open-label</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Oral</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No cognitive benefit (ADAS-Cog); well tolerated</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-inflammatory; antioxidant; inhibition of amyloid-&#946; aggregation</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rainey-Smith et al. [<xref rid="B259-nutrients-17-02884" ref-type="bibr">259</xref>]</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">96 older adults (40&#8211;90 y)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1500 mg/day Biocurcumax&#8482; (BCM-95<sup>&#174;</sup>)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12 months</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Oral</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Prevention of cognitive decline (MoCA) at 6 months; no other changes</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antioxidant; anti-inflammatory</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ghodsi et al. [<xref rid="B260-nutrients-17-02884" ref-type="bibr">260</xref>]</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">60 idiopathic PD patients (&#8805;30 y)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">80 mg/day nanomicellar curcumin</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9 months</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Oral</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No motor or QoL improvement; mild GI adverse effects</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-inflammatory; anti-apoptotic</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Maghbooli et al. [<xref rid="B261-nutrients-17-02884" ref-type="bibr">261</xref>]</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">50 idiopathic PD patients (&#8805;35 y)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">160 mg/day nanomicellar curcumin (80 mg BID)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3 months</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Oral</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Improved sleep quality and QoL (PDQ-39); no effect on fatigue</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Neuroprotective; antioxidant; anti-inflammatory</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Donadio et al. [<xref rid="B262-nutrients-17-02884" ref-type="bibr">262</xref>]</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">19 PD patients + 14 PD controls</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2 g/day curcumin&#8211;phospholipid (Meriva<sup>&#174;</sup>)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12 months</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Oral</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reduced autonomic and non-motor symptoms; slowed progression; reduced phosphorylated &#945;-synuclein deposition</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BBB penetration; anti-amyloidogenic; antioxidant; anti-inflammatory</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Boshagh et al. [<xref rid="B263-nutrients-17-02884" ref-type="bibr">263</xref>]</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56 ischemic stroke patients in rehabilitation</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">500 mg curcumin + 5 mg piperine/day</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12 weeks</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Oral</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reduced hs-CRP, cholesterol, TG, CIMT, BP, weight, waist circumference; increased TAC</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-inflammatory; antioxidant; vascular plaque reduction; BP lowering; lipid profile improvement</td></tr></tbody></table><table-wrap-foot><fn><p>A&#946;&#8212;amyloid-&#946;, ADAS-Cog&#8212;Alzheimer&#8217;s Disease Assessment Scale&#8211;Cognitive Subscale, AD&#8212;Alzheimer&#8217;s disease, Akt&#8212;protein kinase B, &#945;-synuclein&#8212;alpha-synuclein, BBB&#8212;blood&#8211;brain barrier, BID&#8212;twice daily, BP&#8212;blood pressure, BCM-95<sup>&#174;</sup>&#8212;Biocurcumax&#8482; curcumin formulation, CIMT&#8212;carotid intima&#8211;media thickness, GI&#8212;gastrointestinal, hs-CRP&#8212;high-sensitivity C-reactive protein, LDL&#8212;low-density lipoprotein, Longvida<sup>&#174;</sup>&#8212;lipidated curcumin formulation, Meriva<sup>&#174;</sup>&#8212;curcumin&#8211;phospholipid complex, MMSE&#8212;Mini-Mental State Examination, MoCA&#8212;Montreal Cognitive Assessment, Nrf2&#8212;nuclear factor erythroid 2&#8211;related factor 2, PD&#8212;Parkinson&#8217;s disease, PDQ-39&#8212;Parkinson&#8217;s Disease Questionnaire-39, PET&#8212;positron emission tomography, QoL&#8212;quality of life, TAC&#8212;total antioxidant capacity, TG&#8212;triglycerides, Theracurmin<sup>&#174;</sup>&#8212;highly bioavailable curcumin formulation, y&#8212;years.</p></fn></table-wrap-foot></table-wrap></floats-group></article></pmc-articleset>